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ABSTRACT  
 
Over recent decades medical and surgical advances have significantly lowered the 
mortality rate for children born with congenital heart defects. Congenital heart disease 
(CHD) survivors are at high-risk of growth retardation and developmental morbidity that 
negatively affect their health-related quality of life (HRQOL). In addition, caring for a 
child with a chronic health condition such as CHD places a considerable financial and 
emotional burden on parents, putting them at risk of ongoing stress and psychological 
morbidity including anxiety and depression. The outcomes of children living with CHD 
and their families in South Africa (SA) are unknown. Outcomes for children with CHD 
in SA are likely to be further complicated by social disadvantage and Human 
Immunodeficiency Virus (HIV) co-infection. 
 
The aim of this observational descriptive study (Phase I and II) was to determine the 
pre-cardiac intervention, and three-month and six-month post-cardiac intervention 
development, growth, HRQOL and parenting stress outcomes of young children with 
CHD in central SA. Outcomes were compared over time, and variables associated with 
development, HRQOL and parenting stress outcomes determined. In addition, the 
developmental needs of young children living with CHD in central SA were to be 
identified. 
 
In order to meet the Phase I and II objectives, forty-eight consecutive children, 30 
months and younger, and their parents were recruited into this study at the Universitas 
Academic Hospital in Bloemfontein. Children who had previous or emergency cardiac 
surgery were excluded. Development was assessed using the Bayley Scales of Infant 
and Toddler Development, Third Edition (BSID-III), HRQOL using the Paediatric 
Quality of Life Inventory (PedsQLTM) and levels of parenting stress using the Parenting 
Stress Index Short-Form (PSI-SF). Growth outcomes were determined by z-scores 
calculated for growth parameters. Medical severity of the cardiac disease was rated by 
a paediatric cardiologist using the Cardiologists Perception of Medical Severity Scale. 
 
Baseline data was collected for 40 children. The majority of children (n=26) underwent 
open-heart surgery in infancy with cardiopulmonary bypass. Most children (n=30) had 
moderate disease severity, with twenty percent (n=8) having cyanotic heart defects. A 
quarter of the children (n=10) had Down syndrome (DS). Surgical outcomes were 
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comparable to those reported in developed countries, with a mortality rate of 15%. 
There was a high attrition rate during Phase II of this study, with 47.5% of children and 
their families missing one or more follow-up visit. Mothers fulfilled the role of primary 
caregiver, and carried most of the burden of care. The majority of families were from a 
low socioeconomic backgrounds (87.5%) and mothers had low levels of education, 
with only 40% having graduated high school.  
 
The majority (68%) of children had suboptimal growth prior to cardiac intervention. 
There was significant growth catch-up for both weight (p=0.04) and head 
circumference (p= 0.02) by the six-month post-cardiac intervention. Complete catch-
up growth had not yet taken place by the six-month post-cardiac intervention, with 
40.9% of the children still presenting with malnutrition. The growth trends of children 
with CHD with DS were found to be similar to those of children with CHD without DS. 
Growth in children with cyanotic heart defects tended to be poorer both before and 
after cardiac intervention.  
 
There was a high prevalence of moderate developmental delay across all development 
domains. Motor delays (27.5%) were most prevalent prior to cardiac intervention. 
Motor performance improved with age and post cardiac intervention, but language and 
cognitive performance declined with age and increasing skill complexity. There was 
not a significant change in the developmental outcome of the children over the time-
span of this study. The developmental outcome for children with cyanotic heart defects 
tended to be similar to those with acyanotic heart defects. The presence of DS was 
significantly (p<0.001) associated with developmental outcome across all 
developmental domains at all time-points of assessment. Children with CHD with DS 
tended to have considerably poorer developmental outcomes compared to children 
with CHD without DS. Disease severity (p=0.02) and maternal age (p=0.01) were 
significantly associated with cognitive development. Age at first cardiac surgery was 
found to be significantly associated with language development both before cardiac 
intervention (p<0.01) and at three-month post-cardiac intervention (p=0.04). 
Suboptimal growth prior to cardiac intervention (p=0.04) and maternal age (p<0.001) 
were significantly associated with motor development. Developmental performance 
was well below the test mean on all subscales of the BSID-III at all the time points of 
assessment. Although the patterns of development and the prevalence of 
developmental delays in the current study were similar to those reported in developed 
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countries, children living with CHD in central SA performed below the expected 
developmental levels for children with CHD when assessed on the BSID-III. Hypotonia 
was the most significant abnormal neurological finding, with 45% of the children 
presenting with hypotonia prior to cardiac intervention. The hypotonia tended to resolve 
in the children without DS by the six-month post-cardiac intervention. 
 
Overall parents’ perceived their children’s HRQOL as being relatively good, and similar 
to that of their healthy same-aged peers and other children with CHD in developed 
countries. Parents’ perception of their children’s HRQOL improved significantly after 
cardiac intervention (p= 0.04). Perceived HRQOL tended to be similar for children with 
cyanotic and acyanotic heart defects. Parents of children with CHD with DS tended to 
perceive their children’s HRQOL as poorer when compared with parents of children 
with CHD without DS. Motor development (p=0.01) and levels of parenting stress 
(p=0.02) were significantly associated with parents’ perceptions of their children’s 
HRQOL prior to cardiac intervention.  
 
The majority of parents’ (60%) experienced clinically significant levels of stress prior to 
their children undergoing cardiac intervention. Parenting stress decreased significantly 
from pre-cardiac intervention levels at both three-month (p<0.001) and six-month 
(p<0.001) post-cardiac intervention as the child’s cardiac symptoms resolved or 
decreased, and their health status improved. Parents of children with cyanotic and 
acyanotic heart defects tended to experience similar levels of stress. Parents of 
children with CHD with DS tended to experience higher levels of ongoing stress when 
compared with parents of children with CHD without DS. Parenting stress prior to 
cardiac intervention was significantly associated with parents’ perception of their child’s 
HRQOL (p=0.02) and language development (p=0.04).  Parenting stress at three-
month post-cardiac intervention was significantly associated with age at first cardiac 
surgery (p=0.03), language development (p=0.03) and level of maternal education 
(p=0.04). HRQOL and parenting stress outcomes were closely linked before cardiac 
intervention. Parents perceiving their child as having a poor ability to function in 
everyday situations experienced increased stress levels.  
 
Based on developmental performance on the BSID-III 59% of the children in the 
current study would qualify for referral to early intervention (EI) services including 
physiotherapy, occupational therapy and speech therapy, with many children requiring 
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access to more than one service. A home-based parent-driven developmental activity 
programme would likely be best suited to meet the developmental needs of children 
with CHD living in central SA taking into account the geography of the area and service 
delivery challenges in the public healthcare sector.  
 
Phase III of the study resulted in the development of a home-based developmental 
activity programme to meet the identified developmental needs of children with CHD 
in central SA. Qualitative methods, including an expert panel of rehabilitation 
professionals and a focus group of parents, were used to gain consensus on the 
content of the developmental activity programme. 
 
In conclusion, it is encouraging that the longer-term outcomes of children with CHD in 
central SA were not vastly different from those of children in developed countries. The 
greater extent of the growth retardation and developmental delay of the children in the 
current study is however of concern. The findings in this study strongly support the 
implementation of a cardiac neurodevelopmental programme as part standard cardiac 
care in SA. Early developmental intervention and psychosocial support services are 
indicated to optimise the outcome for both children living with CHD and their families. 
A home-based parent-driven developmental stimulation programme provides an 
innovative approach to meeting the developmental needs of young children living with 
CHD.  
 
Keywords  
Congenital heart disease, neurodevelopment, growth, parenting stress, health-related 
quality of life, home-based developmental activity programme, Bayley Scales of Infant 
and Toddler Development, Third Edition, Paediatric Quality of Life Inventory, Parenting 
Stress Index-Short Form. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
1.1 Congenital heart disease: A global perspective  
 
Congenital heart defects are the most common structural birth abnormality affecting children 
(AHA, 2015), as well as being the most commonly diagnosed chronic health condition in 
infancy (CDC, 2015). Congenital heart defects result from the complex interactions of 
multiple environmental and genetic factors, and, in many cases, the exact cause remains 
undetermined (Bernier et al., 2010). 
 
The current incidence of congenital heart disease (CHD) is similar across the world, and is 
estimated to range between eight and twelve per 1000 live births (Hoffman, 2013). This 
equates to approximately one percent of all children being born with a heart defect (Yildiz et 
al., 2009). Geographical location, genetics, ethnicity and environmental factors have not 
been found to have a significant impact on incidence (AHA, 2015; PCHA, 2014; Zühlke et 
al., 2013). The incidence of CHD appears to be on the rise globally (CDC, 2015; Bernier et 
al., 2010). Three per 1000 children born with CHD will require catheter-based or surgical 
intervention early on in life (Marino et al., 2012; The Lancet, 2012; Gruber and Epstein, 
2004; Hoffman and Kaplan, 2002). 
 
Diagnostic, medical and surgical advances over the past few decades have resulted in 
survival becoming the expected outcome for most children born with CHD (Rappaport 2015; 
PCHA, 2014). Most children with complex CHD awaiting heart transplantation require 
mechanical ventilation and/or mechanical circulatory support as a bridge to myocardial 
recovery and transplantation. Mechanical circulatory support technologies including 
extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs), is a 
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rapidly growing field, and the use of these technologies is becoming more popular for 
children with end stage heart disease due to the limited donor pool of organs (Wilmot et al., 
2013; Gazit el al., 2010). A growing number of children are being supported as more centres 
in developed countries adopt these mechanical circulatory support technologies 
(Deshpande et al. 2016).  Today, approximately 85% of children born with CHD survive and 
are expected to live into adulthood (Eagleson et al., 2013; The Lancet, 2012; Hoosen et al., 
2010b). Improved survival has seen CHD become one of the fastest growing chronic health 
conditions in childhood (Lee et al., 2007; Mussatto, 2006). As a result, the focus has shifted 
beyond survival toward looking at longer-term outcomes and morbidities including growth, 
development, health-related quality of life (HRQOL), as well as the psychosocial functioning 
of both the child and family (Eagleson et al., 2013; Marino, 2013; Marino et al. 2012; Marino 
et al., 2010; Baker, 2008).  
 
Children surviving CHD often require ongoing medical care over their lifetime (Nolte and 
McKee, 2008). Many children face an uncertain future requiring long-term follow-up, multiple 
cardiac interventions, the chronic use of medication and the possibility of permanent 
disability (Mussatto, 2006). Increased focus on long-term outcomes is continuing to provide 
convincing evidence that CHD survivors are at considerably higher risk for developmental 
delay and developmental disorders and disabilities (DD) than the general population (Marino 
et al., 2012). Physical and psychosocial dysfunction may in turn negatively affect the child’s 
HRQOL (Marino et al., 2016). 
 
In the light of the developmental findings in the CHD population, the paediatric cardiac 
community has been actively searching for ways in which to improve neurodevelopmental 
outcomes. One of the ways is through advocacy for neurodevelopmental screening and 
evaluation as part of standard cardiac care. The American Heart Association (AHA) and the 
American Academy of Paediatrics (AAP) released a scientific statement in 2012 strongly 
recommending the implementation of routine cardiac neurodevelopmental follow-up (Marino 
et al., 2012).  
 
Since the publication of these evaluation and management guidelines by Marino et al. (2012) 
just over four years ago several cardiac neurodevelopmental programmes (CNPs) have 
been initiated at cardiac centres, mainly across the United States (US). Only a few countries 
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outside of the US have initiated similar programmes, including Canada, Australia, Germany, 
Japan and New Zealand (Gaynor et al., 2015). Existing CNPs tend to be managed by 
interdisciplinary teams collaborating with a psychologist or developmental paediatrician. 
Some CNPs do include the services of allied health professionals including physiotherapists, 
occupational therapists, speech therapists and dieticians (Mahle, 2015; Brosig et al., 2014). 
Today, dedicated CNPs are considered the benchmark of a quality cardiac service (Mahle, 
2015; Brosig et al., 2014). CNPs are a relatively new component of cardiac care, resulting 
in limited scientific evidence being available on the best mode of programme delivery, or the 
success and clinical value of these programmes in addressing the developmental needs of 
children with CHD (Brosig et al., 2014). 
 
Long et al. (2015), Steiber et al. (2012) and Brosig Soto et al. (2011) have noted several 
challenges in implementing both hospital-based and home-based developmental 
intervention programmes in this population. Challenges included distance to travel to cardiac 
centres, lack of motivation on the part of families to attend therapy sessions, and a lack of 
adherence to prescribed home programmes. Valid questions have been raised about the 
feasibility and best model for providing early developmental intervention in the CHD 
population, indicating the need for further investigation. 
 
Many parents find raising a child with CHD challenging (Brosig et al., 2007; Mussatto, 2006). 
The increased burden of caring for a child with a chronic health condition places parents at 
risk of experiencing ongoing stress and psychosocial morbidity, which may later manifest as 
anxiety or depression (Bruce et al., 2014; Solberg et al., 2011; Vrijmoet-Wiersma et al., 
2009). Furthermore, many families experience considerable financial strain because of the 
burden of care preventing gainful employment and the high cost of ongoing treatment. The 
financial strain further contributes to parenting stress (Grønning Dale et al., 2013; Harvey et 
al., 2013; Fonseca et al., 2012; Soulvie et al., 2012; Connor et al., 2010; Lawoko and 
Soares, 2006; Mussatto, 2006). This has resulted in the psychosocial functioning of the 
family becoming an important outcome measure of successful treatment. Routine and 
regular screening of families for psychosocial risk is advocated for as part of standard 
cardiac care so as to identify families in need of additional support (Hearps et al., 2014; 
Mussatto, 2006). 
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In sum, limited information is currently available on the longer-term outcomes, especially for 
young children living with CHD, even in the developed world. For this reason the cardiac 
community at large has identified growth, development and HRQOL outcomes of the child, 
as well as the psychosocial outcomes of both the child and family as key focus areas for 
research endeavours going forward.  
 
1.2 Congenital heart disease: An African perspective 
 
Despite the incidence of CHD being described in the literature as being similar across the 
world, South Africa (SA) has one of the highest incidences of CHD in the world due to the 
high fertility rate and greater number of children born per female member of the population 
(Lee, 2014; Hoffman, 2013; Zühlke et al., 2013; Hoosen et al., 2010a). The SA population 
continues to grow and the paediatric population is large, with nearly 30% of the country’s 
population under the age of 14 years (Zühlke et al., 2013; Statistics South Africa, 2012; 
Hoosen et al., 2011). Studies are also showing the incidence of CHD, especially milder 
forms, to be on the rise in SA (CDC, 2015; Reuters South Africa, 2015). Figure 1.1 provides 
a graphic representation of the total number of children born with CHD per continent 
(Hoffman, 2013). 
 
 
Figure 1.1 Total annual births of children with CHD per continent (Hoffman, 2013, p 
142). 
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Across Africa there is a considerable burden of communicable diseases such as 
tuberculosis (TB), human immunodeficiency virus (HIV) and diarrhoeal disease, as well as 
childhood malnutrition (Bradshaw et al., 2003). Healthcare services and funding have been 
prioritised to meet this considerable burden (Hoosen et al., 2010b; Bradshaw et al., 2003). 
CHD only ranks eighth on the list of leading causes of under-five mortality in SA, perhaps 
putting into perspective the lack of prioritisation of non-communicable diseases such as 
CHD on the African continent (Hoosen et al., 2010b; Bradshaw et al., 2003). African 
countries are now being faced with a growing double burden of disease, with non-
communicable diseases such as cardiac disease becoming a growing cause of morbidity 
(Kengne and Mayosi, 2013; Mbewu, 2009).   
 
CHD continues to have a poor prognosis in SA, and remains a considerable cause of 
mortality in infants and young children (Zühlke et al., 2013; Hoosen et al., 2011; Bernier et 
al., 2010). Despite a large portion of the gross domestic product (GDP) being allocated to 
healthcare in SA, compared to other middle-income countries, health outcomes remain 
poor, and there is a considerable disparity between health services provided in the private 
sector compared to the public sector (Edmeston and Francis, 2014; Hoosen et al., 2010b). 
Despite huge strides being made in the diagnosis and treatment of CHD in the developed 
world, similar successes have not been replicated in Africa (Zühlke et al., 2013). 
 
Based on current population statistics it can estimated that nearly 12 100 children are born 
with CHD in SA each year (Statistics South Africa, 2014). Of these children, 85% are 
dependent on the public health sector for their cardiac care (Edmeston and Francis, 2014; 
Hoosen et al., 2010a). Caring for children with CHD is complex and very resource-intensive 
(CDC, 2015), and access to care is not equal for all children with CHD, especially for those 
living in developing countries (Bernier et al., 2010). Cardiac services are limited in Africa 
and are less accessible to patients than is the case in developed countries (Lee, 2014; 
Kinsley, 2012; Kinsley et al., 2011). Figure 1.2 highlights the lack of well-established 
independent cardiac programmes in Africa, with the only well-established programmes 
running in SA, Sudan and Egypt (Zühlke et al., 2013). 
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Figure 1.2 African countries with cardiac programmes (Zühlke et al., 2013, p 6) 
 
 With the large number of children born annually with CHD, requiring specialist care, there 
is a significant demand for cardiac services, especially in the public health sector in SA, 
which cannot be met despite the country having relatively well-established cardiac services. 
In addition, children from surrounding countries are also referred to SA for treatment, further 
increasing the demand for services (Lee, 2014; Hoosen et al., 2010a). There are only five 
centres that offer comprehensive cardiac care to children and their families in the public 
health sector in SA, and these centres are spread over a wide geographical location 
(Hoosen et al., 2010a; Robertson, 2006). High patient numbers, a shortage of skilled human 
resources (including cardiologists and cardiothoracic surgeons), inadequate infrastructure 
and a shortage of intensive care unit (ICU) beds result in the overburdening of cardiac 
services in the public health sector. The direct result being that cardiac centres are unable 
to provide adequate services to the paediatric cardiac population of SA (Van Deventer et 
al., 2015; Lee, 2014; Zühlke, 2013; Hoosen et al., 2011; Hoosen et al., 2010a; Hoosen 
2010b; Robertson, 2006). Currently it is suggested that about 60% of children requiring 
cardiac services in SA are not being diagnosed or treated (Reuters South Africa, 2015).  
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Of the children diagnosed with CHD in SA, approximately 50% will require invasive 
diagnostic procedures and 40% will require open-heart surgery (Hoosen et al.,  2010a; 
Hoosen et al., 2010b). Based on available data, only around 800 cardiac surgeries are 
performed on children in the public health sector and 570 in the private health sector in SA 
each year. This represents just over a third of the estimated 4 000 children requiring cardiac 
surgery each year in the country (Hoosen et al., 2010a; Hoosen et al., 2010b).  
 
Children with CHD in Africa have a dramatically different prognosis and outcome when 
compared with children living in the developed world (Binagwaho et al., 2013; Zühlke et al., 
2013). Mortality due to CHD remains higher in developing countries compared to developed 
countries (Lee, 2014). It is also estimated that only between 70 and 80% of children born 
with CHD in SA, who receive optimal cardiac services, will survive into adulthood (Gersh, 
2011). Children with complex CHD and those awaiting heart transplantation in SA may have 
access to mechanical ventilatory support, but mechanical circulatory support technologies 
such as ECMO and VADs are relatively new in SA.  Few children, and only those who are 
critically ill, and can no longer wait for a donor, have access to these technologies as a 
bridge to transplantation due to the cost (Carte Blanche, 2017; Hoosen et al., 2010a). 
Children also present with unfavourable health conditions pre-operatively including low birth 
weight, malnutrition and HIV co-infection, which further complicate treatment and outcome 
(Lee, 2014; Kinsley et al., 2011; Hoosen et al., 2010b). 
 
The consequences and cost of untreated CHD to the country is considerable. For some 
children not managed early enough, their defects become inoperable resulting in poor health 
outcomes (Kinsley et al., 2011). Recurrent hospitalisation to manage the resulting 
complications, which may include stroke, pulmonary arterial hypertension (PHTN) and 
congestive cardiac failure (CCF), increase the emotional and financial burden on families 
(Lee, 2014; Hoosen et al., 2011; Hoosen et al., 2010a). 
 
Continuity of care also remains a problem in Africa. There is a high loss to follow-up post-
cardiac surgery and many patients fail to receive the ongoing care they require. The loss to 
follow-up for cardiac care on the continent is estimated to be between 30 and 40% (Lee, 
2014; Mocumbi et al., 2011; Tantchou Tchoumi et al., 2011). 
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In sum, despite the global focus on longer-term outcomes, little is known about the outcomes 
of children living with CHD and their families in Africa and more specifically SA. Growth, 
development and HRQOL outcomes of young children with CHD in SA have not been 
determined. Parenting stress and the burden of caring for a child with CHD in SA is also 
unknown.  
 
1.3. Problem statement   
 
Low and middle-income countries bear 80% of the burden of cardiovascular disease in the 
world (Binagwaho et al., 2013). Despite the considerable burden of cardiovascular disease 
in Africa, socioeconomic circumstances and the health needs of the continent have resulted 
in little cardiovascular research being done in Africa (Edwin et al., 2011; Hoosen et al., 
2010b). Rosmarakis et al. (2005) investigated global cardiovascular research outputs and 
found that Africa’s contribution to the number of published scientific articles on 
cardiovascular disease was the lowest of all continents at only 0.3%.  
 
Clinical cardiovascular research is required to address problems of importance in the African 
context (Gersh, 2011). The burden of disease and health outcomes of children with CHD in 
SA need to be determined (Kengne and Mayosi, 2013; Zühlke et al., 2013; Kinsley et al., 
2011; Hoosen et al., 2010a; Hoosen et al., 2010b). In addition, SA needs population-based 
research to determine the services required to address the burden of cardiovascular disease 
in the country (Smit, 2015). 
 
The Republic of South Africa Department of Health (RSA-DoH) has renewed its commitment 
to improving access to care, ensuring the early identification and appropriate management 
of CHD (Lee, 2014; Bamford, 2013). However, there are considerable challenges in meeting 
this commitment. Finding innovative ways of delivering quality cardiac services to children 
within a human resource, infrastructure and financially-constrained environment should be 
a healthcare priority (Zühlke, 2013). In addition, research in Africa should focus on 
decreasing morbidity and improving the HRQOL and psychosocial outcomes of children 
living with CHD, and their families (Binagwaho et al., 2013; Zühlke, 2013). 
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The growth, developmental and HRQOL outcomes of young children living with CHD in 
Africa have not been determined. The burden of care and psychosocial outcomes of parents 
caring for these children is also unknown. Without knowing these outcomes, it is impossible 
to plan for, and provide suitable interventions. 
 
The feasibility of implementing regular cardiac neurodevelopmental follow-up for children 
with CHD in Africa has not been investigated, and there is no documented record of any 
CNPs or early cardiac developmental intervention programmes running at any of the cardiac 
centres on the African continent at this point in time.   
 
The best mode of providing early developmental intervention to children with CHD at risk of, 
or presenting with developmental delays in SA needs to be investigated, keeping in mind 
that the South African public health system follows a community-based approach. Therefore 
possible ways of providing community-based and home-based intervention services need 
to be explored (Van Deventer et al., 2015). 
 
1.4 Research questions 
 
The following research questions were asked in this study:  
 
What are the pre-cardiac intervention developmental status, HRQOL and burden of care of 
young children living with CHD in central SA? 
 
What are the three-month and six-month post-cardiac intervention developmental status, 
HRQOL and burden of care of young children living with CHD in central SA? 
 
What type of home-based, caregiver-driven developmental stimulation programme would 
be best suited to address the specific developmental needs of young children living with 
CHD, and their caregivers, in central SA? 
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1.5 Aims 
 
The aims of this study were threefold:  
 
The first aim was to determine the pre-cardiac intervention developmental status, HRQOL 
and burden of care of young children living with CHD in central SA. 
 
The second aim was to determine the three-month and six-month post-cardiac intervention 
developmental status, HRQOL and burden of care of young children living with CHD in 
central SA. 
 
The third aim was to identify the developmental needs of young children living with CHD in 
central SA, and to develop a validated, home-based, caregiver-driven developmental 
stimulation programme aimed at addressing their specific needs. 
 
1.6 Objectives 
 
The objectives for the three phases of the study are presented under main and secondary 
objectives. 
 
1.6.1 Main objectives 
 
The main objectives for each of the three phases of the study are stated below:  
 
Phase I 
To establish the pre-cardiac intervention (baseline) growth, development and cardiovascular 
status of children living with CHD in central SA. 
 
To establish the pre-cardiac (baseline) intervention HRQOL of children living with CHD in 
central SA. 
 
To establish the pre-cardiac intervention (baseline) levels of parenting stress and the burden 
of care experienced by parents of children living with CHD in central SA.  
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Phase II 
 
To establish the three-month and six-month post-cardiac intervention growth, development 
and cardiovascular status of children living with CHD in central SA. 
 
To establish the three-month and six-month post-cardiac intervention HRQOL of children 
living with CHD in central SA. 
 
To establish the three-month and six-month post-cardiac intervention levels of parenting 
stress and the burden of care experienced by parents of children living with CHD in central 
SA.  
 
To compare growth, development and HRQOL of children living with CHD, and parenting 
stress over time, from pre-cardiac intervention up until the six-month post-cardiac 
intervention. 
 
Phase III 
 
To establish the nature and severity of the developmental challenges faced by young 
children living with CHD in central SA. 
 
1.6.2 Secondary objectives 
 
Phase II 
 
To compare the growth, development, HRQOL and parenting stress of children with CHD 
with Down Syndrome (DS) to those with CHD without DS over time, from pre-cardiac 
intervention up until the six-month post-cardiac intervention. 
 
To compare growth, development, HRQOL and parenting stress of children with cyanotic 
heart defects with those with acyanotic heart, from pre-cardiac intervention up until the six-
month post-cardiac intervention. 
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To determine the association between multiple variables and development, HRQOL and 
parenting stress outcomes of the children in the current study sample. 
Phase III 
 
To develop and validate a home-based, caregiver-driven developmental stimulation 
programme addressing the specific developmental needs of young children with CHD. 
 
1.7 Significance of the study 
 
This is the first study investigating the developmental outcomes of young children 
undergoing cardiac intervention on the African continent. The determination of 
developmental outcomes using the Bayley Scales of Infant and Toddler Development, Third 
Edition (BSID-III) was considered the most important aim of this study, as it would allow for 
comparison of developmental outcomes of SA children living with CHD with other children 
with CHD in developed countries. Furthermore, determining growth and HRQOL outcomes 
will provide valuable insights into the growth, health and wellbeing of children living with 
CHD in SA. The study also serves to identify variables associated with development and 
HRQOL outcomes in young children living with CHD in SA.  
 
Identification of specific developmental concerns assisted in the development of a home-
based, parent-driven developmental home activity programme that specifically met the 
needs of young children living with CHD in SA. Apart from this, the home-based 
developmental stimulation programme will be the first documented programme providing a 
comprehensive description of the rationale, development, programme content and treatment 
dosage for children living with CHD worldwide (other studies to date have not provided 
specific information on home programme development and content). The programme can 
be issued to parents as a resource tool in order to support and optimise developmental 
outcome as part of a CNP.  
 
The study followed-up young children living with CHD and their families from just before 
cardiac intervention, over a period of six months post-cardiac intervention. This allowed for 
invaluable insights into the possible feasibility and potential challenges of implementing 
CNPs in the South African setting. Recommendations can be provided to stakeholders in 
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both SA and in Africa in this regard.  
 
Establishing the levels of parenting stress and the burden of care was considered an 
extremely important outcome in this study. In following a family-centred approach to cardiac 
care, it is deemed of the utmost important to put strategies in place to better support parents 
in their role of caring for a child with CHD. 
 
1.8 Organisation of the thesis  
 
The thesis is organised under the following chapters: 
 
Chapter 1:  Introduction 
 
Chapter 2:   Literature review 
 
Chapter 3:   Measurement tools and pilot study 
 
Chapter 4:   Methods Phase I and Phase II 
 
Chapter 5:   Results Phase I and Phase II 
 
Chapter 6:   Discussion of the results of Phase I and II 
 
Chapter 7:   Phase III: Development and validation of the developmental home 
activity programme  
 
Chapter 8:   Conclusion  
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
 
2.1 INTRODUCTION  
 
This chapter will provide an overview of CHD in children, with the emphasis on CHD in 
infants, toddlers and pre-schoolers. The chapter is divided into six sections delineating the 
focus areas of this study. Due to the participant profile in the current study outcomes for 
children with CHD with genetic abnormalities will focus on DS. 
 
Section 2.2 will provide a brief overview of CHD, including the classification thereof 
according to the nature of the defect and medical severity. The medical and surgical 
management of CHD will also be indicated.   
 
Section 2.3 will present relevant literature regarding the impact of CHD on the developing 
brain, identify risk factors for adverse neurodevelopmental outcome and describe patterns 
of developmental delay and impairment found in children with CHD. Relevant findings from 
neurodevelopmental outcome studies published to date will also be highlighted. 
Recommendations regarding cardiac neurodevelopmental follow-up and early 
developmental intervention in improving neurodevelopmental outcome will be outlined for 
further discussion in Chapter 7.  
 
Section 2.4 will review the reasons for the high occurrence of malnutrition and growth failure 
in children with CHD, with special attention being paid to the impact of growth failure on 
neurodevelopmental outcome in this population.  
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Section 2.5 will present current literature on HRQOL outcomes in children with CHD, and 
review factors that adversely affect HRQOL in this population. 
 
The last two sections will describe the cost of CHD to families. The burden of CHD for 
families may be both psychosocial and financial in nature. Section 2.6 will review stressors 
associated with parenting and caring for a child with a chronic health condition, while Section 
2.7 will describe the financial burden of care.  
 
Articles for this literature review were sourced using the EBSCO host platform, the following 
databases and search engines were used: CINAHL with full text, Medline with full text, 
PsycINFO, PEDro, Cochrane Library, Africa-wide Information, BMJ journals online, 
Academic Search Complete, GOOGLE scholar, PubMed, African Journals Online and 
Science Direct. Key words used in searches in combination with congenital heart disease 
or congenital heart defect included neurodevelopmental outcome, developmental outcome, 
cardiac neurodevelopmental follow-up, neurodevelopmental risk, early developmental 
intervention, health-related quality of life, quality of life,  growth failure and malnutrition, 
Down syndrome, parenting stress, financial cost to families and burden of care. The search 
period extend up to and including articles published in July 2016. 
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2.2. CONGENITAL HEART DISEASE IN CHILDREN 
 
2.2.1 Risk factors for congenital heart disease  
 
CHD is attributed to multifactorial aetiologies arising from interactions between multiple 
genes and environmental factors (Chaix et al., 2016). Genetic causes can be identified in 
fewer than 20% of cases of CHD (Fung et al., 2013), while around 30% of congenital heart 
defects are attributable to identifiable, non-inherited causes including maternal low 
socioeconomic status (SES), stress, illness, nutritional deficiencies, therapeutic and non-
therapeutic drug use and chemical exposure during early foetal life (Fung et al., 2013; Patel 
and Burns, 2013; Jenkins et al., 2007). However, in many cases the exact cause remains 
unknown (CDC, 2015).  
 
2.2.2 Prevalence and survival 
 
The prevalence of CHD is estimated to be around nine per 1000 live births (Marino et al., 
2012). Most children born with CHD today will survive into adulthood. Survival rates do 
however vary according to disease severity. According to Marino et al. (2012) the long-term 
survival rate for children with simple or mild forms of  CHD (valve disease, and atrial and 
ventricular septal defects) is estimated to be 95%, 90% for children with CHD of moderate 
severity (coarctation of the aorta, atrioventricular septal defect, ventricular septal defect with 
comorbidities, tetralogy of Fallot), and 80% for children with complex or severe forms of 
CHD (single ventricle, truncus arteriosus, complex transposition of the great arteries). Even 
though complex types of CHD such as hypoplastic left heart syndrome (HLHS) have lower 
survival rates, the overall survival rates for even the most complex cardiac defects have 
improved. 
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2.2.3 Classification of congenital heart defects 
 
2.2.3.1 Classification based on the nature of the defect  
 
CHD can be classified according to the presence or absence of cyanosis. Acyanotic lesions 
are characterised by a normal arterial blood oxygen saturation and a pink skin colour. 
Cyanotic lesions on the other hand are characterised by reduced levels of oxygen in the 
arterial blood and a bluish skin discolouration (Nousi and Christou, 2010). 
 
The most common acyanotic heart defects are ventricular septal defects (VSD) and 
artrioventricular septal defects (AVSD) (30-50%), patent ductus arteriosus (PDA) (10%), 
atrial septal defects (ASD) (7-10%), pulmonary valve stenosis (PS) (7%), aortic valve 
stenosis (AS) (6%) and coarctation of the aorta (6%) (Hanson, 2015; Nousi and Christou, 
2010). While the most common cyanotic heart defects include tetralogy of Fallot (TOF) (5%) 
and transposition of the great arteries (TGA) (5%) and double outlet right ventricle (DORV) 
(5%). Several other rare and complex cardiac defects that can occur include hypoplastic left 
heart syndrome (HLHS), truncus arteriosus, tricuspid valve atresia, interrupted aortic arch 
and total anomalous pulmonary venous return (TAPVR)(Hanson, 2015; Nousi and Christou, 
2010). Congenital heart defects occur in between 41 to 56% of children with DS with AVSDs 
being the most common defect (Alsaied et al., 2016; Elmagrpy et al., 2011; Van Gameren-
Oosterom et al., 2011; Visootsak et al., 2011). 
 
The classification of CHD according to the nature of the defect is presented in Appendix I. 
 
2.2.3.2 Classification based on the medical severity 
 
Disease severity may affect prognosis and outcome. Despite the importance of cardiologists 
being able to identify the severity of the defect, no universally agreed upon classification 
system exists (Macran et al., 2006). A medical severity rating scale for CHD, the 
Cardiologist’s Perception of Medical Severity Scale (DeMaso et al., 1991) has been used in 
studies by Uzark et al. (2003) and Yildiz et al. (2009) to rate disease severity. 
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The rating system according to the Cardiologist’s Perception of Medical Severity Scale is 
presented in Appendix II.  
 
2.2.4 Management of congenital heart disease 
 
Treatment is guided largely by the nature and severity of the defect, as well as the child’s 
age. In some cases, minor defects resolve spontaneously and require no intervention. In 
other cases where the defect is more significant, management may include supportive 
medical care in the form of the administration of cardio-active drugs, interventional cardiac 
catheterisation or cardiac surgery (AHA, 2015; Howell and Tapley, 2012; Lee et al., 2007). 
Approximately 25 to 30% of children born with CHD will require surgery which may be 
corrective or palliative (Owen et al., 2011). 
 
2.2.5 Summary  
 
Congenital heart defects are the most common birth abnormality, with a prevalence of 
around nine per 1000 live births. It is estimated that around 85% of children born with a 
congenital heart defect will survive into adulthood. The cause of CHD in many cases remains 
unknown, but the interactions between multiple genetic and environmental factors are 
believed to be causative. Management of CHD is determined by the nature and severity of 
the cardiac defect, and may require a combination of medical, interventional cardiology and 
cardiac surgery interventions to palliate or repair the defect.  
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2.3 NEURODEVELOPMENTAL OUTCOME IN CHILDREN WITH CONGENITAL HEART 
DISEASE 
 
2.3.1 Introduction  
 
Over recent decades advances in medical management and surgical techniques have 
significantly reduced mortality in children born with CHD (Gaynor et al., 2015; Marino et al., 
2012; Snookes et al., 2010). More children at high-risk of neurodevelopmental morbidity are 
now undergoing cardiac surgery than ever before, and are surviving. This has resulted in a 
growing population of CHD survivors who are presenting with neurodevelopmental problems 
(Gaynor et al., 2015).  As a result, the focus has shifted to these longer-term outcomes 
(Naguib et al., 2015). 
 
Brain injury and subsequent developmental disability is the most common and potentially 
devastating long-term complication of CHD (Gaynor et al., 2015; Snookes et al., 2010). 
Impairments include developmental delays, difficulty in school, and challenges in living 
independently (Rollins and Newburger, 2014).  
 
Children with CHD are at risk of neurodisability regardless of the severity of their CHD 
(Mussatto et al., 2014; Snookes et al., 2010). It is well established that children with CHD 
experience a higher prevalence of developmental delay and disability than typically 
developing healthy children (Mussatto et al., 2015; Martinez-Biarge et al., 2013). For many 
children and their families the neurodevelopmental burden of disease is far greater than the 
daily impact of the CHD itself (Wernovsky, 2008). 
 
Children with CHD typically show areas of strength and weakness in their development, a 
so-called unique “developmental signature” that changes with developmental age (Brosig et 
al., 2014). The extent of the developmental deficits tend to become more apparent over time 
and with age, becoming more pronounced as the child attempts to master tasks that are 
more complex. These deficits do not disappear upon transition into adolescence and later 
into adulthood (Wilson et al., 2015). Significant variation is seen in developmental outcome; 
even amongst children with the same cardiac defect (Gaynor et al., 2014; Sananes et al., 
2012; Acton et al., 2011), suggesting that patient-specific factors may play an important role 
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in determining central nervous system (CNS) injury and therefore neurodevelopmental 
outcome (Mussatto et al., 2015; Gaynor et al., 2014; Sananes et al., 2012). 
 
The cause of neurodevelopmental disability in children with CHD is most likely multifactorial, 
but the precise role of specific medical, surgical, and sociodemographic variables is not yet 
fully understood (Medoff-Cooper et al., 2016; Ravishankar et al., 2013). Various patient-
specific and management factors have the potential to interact during the pre-operative, 
peri-operative, and post-operative periods, manifesting as a spectrum of developmental 
difficulties in children with CHD (Chock et al., 2012; Long et al., 2012b; Owen et al., 2011; 
Joynt et al., 2009). 
 
In the light of the aforementioned, neurodevelopment now ranks amongst the most 
important outcomes being scrutinised in children with CHD (Goldberg et al., 2011; Dittrich 
et al., 2003). Research is becoming more focused on defining the impact of CHD on brain 
development, minimising postnatal brain injury, and improving long-term 
neurodevelopmental outcomes for survivors (Donofrio and Massaro, 2010). This creates a 
new challenge for healthcare professionals of coming to understand the neurobehavioural 
profile of these children and being able to respond to this with the provision of the necessary 
early intervention (EI), psychological and educational services needed to support these 
children’s optimal development and long-term outcome (Gerdes and Flynn, 2010). 
 
2.3.2 Brain abnormalities associated with congenital heart disease 
 
Brain injury is a potentially devastating complication of CHD (Gunn et al., 2012).  CHD can 
affect the brain in several different ways (Rollins and Newburger, 2014; Goldberg et al., 
2011). The structural differences in the brains of children with CHD can be divided into two 
categories: abnormalities of brain development and acquired brain injury (Martinez-Biarge 
et al., 2013). In addition to this, genetic susceptibility may also play a role in predisposing 
the brain to injury in children with CHD (Homsy et al., 2015). 
 
The mechanisms contributing to CNS injury in children with CHD are complex and 
multifactorial (Albers et al., 2010). Both pre-existing and acquired brain injury have been 
associated with poorer neurodevelopmental outcomes (Long et al., 2011). 
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The persistence of poor neurodevelopmental outcome in some children despite the 
significant improvements in medical and surgical management may indicate the important 
impact abnormal brain development may have in determining neurodevelopmental outcome 
in children with CHD (Gaynor et al., 2015).  
 
2.3.2.1 Genetic susceptibility  
 
Scientists at the Harvard Medical School have found a link between a set of gene mutations 
in the development of CHD and various other neurodevelopmental abnormalities. Homsy et 
al. (2015) found that children with both CHD and other neurodevelopmental disorders have 
a much higher burden of damaging de novo gene mutations, particularly in genes that play 
an important role in the development of both the heart and brain. The risk of developing 
neurodevelopmental disabilities in children with CHD is considered to be extremely high 
when these specific gene mutations are present. Thus, there is also an increased incidence 
of structural brain abnormalities in infants with CHD (Rollins and Newburger, 2014; Long et 
al., 2011). 
 
In addition to this, children carrying the epsilon2 version of the apolipoprotein E (APOE) are 
likely to have a worse neurodevelopmental outcome after undergoing cardiac surgery than 
those children who do not possess the gene variant. The epsilon2 gene variant decreases 
the ability of neurons to repair themselves after brain ischaemia and traumatic brain 
damage. Genetic variants that decrease the brain’s resilience and impair neuronal repair 
after injury are to be considered an important risk factor for developmental delay and 
developmental disorder or disability (DD) following cardiac surgery in infants (Gaynor et al., 
2014; Fuller et al., 2009). 
 
2.3.2.2 Structural differences in the brain 
 
There is a growing body of evidence to suggest that many children with CHD have abnormal 
or delayed brain development, potentially making them more vulnerable to neurologic insult 
(Albers et al., 2010). Abnormal blood flow may occur in the brain of a foetus and infant with 
CHD, reducing the volume of blood reaching the brain or the oxygen content of the blood 
(Brosig et al., 2014). Reduced blood flow and oxygen content may retard brain maturation 
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(Gaynor et al., 2015; Brosig et al., 2014; Rollins and Newburger, 2014; Donofrio et al., 2011; 
Goldberg et al., 2011), resulting in cerebral hypoxic ischaemia and metabolic acidosis which 
may give rise to haemorrhaging (intraventricular, parenchymal or subdural), periventricular 
leukomalacia (PVL) or stroke (Marino, 2013; Tabbutt et al., 2012; Donofrio et al., 2011; 
Owen et al., 2011).  
 
Magnetic resonance imaging (MRI) studies have shown smaller brain volume, decreased 
cerebral blood flow and abnormal brain metabolism in infants with CHD (Gaynor et al., 2015; 
Brosig et al., 2014; Martinez-Biarge et al., 2013; Tabbutt et al., 2012). Brain development 
has also been found to be slower in children with cyanotic types compared to acyanotic 
types of CHD (Abdel Raheem and Mohamed, 2012). 
 
2.3.2.3 Acquired brain injury  
 
Beyond these structural differences, infants with CHD are also at high-risk for acquired brain 
injury (Martinez-Biarge et al., 2013). Injury may be caused by a combination of pre-
operative, peri-operative and post-operative factors (Hövels-Gürich et al., 2006). It is 
suggested that brain injury occurs in approximately 26% of infants with CHD before cardiac 
surgery and new brain injury occurs in around 44% of infants after undergoing cardiac 
surgery (Beca et al., 2013). White matter injury is the most common form of brain injury both 
before and after cardiac surgery (Beca et al., 2013). The risk of brain injury increases with 
the severity of the defect and the complexity of the surgery required (Snookes et al., 2010).  
 
Altered brain development may increase the vulnerability of the neonatal and infant brain to 
injury, subsequently increasing the risk of white matter injury as a result of haemodynamic 
instability and changes in cerebral perfusion and oxygenation (Gaynor et al., 2015; Gunn et 
al., 2012; Long et al., 2011; Von Rhein et al., 2011; Snookes et al., 2010). Brain injury may 
result from hypo-perfusion, cerebral venous thrombosis, thromboembolism and infarction, 
which may be related to the cardiac defect itself, or to the procedures required to repair or 
palliate the defect (Albers et al., 2010; Dittrich et al., 2003).  
 
In addition, brain immaturity increases the risk of brain injury occurring with stressors such 
as labour, haemodynamic instability or infection (Rollins and Newburger, 2014; Owen et al., 
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2011). The pattern of brain injury seen in a term newborns with CHD is similar to that seen 
in preterm neonates (Brosig et al., 2014; Martinez-Biarge et al., 2013). In term newborns 
with CHD, brain maturity may be delayed with as much as a month (Rollins and Newburger, 
2014).  
  
Apart from brain maturity, white matter injury is also associated with longer durations of 
cardiopulmonary bypass (CPB) and the use of deep hypothermic circulatory arrest (DHCA) 
(Gaynor et al., 2015; Beca et al., 2013). White matter injury can impair both motor and 
cognitive function, which in turn will negatively affect development and learning (Rollins and 
Newburger, 2014).  
 
Haemorrhage and stroke occur less frequently, with PVL and stroke occurring in between 
23 and 48% of children with CHD, whilst haemorrhages occur in between 7 and 54% of 
children with CHD (Tabbutt et al., 2012). Davidson et al. (2015) reported that strokes occur 
secondary to hypoxic or ischaemic damage during CPB in children with complex CHD.  
Some types of CHD are also more likely to cause blood clot formation. These blood clots 
may travel to the brain, obstructing blood vessels, causing a stroke. Both cardiac surgery 
and cardiac catheterisations can be complicated by a stroke (Rollins and Newburger, 2014). 
Domi et al. (2008) investigated the frequency and predictors of vaso-occlusive strokes in 
children undergoing cardiac surgery. They found one in 185 children undergoing cardiac 
surgery suffered a stroke (risk of 5.4 strokes per 1000 children). The study also revealed 
that older age at the time of surgery, longer durations of CPB, longer post-operative hospital 
length of stay and reoperation to be associated with stroke.  
 
2.3.3 Abnormal neurological examinations 
 
Abnormal neurological examinations have been reported in between 36 and 56% of 
newborns and infants with CHD (Marino et al., 2012; Tabbutt et al., 2012; Donofrio et al., 
2011). Neurological abnormalities include hypotonia, hypertonia, jitteriness, motor 
asymmetry, and poor sucking reflexes (Marino et al., 2012; Donofrio et al., 2011; Donofrio 
and Massaro, 2010). Of the aforementioned, hypotonia is by far the most frequently reported 
neurological abnormality in children with CHD (Lata et al., 2015; Majnemer et al., 2009; 
Limperopoulos et al., 2000). Newborns and infants may exhibit profound hypotonia post-
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cardiac surgery, especially in cases of prolonged post-operative sedation and mechanical 
ventilation (Long et al., 2011). Abnormal neuromotor findings are associated with adverse 
neurodevelopmental outcomes (Chock et al., 2012).  
 
2.3.4 Risk factors for poor neurodevelopmental outcome  
 
From a dynamic system theories approach, human development is influenced by genetic 
inheritance, nutrition, quality of care, SES, child rearing practices, disease processes and 
trauma. In addition to this, opportunity for play and refinement of skills, personality and 
motivation, level and quality of the stimulation and cognitive abilities all impact on 
developmental skill acquisition in a child (Aubert, 2015). Developmental outcome in children 
with CHD will be viewed within the framework of this approach. The cause of adverse 
neurodevelopmental outcome in children with CHD is multifactorial. Factors are often 
interrelated, and are also likely to be cumulative in nature (Wilson et al., 2015; Long et al., 
2011; Robertson et al., 2011). In the light of the diversity of the risks for neurodevelopmental 
morbidity in the child with CHD, the child should be viewed holistically, considering multiple 
factors when risk is evaluated (Mussatto et al., 2014).  
 
Current known patient and management-related risk factors only explain between 30 and 
40% of the variance in neurodevelopmental outcome in children with CHD (Wilson et al., 
2015; Gaynor et al., 2015; Mussatto et al., 2015; Martinez-Biarge et al., 2013). Many risk 
factors for adverse neurodevelopmental outcome are not modifiable, such as innate patient 
factors including genetic abnormalities, parental level of education and SES (Tabbutt et al., 
2012). Only a few of the identified risk factors for poor neurodevelopmental outcome can 
potentially be modified in order to reduce the vulnerability of the CNS (Gaynor et al., 2015). 
These include delaying elective delivery to 39 weeks gestation and implementing CNS 
protection strategies during the pre-operative and post-operative periods (Tabbutt et al., 
2012).  
 
The most important risk factors for poor neurodevelopmental outcome will be presented 
below. They will be discussed under type and severity of CHD, children requiring cardiac 
surgery in early infancy, children with cyanotic types of CHD not requiring surgery in infancy, 
and peri-operative risks, patient-specific risks and sociodemographic risks.  
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2.3.4.1 Type and severity of the congenital heart disease 
 
The severity of the CHD is associated with neurodevelopmental outcome. The more 
complex the CHD, the poorer the neurodevelopmental outcome has shown to be (Gaynor 
et al., 2015; Mussatto et al., 2015; Marino, 2013; Martinez-Biarge et al., 2013; Sananes et 
al., 2012; Tabbutt et al., 2012; Goldberg et al., 2011; Long et al., 2011; Hoskoppel et al., 
2010; Simons et al., 2010). 
 
Children with milder forms of CHD have shown to have a low incidence of developmental 
delay and DD (Rollins and Newburger, 2014; Marino et al., 2012); whereas more complex 
forms of CHD including moderate two-ventricle CHD (coarctation of the aorta, complex 
semilunar valve disease, VSD, VSD with comorbidities, TOF, TAPVD) are associated with 
increasing numbers of children presenting with developmental delay and DD (Marino et al., 
2012). Severe two-ventricle or palliated single-ventricle CHD (TGA, truncus arteriosus, 
interrupted aortic arch, TOF, pulmonary atresia, tricuspid atresia and HLHS) is associated 
with a very high incidence of  developmental delay and DD (Davidson et al., 2015; Marino 
et al., 2012; Tabbutt et al., 2012). 
 
 The need for multiple surgeries would be associated with more severe or complex forms of 
CHD; and is therefore also associated with worse neurodevelopmental outcomes (Mussatto 
et al., 2015; Tabbutt et al., 2012; Fuller et al., 2009). 
 
2.3.4.2 Surgery in early infancy 
 
Age at first cardiac surgery is associated with neurodevelopmental outcome (Majnemer et 
al., 2009). Children with more severe forms of CHD often require cardiac surgery in infancy 
(Marino et al., 2012; Tabbutt et al., 2012; Long et al., 2011; Snookes et al., 2010; Dittrich et 
al., 2003). Cardiac surgery itself poses a risk in early infancy. Cerebral perfusion and 
oxygenation may be compromised during cardiac surgery with CPB (Donofrio and Massaro, 
2010). Inadequate cerebral perfusion and metabolism, temperature alterations, and 
cardiogenic emboli during cardiac surgery may result in hypoxic-ischaemic reperfusion 
injury. Complications can also arise post-operatively including cardiac arrest, infection and 
poor cerebral perfusion. These post-operative complications pose an additional risk for brain 
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injury (Majnemer et al., 2009) and may adversely affect neurodevelopmental (Marino et al., 
2012; Long et al., 2011; Snookes et al., 2010; Dittrich et al., 2003).  
 
Cardiac surgery with CPB during infancy is associated with impaired cognitive and motor 
development outcomes (Marino et al., 2012). Studies have shown these children to have 
more problems in reasoning, learning, executive function, inattention and impulsive 
behaviour, and language and social skills when compared to their healthy same-aged peers. 
Survivors of infant cardiac surgery were also found to be more likely than the general 
population to require remedial and EI therapy services including physiotherapy (PT), 
occupational therapy (OT) and speech therapy (ST) (Gaynor et al., 2015; Marino, 2013). 
 
2.3.4.3 Cyanotic heart defects not requiring surgery in infancy 
 
Children with cyanotic heart defects who do not require cardiac surgery in infancy may avoid 
some of the risks associated with open-heart surgery. However, these children are still to 
be considered at high-risk for developmental delays due to the effects of chronic hypoxemia 
caused by their underlying CHD. They may also be at risk later in childhood when they may 
need to undergo palliative or reparative surgeries (Marino et al., 2012).  
 
Cyanotic infants with oxygen saturation (SpO2) less than 85% have shown a higher 
incidence of neurological abnormalities (Owen et al., 2011; Donofrio and Massaro, 2010), 
and adverse neurodevelopmental outcomes have been reported in children with cyanosis 
beyond two years of age (Rappaport, 2015). 
 
2.3.4.4 Peri-operative risk factors 
 
Regulating the stress response and managing peri-operative factors can have an important 
impact on the neurodevelopmental outcome of infants who undergo cardiac surgery using 
CPB (Naguib et al., 2015).  
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2.3.4.4.1 Cardiopulmonary bypass  
 
Nearly all surgery for complex CHD is performed on CPB with cross-clamping of the aorta 
(Tabbutt et al., 2012). During CPB, the infant brain may be subjected to global or focal 
ischaemia caused by gaseous or particulate micro emboli and hypo-perfusion (Dittrich et al., 
2003). Cardiac surgery with CPB provokes a pronounced systemic inflammatory response 
(McCrindle et al., 2014; Tabbutt et al., 2012; Gessler et al., 2009). Brain dysfunction or 
encephalopathy is frequently accompanied by a general inflammatory response (Gessler et 
al., 2009). Longer CPB duration has been associated with worse neurodevelopmental 
outcome (Bellinger et al., 2011; Bellinger et al., 2003; Bellinger et al., 1999; Bellinger et al., 
1995).  
 
The concern for neurodevelopmental outcome relates to the longer exposure of the brain to 
CPB-induced pro-inflammatory cytokines (Sananes et al., 2012). Long-term 
neurodevelopmental sequelae associated with CPB include neurologic, developmental and 
behavioural deficits (Bellinger et al., 2011; Gessler et al., 2009; Bellinger et al., 2003; 
Bellinger et al., 1999; Bellinger et al., 1995). 
 
2.3.4.4.2 Deep hypothermic circulatory arrest   
 
Cardiothoracic surgeons may make use of DHCA due to the small structures of the heart 
and/ or the need for aortic arch reconstruction. DHCA is performed with deep hypothermia, 
and for periods during the surgery, there is no systemic blood flow (Tabbutt et al., 2012). 
The adverse impact of DHCA on neurodevelopmental outcome could possibly be attributed 
to hypoxic-ischaemic injury to the brain (Tabbutt et al., 2012; Bellinger et al., 2011). DHCA 
has also been associated with clinical seizures (Tabbutt et al., 2012). 
 
Concerns have been voiced about longer durations of DHCA, with both Tabbutt et al. (2012) 
and Wypij et al. (2003) suggesting that  a DHCA time exceeding 41 minutes to be of concern. 
However, Fuller et al. (2009) reported that DHCA for repair of single ventricle and 
biventricular CHD was however not predictive of worse neurodevelopmental performance 
at four years of age.  
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2.3.4.4.3 Aorta cross-clamp time 
 
During the repair of intracardiac malformations the aorta is cross-clamped and the heart is 
arrested. Cross-clamping of the aorta results in a period of time in which there is no blood 
supply to the myocardium (Talwar et al., 2015; Schlensak, 2005). Once the cardiac surgery 
is completed the aortic cross-clamp is released and the heart is suddenly re-perfused with 
blood with a very high partial pressure of oxygen due to its exposure to the CPB circuit. As 
a result, the post-cardiac surgery myocardium is exposed to the dramatic extremes of 
ischaemia and reperfusion. Ischaemic reperfusion injury after cardiac surgery may manifest 
as arrhythmias, myocardial stunning, low cardiac output, and peri-operative myocardial 
infarction (Turer and Hill, 2010). The longer the cross-clamp time is, the greater the risk of 
myocardium suffering ischaemic-reperfusion damage when the aortic cross-clamp is 
released (Talwar et al., 2015; Turer and Hill, 2010; Schlensak, 2005). 
 
To conclude the discussion on peri-operative risk factors, the landmark Boston circulatory 
arrest study (BCAS) has followed the neurodevelopmental outcome of the largest cohort of 
infants who underwent cardiac surgery between 1988 and 1992 longitudinally, providing 
invaluable insights on the effects of peri-operative strategies on developmental outcome. In 
their study, 177 infants were randomly assigned to deep hypothermia with either circulatory 
arrest or low-flow bypass support during surgical repair for TGA. Bellinger and colleagues 
have followed-up in excess of 80% of these children at one year of age (Bellinger et al., 
1995), four years (Bellinger et al., 1999) eight years (Bellinger et al., 2003) and 16 years 
(Bellinger et al., 2011). They found that total circulatory arrest to support vital organs during 
cardiac surgery is associated with poorer developmental and behavioural outcomes. 
However, when reviewing outcomes of the BCAS one has to keep in mind that contemporary 
peri-operative strategies differ significantly from those used when the adolescents in the 
BCAS had heart surgery as infants nearly 20 years ago.  
 
The BCAS and the desire to address modifiable surgical risk factors have resulted in 
advances in anaesthetic and surgical procedures aimed at protecting the brain (Tabbutt, 
2013). With the exception of a higher haematocrit level during CPB, no other intraoperative 
interventions or procedural modifications have shown improvements in neurodevelopmental 
outcomes (Tabbutt, 2013). No significant differences were found on neuropsychological 
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testing or structural brain imaging between low-flow CPB and DHCA (Marino, 2013; 
Bellinger et al., 2011). Mussasto et al. (2015) also found no differences in cognitive, 
language, or motor outcomes for children that had CPB in comparison with those who did 
not undergo CPB.  
 
Overall, risk factors related to cardiac surgery appear to play a limited role in the 
neurodevelopmental morbidity seen in CHD survivors (Gaynor et al., 2014; Von Rhein et al., 
2012). This highlights the potential importance of patient-specific and sociodemographic 
factors, as well as abnormal brain development in determining neurodevelopmental 
outcome (Bellinger et al., 2011).  
 
2.3.4.5 Medical complications and haemodynamic instability in the post-operative 
period  
 
Haemodynamic instability and medical complications during the post-operative period may 
have an adverse effect on the brain during infancy. The developing brain has been shown 
to be vulnerable during the period of synaptogenesis and growth from the sixth month of 
gestation into the first year of life. Exposure to barbiturates, benzodiazepines and other 
neurotropic drugs during anaesthesia and ICU stay may result in widespread apoptotic 
neurodegeneration resulting in the death of millions of neurons. The excitotoxic 
consequences of ischaemic events are also amplified in the developing brain (Dittrich et al., 
2003).  
 
2.3.4.5.1 Cardiopulmonary resuscitation 
 
Children with CHD may experience acute medical events, including cardiac arrest (Rollins 
and Newburger, 2014). Children who need cardiopulmonary resuscitation tend to 
experience a period of decreased cerebral perfusion and hypoxia. Depending on the 
duration of the cardiac arrest, limited or widespread injury may be caused to the brain 
structures that are most sensitive to oxygen and nutrient deprivation. This may result in 
permanent neurological injury, predisposing the child to subsequent neurological 
impairment and/or developmental delays and disorders (Rollins and Newburger, 2014; 
Marino et al., 2012; Sananes et al., 2012; Majnemer et al., 2009). 
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2.3.4.5.2 Prolonged hospital length of stay 
 
Prolonged hospital length of stay may occur because of the severity of the CHD and/ or a 
complicated medical course (Marino et al., 2012; Majnemer et al., 2009). The need for pre-
operative mechanical ventilation (Long et al., 2012b) and/ or prolonged  hospital length of 
stay (Mussatto et al., 2015; Tabbutt, 2013; Sananes et al., 2012; Von Rhein et al., 2012) are 
associated with poorer developmental outcome. In addition, the need for repeated 
hospitalisation, as is often the case in more severe types of CHD, is also associated with 
worse developmental outcome (Long et al., 2011; Majnemer et al., 2009; Dittrich et al., 
2003). 
 
Hospitalisation results in periods of immobilisation, limited developmentally appropriate 
stimulation and decreased opportunities for play and practice of developmental skills that 
may negatively affect motor and cognitive development (Dittrich et al., 2003). Surgery and 
hospitalisation early in life requiring anaesthesia and the administration of analgesics may 
result in localised pain sensitivity (hyperalgesia) which may continue for years after the 
cardiac surgery, negatively affecting motor development (Long et al., 2011). 
 
Marino et al. (2012) and Long et al. (2011) both reported that longer post-operative cardiac 
ICU length of stay and a hospital length of stay exceeding two weeks to be independently 
associated with poorer later cognitive function. Long et al. (2012b) found that increased 
hospital length of stay was also associated with poorer gross motor outcome in infancy.  
 
2.3.4.5.3 Peri-operative seizures and stroke 
 
Seizures are a common manifestation of acquired brain injury in children during the 
immediate post-operative period following cardiac surgery, and occur in approximately 30% 
of children with CHD (Gunn et al., 2012). Seizures may occur for no identifiable reason, but 
sometimes are secondary to an acute ischaemic or haemorrhagic event (Martinez-Biarge et 
al., 2013). Peri-operative seizures are associated with an increased risk of poorer 
neurodevelopmental outcome and neurological abnormalities (Davidson et al., 2015; Marino 
et al., 2012; Sananes et al., 2012; Sarajuuri et al., 2009).  
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Stroke is seen on MRI in 10 to 30% of infants with CHD, both before and after surgical repair. 
Strokes are often not clinically evident, but can cause later motor deficits and other 
neurodevelopmental problems (Martinez-Biarge et al., 2013; Sananes et al., 2012; Owen et 
al., 2011). 
 
2.3.4.6 Patient-specific risk factors 
 
The presence of the following comorbidities with CHD are associated with an increased risk 
of adverse neurodevelopmental outcome (Marino et al., 2012). Patient factors were found 
to be significant determinants of neurodevelopmental outcomes in children with CHD, as 
opposed to surgical management strategies (Fuller et al., 2009). 
 
2.3.4.6.1 Prematurity and low birth weight 
 
In addition to delayed maturation of the brain evident in some term newborns with CHD, 
some infants with CHD have the additional risk associated with being born prematurely. 
Infants with CHD born prematurely (gestational age of less than 37 weeks), and with a birth 
weight of less than 1500 grams are at increased risk for neurodevelopmental morbidity 
(Tabbutt, 2013; Chock et al., 2012; Long et al., 2012b; Marino et al., 2012; Sananes et al., 
2012; Goff et al., 2011). Approximately 15% of neonates with CHD are born prematurely 
and/or with a low birth weight (Goff et al., 2011). 
 
2.3.4.6.2 Genetic abnormalities associated with developmental disorders 
 
Genetic disorders or syndromes occur in up to 30% of children with CHD (Martinez-Biarge 
et al., 2013; Marino et al., 2012). DS, Williams’s syndrome, Noonan syndrome, CHARGE 
syndrome, VACTERL association, and deletion 22q11 are all genetic abnormalities 
associated with CHD (Marino et al., 2012). Neurodevelopmental outcome is strongly and 
independently associated with the presence of an underlying genetic abnormality (Martinez-
Biarge et al., 2013; Marino et al., 2012; Long et al., 2011). Developmental outcome in 
children with CHD with DS is presented under section 2.3.6.  
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2.3.4.6.3 Neuroimaging abnormalities and microcephaly 
 
There is a high prevalence of microcephaly in children with CHD. The prevalence of 
microcephaly is related to disease severity, and is reported in between 8 and 36% of children 
with CHD. The presence of microcephaly is associated with worse neurodevelopmental 
outcome (Marino et al., 2012; Goldberg et al., 2011; Long et al., 2011; Hoskoppel et al., 
2010; Majnemer et al., 2009). 
 
Neuroimaging literature is of the opinion that up to 59% of term infants with CHD experience 
some form of brain injury before undergoing cardiac surgery. Ischaemic lesions are 
observed in 21 to 41% of the population, with white matter injury occurring in 7 to 27%, PVL 
affects 17 to 38%, and strokes are evident in up to 30% of infants on neuroimaging studies 
(Owen et al., 2011). Neuroimaging abnormalities have shown to be associated with 
developmental delays and disorders in children with CHD (Marino et al., 2012). 
 
2.3.4.6.4 Gender and ethnicity 
 
Gaynor et al. (2015), Sananes et al. (2012) and Majnemer et al. (2012) all reported male 
gender to be associated with poorer developmental outcome, especially relating to cognitive 
and fine motor skills. Recent evidence suggests that there is a gender-specific response to 
hypoxic ischaemic injury to the immature CNS due to intrinsic differences in the male-female 
cell death pathways. Boys appear to be more vulnerable to a glutamate-mediated 
excitotoxicity cascade following hypoxic-ischaemic injury resulting in neuronal apoptosis 
(Majnemer et al., 2012). 
 
Naguib et al. (2015) and Gaynor et al. (2015) noted that ethnicity potentially could be 
associated with poorer neurodevelopmental outcome, but currently this association has not 
been well established. Gaynor et al. (2015) reported that children of white ethnicity had 
poorer neurodevelopmental outcome. This finding however needs to be interpreted with 
caution against the background that the majority of participants in all neurodevelopmental 
outcome studies to date have been of white ethnicity (Gaynor et al., 2015). 
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2.3.4.6.5 Feeding problems and growth failure  
 
Children with inadequate nutrition may tire easily, and be too weak and have inadequate 
energy for typical age-related play and exploration (Long et al., 2011; Dittrich et al., 2003). 
Poor growth and the need for tube feeding are associated with poorer developmental 
outcome (Mussatto et al., 2015). The relationship between growth and developmental 
outcome in children with congenital heart disease is presented under section 2.4.8. 
 
2.3.4.6.6 Sociodemographic factors  
 
There is growing evidence that non-modifiable patient-specific factors such as SES and 
level of parental education, as well as modifiable factors such as the  home environment 
and parenting practices may be important determinants of later developmental functioning 
in children with CHD (Sarrechia et al., 2015; Sananes et al., 2012; Tabbutt et al., 2012). 
Lower levels of maternal education (Tabbutt et al., 2012; Majnemer et al., 2009) and lower 
SES is associated with worse developmental outcome in children with CHD (Gaynor et al., 
2015; Mussatto et al., 2015; Naguib et al., 2015; Tabbutt et al., 2012; Majnemer et al., 2009), 
especially relating to cognitive ability (Sarrechia et al., 2015; Sananes et al., 2012; Von 
Rhein et al., 2011). Lower SES negatively impacts a family’s ability to access both 
healthcare and EI services that potentially might have a positive influence on the child’s 
developmental outcome (Riehle-Colarusso et al., 2015).  
 
Typically, socioeconomic factors are not modifiable but supportive parenting practices can 
mediate the effect of poverty on brain development in children (Mussatto et al., 2015). 
Parenting practices, including maternal overprotection, are associated with poorer 
developmental outcome in children with CHD (Mussatto et al., 2015; Majnemer et al., 2009). 
Maternal overprotection may unnecessarily limit physical activity and social interaction of 
the child that can adversely affect their development (Sarrechia et al., 2015; Dittrich et al., 
2003). Furthermore, parents’ expectations of their child may also influence developmental 
outcome (Riehle-Colarusso et al., 2015). 
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2.3.5 Neurodevelopmental outcomes in children with congenital heart disease  
 
2.3.5.1 Introduction  
 
Neurodevelopmental difficulties occur in as many as 50% of CHD survivors (Mussatto et al., 
2015; Knowles and Bull, 2012; Wernovsky, 2008). For many children and their families, the 
impact of the developmental difficulties on their daily lives is far more significant than that of 
the CHD itself (Wernovsky, 2008). 
 
The spectrum of neurodevelopmental impairment is broad in children with CHD. Some 
children have minimal to no impairment, whilst others may be severely affected (Rollins and 
Newburger, 2014). Severe global developmental delay is relatively uncommon, but a 
characteristic pattern of mild or combined disabilities across multiple developmental 
domains has emerged (Mussatto et al., 2015). Injury to the white matter can result in 
cerebral palsy (Long et al., 2011). However, severe neurological deficits, such as cerebral 
palsy, epilepsy, hearing and visual impairment are uncommon and only affect around 5% of 
children with CHD (Martinez-Biarge et al., 2013; Knowles and Bull, 2012; Marino et al., 2012; 
Robertson et al., 2011; Hoskoppel et al., 2010).  
 
Despite the heterogeneity in methodology between studies investigating 
neurodevelopmental outcome in children with CHD, results have shown a consistent pattern 
of developmental impairment (Martinez-Biarge et al., 2013; Sananes et al., 2012). These 
studies consistently revealed a pattern of mild motor and cognitive delays after cardiac 
surgery in early infancy (Tabbutt, 2013; Snookes et al., 2010). However, very few studies 
have described the neurodevelopmental status of neonates and infants with CHD before 
surgery (Limperopoulos et al., 2000).  
 
Children with CHD experience neurodevelopmental problems through infancy, childhood 
and adolescence into adulthood (Brosig et al., 2014; Marino, 2013). By school entry, many 
children with CHD present with developmental delays across a number of developmental 
domains, including gross and fine motor, cognitive, and language deficits, behavioural 
problems, inattention and hyperactivity. These developmental deficits may be associated 
with greater difficulties in performing everyday activities and achieving independence in 
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personal maintenance tasks such as eating, dressing and toileting (Majnemer et al., 2009). 
Knowles and Bull (2012) reported that mild neurological problems might affect up to 25% of 
children with CHD. These authors reported that only 21% of children had completely normal 
mobility, cognition and self-care skills for their age, whilst 37% were moderately disabled. 
 
There is considerable variability in neurodevelopmental outcome in adolescents following 
cardiac surgery in infancy (Bellinger et al., 2011). It has become evident that the 
developmental outcomes and needs of children with CHD change over time and with age 
(Mussatto et al., 2015; Mussatto et al., 2014). The societal costs of early childhood 
developmental delay are enormous and could have an impact across the lifespan. 
Developmental delay requires early developmental intervention services and special 
educational support. These costs will increase exponentially if the need for special education 
and developmental delays are not addressed effectively to optimise outcome. Adverse 
neurodevelopmental outcomes may also negatively impact on the child’s later potential for 
education, lifetime employment and earnings (Mussatto et al., 2015).  
 
2.3.5.2 Patterns of developmental delay and impairment  
 
A better understanding is emerging of the patterns of neurodevelopment in children with 
CHD (Robertson et al., 2011). Children with CHD present with a distinctive pattern of 
neurodevelopmental and behavioural impairment characterised by mild impairments in 
cognition, motor skills, language, inattention, impulsivity, impaired executive function and 
psychosocial maladjustment (Gaynor et al., 2014; Mussatto et al., 2014; Marino, 2013; 
Martinez-Biarge et al., 2013; Knowles and Bull, 2012; Marino et al., 2012; Sananes et al., 
2012; Robertson et al., 2011; Gerdes and Flynn, 2010; Matsuzaki et al., 2010). Moreover, 
there are often accompanying psychological issues such as anxiety, and depression 
(Marino, 2013). 
 
Delays in cognitive, language and motor development are common in infancy (Brosig et al., 
2014). Brosig Soto et al. (2011) found that nearly half of children were delayed in at least 
one developmental domain. However, early developmental outcomes have not been found 
to be highly predictive of school age developmental performance (Mussatto et al., 2015).  
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It is well established that children with more complex forms of CHD have more significant 
developmental delays (Sarrechia et al., 2015). The prevalence and severity of the 
developmental delay increase with disease severity and are associated with several genetic 
syndromes (Marino et al., 2012). Table 2.1 depicts the association between disease 
complexity and developmental disability.  
 
Table 2.1 CHD complexity and the presence and severity of developmental disability  
 
Severity of 
CHD  
No disability Mild disability Severe disability 
Mild  90% 8% 2% 
Moderate 70% 20% 10% 
Severe 40% 45% 15% 
Palliated 30% 50% 20% 
Syndromic 5% 65% 30% 
(Adapted from Marino et al., 2012, p1147) 
 
Patterns of developmental delay in each of the main domains of development will be 
discussed below.  
 
2.3.5.2.1 Motor development 
 
The majority of studies investigating motor outcomes in children after cardiac surgery have 
revealed some degree of persistent impairment in fine and/or gross motor function (Marino 
et al., 2012; Snookes et al., 2010). Motor deficits appear to be more significant than cognitive 
deficits in younger children with CHD (Wilson et al., 2015; Mussatto et al., 2014; Martinez-
Biarge et al., 2013; Long et al., 2012b; Sananes et al., 2012; Tabbutt et al., 2012; Hoskoppel 
et al., 2010; Snookes et al., 2010; Fuller et al., 2009; Joynt et al., 2009). Gross motor delays 
are reported more frequently in infancy, whereas fine motor delays become more apparent 
by the age of two years (Sananes et al., 2012). Long et al. (2012a) concurred, reporting 
moderate motor delays in up to 10% of children with CHD aged two years.  
 
Long et al. (2012b) investigated the gross motor development of 50 children with CHD who 
underwent cardiac surgery in infancy on the Alberta Infant Motor Scales (AIMS). They found 
that the children showed delays in gross motor development at four, eight, 12 and 16 months 
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of age, with 62% of the children exhibiting atypical gross motor development during the first 
year of life. Matsuzaki et al. (2010) investigated the neurodevelopmental outcome of one-
year-old Japanese children with CHD following cardiac surgery on the Bayley Scales of 
Infant Development, Second Edition (BSID-II). They similarly reported that delays in gross 
motor development were common.   
 
Limperopoulos et al. (2002) reported that up to 42% of children undergoing cardiac surgery 
with CPB exhibited delays in gross and/or fine motor skills at a mean age of 19 months on 
the Peabody Developmental Motor Scales (PDMD-4). When Majnemer et al. (2006a) re-
evaluated the same cohort of children at five years of age, it was found that the motor delay 
persisted, with 49% exhibiting gross motor delays, and 39% had fine motor delays.  
 
Gross and fine motor delay occurred more often in children undergoing palliative 
procedures, whereas fine motor delays were associated with DHCA time, microcephaly, and 
the number of hospitalisations (Marino et al., 2012). Motor performance was also poorer in 
children with cyanotic and complex lesions (Lata et al., 2015; Hövels-Gürich et al., 2006). 
Sarajuuri et al. (2009) found that gross motor development in children with single ventricle 
physiology was particularly delayed at the age of one year, and that children who had HLHS 
tended to show more globally delayed development. The aforementioned studies suggest 
that some degree of fine or gross motor impairment is common in survivors with complex 
CHD (Marino et al., 2012). Cardiac intervention may also be complicated by a stroke. More 
than half of the children who suffer a stroke in the peri-operative period experience ongoing 
sensory and/or motor impairments, with hemiplegia being the most common finding 
(Davidson et al., 2015; Rollins and Newburger, 2014).  
  
Environmental factors have a significant impact on motor outcomes. Prolonged and 
repeated hospitalisation (Long et al., 2011; Dittrich et al., 2003), hyperalgesia (Long et al., 
2011), musculoskeletal impairments (Long et al., 2011) and hypotonia (Rollins and 
Newburger, 2014) can all adversely affect gross motor and fine motor development. 
Maternal overprotection may further contributes to poor motor outcomes (Knowles and Bull, 
2012). Delayed milestone acquisition in prone is common in children with CHD as a result 
of a lack of exposure to prone positioning. Prone positioning is often avoided due to 
respiratory compromise, immobilisation in hospital and post-sternotomy (Long et al., 2011). 
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Reduced endurance during physical activity is also associated with delayed motor 
development (Hövels-Gürich et al., 2006). 
 
Fine and gross motor functioning is critical to overall physical functioning and depending on 
the severity of the motor impairments, may also affect cognitive, behavioural and 
psychosocial outcomes as well (Marino et al., 2012).  Motor development outcomes may be 
variable over time due in part to the natural variability that occurs throughout typical infant 
gross motor development (Long et al., 2012b). At school age, 42.5% of children who 
underwent cardiac surgery in infancy still exhibit motor problems. The risk of having some 
degree of motor difficulty was shown to be six times greater, and the risk of severe motor 
impairment was eleven times greater for children with CHD compared to their healthy peers 
at school-going age (Marino et al., 2012).  
 
Reports on motor outcomes in children with CHD in the literature are conflicting with some 
authors reporting that in some children early motor impairments tend to resolve over time 
(Wilson et al., 2015; Mussatto et al., 2014; Chock et al., 2012; Hoskoppel et al., 2010), whilst 
other authors report motor problems persisting throughout childhood and adolescence 
(Riehle-Colarusso et al., 2015; Schaefer et al., 2013; Von Rhein et al., 2012). The 
contradictory findings may possibly be explained by the varying patient profiles of the 
children included in these studies relating to both age and disease severity.  
 
2.3.5.2.2 Cognitive development  
 
Cognitive difficulties tend to become more apparent as the developmental skills become 
more complex with increasing age (Wilson et al., 2015; Mussatto et al., 2014; Martinez-
Biarge et al., 2013; Long et al., 2012b; Tabbutt et al., 2012; Sananes et al., 2012; Snookes 
et al., 2010). Long et al. (2012a) noted mild cognitive delays in 17% and moderate cognitive 
delays in 2% of children aged two years with CHD. Cognitive deficits in children not requiring 
cardiac surgery in infancy are often subtle or absent (Tabbutt et al., 2012). There is an 
increased frequency of poor cognitive outcomes in children with more complex types of 
CHD, including TGA, TOF, single ventricle physiologies and HLHS (Riehle-Colarusso et al., 
2015). Children who have neurological abnormalities and/ or abnormalities on neuroimaging 
studies were also shown to have worse cognitive outcomes (Von Rhein et al., 2011). 
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The patterns of developmental impairment in children with CHD displayed during the 
preschool years place them at high risk for difficulties as they go on to face the challenges 
and demands of the school environment (Sananes et al., 2012). Mild cognitive difficulties 
are cumulative and limit the child as they grow older and enter school (Sarrechia et al., 2015; 
Knowles and Bull, 2012). Despite their intelligence quotient (IQ) being in the normal range 
(Bellinger et al., 2011; Donofrio and Massaro, 2010), many school-aged children and 
adolescents with CHD display mild cognitive deficits. 
  
One in three children with CHD have educational concerns raised by parents, the teacher, 
or the child (Davidson et al., 2015; Wilson et al., 2015; Martinez-Biarge et al., 2013). It is 
estimated that up to 50% of school-aged children with CHD require rehabilitation services 
(including PT, OT and ST) and remedial educational services (Gaynor et al., 2015; Riehle-
Colarusso et al., 2015; Wilson et al., 2015; Knowles and Bull, 2012; Marino et al., 2012). 
According to Bellinger et al. (2011), 33% of school-aged children followed up as part of the 
BCAS required tutoring, 25% received special education and 17% had to be kept back at 
least one grade in school.   
 
Mild cognitive deficits that  are present in childhood  may persist into adulthood (Riehle-
Colarusso et al., 2015; Schaefer et al., 2013; Von Rhein et al., 2012), limiting educational 
achievement, employability and ultimately HRQOL (Davidson et al., 2015; Gaynor et al., 
2015; Sarrechia et al., 2015; Wilson et al., 2015; Marino et al., 2012; Bellinger et al., 2011).  
 
2.3.5.2.3 Language development  
 
Children who have CHD with genetic syndromes or have undergone extracorporeal 
membrane oxygenation therapy (ECMO) are at a higher risk for sensorineural hearing loss. 
This hearing loss may be subtle and may go unidentified during the first year of life (Marino 
et al., 2012). Hearing loss may impair normal language development. Language difficulties 
tend to become more apparent as the skills become more complex with increasing age 
(Wilson et al., 2015; Mussatto et al., 2014; Martinez-Biarge et al., 2013). Language is one 
of the neurodevelopmental aspects most frequently affected in school-age children with 
CHD (Rollins and Newburger, 2014).   
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Mild speech and language delays reported after cardiac surgery in pre-school children with 
CHD; problems however seem less marked by school age. Subtle delays in expressive and 
receptive language have been reported in up to 40% of children with CHD (Knowles and 
Bull, 2012; Gerdes and Flynn, 2010).  
 
In some children with CHD, language deficits relate to the level of cognitive functioning, 
while for other children it appears that language dysfunction may be an area of particular 
deficit in itself (Gerdes and Flynn, 2010). At school entry, language impairments may 
contribute to the social and academic challenges faced by children with CHD (Sarrechia et 
al., 2015; Brosig et al., 2014; Gerdes and Flynn, 2010). 
 
2.3.5.2.4 Behavioural and psychosocial outcomes 
 
There is growing consensus that children with CHD are at increased risk of behavioural 
difficulties and social incompetence (Davidson et al., 2015; Wilson et al., 2015; McCusker 
et al., 2013; Bellinger et al., 2009). The reported prevalence of psychosocial problems in 
children with CHD ranges between 15 and 25% (Brosig et al., 2014; Rollins and Newburger, 
2014; Marino et al., 2012). 
 
Children with CHD are three to four times more likely to present with inattention and 
hyperactivity than the population norm (Wilson et al., 2015; Tabbutt, 2013; Tabbutt et al., 
2012). Up to 50% of children present with signs of inattention and hyperactivity (Mahle, 
2015; Liamlahi et al., 2014; Marino et al., 2012). Cardiac surgery with CPB during infancy is 
thought to increase the risk of attention deficits (Davidson et al., 2015; Wilson et al., 2015; 
Gerdes and Flynn, 2010). Children with CHD with attention deficit hyperactivity disorder 
(ADHD) are at high risk of poor academic performance, and social and behavioural 
difficulties in childhood (Rollins and Newburger, 2014; McCusker et al., 2013; Schaefer et 
al., 2013; Marino et al., 2012). In addition, children with CHD have been found to be at a 
slightly increased risk for autism spectrum disorders compared with the population norm 
(Marino et al., 2012). 
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2.3.6 Developmental outcomes in children with congenital heart disease with Down 
syndrome 
 
An important feature of children with DS is that their development is considerably delayed 
when compared to their typically developing peers (Van Gameren-Oosterom et al., 2011). 
Children with DS acquire gross motor and fine motor skills at a slower rate compared to 
typically developing children (Alsaied et al., 2016; Bertoti and Schreiner, 2015). Intellectual 
disability and hypotonia are present in nearly all children with DS (Visootsak et al., 2011).  
 
Hypotonia and joint laxity contribute significantly to the delay in acquisition of gross motor 
skills. Children with DS also experience difficulties in postural and antigravity control, as well 
as balance and coordination (Bertoti and Schreiner, 2015; Visootsak et al., 2011). Motor 
impairments, may also result in secondary impairments related to cognition, 
communications and socialisation (Bertoti and Schreiner, 2015; Visootsak et al., 2011). 
Intellectual disability results in difficulties with academic activities such as reading, writing 
and mathematics (Alsaied et al., 2016; Van Gameren-Oosterom et al., 2011). School-aged 
children with DS show significant impairments in executive brain function (Alsaied et al., 
2016). Impairments in both expressive and receptive language, and speech problems are 
prevalent in children with DS (Alsaied et al., 2016; Van Gameren-Oosterom et al., 2011; 
Visootsak et al., 2011). Other developmental disorders associated with DS include autism 
spectrum disorder (7%) and ADHD (6 to 9%) (Alsaied et al., 2016; Van Gameren-Oosterom 
et al., 2011).  
 
As indicated above children with known genetic syndromes such as DS tend to have 
significant delays across all developmental domains (Mussatto et al., 2014). In addition, 
children with CHD are at increased risk for neurodevelopmental problems (Alsaied et al., 
2016). The neurodevelopmental outcome after cardiac surgery is worse for children with 
genetic syndromes than for children without a genetic syndrome (Gaynor et al., 2015; 
Mussatto et al., 2015; Naguib et al., 2015; Marino et al., 2012; Tabbutt et al., 2012; Goldberg 
et al., 2011; Long et al., 2011; Fuller et al., 2009; Joynt et al., 2009). Worse outcomes in 
children with genetic abnormalities may be related to gene-environment interactions 
involving susceptible genes in multiple biological systems (including inflammatory and 
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oxidative pathways, coagulation cascades and the response to hypoxia/ischaemia) that may 
exacerbate the extent of the CNS injury after cardiac surgery (Marino et al., 2012).  
 
The impact that CHD has on the neurodevelopment of children with DS is largely unknown 
(Alsaied et al., 2016). Most neurodevelopmental outcome studies in children with CHD 
conducted to date have specifically excluded children with chromosomal abnormalities, as 
chromosomal abnormalities associated with CHD are also independently associated with 
developmental delays and disorders (Rappaport, 2015). This has resulted in very little 
information being available on the course of development in children presenting with both 
CHD and DS, despite them being at even greater risk of adverse neurodevelopmental 
outcomes (Visootsak et al., 2011). Only studies by Alsaied et al. (2016) and Visootsak et al. 
(2011) have specifically investigated the impact of CHD on neurodevelopmental outcome in 
children with DS.  
 
Alsaied et al. (2016) performed a single centre retrospective chart review of 1092 children 
younger than 18 years with DS that included 36 infants and toddlers with 12 children with 
DS with CHD and 24 with DS without CHD. Neurodevelopment in children younger than 
three years was determined using the BSID-III. They reported significant early motor and 
language delays in children younger than three years with DS with CHD. Visootsak et al. 
(2011) compared the developmental outcome of 12 children with AVSDs with DS and 17 
children with DS without CHD using the BSID-III. They found that children with CHD with 
DS had significantly worse motor outcomes than children with CHD without DS. Cognitive 
and language development was poorer in children with CHD with DS compared to those 
with DS alone, but not significantly so. They attributed poorer developmental performance 
in children with CHD with DS to the fact that pre-operatively these children presented with 
poorer endurance and tired more easily. Post-operative hypotonia, asymmetry and 
decreased levels of alertness were also believed to contribute to worse developmental 
outcomes. CHD with DS requiring early surgical intervention and initial prolonged 
hospitalisation could also be seen to limit early therapeutic intervention which could also 
have negatively affected developmental outcome.  
 
The combined results of the studies by Visootsak et al. (2011) and Alsaied et al. (2016) can 
be viewed to similarly suggest that children with CHD with DS have worse developmental 
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outcomes than children with CHD or DS alone across all developmental domains, in 
particular with regard to motor development.  
 
Mussatto et al. (2014) conducted one of the only neurodevelopmental outcome studies to 
have included children with genetic abnormalities in the sample of a longitudinal 
neurodevelopmental follow-up study. Twenty percent of their study sample had genetic 
syndromes, including DS. They reported that genetic comorbidities were a risk factor for 
adverse neurodevelopmental outcome, and that 74% of the participants with known genetic 
syndromes in their study were found to have severe developmental delays. For children with 
genetic syndromes, cognitive and language scores on the BSID-III declined over time, and 
motor scores consistently remained poor. 
 
2.3.7 Decreasing developmental morbidity in children with congenital heart disease: 
Implications for clinical practice 
 
The AHA (2012) published a specific guideline targeting the identification and management 
of neurodevelopment in children with CHD (Marino et al., 2012). Consensus opinion is that 
developmental surveillance should form part of routine cardiac care (Marino et al., 2012), 
Periodic developmental surveillance, screening, evaluation, and re-evaluation at specific 
age points, including the first year of life, at school entry, middle school, and again in 
adolescence is recommended (Mahle, 2015; Mussatto et al., 2014; Marino, 2013; Marino et 
al., 2012). The goal of the guideline is to identify those children at greatest risk of 
developmental morbidity through childhood and adolescence, and to create opportunities 
for early developmental intervention and support to optimise the development, academic, 
behavioural, psychosocial, and adaptive functioning of the child (Knutson et al., 2016; 
Marino et al., 2012). Evaluation should also include growth monitoring, neuromotor 
examination, and hearing screening (Marino et al., 2012).  
 
In accordance with the AHA (2012) guideline children with a genetic abnormality or 
syndrome are to be considered at high risk of developmental delay and disability. Both 
Alsaied et al. (2016) and Visootsak et al. (2011) recommend that in children with DS 
development be evaluated soon after birth, and they be referred for early developmental 
intervention (Alsaied et al., 2016; Visootsak et al., 2011). 
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Early developmental intervention in children with CHD is discussed in Chapter 7. 
 
2.3.8 Childhood development in developing countries 
 
A large number of children in developing countries are exposed to multiple risks for poor 
development.  In addition to a diagnosis of CHD, other factors such as poverty, poor health 
and inadequate nutrition influence developmental outcome in children living in developing 
countries, including SA (Grantham-McGregor et al., 2007). Social disadvantage is 
considered a major risk to the childhood development. Poverty is associated with low levels 
of maternal education, increased maternal stress and depression, and inadequate 
developmental stimulation within the home. These are all factors that negatively affect 
childhood development (Grantham-McGregor et al., 2007). A lack of responsive parenting 
and inadequate stimulation within the home affects childhood development by disrupting the 
brain’s neuronal circuitry (Engle et al., 2007). Appropriate interactions between a caregiver 
and child are critical to the development of the necessary cognitive and social-emotional 
skills that will serve as the foundation of later academic success (Engle et al., 2007). 
 
As previously highlighted (Refer to 1.2) development outcomes for children living with CHD 
in developing countries are likely to be negatively impacted by late diagnosis (Reuters, 
South Africa, 2015), a lack of access to specialist care (Hoosen et al., 2010a; Hoosen et al., 
2010b), the availability of mechanical circulatory support technologies (Carte Blanche, 2017; 
Hoosen et al., 2010a) and long waiting periods for cardiac surgery (Hoosen et al.,  2010a; 
Hoosen et al., 2010b). Delayed treatment, prolonging the duration of cardiovascular 
compromise, could potentially increase the magnitude of the neurological insult suffered by 
children with CHD in developing countries.   
 
Furthermore communicable diseases such as HIV may also threaten childhood 
development (Refer to 1.2). HIV-infection in infancy may cause severe encephalopathy 
resulting in severe developmental impairment. Even in HIV-infected children with less 
severe outcomes, there is an increased risk of developmental delay across all 
developmental domains (Potterton et al., 2010; Walker et al., 2007). The pathways from 
poverty to poor childhood development are shown in Figure 2.1. 
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Figure 2.1 Pathways from poverty to poor development (Walker et al., 2007,  
p 146). 
 
2.3.9 Summary  
 
Children with CHD are at risk of neurodisability regardless of the severity of their cardiac 
disease. A better understanding has begun to emerge of the patterns of neurodevelopment 
in children with CHD, and the patient-specific and management- specific factors that place 
these children at increased risk of developmental morbidity. Children with CHD have been 
found to present with a distinctive pattern of neurodevelopmental and behavioural 
impairment characterised by mild impairments in cognition, motor skills, language, 
inattention, impulsivity, impaired executive function and psychosocial maladjustment. The 
extent and nature of the deficits have been found to change with developmental age.   
 
Apart from CHD, children in developing countries are exposed to multiple other risks for poor 
development associated with social disadvantage, including inadequate stimulation within 
the home, and increased maternal stress and depression resulting in unresponsive 
parenting and inadequate nutrition. In addition, communicable diseases, especially HIV co-
infection, may also threaten developmental outcome. 
 
Based on neurodevelopmental outcome findings, the American Heart Association (2012) 
guidelines recommend regular neurodevelopmental follow-up should form part of routine 
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cardiac care. On diagnosis of developmental problems, child should be referred for EI 
services in order to optimise functional outcome and family participation. However, the 
model best suited to deliver EI services in this population in yet to be determined.  
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2.4 GROWTH FAILURE AND FEEDING DIFFICULTIES IN CHILDREN WITH 
CONGENITAL HEART DISEASE 
 
2.4.1 Introduction 
 
Inadequate nutrition is a coexisting concern for children with CHD. Nutritional deficiency, 
growth failure and feeding problems are associated with worse developmental outcome. 
Growth status is now considered an important measure of the child with CHD’s health and 
wellbeing. (Irving, 2011). Therefore, it was deemed pertinent to review the role of nutrition 
in CHD outcomes.  
 
2.4.2 Growth trends in children with congenital heart disease 
 
Growth is considered an important global indicator of children’s health and wellbeing 
(Okoromah et al., 2011). Nutritional status during the early years of life has a significant 
impact on the overall health and wellbeing of the child (Grantham-McGregor et al., 2007; 
Martorell, 1999). Improved survival in children with CHD has brought to light the fact that 
children with CHD face several challenges relating to both growth and feeding, which in turn 
affect development (Daymont et al., 2013; Ravishankar et al., 2013; Roman, 2011; Knirsch 
et al., 2010). Children with CHD may present with growth failure, as well as a feeding 
dysfunction (Medoff-Cooper et al., 2016).  
 
Growth failure is a risk factor for adverse developmental outcome in children with CHD, and 
is associated with impaired cognitive and motor development outcomes (Lata et al., 2015; 
Irving, 2011). Nutrition is however considered a modifiable risk factor for developmental 
outcome (Medoff-Cooper et al., 2016; Knirsch et al., 2010). As a result, there is an increased 
interest in nutrition-related aspects, such as feeding ability and growth trajectories, in this 
population as possible predictors of developmental outcome (Medoff-Cooper et al., 2016).  
 
2.4.3 Malnutrition and growth failure in children with congenital heart disease  
 
Malnutrition (undernutrition) and growth failure are common in children with CHD, both 
before and after medical and surgical intervention (Irving, 2011; Varan et al., 1999). The 
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severity of the malnutrition can range from mild to severe, resulting in failure to thrive (FTT) 
(Wheat, 2002; Varan et al., 1999). In more severe cases, malnutrition may result in 
permanent physical or developmental impairment (Wheat, 2002). There is also a high 
occurrence of protein energy malnutrition (PEM) in children with CHD (Knirsch et al., 2010). 
Growth failure, FTT, growth retardation, undernutrition and PEM are terms that are used 
interchangeably to describe less-than-adequate weight gain and poor physical development 
in young children (Cole and Lanham, 2011; Irving, 2011). Malnutrition results from a diet 
that provides inadequate calories and protein for growth, or where the child is unable to fully 
utilise the food he/she consumes due to illness (Blössner and De Onis, 2005).  
 
The WHO (2006) criteria for the determination of malnutrition indicates that a cut-off z-score 
of ≤−2 standard deviations (SD) below the age- and gender-specific median for the normal 
population classifies as a low weight-for-age z-score (WAZ) (underweight), low height-for-
age z-score (HAZ) (stunting), and low weight-for-height z-score (WHZ) (wasting). Z-scores 
of ≤−2 SD equate to moderate malnutrition, stunting and wasting. Z-scores of ≤−3 SD below 
the age- and gender-specific median for the normal population equates to severe 
malnutrition, stunting and wasting. Weight-for-age z-scores between −2 and 2 indicate 
normal nutrition (Wang and Chen, 2012; Roman, 2011; WHO, 2006). Stunting (height-for-
age ≤ -2 SD below the normal) is to be considered an indicator of chronic malnutrition 
(Ravishankar et al., 2013; Wang and Chen, 2012).  
 
Even if the child with CHD is born with a weight that is appropriate for gestational age, growth 
failure typically becomes apparent during the neonatal period if haemodynamically 
significant CHD is present. Estimates of malnutrition in unrepaired CHD in infants ranges 
between 50 and 90% (Roman, 2011). Infants and young children are the most vulnerable to 
malnutrition and FTT because of their high nutritional requirements for growth and 
development (Blössner and De Onis, 2005).  
 
Malnutrition and growth failure can have a notable effect on the outcome of cardiac surgery 
(Okoromah et al., 2011; Varan et al., 1999). Post-surgery growth, and in particular weight 
gain, is considered a measure of surgical success and disease management (Irving, 2011).  
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 In addition, children with poor growth tend to be more susceptible to infectious diseases, 
such as meningitis and pneumonia, which also contribute to mortality and morbidity 
(Okoromah et al., 2011).  
 
2.4.4 Causes of growth failure in children with congenital heart disease  
 
The causes of malnutrition and FTT in children with CHD is most often multifactorial. Causes 
can be divided into three key categories namely; inadequate intake of nutrients, increased 
energy needs and ineffective nutrient absorption (Roman, 2011).  
 
2.4.4.1 Inadequate calorie intake 
 
Inadequate calorie intake has been shown to be the most important cause of growth 
disturbances in children with CHD (Lata et al., 2015; Daymont et al., 2013; Wheat, 2002; 
Varan et al., 1999). Reasons for inadequate calorie intake may include fatigue during 
feeding and malabsorption (Daymont et al., 2013; Wheat, 2002). Chronic hypoxia causes 
both dyspnoea and tachypnoea during feeding resulting in the child tiring easily, reducing 
the quantity of food consumed (Wheat, 2002). Cardiopulmonary dysfunction may therefore 
lead to an inability to feed adequately, children may require a longer time to feed, or may 
present with a lack of appetite and refuse food intake (Da Rosa Pereira et al., 2015; Roman, 
2011). Feeding problems may also contribute to inadequate food intake (Refer to section 
2.4.7) (Daymont et al., 2013; Roman, 2011; Wheat, 2002).  
 
2.4.4.2 Increased metabolism 
 
Increased metabolism due to the cardiac defect causes a state of constant metabolic stress, 
resulting in increased energy expenditure (Lata et al., 2015; Daymont et al., 2013; Knirsch 
et al., 2010; Wheat, 2002; Varan et al., 1999). Children with CHD also have less body fat 
and a higher percentage of lean body mass, which increases their metabolic rate (Roman, 
2011; Long et al., 2011; Wheat, 2002). Other reasons for increased energy expenditure 
include tachypnoea, tachycardia, cardiac hypertrophy, polycythaemia, increased 
sympathetic nervous system activity, and sepsis(Roman, 2011). 
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2.4.4.3 Inadequate and ineffective nutrient absorption 
 
Inadequate or ineffective nutrient absorption after birth in children with CHD may occur due 
to vomiting, reduced splanchnic blood flow, poor gastric emptying and altered gut motility, 
oedema of the small intestine (in the case of right-sided cardiac failure), excessive nutrient 
loss including protein and trace nutrients, gut mucosal atrophy leading to malabsorption in 
childrenwith significant pre-existing malnutrition, and IGF-1 deficiency(Roman, 2011). 
 
2.4.4.4 Additional factors contributing to growth failure 
 
Other factors that may play a role in growth failure in children with CHD include abnormal 
foetal blood flow and intrauterine growth restriction (Knirsch et al., 2010) and low birth weight 
(Roman, 2011; Knirsch et al., 2010).  
 
The extent and type of malnutrition may be related to characteristics of the CHD, including 
presence of cyanosis, CCF or PHTN (Daymont et al., 2013; Tabbutt et al., 2012; Roman, 
2011). The duration of cyanosis appears to be more important than the severity of the CHD 
in determining the extent of the malnutrition (Daymont et al., 2013; Tabbutt et al., 2012; 
Roman, 2011). According to Okoromah et al. (2011) most children with CHD showed 
wasting rather than underweight and stunting. Wasting was associated with acyanotic CHD, 
whilst stunting was linked to cyanotic CHD. Children with complex CHD show large, early, 
and sustained decreases in growth trajectories (Daymont et al., 2013).  
 
Chromosomal abnormalities (Daymont et al., 2013; Knirsch et al., 2010) and non-cardiac 
abnormalities (Daymont et al., 2013) are linked to poor growth. (Refer to 2.4.6). Cardio active 
medication is also known to have nutrition-related side effects (Roman, 2011). Malnutrition 
may also be due to decreased growth factors and hormonal changes (Lata et al., 2015; 
Daymont et al., 2013). 
 
Figure 2.2 proves a schematic representation of the factors affecting growth in children with 
CHD. 
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Figure 2.2 Potential influences on growth in children with CHD (Irving, 2011, p 29). 
 
2.4.5 Growth outcomes in children with congenital heart disease 
 
The consequences of malnutrition in the short term for children with CHD include an 
impaired ability to fight infection and for surgical wounds to heal optimally. Infants with poor 
nutritional status tend to have a prolonged ICU and total hospital length of stay post-cardiac 
surgery (Roman, 2011). Over the longer term, malnutrition results in suboptimal growth and 
impaired physical development (Roman, 2011). Growth status in childhood is also linked to 
adult height and weight (Daymont et al., 2013; Tabbutt et al., 2012). Some children with 
CHD do show significant growth catch-up after corrective or palliative cardiac surgery. 
Children who undergo surgery in infancy have a better chance of improving both their weight 
and length growth (Roman, 2011).  
 
There are a limited number of published studies reporting specifically on the growth 
outcomes of young children with CHD. Studies in developed countries include those by 
Infant with CHD Disease severity  
Weight-,  
Height- and 
Head 
circumference- 
for age  Cardiac haemodynamics 
Nutrient intake 
Malabsporption 
Neurologic factors  
Surgical factors 
Post-operative course  
Influencing factors 
Energy Balance   
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
52 
 
Medoff-Cooper et al. (2016), Costello et al. (2015), Daymont et al. (2013), Ravishankar et 
al. (2013) and Irving (2011). 
 
Medoff-Cooper et al. (2016) investigated the association between growth and device-
assisted feeding and the early neurodevelopmental outcome in infants with CHD. Their 
prospective cohort study included 72 infants with complex CHD who underwent cardiac 
surgery. They found that 30% of their study participants had weight for age z-scores of ≤ -2 
SDs from the norm. Infants with complex CHD who required device assisted feeding and 
those who showed growth failure at three months of age were found to be at risk of 
developmental delay at six and 12 months of age. 
 
Costello et al. (2015) aimed to determine the prevalence of growth failure in infants and 
young children with CHD and establish the relationship between poor growth, feeding 
difficulties, disease severity, and nutritional intervention on outcomes. This prospective 
cohort study in Australia collected growth data for 78 children with CHD younger than three 
years. They found that 23% of their participants demonstrated growth restrictions as 
evidenced by z-scores of ≤−2 for weight-for-age and 21% for length-for-age. Growth failure 
was found to be high especially prior to cardiac intervention. No relationship was found in 
their study between the presence of cyanosis and growth. Half of the participants were found 
to have feeding difficulty on admission, and this was associated with poorer growth.  
 
Daymont et al. (2013) described the growth outcomes of 248 young children with CHD in a 
retrospective cohort matched study in the US. They found that children with single ventricle 
physiology and those requiring surgical intervention showed a significant decrease in 
weight-for-age and length-for-age, which appeared within the first month of life, then peaked 
near four months of age, and persisted through 24 to 36 months of life. By 36 months, it was 
found their growth had not yet caught up. They also noted microcephaly in 3% of children 
with CHD, making them more likely to have microcephaly than their healthy same aged 
peers. They deducted that the presence of microcephaly was indicative of restricted brain 
growth during the critical developmental period of infancy, which potentially could have 
lifelong consequences for neurodevelopment. 
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Ravishankar et al. (2013) conducted a multi-centre randomised controlled clinical drug trial 
in North America to investigate whether Enalapril improved growth and ventricular function 
in 230 children with single ventricle physiology.  They concluded that poor height-for-age    
z-score trajectories in early infancy were associated with neurodevelopmental disability.  
 
Irving (2011) looked at patterns of weight change in infants with CHD following neonatal 
cardiac surgery, aiming to identify potential predictors of growth failure. She reported that 
50% of infants with CHD in their study exhibited poor growth early on in life and 30% fell 
below the third percentile for weight on standard growth charts for age and gender during 
infancy. They reported a pattern of poor growth in the birth to three-month interval across 
gender. 
 
Published data on the growth outcomes of children with CHD in developing countries, and 
in particular African countries, is scant. Studies published in developing countries include 
those by Lata et al. (2015), Okoromah et al. (2011), Vaidyanathan et al. (2008) and Varan 
et al. (1999). 
 
Lata et al. (2015) investigated the neurodevelopmental outcome of 75 children aged six to 
30 months in India. As part of their outcomes they assessed growth, and reported that 57.3% 
of the children in their study had weight ≤ -3 SD from the norm. Low pre-operative weight 
and older age at surgery were found to be associated with post-operative weight below the 
tenth percentile. 
 
Okoromah et al. (2011), in an observational case-control study done in Nigeria, investigated 
the prevalence of malnutrition in 73 children with CHD aged three to 192 months. They 
reported a prevalence of malnutrition of 90.4% in the children in their study, and in 61.2 % 
of cases the malnutrition was found to be severe. ͒
 
Vaidyanathan et al. (2008) conducted a prospective cohort study in India, investigating the 
determinants of malnutrition in 476 children with CHD under the age of five years. They 
reported a very high prevalence of malnutrition in children undergoing cardiac surgery. At 
three-month post-cardiac surgery they found that 55.9% had weight-for-age, and 26.3% had 
height-for-age ≤ -2 SD from the norm, while 27.7% had weight-for-age and 10.1% had 
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height-for-age ≤ -3 SD from the norm.  
 
Varan et al. (1999) investigated the prevalence of malnutrition and growth failure in 89 
Turkish children with CHD aged one to 45 months. They reported that 65.2% of the children 
were below the fifth percentile for weight, and 41.6% were below the fifth percentile for both 
weight and height. Moderate to severe malnutrition was more common in children with 
cyanotic CHD. 
 
2.4.6 Growth outcomes in children with congenital heart disease and Down syndrome 
 
Children with DS have different growth trajectories from the general paediatric population. 
Children with DS have been shown to have lower birth weights and a slower growth rate. 
They are also characterised by short stature and a tendency to overweight and obesity in 
later childhood (Zemel et al., 2015; Bravo-Valenzuela et al., 2011; Myrelid et al., 2002). 
Growth outcomes for children with DS have improved over recent decades due to advances 
in- and increased access to medical care (Zemel et al., 2015). Growth failure in infants with 
DS may occur due to feeding difficulties and other medical problems (Charleton et al., 2010).   
 
There are few studies that have specifically investigated the growth outcomes in children 
with CHD with DS. Bravo-Valenzuela et al. (2011) retrospectively investigated the impact of 
CHD with DS, on the weight and height recovery after surgical correction in 181 children 
with DS, from birth until 18 years. They found that children with DS who had cardiac disease 
requiring surgical intervention showed greater weight and height impairments, with 55% of 
the children in their sample being malnourished and 60% stunted. Weight and height 
recovery after surgery occurred in most cases in a period of six months to one year. 
 
Van Gameren-Oosterom et al. (2012), on the other hand, investigated growth outcomes in 
890 Dutch children with DS. Of their sample 234 children were also diagnosed with CHD. 
They found that the growth outcomes of healthy children with DS and those with mild CHD 
to be similar. However, the children with severe CHD showed significantly poorer growth 
outcomes. These authors reported that growth failure arose in the first year of life, but no 
further growth deflection neither catch-up growth occurred.  
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Knirsch et al. (2010) examined the determinants of growth failure and their association with 
neurodevelopmental outcome in a sample of 107 infants in Switzerland, which also included 
infants with genetic comorbidity. Fifteen of the children in their sample had CHD with DS. 
They reported that the extent of the growth failure was significantly greater in children with 
CHD with genetic comorbidity, finding genetic comorbidity to be the single most significant 
predictor of poor catch-up growth post-surgery.   
 
From the reported studies to date, it can be best concluded that children with mild CHD 
follow similar growth trajectories to healthy children with DS without CHD. Children with 
severe CHD tend to exhibit significant growth failure across all growth parameters. Infants 
tend to show considerable catch-up growth after corrective cardiac surgery in infancy. 
 
2.4.7 Feeding problems in children with congenital heart disease  
 
Feeding difficulties are common in children with CHD, with feeding dysfunction noted in 
upwards of half of children with CHD (Medoff-Cooper et al., 2016; Costello et al., 2015; Da 
Rosa Peirera et al., 2015; Brosig et al., 2014). Early sucking and swallowing difficulties have 
been associated with growth failure and poorer catch-up growth (Medoff-Cooper et al., 
2016). Children undergoing cardiac surgery in infancy have a high risk of presenting with 
feeding difficulties up until the age of two years (Da Rosa Peirera et al., 2015). Feeding 
difficulties may present as swallowing dysfunction or gastroesophageal reflux disease 
(GORD) (Da Rosa Pereira et al., 2015). 
 
Poor oral feeding post-cardiac surgery, and the need for a medical feeding appliance are 
associated with prolonged hospital length-of-stay and impaired HRQOL (Costello et al., 
2015; Da Rosa Pereira et al., 2015; Tabbutt et al., 2012). The use of a feeding appliance 
may adversely affect cognitive development as it may interfere with the exploratory activities 
of a child (Da Rosa Pereira et al., 2015). Abnormal brain development (Mussatto et al., 
2014), and brain immaturity resulting from the CHD (Medoff-Cooper et al., 2016) may result 
in abnormal feeding, and are considered to put the child with CHD at risk of developmental 
delay (Mussatto et al., 2014). 
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In addition, feeding problems may be exacerbated in children with CHD with genetic 
abnormalities or syndromes where feeding difficulties also arise for reasons unrelated to the 
CHD (Roman, 2011). Children with DS have feeding difficulties because of their poor oral 
motor function resulting from hypotonia of the oral musculature and a protuberant tongue 
which interferes with feeding (Charleton et al., 2010). 
 
2.4.8 Relationship between growth and developmental outcome in children with 
congenital heart disease 
 
Malnutrition and growth failure is a risk factor for poor developmental outcome in vulnerable 
children with CHD (Lata et al., 2015; Daymont et al., 2013; Tabbutt et al., 2012; Irving, 2011). 
The impact of poor growth on neurodevelopmental outcome in infants with CHD has not 
been widely studied to date (Ravishankar et al., 2013). Poor nutrition during the foetal period 
results in a reduction in brain size. The late foetal period is a period of rapid brain growth, 
and during this period the brain is particularly vulnerable to inadequate nutrition (Medoff-
Cooper et al., 2016). Available literature suggests that adequate nutrition is essential to 
optimise brain growth during the first months of life (Medoff-Cooper et al., 2016). 
 
Adequate nutrient intake in infancy is crucial to promote a positive energy balance to support 
brain growth, neurodevelopment, and physical maturation (Irving, 2011). Children who post-
cardiac surgery still have unresolved cardiac problems, or those with genetic and other 
congenital abnormalities that affect growth may miss the critical window for appropriate 
growth (Roman, 2011). These children may have fewer body cells including adipose, 
muscle, and bone cells resulting in poor growth and delayed maturation of the bony skeleton, 
but also result in poor of motor skills. Children younger than three years with cyanotic heart 
defects younger, tend to have lower than normal intelligence scores, due to lower brain 
weight impairing cognitive function (Roman, 2011). The use of a medical feeding appliance, 
such as feeding tube, has also been found to be associated with an increased risk of poor 
cognitive and motor development outcomes (Medoff-Cooper et al., 2016).  
 
Poor nutrition during the intrauterine period and early years adversely affects motor 
development and cognitive development (IQ scores are lower) in children with CHD, and 
results in deficient social skills, behavioural problems, decreased attention, learning 
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problems and poorer academic achievement at school (Medoff-Cooper et al., 2016; Lata et 
al., 2015; Irving, 2012; Okoromah et al., 2011; Martorell, 1999).  
 
In addition, infants with CHD who have inadequate nutrition may lack the muscle strength 
and energy needed for typical age–related developmental activities. This would result in 
them tiring easily with physical activity resulting in delays in the achievement of age 
appropriate gross motor milestones (Long et al., 2011). Irving (2011) also found infants with 
growth failure to be more irritable and more difficult to parent.  
 
2.4.9 Growth in children in developing countries 
 
Growth in infants and young children is directly related to the socioeconomic environment 
in which they live (Lunn, 2002). Malnutrition and SES are closely linked in that poverty 
results in inadequate food being available for consumption (Grantham-McGregor et al., 
2007; Martorell, 1999). In turn, inadequate nutrition due to poor socioeconomic 
circumstances has been found to inhibit brain growth (Balter, 2015). 
 
Poverty-related factors including households’ low socio-economic status, food insecurity, 
poor quality diets, poor maternal health before, during and after pregnancy, and the high 
prevalence of infectious diseases mediate growth failure in children living in developing 
countries (Grantham-McGregor et al., 2007; Lunn, 2002).  
 
Children from developing countries grow more slowly (Lunn, 2002). Growth faltering in 
children in developing countries begins in utero or shortly after birth, becoming pronounced 
in the first 12 to 18 months of life. It is possible that it can even continue to around 40 months 
of age, after which it levels off. Some catch-up may occur but most stunted children remain 
stunted through to adulthood (Grantham-McGregor et al., 2007; Lunn, 2002). Sub-Saharan 
Africa and South Asia are home to three-quarters of the world’s stunted children. In sub-
Saharan Africa, 40% of children under the age of five years are stunted (Said-Mohamed et 
al., 2015; UNICEF-WHO-WB, 2015; UNICEF, 2013). Children from developing countries 
who are stunted have been shown to have poorer cognition, scholastic achievement, and 
psychosocial functioning in later childhood (Ravishankar et al., 2013; Grantham-McGregor 
et al., 2007). Growth failure during infancy has been implicated in impaired development of 
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executive function and poor school performance (Ravishankar et al., 2013; Okoromah et al., 
2011; Grantham-McGregor et al., 1999; Martorell, 1999). 
 
The poor socioeconomic circumstances of many families living in developing countries, is 
likely to amplify the growth-related challenges faced by children living there with CHD due 
the inability of parents to provide an adequate cardiac diet. This situation is even direr for 
single parent, female-headed households, where poverty and vulnerability to financial crisis 
and malnutrition is heightened (Amakali and Small, 2013). 
 
2.4.10 Reducing growth failure in children with congenital heart disease: Implications 
for clinical practice 
 
It is important to identify the cause of poor growth in children with CHD in order to improve 
growth outcomes (Daymont et al., 2013).  Monitoring of growth trajectories and feeding skills 
should be implemented in at risk children with CHD (Medoff-Cooper et al., 2016; Da Rosa 
Peirera et al., 2015; Roman, 2011). Where indicated nutritional interventions such as dietary 
supplementation and nutritional counselling could be beneficial in limiting growth failure 
(Irving, 2011). Strategies to improve feeding skills, such as speech and feeding therapy 
should be recommended for children requiring device assisted feeding (Mussatto et al., 
2014; Wheat, 2002).  
 
2.4.11 Summary   
 
Growth failure is common in children with CHD due to inadequate caloric intake, increased 
metabolic demand and nutrient malabsorption. Many children with CHD also experience 
feeding difficulties including swallowing dysfunction and GORD, which contributes to growth 
failure. Malnutrition and growth failure place children with CHD at risk of poorer 
developmental outcome. Growth outcomes of children with DS and CHD are similar to 
children with DS alone, but is dependent on disease severity. Considerable catch–up growth 
does take place after cardiac intervention. Regular monitoring of growth and feeding skills 
is advised in children with CHD. Where indicated, nutritional interventions and feeding 
therapy could be beneficial in limiting growth failure in these children. 
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2.5 HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH CONGENITAL HEART 
DISEASE 
 
2.5.1 Introduction  
 
Improved survival and advances in the treatment of CHD allows for what is to be considered 
as an almost normal life for many children living with CHD (Amedro et al., 2015; Bertoletti et 
al., 2015; Werner et al., 2014; Eagleson et al., 2013; Nousi and Christou, 2010). However, 
survival is not necessarily synonymous with a good quality of life (Nousi and Christou, 2010). 
It is well documented that children living with CHD present with physical, 
neurodevelopmental and psychosocial morbidities related to complications of their cardiac 
disease and the treatment thereof. This may in turn have a significant impact on their 
wellbeing (Marino et al., 2016; Marino et al., 2010; Nousi and Christou, 2010).  
 
Determining the health status and neurodevelopment of children with CHD has recently 
become a healthcare priority, but determining these outcomes alone will fail to paint the full 
picture of the true impact of CHD and its treatment on the child (Landolt et al., 2008). To 
better understand the full and ongoing extent of the impact of cardiac disease and its 
treatments on the lives of children, attention has to be focused on how CHD affects HRQOL 
through the various stages of childhood development, into adolescence and later adulthood 
(Amedro et al., 2015; Bertoletti et al., 2015; Knowles et al., 2014; Eagleson et al., 2013; 
Uzark et al., 2013; Nousi and Christou, 2010). Psychosocial difficulties of survivors, and 
poor coping and adaptation exhibited by families have become the new hidden morbidities 
of this high-risk population (Uzark et al., 2013; Majnemer et al., 2006b). 
 
As HRQOL continues to emerge as an important outcome measure and health indicator 
(Pike et al., 2007), both healthcare professionals and parents have a responsibility to 
promote coping and the successful adaptation of the child with CHD in their daily 
environment and in their communities to ensure a good QOL (Mussatto, 2006). 
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2.5.2 Defining quality of life, health-related quality of life and wellbeing 
 
There is a lack of consensus in the literature regarding the definition of, and 
conceptualisation of, quality of life (QOL) and health-related quality of life (HRQOL). QOL 
and HRQOL are separate, yet interrelated concepts (Eagleson et al., 2013; Pike et al., 
2007). 
 
QOL is defined as the perception of the individual of their wellbeing and general satisfaction 
with life (Majnemer et al., 2006b). QOL is dynamic and is affected by a person’s ability to 
adapt to disparities in expected and experienced wellbeing, as well as the ability to maintain 
a level of functioning that allows for the pursuit of life goals (Pike et al., 2007). 
 
HRQOL differs from QOL in that it characterises life when a medical condition and the 
treatment thereof is relevant. HRQOL reflects the perception of a person’s health status as 
defined by the impact of a medical condition and its treatment on their life (Marino et al., 
2010; Pike et al., 2007). HRQOL is a multidimensional construct, composed of the person’s 
perception of the impact of disease and treatment on their functioning and ability to derive 
satisfaction in a variety of aspects of life, including in physical, psychological and social 
domains (Eagleson et al., 2013; Pike et al., 2007). Health and wellbeing are concepts closely 
related to HRQOL. The World Health Organisation (WHO) defines health as "a state of 
complete physical, mental, and social wellbeing and not merely the absence of disease or 
infirmity" (WHO, 1948). Wellbeing on the other hand, refers to the positive aspects of a 
person’s life, such as positive emotions and life satisfaction (United States Department of 
Health and Human Services, 2014). 
 
HRQOL can then be defined as the subjective impact of a specific illness and its treatment 
on the ability of the person to both function in and derive personal satisfaction from various 
physical, psychological, and social life aspects of health  (Marino et al., 2016; Werner et al., 
2014; Marino et al., 2010). A better understanding by healthcare professionals of parental 
perceptions of their child with CHD’s HRQOL has the potential to improve both treatment 
and health outcomes (Marino et al., 2016).  
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Figure 2.3 provides a schematic representation of the relationship between cardiac disease-
related morbidity and HRQOL. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Relationship between cardiac disease-related morbidity and HRQOL 
(Marino et al., 2016, p12). 
 
2.5.3 Factors affecting health-related quality of life in children with congenital heart 
disease 
 
Children with CHD, especially those with more complex cardiac disease, are at risk of poorer 
long-term outcomes compared to their healthy same-aged peers. The psychosocial 
outcome of these children is shaped by the medical care they received in infancy, which 
may include recurrent hospitalisations and repeat procedures that may negatively affect 
parent-child attachment. More importantly though, these outcomes are influenced by how 
parents and the extended family integrate medical care and education with the psychosocial 
needs of the child (Berkes et al., 2010). 
 
Numerous factors have been identified to have a negative impact on HRQOL in children 
with CHD. Factors influencing HRQOL may vary in accordance with the child’s 
developmental age and level of physical growth (Marino et al., 2010; Nousi and Christou, 
2010). The factors affecting HRQOL outcomes are however still poorly understood and little 
is known about determinants of HRQOL in this population (Pike et al., 2007). 
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Delayed physical growth with respect to height and weight is the single factor shown to be 
most significantly associated with poor HRQOL in children with CHD. The extent of the 
growth failure varies in accordance with the type and severity of the CHD (Nousi and 
Christou, 2010).  
 
Parents and/or the child’s physical health may impose restrictions on the child’s level of 
physical activity (Nousi and Christou, 2010). Physical activity limitations also curb activities 
of daily living (ADL) such as walking, running and climbing stairs. Physical activity limitations 
in turn may also result in restrictions’ in participatory activities such as play and social 
interactions with same-aged peers, negatively affecting socialisation and community 
participation, diminishing HRQOL (Amedro et al., 2015; Eagleson et al., 2013; Birks et al., 
2006). Miatton et al. (2007) contradicted the aforementioned finding, noting that the physical 
activity levels of children with CHD were similar to that of their healthy same-aged peers. 
The conflicting reports can possibly be explained by the differing patient profiles in the 
represented studies with regard to disease severity. Physical activity is most often only 
limited in children with severe CHD, while most children with mild or moderate forms of CHD 
face very few limitations in this regard.  
 
Anxiety and depression can result from frequent follow-ups and repeated hospitalisations, 
multiple medical procedures and the use of daily medications. Depression and anxiety often 
goes unrecognised or is overlooked in children with CHD as a result of the magnitude of 
other complications and concerns (Bertoletti et al., 2015; Nousi and Christou, 2010; Miatton 
et al., 2007). Children who undergo open heart surgery may also develop a poor body image 
due to the large scar on their chest (Nousi and Christou, 2010).  
 
The family environment is an important determinant of HRQOL. Family functioning has an 
important impact on the life experiences and happiness of the child (Majnemer et al., 2006b). 
Parents who overprotect and project their own distress onto their child may not allow the 
child to take own initiative, leading to poor self-esteem and impaired HRQOL (Nousi and 
Christou, 2010). Contextual factors such as peers, family, school and the community also 
have an important impact on HRQOL in the child with CHD (Bertoletti et al., 2015). 
 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
63 
 
Social disadvantage affects HRQOL outcomes in children with CHD. Low levels of parental 
education, prior to the diagnosis, may result in them not seeking or delay seeking of medical 
assistance, potentially worsening the child’s health and outcome. Parents with low levels of 
education also tend to have difficulties in recognising their child’s need for support, or they 
may ignore its importance, and consequently, their child may show symptoms of anxiety, 
depression or have behavioural problems (Nousi and Christou, 2010). Low SES of the family 
is associated with poor QOL of both the child with CHD and the family. Having to care for a 
child with CHD heightens the financial burden placed on the family, and financial difficulties 
may result in family and marital conflict (Nousi and Christou, 2010). Financial difficulties lead 
to increased levels of parental stress. High levels of parental stress is associated with poorer 
psychosocial wellbeing of the child with CHD (Dulfer͒et al., 2015; Majnemer et al., 2006b). 
Behavioural difficulties of the child are strongly associated with higher levels of parental 
distress (Miatton et al., 2007; Majnemer et al., 2006b). In turn, parents with increased 
distress are more likely to report on behavioural problems in their children (Spijkerboer et 
al., 2010).  
 
Parental QOL may also influence the QOL of the child. The overlap of parental QOL and 
children’s QOL is seemingly due to a shared family environment influencing wellbeing and 
functioning (Goldbeck and Melches, 2005). In addition, the ability of the child and family to 
cope and adapt to adverse experiences related to the child’s CHD has a significant impact 
on the child’s HRQOL (Bertoletti et al., 2015). 
 
2.5.4 Establishing health-related quality of life in children with congenital heart 
disease 
 
HRQOL measures allow for the determination of the impact of health on QOL. They can 
also be used to establish the burden of a chronic illness (CDC, 2016a). Establishing HRQOL 
in children with CHD is complicated by widely variable age, developmental stage and 
diagnoses (Garcia Guerra et al., 2014). Historically, HRQOL outcomes in CHD populations 
have been based on clinical assessment findings, and have had a motor development or 
functional focus (Eagleson et al., 2013; Berkes et al., 2010; Birks et al., 2006). Assessing 
HRQOL comprehensively requires not only looking at physical functioning and symptoms, 
but also at psychosocial and cognitive functioning (Varni et al., 1999). 
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There are several generic HRQOL measures, but disease-specific HRQOL measures for 
CHD are now becoming available (Bertoletti et al., 2015). In contrast to generic measures, 
disease-specific measures focus on the dimensions of health that are likely to be affected 
by a specific medical condition and its treatment (Berkes et al., 2010; Pike et al., 2007; Raat 
et al., 2006). HRQOL measures should be multidimensional and include physical, social, 
psychological, mental and functional aspects (Amedro et al., 2015). 
 
Both child and parent reported experiences and outcomes are considered to be important 
in ascertaining the HRQOL of children with CHD over the longer-term. It is therefore 
recommended that multiple reporters be used to determine the HRQOL of children with 
CHD; including parent and child self-reporting, where the child is old enough (Knowles et 
al., 2014; Goldbeck and Melches, 2005). Furthermore, HRQOL needs to be assessed 
holistically, taking into account community, socioeconomic conditions, and the personal and 
interpersonal needs of the child to function and develop (Bertoletti et al., 2015). It is 
important to acknowledge that children do not have the capacity to alter their environment, 
as adults do. Their environment is determined for the most part by their parents (Bertoletti 
et al., 2015). 
 
HRQOL in children with CHD needs to be assessed in infancy and toddlerhood, as this is 
the time during which most cardiac interventions take place. In younger survivors, parents 
or primary caregivers have to report on their perception of the child’s HRQOL, as the child 
is too young and does not have the cognitive or language skills to provide a self-report 
(Werner et al., 2014). In most cases, it is mothers who report on HRQOL outcomes as they 
in most instances fulfil the role of primary caregiver (Berkes et al., 2010).  
 
It is believed that parents provide a valid appraisal of their child’s HRQOL (Eagleson et al., 
2013; Majnemer et al., 2006b). Parent proxy reporting of their child’s HRQOL in the case of 
children with CHD has however been shown to be variable, with some parents 
overestimating and others underestimating their child’s health and performance abilities 
(Pike et al., 2007). Bertoletti et al. (2015), Knowles et al. (2014), Schaefer et al. (2013) and 
Tahirović et al. (2010) noted that parents perceived their child’s HRQOL as poorer than the 
child did. Uzark et al. (2008), on the other hand, found that for the most part parents perceive 
their children’s overall HRQOL to be comparable to that of their healthy same-aged peers. 
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The contradictory findings can potentially be explained by the varying participant profiles of 
the aforementioned studies with regard to disease severity (Uzark et al., 2008). Parental 
responses are also likely to be influenced by their stress levels (Spijkerboer et al., 2010), 
their hopes and expectations for their child, and how well they as a family are coping 
(Majnemer et al., 2006b). Family functioning has an important influence on parents’ 
perception of life experiences and the happiness of their child (Majnemer et al., 2006b).  
 
A child’s perception of the impact of their disease on their life may differ from that of their 
parents, educators and healthcare professionals (Knowles et al., 2014). The divergent 
perceptions between parents and their children, so-called cross-informant variance, have 
been frequently and widely reported in the literature. This reflects the different but 
complementary perspectives that are both to be considered as equally important. The value 
of using multiple reporters in determining the HRQOL of the child with CHD is again 
highlighted (Amedro et al., 2015; Eagleson et al., 2013; Latal et al., 2009). Assessing the 
perceptions of both the parent and child, where age appropriate, are believed to provide a 
more comprehensive picture of the HRQOL of the child (Nousi and Christou, 2010).  
 
Clinicians tend to rely solely on proxy reporting by parents and their own perceptions of the 
child’s HRQOL (Goldbeck and Melches, 2005). Marino et al. (2009) goes on to highlight that 
important differences also exist in the HRQOL perceptions of parents and healthcare 
professionals. This further strengthens opinion that multiple reporters on HRQOL, including 
the child, parents and healthcare professionals are most likely to provide the most 
comprehensive view of the overall HRQOL outcome of the child. 
 
2.5.5 Health-related quality of life outcomes in children with congenital heart disease 
 
There has been increasing interest in studying HRQOL in children with CHD (Landolt et al., 
2008). Whilst HRQOL has been investigated in the adult population for over a decade, the 
study of HRQOL in children and adolescents is a relatively new focus area (Bertoletti et al., 
2015; Uzark et al., 2013).  
 
HRQOL is not currently assessed as part of routine cardiac care (Amedro et al., 2015; Uzark 
et al., 2013), and there is limited published data on the psychosocial and HRQOL outcomes 
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of infants and young children living with CHD (Berkes et al., 2010; Miatton et al., 2007; Pike 
et al., 2007). To date the study by Werner et al. (2014) is the only study that has investigated 
HRQOL in children as young as one year. Studies by Eagleson et al. (2013), Berkes et al. 
(2010), Tahirović et al (2010) and Uzark et al. (2008) included children of wide ranging of 
ages, also including children as young as two years.  
 
Studies done on the HRQOL outcomes in children with CHD are limited by several factors. 
These include small sample size, use of varied measurement tools, varied and wide ranging 
ages of participants, reliance on parent proxy-reporting of HRQOL and health status of the 
child and observed functional status, and often only a single dimension of HRQOL was the 
focus (Amedro et al., 2015; Werner et al., 2014; Marino et al., 2010). 
 
HRQOL outcomes in children with CHD remain controversial, with findings throughout 
published literature being inconsistent and contradictory (Werner et al., 2014; Landolt et al., 
2008). Some studies report HRQOL outcomes that are comparable to those of healthy 
same-aged peers, whilst others report impaired HRQOL (Amedro et al., 2015; Garcia Guerra 
et al., 2014; Werner et al., 2014; Eagleson et al., 2013; Pike et al., 2007; Mussatto, 2006). 
These contradictory findings highlight the challenges faced in establishing HRQOL in a 
growing child (Amedro et al., 2015). 
 
HRQOL findings in children with CHD are conflicting when compared to norms for healthy 
and chronic illness populations (Eagleson et al., 2013). Mellion et al. (2014) found that both 
children and adolescents with mild and complex CHD had significantly lower HRQOL than 
their healthy same-aged peers, but similar HRQOL as children with other chronic paediatric 
diseases including diabetes, obesity and asthma. 
 
Several factors have been reported to influence HRQOL outcomes. The impact of cardiac 
disease severity and the presence of cyanosis on HRQOL outcomes remain unclear 
(Eagleson et al., 2013). Congenital heart defects associated with cyanosis were found to be 
predictive of the physical wellbeing of the child (Schaefer et al., 2013). In contrast, Hövels-
Gürich et al. (2007) found that HRQOL in children with cyanotic lesions was similar to that 
of children with acyanotic lesions, and comparable to that of their healthy same-aged peers. 
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A reason for the contradictory findings could be that the disease severity profiles of the 
samples may have differed. 
 
Findings regarding the impact of disease severity on HRQOL outcomes are contradictory. 
Eagleson et al. (2013), Tahirović et al. (2010) and Uzark et al. (2008), on the one hand, 
found that the severity of the defect was related to HRQOL outcomes. Children with complex 
defects were found to have worse HRQOL outcomes. Complex CHD resulting in 
haemodynamic instability, cyanosis and CCF negatively affected functioning during ADL, 
and negatively influenced HRQOL (Birks et al., 2006; Tahirović et al., 2010). Macran et al. 
(2006), in turn, found that disease severity influenced HRQOL only in younger children with 
complex CHD. In contradictory findings, Amedro et al. (2015), Bertoletti et al. (2015), Latal 
et al. (2009) and Majnemer et al. (2006b) determined that the severity of the CHD was not 
significantly related to HRQOL outcomes. 
 
The contradictory findings in the literature show disease severity not to be a reliable predictor 
of the longer-term psychosocial outcomes of the child with CHD. Rather, as Mussatto (2006) 
suggests, parents’ perception of the impact of the cardiac disease, irrespective of the 
disease severity, play a more significant role in determining parents’ view of their child’s 
physical and psychosocial functioning. It was also established in various studies that around 
20% of children with CHD have impaired psychosocial functioning, irrespective of disease 
severity (Knowles et al., 2014; Eagleson et al., 2013; Uzark et al., 2013; Berkes et al., 2010). 
Amedro et al. (2015), Uzark et al. (2013), Marino et al. (2009) and Pike et al. (2007) all found 
physical and psychosocial impairments had a significant impact on HRQOL. Furthermore, 
vision and hearing impairments (Knowles et al., 2014), as well as feeding difficulties were 
associated with poorer HRQOL (Werner et al., 2014).  
 
Studies on associations between HRQOL and a range of variables, such as demographic 
factors, SES and surgical factors, have also produced inconsistent findings (Eagleson et al., 
(2013). Majnemer et al. (2006b) reported that surgical factors were not strong indicators of 
HRQOL outcomes. To the contrary, Schaefer et al. (2013), Latal et al. (2009) and Hövels-
Gürich et al. (2007) reported a connection between the duration of CPB and DHCA and 
HRQOL outcomes relating to psychosocial wellbeing and autonomy. Older age at the time 
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of the first cardiac surgery and the need for multiple surgeries were also associated with 
worse HRQOL outcomes (Latal et al., 2009).  
 
Eagleson et al. (2013) reported an association between age and HRQOL. HRQOL 
outcomes are believed to improve with age, with adolescents having a HRQOL comparable 
to their healthy same-aged peers (Latal et al., 2009). No connection was however found 
between gender and HRQOL (Latal et al., 2009). Children with CHD are particularly affected 
in terms of their physical and cognitive functioning in early childhood; and these children 
face the greatest risk for poor HRQOL outcomes. Appropriate interventions (including parent 
training regarding appropriate developmental stimulation, feeding assistance, and social 
and emotional interaction with their child), and the facilitation of adequate adaptation to the 
child’s CHD may also serve to explain why over time children may be experience HRQOL 
similar to that of their healthy same-aged peers (Latal et al., 2009; Pike et al., 2007). 
 
Higher SES has been found to be associated with better HRQOL outcomes in children with 
CHD (Amedro et al., 2015, Latal et al., 2009). Parenting style, levels of parenting stress, and 
family coping and adaptation to the child’s cardiac disease also influenced the child’s 
HRQOL (Knowles et al., 2014).  
 
Cardiac interventions, regular use of medication, and non-cardiac comorbidities were 
independently associated with reduced HRQOL. The burden of cardiac intervention is 
considered to be cumulative over time (Knowles et al., 2014).  
 
Most of the HRQOL research data collected to date has been in North America and Europe. 
The generalisability of these findings to all children with CHD is difficult due to cultural, 
socioeconomic and social diversity (Pike et al., 2007). In addition, most HRQOL studies that 
were conducted represent only a single CHD diagnosis, making the outcomes difficult to 
generalise to the general CHD population (Knowles et al., 2014). 
 
Overall, the HRQOL of children with CHD would seem to be comparable to that of their 
healthy same-aged peers (Schaefer et al., 2013). Despite feeling that there were areas of 
their lives that could be improved upon, it appears that children develop successful 
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strategies for coping with any problems that their cardiac condition causes, even more so 
where the cardiac condition is corrected early in life (Marino et al., 2009; Birks et al., 2006).  
 
2.5.6 Health-related quality of life outcomes in children with congenital heart disease 
and Down syndrome 
 
Scant information is available on the HRQOL outcomes of children with CHD with DS who 
have undergone cardiac intervention. For the most part, children with chromosomal 
abnormalities have been excluded from outcome studies as the presence of a chromosomal 
abnormality was considered a confounding factor that independently influenced health-
related outcomes (Garcia Guerra et al., 2014). Three studies were identified to have 
assessed HRQOL of children with genetic abnormalities including DS. It must be noted 
however, that Werner et al.’s (2014) study was the only study to investigate HRQOL in 
children with CHD with genetic abnormalities younger than four years. 
 
Werner et al. (2014) determined the perceived HRQOL of 144 Austrian children, including 
those with genetic comorbidity, who had undergone cardiac surgery before the age of six 
months, using the Netherlands Organisation for Applied Scientific Research Academic 
Medical Centre Preschool Children Quality of Life (TAPQOL). They found that children with 
CHD with a genetic abnormality were at increased risk for reduced HRQOL due to the 
cognitive and neurodevelopmental impairments associated with genetic abnormalities. 
 
Other studies to take note of are those by Garcia Guerra et al. (2014) and Van Gameren-
Oosterom et al. (2011). Garcia Guerra et al. (2014) investigated the perceived HRQOL of 
16 Canadian children aged four years with CHD who also had chromosomal abnormalities 
(including DS), who underwent cardiac surgery for complex CHD in infancy, using the  
Paediatric Quality of Life Inventory (PedsQLTM). They similarly reported significantly worse 
HRQOL outcomes for children with CHD with genetic comorbidity when compared to their 
healthy same-aged peers, and when compared to children with CHD without genetic 
abnormalities. The children in their study with CHD with genetic abnormalities showed 
significantly lower scores across all HRQOL dimensions including emotional, social and 
physical functioning.   
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Van Gameren-Oosterom et al. (2011) investigated the QOL of a sample of eight-year-old 
Dutch children with DS using the TNO-AZL Children’s Quality of Life (TACQOL). Similar to 
Garcia Guerra et al. (2014), they found that children in their study with DS had poorer 
HRQOL related to gross motor skills, autonomy and social and cognitive functioning in 
comparison with the normative sample.  
 
Based on the available literature it can be concluded that children with CHD with DS are at 
increased risk of impaired HRQOL compared to children with CHD without DS, and 
compared to their healthy same-aged peers. Impaired HRQOL in young children with CHD 
with DS is associated with the cognitive and neurodevelopmental impairments that are 
characteristic of children with DS.  
 
2.5.7 Improving health-related quality of life outcomes in children with congenital 
heart disease: Implications for clinical practice  
 
Long-term HRQOL outcomes are important markers of the success of cardiac intervention 
aimed at maximising health and minimise symptoms, disability, and dysfunction. No cardiac 
programme is to be considered complete without attention being paid to the physical, 
psychological and social-emotional wellbeing of the child (Marino et al., 2010; Baker, 2008). 
Routine and ongoing screening of HRQOL is recommended as part of standard cardiac care 
(Eagleson et al., 2013). Subjective HRQOL information in combination with objective clinical 
assessment provides a comprehensive picture of physical, emotional and social concerns 
in the child with CHD (Pike et al., 2007).  
 
HRQOL information empowers the cardiac team to counsel parents on the expected 
performance of their child in everyday life (Bertoletti et al., 2015; Garcia Guerra et al., 2014). 
It also prompts referral for intervention (Uzark et al., 2013), which may include 
developmental therapy, psychological and social support services (Majnemer et al., 2006b; 
Mussatto, 2006), and educational interventions to promote resiliency and coping (Eagleson 
et al., 2013; Mussatto, 2006). Intervention serves to optimise HRQOL in children identified 
as being at risk (Bertoletti et al., 2015; Werner et al., 2014; Eagleson et al., 2013; Uzark et 
al., 2013; Marino et al., 2010; Majnemer et al., 2006b). Specific tailored interventions need 
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to be developed to improve HRQOL outcomes in children with CHD in the future (Landolt et 
al., 2008; Pike et al., 2007). 
 
2.5.8 Summary  
 
The physical, neurodevelopmental and psychosocial morbidities related to cardiac disease 
and the treatment thereof may have a significant impact on the health and wellbeing of 
children living with CHD. In an attempt to better understand the full and ongoing extent of 
the impact of CHD on the lives of children, HRQOL has emerged as an important outcome 
measure and health indicator. 
 
HRQOL refers to the perceived impact of the cardiac disease and its treatment on the 
function and ability of the child to derive satisfaction in a variety of aspects of life, including 
the physical, psychological and social domains. HRQOL in young children is established by 
parent-proxy reporting, which serves as a valid appraisal of their perception of their child’s 
health and wellbeing. Parent proxy-reporting can be supplemented by the healthcare 
practitioner reporting.  
 
Child-related and family-related factors impact on HRQOL in children with CHD. Child-
related factors include treatment-related factors, impaired growth, physical activity limitation, 
physical symptoms related to the cardiac disease, social isolation and the presence of a 
genetic abnormality such as DS. Family-related factors include parental educational 
attainment, SES and parenting stress.  
 
Routine and ongoing screening of HRQOL is recommended as part of standard care. 
Subjective HRQOL information used in combination with objective clinical assessment 
information provide a comprehensive picture of the physical, emotional and social concerns 
of the child. Where indicated, children should be referred for appropriate intervention to 
optimise HRQOL outcomes.  
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 2.6 PARENTING STRESS AND THE BURDEN OF CARING FOR A CHILD WITH 
CONGENITAL HEART DISEASE 
 
2.6.1 Introduction 
 
Improved survival rates have seen CHD become the second most prevalent chronic illness 
in childhood (Bruce et al., 2014; Grønning Dale et al., 2013; Hartman and Medoff-Cooper, 
2012). More parents than ever before are having to care for children living with CHD. The 
experience of raising a child with CHD has proven to be a challenge for many families 
(Brosig et al., 2007; Mussatto, 2006). The news that their child has a congenital heart defect 
suddenly and unexpectedly disrupts parents’ expectations of a healthy infant and their world 
is forever changed. Parents must cope with both transitioning into parenthood and the 
diagnosis of CHD, with all its associated medical, financial, social, and emotional 
implications (Fonseca et al., 2012; Yildiz et al., 2009).  
 
Parenting stress is defined as the psychological distress experienced by parents in trying to 
meet the demands of their parenting role Golfenshtein et al. (2016). Burden of care on the 
other hand refers to discomfort experienced by a parent in their caregiving role, which affects 
their health, psychosocial wellbeing, financial status and social life (Zarit et al., 1980).  
 
Little is known about how parents’ wellbeing is affected by having to care for a child with 
CHD (Grønning Dale et al., 2013). There is growing interest in the impact of a child’s CHD 
on parents’ psychological health, family life and parenting experiences, considering parents 
have a considerable influence on their child’s health and development (Wei et al., 2016; 
Hearps et al., 2014; Grønning Dale et al., 2013; Rempel et al., 2013). Furthermore, there is 
a strong relationship between parental wellbeing and a child’s health outcomes, further 
driving interest in this area (Moola, 2012). 
 
The ongoing treatment of CHD; which may include the use of medication, regular follow-up 
and multiple interventions (Bruce et al., 2014; Vrijmoet-Wiersma et al., 2009), as well as 
comorbidities affecting neurodevelopment and HRQOL (Vrijmoet-Wiersma et al., 2009; 
Majnemer et al., 2006b), contribute to parenting stress.  
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Many parents are able to cope and successfully adapt to having a child with CHD (Bruce et 
al., 2014; Tak and McCubbin, 2002). However, for other parents the chronic health problems 
faced by their child due to their CHD place them at high-risk of experiencing ongoing stress 
(Bruce et al., 2014; Solberg et al., 2011; Vrijmoet-Wiersma et al., 2009). Ongoing stress 
affects a parent’s ability to cope, undermines their health and wellbeing, as well their family 
functioning (Majnemer et al., 2006b). Over time, ongoing stress may manifest in 
psychological problems including anxiety and depression (Bruce et al., 2014; Solberg et al., 
2011; Vrijmoet-Wiersma et al., 2009).  Parents of children with CHD often feel hopeless and 
lack confidence and conviction in their parenting abilities (Connor et al., 2010; Vrijmoet-
Wiersma et al., 2009; Brosig et al., 2007). 
 
2.6.2 Stressors associated with psychosocial morbidity in parents of children with 
congenital heart disease 
  
It has been established that parents of children with CHD experience higher levels of stress 
compared to parents of healthy children or parents of children with other chronic illnesses 
(Wei et al., 2016; Hearps et al., 2014; Grønning Dale et al., 2013; Harvey et al., 2013). 
Parents of children with CHD face a multitude of stressors that are unique to parenting a 
child with cardiac disease. These stressors affect their levels of stress and their sense of 
personal wellbeing (Soulvie et al., 2012; Lan et al., 2007).  
 
Findings on the levels of stress experienced by parents of children with CHD in the literature 
are conflicting (Wei et al., 2016; Grønning Dale et al., 2013; Fonseca et al., 2012). Parental 
emotions change over time, based on their child’s condition and the specific stressors in 
play at the time (Wei et al., 2016; Grønning Dale et al., 2013). This may in part explain the 
inconsistencies in the literature regarding the extent and impact of various parental stressors 
(Wei et al., 2016). 
 
For the purpose of this literature review, the most important parental stressors will be 
discussed below. 
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2.6.2.1 Diagnosis, hospitalisation and cardiac surgery  
 
Parents face a “roller coaster” of emotions when their child is diagnosed with a congenital 
heart defect. All parents face similar emotions irrespective of the severity of the cardiac 
disease (Wei et al., 2016). The emotions experienced range from shock, disbelief, fear, 
sadness, anxiety, and guilt to grief (Wei et al., 2016; Bruce et al., 2014; Hearps et al., 2014; 
Hartman and Medoff-Cooper, 2012). Parents feel the diagnosis comes at a considerable 
personal emotional cost (Connor et al., 2010). They feel ill-equipped to deal with their child’s 
heart condition (Hartman and Medoff-Cooper, 2012), and struggle to make decisions 
regarding the child’s care (Soulvie et al., 2012; Lan et al., 2007). Hospitalisation of the child, 
cardiac surgery, family separation and financial pressures exacerbate the emotional distress 
felt by parents during this time (Hearps et al., 2014).  
 
Parents report experiencing extremely high levels of stress before their children go in for 
cardiac surgery (Wei et al., 2016; Harvey et al., 2013; Landolt et al., 2011; Solberg et al., 
2011; Franck et al., 2010). Parents also report feeling extremely anxious whilst waiting for 
their children to come out of surgery (Wei et al., 2016). However, the most stressful and 
overwhelming experience for almost all parents of children undergoing cardiac surgery was 
seeing their child in the ICU after the surgery (Wei et al., 2016; Harvey et al., 2013; Franck 
et al., 2010). Multiple surgical interventions also increase parents’ vulnerability for ongoing 
psychological stress (Vrijmoet-Wierma et al., 2009). Hospitalisation in general was found to 
be moderately to very stressful for parents, regardless of the child’s cardiac disease severity 
(Harvey et al., 2013; Franck et al., 2010).  
 
In addition, parents are concerned about their child’s future health and wellbeing (HRQOL), 
worrying about the prognosis and their child’s outcome over time. Parents have often voiced 
a sense of hopelessness and distress related to the aforementioned (Bruce et al., 2014; 
Connor et al., 2010). 
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2.6.2.2 Role stress and burden of care  
 
Each parent has a unique reaction to stress and will exhibit varying degrees of anxiety 
(Bruce et al., 2014). Parents of a child with CHD often experience role strain (Lan et al., 
2007). It is reported that mothers are more strongly affected by a child’s cardiac disease 
than fathers (Yildiz et al., 2009). Mothers have been found to experience more stress than 
fathers based on their role within the family (Franck et al., 2010; Uzark and Jones, 2003; 
Goldberg et al., 1990).  In addition, mothers of children with CHD experience an increased 
burden of care. This is by virtue of the fact that they tend to fulfil the role of primary caregiver, 
spending more time on and being actively engaged in the care of the child (Fonseca et al., 
2012; Yildiz et al., 2009).   
 
Parenting a child with CHD is considered to be more demanding and more time consuming 
(Bruce et al., 2014; Grønning Dale et al., 2013; Yildiz et al., 2009; Lawoko and Soares, 
2006). This ongoing burden of care often results in increased levels of stress (Torowicz et 
al., 2010; Lawako and Soares, 2006), physical exhaustion and social isolation (Bruce et al., 
2014; Grønning Dale et al., 2013; Yildiz et al., 2009). In addition to caring for the child with 
CHD, mothers are also responsible for domestic chores and caring for siblings (Harvey et 
al., 2013; Lawoko and Soares, 2002). A father’s role is two-fold, caring for both the mother 
and child in the situation (Wei et al., 2016). In most cases, fathers are less involved in the 
care of the children as they fulfil the role of the primary breadwinner, responsible for 
providing the financial means of the family (Menahem et al., 2008). Single parent and 
female-headed households have been found to experience extremely high levels of stress 
associated with parenting a child with CHD as the burden of care is not shared with anybody 
(Amakali and Small, 2013; DeMaso et al., 1991). 
 
2.6.2.3 Feeding difficulties and growth failure  
 
Feeding plays an important role in the parent-child relationship (Bevilacqua et al., 2015). 
Feeding difficulties and growth failure are common in children with CHD, and serve as 
ongoing stressors for parents (Harvey et al., 2013; Soulvie et al., 2012; Hartman and Medoff-
Cooper, 2012). 
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2.6.2.4 Severity of the congenital heart disease 
 
It has been suggested that disease severity is not a reliable predictor of the longer-term 
psychosocial outcome of parents (Grønning Dale et al., 2013). Rather, parents perception 
of the impact of their child’s CHD on the family, has proven to be a far more powerful 
predictor of parental stress, than the disease severity itself (DeMaso et al., 1991). It is 
acknowledged that levels of parenting stress may change over time in accordance with the 
developmental stage of the child and course of the illness (Goldberg et al., 1990).  
 
Research findings on the relationship between disease severity and psychosocial problems 
in parents of children with CHD are divergent (Lawoko and Soares, 2006). Grønning Dale 
et al. (2013), Connor et al. (2010), Torowicz et al. (2010), Majnemer et al. (2006b) and 
Mörelius et al. (2002) all reported that the severity of the child’s cardiac disease affected the 
levels of stress experienced by parents. Parenting a child with severe CHD was found to be 
more stressful than parenting a child with moderate or mild disease. The reasons for 
increased levels of stress in the case of parenting a child with severe CHD may be attributed 
to multiple stressors, including repeated cardiac surgeries, recurrent hospitalisations; as well 
as feeding problems, behavioural problems, and developmental delays and disorders in the 
child (Grønning Dale et al., 2013). 
 
To the contrary, Hartman and Medoff-Cooper (2012) reported that parents of children with 
CHD experienced heightened levels of emotional distress irrespective of disease severity. 
The authors viewed disease severity to be less important than other factors such as 
sociodemographic stressors, coping strategies, and the excessive burden of care (Lawoko 
and Soares, 2006). Srichantaranit et al. (2010) found in addition to the aforementioned 
religion and cultural beliefs affected parents’ experiences and wellbeing. 
 
2.6.2.5 Age and characteristics of the child 
 
Parenting stress in children with CHD has been shown to be especially high during infancy 
and toddlerhood. A heightened level of caregiving is required at this age, in addition to the 
stressors caused by the child’s CHD. High levels of parenting stress have also been found 
to continue in the preschool years (Soulvie et al., 2012; Lee et al., 2007). Uzark and Jones 
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(2003), by contrast, found that the older the age of the child the higher the levels of parenting 
stress. 
 
Other factors that influence the parent-child relationship are the parents’ mental health, 
ability to cope and family functioning. The diagnosis of CHD can have a profound impact on 
the parent-child relationship (Doherty et al., 2009). Parents often feel stressed or defensive 
about their child, particularly if their child exhibits behavioural problems (Majnemer et al., 
2006b). 
 
Parents also report that children with CHD, especially those with severe disease, are often 
difficult to parent. Increased levels of stress are often related to the characteristics of the 
child, which make them difficult to parent (Soulvie et al., 2012; Uzark and Jones, 2003). 
Parents’ view children with severe CHD as having difficult temperaments, characterised by 
being difficult to soothe and being irritable and moody. Irritable infants have been linked to 
maternal feelings of stress, inadequacy, fatigue and resentment (Torowicz et al., 2010). The 
exact cause of infant irritability in children with severe CHD remains unclear. It has been 
suggested that it may be related to the complex surgical intervention, repeated exposure to 
noxious stimuli during hospitalisation (hyperalgesia) and prolonged ICU and/or hospital 
length of stay (Torowicz et al., 2010). 
 
The parents' behaviour towards their child plays a critical role in the child’s development in 
infancy and toddlerhood. The quality of the parent–child relationship, in particular the 
responsiveness of the caregiving, affects brain growth and neuronal organisation. The 
quality of the caregiving therefore also influences social-emotional, cognitive and language 
development (Laing et al., 2010; Torowicz et al., 2010). Anxiety and depression in mothers 
can interfere with the quality and responsiveness of the parenting, negatively impacting on 
the child’s development, especially cognitive development (Soulvie et al., 2012; Landolt et 
al., 2011; McCusker et al., 2009).   
 
Family and maternal adjustment in particular play a central role in the behavioural outcomes 
of the children with CHD (McCusker et al., 2009). The child’s unique characteristics, 
including temperament and health status, influence parenting practices in a child with 
chronic disease (Carey et al., 2002). Parents are often hyper-vigilant and overprotective of 
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their child who they see as vulnerable, resulting in so-called “vulnerable child syndrome” 
(Connor et al., 2010; Laing et al., 2010). Excessive parental concern and overindulgence 
can negatively influence the developmental outcome of these children over time. Parenting 
style tends to be more permissive, with a lack of discipline and failure to set boundaries 
(Vrijmoet-Wiersma et al., 2009; Brosig et al., 2007; Mussatto, 2006; Uzark and Jones, 2003; 
Carey et al., 2002). Mothers of children with CHD have also been found to have lower 
expectations of their children compared to mothers of healthy children (Brosig et al., 2007, 
Mussatto, 2006; Carey et al., 2002). Parents are often more sympathetic towards the child 
reinforcing illness behaviours, with the child becoming overly dependent, disobedient, 
irritable and uncooperative (Connor et al., 2010). This in turn influences developmental and 
behavioural outcomes of the child in the long-term (Vrijmoet-Wiersma et al., 2009; Brosig et 
al., 2007). 
 
The parenting style described above has frequently been associated with behavioural 
difficulties in children (Laing et al., 2010). Behavioural difficulties in children with CHD have 
been directly related to the levels of parental stress and the burden of care (Vrijmoet-
Wiersma et al., 2009; Mussatto, 2006).  
 
2.6.2.6 Socioeconomic conditions and cost of care 
 
Many families caring for a child with CHD experience financial strain and have been found 
to be financially unstable. Low SES and financial strain are stressors contributing to the 
psychological problems in parents of children with CHD (Grønning Dale et al., 2013; Harvey 
et al., 2013; Soulvie et al., 2012; Connor et al., 2010; Lawako and Soares, 2006). Living at 
lower socioeconomic levels is associated with more severe and numerous symptoms of 
depression in parents of children with CHD due to the difficulty in meeting the expensive 
and long-term care requirements (Yildiz et al., 2009). 
 
Mothers, as primary caregivers, must often stay at home for extended periods of time to 
care for the ill child before cardiac intervention, and during the sometimes long recovery 
period post-cardiac intervention. This might result in mothers having to give up her 
employment or being unable to seek gainful employment during this period. The result being 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
79 
 
reduced financial resources available to the family; limiting what they can afford (Bruce et 
al., 2014; Connor et al., 2010). 
 
2.6.2.7 Low levels of parent education  
 
Little has been reported in the literature on the effect of parental educational attainment on 
levels of parenting stress in children with CHD. Hearps et al. (2014) found that low levels of 
parental education increased psychosocial risk, increasing levels of parental stress. Yildiz 
et al.’s (2009) findings were at variance with the aforementioned, suggesting that parents’ 
level of education did not have a significant effect on the level of stress experienced by 
parents. The true impact of parental educational attainment on levels of parenting stress 
remains poorly established and requires further investigation.  
 
2.6.2.8 Family strain 
 
Parenting a child with CHD comes at an emotional cost to the parents, but also to siblings 
and the rest of the family (Connor et al., 2010). Parents feel that the impact on siblings is a 
cause of considerable stress to them, and they experience guilt that they are neglecting their 
wellbeing (Bruce et al., 2014; Connor et al., 2010).The impact on members of the extended 
family can also be considerable. It may require family members to take time off work, 
assume childcare responsibilities for siblings, and assist the family financially (Connor et al., 
2010).  
 
2.6.2.9 Marital strain  
 
Stress caused by having a child with CHD can place strain on a marriage. Marital 
unhappiness is considered a stressor for parents’ psychosocial wellbeing (Grønning Dale et 
al., 2013; Yildiz et al., 2009; Goldberg et al., 1990). The impact of CHD on marital 
relationships in the available research is however inconclusive (Tak and McCubbin, 2002). 
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2.6.2.10 Lack of social support  
 
Social support refers to the relationships parents have with other persons, including a 
spouse, other children, grandparents, friends, and colleagues who can provide emotional 
support (Bruce et al., 2014). Mothers who stay at home to care for the child with CHD may 
have few opportunities to participate in their social role, recreation and to socialise (Connor 
et al., 2010; Goldberg et al., 1990). The child’s illness may force mothers into unwanted 
roles, limiting them to a lifestyle where they can rarely prioritise their own interests and social 
activities (Bruce et al., 2014; Connor et al., 2010).  
 
Social support, social resources, social disadvantage, religion and family functioning have 
been identified as important indicators of psychosocial outcome in parents of children with 
CHD (Hearps et al., 2014). Mothers who experience role stress report inadequate social 
support. This lack of social support amplifies poor coping and serves as a stressor that may 
lead to psychosocial problems (Grønning Dale et al. 2013; Connor et al., 2010). Social 
isolation is associated with an increased risk of long-term psychosocial morbidity in parents 
of children with CHD (Srichantaranit et al., 2010; Vrijmoet-Wiersma et al., 2009; Mussatto, 
2006).  
 
2.6.3 Psychological morbidity in parents of children with congenital heart disease 
 
It has been established that having a child with CHD has a profound negative effect on 
parental mental health (Grønning Dale et al., 2013). Psychological distress is an indicator of 
parents not coping and adjusting to their child’s CHD (Fonseca et al., 2012; Connor et al., 
2010). The effects of stressors are also cumulative over time (Fonseca et al., 2012). 
Although most parents show resilience in the face of the stressors caused by their child’s 
CHD; a considerable number of families report persistent distress requiring psychosocial 
interventions (Hearps et al., 2014). 
 
Parents of children with CHD report more psychological problems than parents of healthy 
children (Bruce et al., 2014; Fonseca et al., 2012; Vrijmoet-Wiersma et al., 2009; Yildiz et 
al., 2009; Mussatto, 2006) and children with other chronic diseases (Moola, 2012; Goldberg 
et al., 1990). As a consequence, parents may develop psychological symptoms, such as 
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stress, anxiety, depression and problems with coping and adaptation (Wei et al., 2016; 
Bruce et al., 2014; Soulvie et al., 2012; Solberg et al., 2011; Vrijmoet-Wiersma et al., 2009; 
Yildiz et al., 2009). Uzark and Jones (2003) suggested that as many as one in five parents 
of children with CHD exhibit clinically significant levels of stress.  
 
Doherty et al. (2009) and Vrijmoet-Wiersma et al. (2009) reported that more than one-third 
of mothers of children with CHD met the criteria for poor adjustment and displayed clinically 
significant levels of stress. Soulvie et al. (2012) found elevated levels of psychological 
distress in 33% of parents with children with mild or moderate CHD, and in as many as 81% 
of mothers of children with severe CHD. 
 
Lawoko and Soares (2006) reported on long-standing symptoms and psychosocial 
morbidity. They found that disease severity failed to explain parents’ psychosocial morbidity 
over time. Instead, burden of care, social isolation, and financial instability were associated 
with an increased risk of long-standing psychological morbidity. Majnemer et al. (2006b) 
found that 25% of mothers’ still experienced significant levels of stress five years after their 
child’s cardiac surgery, while Hearps et al. (2014) reported that almost 40% of mothers were 
at risk of ongoing psychological problems. 
 
2.6.4 Parenting stress outcomes in children with congenital heart disease  
 
Very few studies have explored the experiences of parents who have had a child diagnosed 
with CHD and whose child had undergone cardiac surgery (Wei et al., 2016; Fonseca et al., 
2012). Rempel et al. (2013) aptly described caring for a child with CHD as “parenting under 
pressure”.  
 
In their review of 25 studies on parenting stress in children with CHD, Soulvie et al. (2012) 
found that parents experienced increased levels of stress across the continuum of cardiac 
care. Studies by Bruce et al. (2014), Moola (2012), Fonseca et al. (2012) and Yildiz et al. 
(2009) similarly reported that parents of children with CHD experienced heightened levels 
of stress. 
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In contrast, Vrijmoet-Wiersma et al. (2009), Brosig et al. (2007) and Mussatto (2006) found 
that parents of children with CHD reported stress levels that were not significantly higher 
than those of parents of healthy children; in fact, in some instances parents of children with 
CHD reported lower stress levels than parents of healthy children. These lower stress levels 
could be explained by the fact that parents of children with CHD develop a higher threshold 
for what they perceive to be stressful, given their lived experiences. Parenting stress 
outcomes in the published literature suggest considerable variability in stress outcomes 
amongst individual parents.  
 
Research has shown that parental stress levels decrease over time, after surgical 
intervention and with improvement of the child’s condition (Moola, 2012; Landolt et al., 2011; 
Menahem et al., 2008). The majority of parents are able to adapt to caring for a child with 
CHD; however, almost 40% are at increased risk of psychosocial morbidity due to continued 
emotional stress. This may adversely impact on parental QOL and the capacity for optimal 
parenting (Hearps et al., 2014).  
 
Improved social support has been found to mediate psychosocial distress. Family friends, 
an extended community and healthcare professionals can provide the necessary social 
support to parents. Increased opportunities for socialisation and physical exercise have also 
been shown to be beneficial for parents (Hartman and Medoff-Cooper, 2012; Lawoko and 
Soares, 2006). Most parents, despite the challenges faced by having a child with CHD, 
display the ability to cope, and are resourceful and resilient (Rempel et al., 2013). Wei et al. 
(2016) reported that over the long-term many parents view their child’s CHD as a positive 
life experience that brought their family closer together. 
 
2.6.5 Parenting stress outcomes in children with congenital heart disease and Down 
syndrome 
 
Parental adaptation to having a child with DS has been studied extensively in relation to 
parental emotions and wellbeing. It has been found that parenting stress levels increase 
with the increasing age of the child with DS, and as developmental and behavioural 
problems became more apparent (Cuskelly et al., 2008). Parents of infants with DS have 
reported more stress than parents of infants without disabilities (Pelchat et al., 1999).  
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The aforementioned studies, however, did not take into account co-morbid medical 
problems in children with DS, such as CHD. Many children with DS also have CHD, and 
many more of these children are surviving making it increasingly important to evaluate the 
impact of CHD in addition to DS on family psychosocial functioning, including parenting 
stress and the impact on family life (Visootsak et al., 2015).   
 
Visootsak et al.’s (2015) study is the only study to date that has evaluated family 
psychosocial outcomes associated with children with CHD with DS. They reported that the 
presence of CHD in addition to DS resulted in much greater levels of parenting stress than 
in cases where children were diagnosed with DS alone. Having a child with CHD in addition 
to DS was found to elevate parental concern and disrupt family dynamics, resulting in further 
neurodevelopmental deficits.  
 
2.6.6 Parenting stress outcomes in resource-poor communities  
 
It has been suggested that parenting stress is amplified by poor socioeconomic 
circumstances. There is little published data reporting on parental stress in children with 
CHD residing in poorer communities. In their study in the United Kingdom (UK), Franck et 
al. (2010) reported considerably higher levels of parenting stress in parents from poorer 
communities and where mothers were immigrants to the UK.  
 
Amakali and Small (2013) investigated parenting stress in families of children with CHD in 
Namibia, a sub-Saharan African country. Most of the parents in their study had a low SES.  
Parents found parenting a child with CHD in these circumstances to be a greater challenge. 
Families who lived in rural communities had a greater burden of care in that they were 
expected to cope with all the care demands on their own. Most of the parents had low levels 
of education and as a result most had no steady income. A lack of financial means impeded 
access to the healthcare services that could have optimised the health and wellbeing of 
these children. Parents’ poor coping and adaptation skills were found likely rooted in their 
lack of financial means to facilitate coping with the demands of care. Poor coping was further 
amplified in single parent and, female-headed households (Amakali and Small, 2013). 
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2.6.7 Parenting a child in a developing country  
 
Parents in developing countries face multiple risks for psychosocial morbidity. Poverty and 
social disadvantage pose a considerable risk to parenting in SA (Gould and Ward, 2015, 
Ward et al., 2015; Cooper et al., 2009; Engle et al., 2007; Walker et al., 2007). A lack of 
financial resources does not only affect the ability of parents to provide nutrition and 
healthcare to their child, but also inherently makes parenting in itself more difficult (Gould 
and Ward, 2015). In addition, more than half of children in SA grow up in single parent-
headed households, where the absent parent is largely uninvolved in the day-to-day 
parenting of the children (Gould and Ward, 2015). Parents living in poverty are also less 
likely to have the necessary social support that would assist them in their parenting role 
(Gould and Ward, 2015; Engle et al., 2007).  
 
It has also been established that parents living in poverty are more likely to suffer from 
anxiety, stress and depression (Gould and Ward, 2015; Cooper et al., 2009; Walker et al., 
2007). Cooper et al. (2009) reported that 34.7% of mothers in low-income peri-urban settings 
in SA suffer from depression. Walker et al. (2007) have even suggested that the prevalence 
of depression in mothers in developing countries may be as high as 60%.  
 
Poverty and maternal depression severely compromises the ability of parents to provide the 
kind of childcare that promotes secure attachment in infancy, and the type of stimulation 
needed for optimal developmental outcome (Cooper et al., 2009). Maternal depression has 
been found to affect child-rearing practices in SA, in that depressed mothers have been 
found to be less involved, less sensitive and less responsive in their parenting style, resulting 
in them being more negative in their interactions with their infants (Walker et al., 2007).  
 
2.6.8 Reducing psychosocial morbidity in parents of children with congenital heart 
disease: Implications for clinical practice  
 
Routine screening of the psychosocial status and functioning of the family over the course 
of the child’s cardiac care will assist in the identification of families at risk of psychosocial 
morbidity (Bruce et al., 2014; Hearps et al., 2014; Vrijmoet-Wiersma et al., 2009; Yildiz et 
al., 2009; Brosig et al., 2007; Mussatto, 2006; Carey et al., 2002). These parents should be 
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reffered for suitable interventions to reduce their stress (Soulvie et al., 2012; Mussatto, 
2006), and help them to cope and adapt to their child’s CHD and the subsequent lifestyle 
changes it demands (Wei et al., 2016; Bruce et al., 2014; McCusker et al., 2009; Yildiz et 
al., 2009; Lee et al., 2007; Lawoko and Soares, 2006).  
 
Interventions may include educational, psychological and/or social support services 
(Rempel et al., 2013; Soulvie et al., 2012; Uzark and Jones, 2003). In addition, parent 
support groups may be beneficial in providing emotional support to parents (Bruce et al., 
2014; Grønning Dale et al., 2013; Hartman and Medoff-Cooper, 2012; Solberg et al., 2011; 
Lee et al., 2007).  
 
2.6.9 Summary  
 
More parents than ever before are parenting children with CHD, and for many parents the 
experience of raising a child with CHD has proven to be challenging. Although little is known 
about how parents’ wellbeing is affected by caring for a child with CHD, they are considered 
to be at risk of ongoing stress that over time may manifest as anxiety and depression. 
Parenting a child with CHD with DS is more stressful than parenting a child with CHD alone. 
Parents in developing countries such as SA face a multitude of stressors, in addition to the 
stressors related to their child’s CHD, placing them at even higher risk of ongoing stress and 
depression. Poverty and social disadvantage pose a considerable risk to parenting in 
developing countries.  
 
Families should be screened regularly for psychosocial risk as part of standard cardiac care. 
Where indicated, parents should be provided with anticipatory guidance, educational 
interventions and psychological support. Parent support groups may be valuable in 
mediating stress.  
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2.7. THE BURDEN OF CARING FOR A CHILD WITH CONGENITAL HEART DISEASE 
 
2.7.1 Introduction  
 
As a chronic health condition, the burden or cost of caring for a child with CHD is not only 
physical and emotional for parents, but also financial (Zarit et al., 1980). The financial cost 
of caring for a child with a chronic health condition is considerable, and may even be life-
long (Connor et al., 2010; Gerber et al., 2010). Medical and other costs related to care begin 
almost immediately after birth for families of a child with CHD (Connor et al., 2010). Non-
medical related factors, including SES and parental level of education, may influence both 
the survival and outcome of a child born with CHD (Kucik et al., 2014). 
 
2.7.2 Financial burden of caring for a child with congenital heart disease 
 
The financial cost of having a child with CHD is life-changing for many families (Raj et al., 
2015). The continued care that is required may explain why the socioeconomic impact is so 
great (Kucik et al., 2014). Caregiving creates a financial burden for parents and, in many 
cases, the extended family. The increased financial burden may be the result of expenses 
related to the child’s care and/or a loss of income (Girgis et al., 2013). In addition lower 
levels of income, educational attainment, and occupational prestige are associated with 
greater family instability, which increases the risk of parental separation and divorce (Conger 
et al., 2010).  
 
Many families of children born with CHD experience a considerable decline in family income 
after having a child born with CHD. In many instances parents may have to give up their 
employment to take care of the ill child. This is especially true for mothers, who in most 
cases fulfil the role of primary caregiver. Caregiving reduces the likelihood of a parent being 
employed, and many caregivers are unable to work, need to take unpaid leave, have fewer 
work hours, are employed in lower paying jobs, or work from home to manage the demands 
of care (Raj et al., 2015; Girgis et al., 2013; Hoffman, 2013; Mughal et al., 2011; Connor et 
al., 2010; Gerber et al., 2010). This loss of income reduces the financial resources available 
to the family (Bruce et al., 2014). 
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For most parents the financial uncertainty of having to care for a child with a chronic health 
condition is a considerable burden to carry. The immediate and long-term out-of-pocket 
costs associated with caring for the child are often unpredictable (Raj et al., 2015; Mughal 
et al., 2011; Connor et al., 2010). The SES of families at diagnosis is associated with the 
extent of the financial strain experienced by families going forward. Middle and lower 
socioeconomic class families experience greater financial strain caused by unexpected out-
of-pocket expenses (Connor et al., 2010). 
 
In addition, financial strain placed on families during the hospitalisation of a child with CHD 
is often overwhelming (Raj et al., 2015). Unplanned out-of-pocket expenses during 
hospitalisation may include accommodation, food, transport and phone charges. Parents 
find these unplanned costs extremely stressful (Connor et al., 2010; Gerber et al., 2010). 
Having a child with more severe CHD is associated with even greater out-of-pocket costs 
incurred (Connor et al., 2010; Gerber et al., 2010).   
 
Apart from the costs related to hospitalisation, out-of-pocket expenses for long-term follow-
up are also considerable. These costs include transportation to and from the hospital for 
cardiac follow-up, and having to attend other services such EI services further increases the 
costs for families (Kucik et al., 2014; Amakali and Small, 2013; Hoffman, 2013; Gerber et 
al., 2010). The magnitude of the financial burden often results in families having to incur 
debt to cover out-of-pocket and monthly expenses (Raj et al., 2015; Amakali and Small, 
2013; Connor et al., 2010). 
 
Family income affects both the children’s health and their access to healthcare (Kucik et al., 
2014; Cassedy et al., 2013). Lower SES may negatively influence the ability of parents to 
seek out and access healthcare services (Kucik et al., 2014; Cassedy et al., 2013; Mughal 
et al., 2011). As a result socioeconomic disadvantage is associated with poorer survival and 
outcome in children born with CHD (Kucik et al., 2014; Cassedy et al., 2013), including 
adverse developmental outcomes (Conger et al., 2010). Income level is also associated with 
the quality of nutrition and the housing families can afford (Amakali and Small, 2013; 
Cassedy et al., 2013).  
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According to Hoffman (2013) poverty is considered one of the greatest barriers to the 
successful treatment of CHD in the developing world. The cost of chronic treatment in 
resource poor settings and the developing world is often higher due to late diagnosis and 
management of CHD, and the treatment of complications such as cardiac failure that would 
require frequent clinic visits adds to the economic strain experienced by the families in these 
settings (Sadoh et al., 2011).   
 
Sadoh et al. (2011) found that in Nigeria over a third of families spent more than 10% of 
their monthly income on caring for the child with CHD (8% was spent on covering transport 
costs for medical care). This meant that families had less money available for necessities 
such as food, clothing and housing. Families from lower SES therefore proportionally spend 
more of their income on healthcare than would be the case in middle or upper class families. 
 
According to Amakali and Small (2013) many families with children with CHD in sub-
Saharan Africa live in rural areas and the parents have a low level of education resulting in 
them not being able to secure fixed employment. This resulted in no secure source of 
income and financial insecurity. Many of these families living in poverty were unable to 
provide the care necessary for a child with CHD. Dire financial situations also result in 
children missing healthcare appointments, as families cannot afford the transport costs to 
get them there. Financial problems have also been found to negatively impact parents’ 
psychological functioning (Amakali and Small, 2013; Conger et al., 2010) and their QOL (Raj 
et al., 2015).  
 
2.7.3 Educational attainment and the occupational prestige of parents 
 
Family income, occupational prestige, and educational attainment serve as measures of 
SES and are considered to influence a person’s life opportunities (Cassedy et al., 2013).  
According to Kucik et al. (2014) level of parental education serves as a proxy for health 
literacy and family income. These authors (Kucik et al., 2014) found that lower levels of 
maternal education were associated with poorer survival and outcome in infants with CHD. 
In addition, it was found that the SES and education level of the community in which these 
families lived also played an important role in survival and outcome.  
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2.7.4 Summary  
 
The cost for families of caring for a child with CHD is not only physical and emotional, but 
also financial. The cost of caring for a child with a chronic health condition that requires 
ongoing medical care is considerable, and may potentially be life-long.  
 
Many families of children born with CHD experience a considerable decline in family income 
as mothers take on the role of caring for the ill child full-time and therefore cannot be gainfully 
employed. In addition, the cost of travelling long distances to main city centres where cardiac 
units are located for follow-up and cardiac surgery are costly, with considerable out-of-
pocket expenses for families such as accommodation, food and cellular phone charges, 
which add to the financial burden of families. As a result, many families face financial 
insecurity. The financial burden of care is amplified for parents living in developing countries 
where many families live in poor socioeconomic circumstances.  
 
Family income, occupational prestige, and educational attainment are considered to serve 
as measures of the SES. Socioeconomic disadvantage is associated with poorer survival 
and outcome in children born with CHD, including worse developmental outcomes. 
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CHAPTER 3 
 
OUTCOME MEASURES AND PILOT STUDY 
_____________________________________________________ 
 
 
In Chapter three the outcome measures used in this study will be described with regards to 
their purpose, content, administration and scoring. Standardisation, reliability and validity of 
the outcome measures will be highlighted. The use of each outcome measure in the SA 
population and in the CHD population will be justified.  
 
The pilot study, which served to determine the feasibility of the study and the suitability of 
each of the chosen outcome measures, will also be described.  
 
3.1 Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) 
 
3.1.1 Description of the Bayley Scales of Infant and Toddler Development, Third 
Edition (BSID-III) 
 
The BSID-III is an individually administered instrument designed to assess the 
developmental performance of infants and young children aged one to 42 months (Bayley, 
2006b). The BSID-III contains three administered scales, namely the cognitive scale, the 
language scale (including expressive and receptive language subtests) and the motor scale 
(including fine motor and gross motor subtests). The BSID-III also contains the social 
emotional and adaptive behaviour scales in the form of a parent self-report questionnaire 
(Bayley, 2006b). The social emotional and adaptive behaviour questionnaire was not utilised 
in this study, as its psychometric properties are not yet well established. 
 
The BSID-III scales provide a comprehensive developmental assessment across the most 
important domains of childhood development. This contributes to the BSID-III’s standing as 
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the “golden standard” measure for developmental assessment (Johnson et al., 2014; Marino 
et al., 2012). 
 
The cognitive scale assess the child’s play (including play with objects, relational play and 
symbolic play), ability to process information (including novelty preference, habituation to 
visual and auditory information, paired comparisons, memory, problem solving, reaction 
time and anticipation of patterns), and number concepts and counting (Acton et al., 2011; 
Bayley, 2006b).  
 
The language scale is comprised of a receptive communication subtest and an expressive 
communication subtest. The receptive communication subtest assesses the child’s auditory 
acuity, sound discrimination, verbal understanding, verbal concept development, and 
response to words and spoken requests (Acton et al., 2011; Bayley, 2006b). The expressive 
communication subtest on the other hand assess the child’s ability to vocalise and 
communicate via sounds, gestures and words (Bayley, 2006b). 
 
The motor scale is comprised of a fine motor subtest and a gross motor subtest. The fine 
motor subtest assess the child’s co-ordination and control of eye movements, visual motor 
and visual spatial skills, and motor control of the hands (reach, grasp and manipulation skills) 
(Acton et al., 2011; Bayley, 2006b). The gross motor subtest assessing the child’s large 
body and complex movements as well as mobility. Motor development is assessed with 
increasing emphasis on the quality of movement (Acton et al., 2011; Bayley, 2006b). 
 
3.1.2 Administration and scoring procedures for the BSID-III 
 
No specific qualifications or training is required to administer the BSID. It is however 
recommended that clinicians who administer the BSID-III should be experienced in 
paediatric developmental assessment and interpretation (Albers and Grieve, 2007; Bayley, 
2006a).  
 
The child’s chronological age is calculated in years, months and days at the time of testing 
to determine the appropriate starting point for subtest administration. Where indicated, age 
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is to be adjusted for prematurity through 24 months chronological age. A child is considered 
premature if born at 36 weeks or less gestation (Bayley, 2006a). 
 
Administration time for children under the age of 12 months is approximately 50 minutes 
and for children older than 13 months up to 90 minutes (Bayley, 2006a). Items are 
administered following the administration guidelines provided in the BSID-III administration 
manual. Items receive a score of one if the child meets the scoring criteria and, a score of 
zero if the criterion is not met (Bayley, 2006a).   
 
Raw scores for each subscale are converted into composite scores (Bayley, 2006a) 
Composite scores are a transformation of the distribution of the scores and have a given 
mean and standard deviation. A score of 100 is the test mean score, and indicates average 
performance. Composite scores allow for the determination of the number of standard 
deviations the child’s score is from the mean test score for all three subscales of 100 (Bayley, 
2006b).  
 
Table 3.1 shows the relation of composite scores to standard deviations from the mean.  
 
Table 3.1 BSID-III composite scores and standard deviation equivalents 
 
Composite score  Standard deviation from the mean 
55 -3 
70 -2 
85 -1 
100 0 
115 +1 
130 +2 
145 +3 
(Bayley, 2006b, p109). 
 
Composite scores can be described in more qualitative terms in accordance with the child’s 
level of developmental performance (Bayley, 2006b). Descriptive classifications for the 
composite scores are provided in Table. 3.2 (Bayley, 2006b). 
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Table 3.2 Descriptive classifications of the BSID-III composite scores  
 
Score  Performance category 
130 and above Very superior 
120 - 129 Superior 
110 - 119 High average 
90 - 109 Average  
80 - 89 Low average 
70 - 79 Below average 
69 and below Extremely low  
(Bayley, 2006b, p113). 
 
For the purpose of this study, the same descriptive classification system as described by 
Mussatto et al. (2014), based on the standard deviations of the composite scores from the 
mean test score, will be used to allow for comparison of developmental outcomes between 
studies. Developmental performance is to be classified as “average” if the score is within 
one SD of the mean or higher (scores > 85), “at risk” if the score is between one and two 
SDs below the mean (scores of 70–84), and “delayed” if the scores are more than two SDs 
below the mean (scores <70).  
 
3.1.3 Standardisation and norming of the BSID-III 
 
The clinical use of the BSID-III was improved during its standardisation through the 
numerous special population studies undertaken in children diagnosed with developmental 
delay, at risk of developmental delay (including those born prematurely and those with 
genetic or congenital disorders) and/ or a clinical diagnosis (for example DS, cerebral palsy 
and birth asphyxia) (Bayley, 2006b). The BSID-III was normed in a stratified, random sample 
of 1700 children representative of children aged 16 days to 42 months in the US (Bayley, 
2006b). 
 
3.1.4 Reliability and validity of the BSID-III 
 
The BSID-III has been proven a reliable measure, which suggests that the test scores are 
accurate, consistent and stable. Evidence of the internal consistency of the BSID-III 
composite scores has been shown with reliability coefficients of .91 for the cognitive scale, 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
94 
 
.93 for the language scale, and .92 for the motor scale respectively (Bayley, 2006b). The 
reliability coefficients for special populations (as outlined under 3.1.5) support the 
generalisability of the instrument (Bayley, 2006b). The BSID-III has also been shown good 
test-retest stability over time (Bayley, 2006b). The BSID-III has also shown good content 
and construct validity (Bayley, 2006b).  
 
3.1.5 Concerns regarding the BSID-III 
 
Despite the extensive use of the BSID-III in both the clinical and research setting, there are 
published concerns that the BSID-III overestimates developmental performance (Johnson 
et al., 2014; Jary et al., 2013; Bos, 2013; Moore et al., 2012; Lowe et al., 2012; Vohr et al., 
2012; Acton et al., 2011; Anderson et al., 2010). This could affect the interpretation of test 
results, with further implications in both the clinical and research setting (Acton et al., 2011; 
Anderson et al., 2010). Research in various populations has found that the BSID III identifies 
fewer children with scores of less than 70 than the BSID-II. Overestimation of developmental 
performance could result in children who have developmental delay not being identified 
(Jary et al., 2013; Moore et al., 2012; Vohr et al.; 2012; Acton et al., 2011). Test performance 
is also used to determine the need for referral to EI services. This would mean that some 
children who should be referred for early developmental intervention would not be referred, 
potentially impacting on their long term developmental outcome (Johnson et al., 2014; Vohr 
et al., 2012; Anderson et al., 2010). 
 
Concerns regarding language, and cultural biases contained in the BSID-III have also been 
noted (Acton et al., 2011). Linguistic bias is of concern in children who do not learn and 
speak English as a first language (Madaschi et al., 2016; Paradis, 2005). SES could affect 
language performance, with children from poorer socioeconomic backgrounds and parents 
with lower levels of education exposed to far fewer words. Children with better 
socioeconomic backgrounds may therefore have an advantage on the assessment because 
of their more extensive vocabularies (Risley and Hart, 2006). 
 
Prior experience with test content and the testing environment may affect a child’s 
performance on the BSID-III. The test may contain tasks that the child is not exposed to in 
their culture or environment. Furthermore, a child’s performance may be affected by their 
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exposure to books (Pēna and Quinn, 1997). Test items on the language subscale also do 
not consider socialisation practices. The child’s interaction with the examiner during the test 
may be influenced by cultural experiences and practices (Pēna and Quinn, 1997). 
 
The entire test battery and duration of the test requires considerable attention. If the child is 
unmotivated, disinterested and does not pay adequate attention during the test he/she may 
underperform and the results may not be a true indication of the child’s capability. In addition 
fatigue may play a role in performance (Columbia University Leaders Project, 2013). 
 
3.1.6 Use of the BSID-III as a measure of development in the South African population 
 
The BSID-III has only been used in a handful of clinical studies in Africa and SA to date. No 
published norms for the BSID-III in African countries are currently available (Hutchings and 
Potterton, 2014). The BSID-III was found to be a valid measure of infant development in 
South Africa (Rademeyer and Jacklin, 2013), and has been used in studies on children with 
low birth weight (Ballot et al., 2012), Down syndrome (Russell et al., 2016) and HIV 
(Whitehead et al., 2014; Hutchings and Potterton, 2014). Scant information was provided by 
the aforementioned authors on any challenges of using the BSID-III in the SA context.  
 
3.1.7 Use of the BSID-III as a measure of development in children with congenital heart 
disease  
 
The AHA guideline on the evaluation of development in children with CHD indicates the 
BSD-III to be the outcome measure of choice for evaluating development in infants and 
toddlers (Marino et al., 2012). Only eight cardiac neurodevelopmental outcome studies have 
so far made use of the BSID-III. These included studies by Alsaied et al. (2016), Mussatto 
et al. (2015); Mussatto et al., (2014), Beca et al. (2013), Brosig Soto et al. (2011), Acton et 
al. (2011), Long et al. (2012a) and Visootsak et al. (2011). All of the aforementioned authors 
found the BSID-III to be a valid measure of developmental outcome in children with CHD. 
No mention was made of any specific challenges in using the measure in children with CHD. 
To date, the BSID-III has not been used to determine developmental performance in children 
with CHD in Africa.  
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3.1.8 Permission to use the BSID-III 
Pearson Inc. granted written permission for the use of the test in its as-published formats for 
this research thesis. (See Appendix III for the user agreement with Pearson Inc.).  
3.2 Parenting Stress Index Short Form (PSI-SF) 
3.2.1 Description of the PSI-SF subscales 
 
The PSI-SF (Abdin, 1995) is a self-report measure that measures parental stress across 
three subscales. The “parenting stress (PS)” subscale determines the extent of the distress 
a parent experiences in his/her role directly related to parenting a child, whilst the “parent-
child dysfunction(P-CDI)" subscale looks at parents perception that his/her child does not 
meet their expectations. The “difficult child (DC)” subscale focuses on the behavioural 
characteristics of the child that make them either easy or difficult to parent (Abdin, 1995).  
 
The theoretical model for the PSI-SF as developed by Abdin (1995) is depicted in Figure 
3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Theoretical model of the PSI-SF (Abdin, 1995, p 54). 
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3.2.2 Administration and scoring of the PSI-SF  
 
No specific professional qualifications or training is required to administer or score the PSI-
SF. The Parenting Stress Index (PSI) manual does however recommend that the 
interpretation of the PSI-SF scores require graduate training in clinical psychology or a 
related medical field (Abdin, 1995). 
 
On average it should not take a parent more than ten minutes to complete the PSI-SF. 
(Abdin, 1995). Parents make use of a five-point Likert scale to indicate the extent to which 
they agree or disagree with each statement. “Strongly agree” is scored a 5, “agree” a 4, “not 
sure” a 3, “disagree” a 2 and “strongly disagree” a 1 (Abdin, 1995). The scoring sheet is then 
used to calculate a total score for each subscale. A total stress score is calculated by adding 
the scores from the three subscales. Raw scores are then converted into percentiles (Abdin, 
1995). Normal scores lie between the 15th and 80th percentile. Scores are considered to be 
high if they are above the 85th percentile, and clinically significant if above the 90th percentile. 
A high score on any of the subscales is indicative of increased levels of parenting stress 
(Abdin, 1995).   
 
3.2.3 Standardisation and norming of the PSI-SF 
 
The PSI has been standardised for use in a stratified sample of parents of children between 
the ages of one month and 12 years (Abdin, 1995). The PSI was normed in a sample in the 
US consisting of 2 633 mothers of children ranging in age from one month to 12 years, and 
in 200 fathers of children aged six months to six years (Abdin, 1995). The PSI-SF was 
developed by means of a series of factor analyses of the PSI done in two samples of 530 
and 270 mothers respectively in the US (Abdin, 1995).  
 
3.2.4 Reliability and validity of the PSI-SF 
  
The PSI-SF is feasible to use in a busy clinical setting and was specifically designed for 
administration under time constraints (Abdin, 1995). The PSI-SF has been shown to be a 
reliable measure with test-retest reliabilities of .84 for total stress, .85 for PD, .68 for P-CDI, 
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and .78 for DC respectively. The alpha internal reliability coefficients for total stress were 
.91 for total stress, .79 for PD, .80 for P-CD and .78 for DC respectively (Abdin, 1995).  
 
The PSI has been shown to have good construct and predictive validity; there is however 
no body of independent research to show the validity of the PSI-SF. The PSI-SF has been 
shown to strongly correlate with the PSI on the total stress score with a correlation of .94. 
As the PSI-SF is a direct derivative of the PSI it is most likely that it will share the same 
validity. The PSI has been used in various non-English speaking cultures and had been 
shown to maintain its validity (Abdin, 1995). Studies by Pérez Padilla et al. (2015), McKelvey 
et al. (2009), Haskett et al. (2006) and Reitman et al. (2002) have supported the validity of 
the PSI-SF. 
 
3.2.5 Use of the PSI-SF as a measure of parenting stress in the South African 
population 
 
The PSI-SF has been used in a very limited number of clinical studies in SA including in 
parents of children with HIV (Verster, 2010; Potterton et al., 2007) and cerebral palsy (Pugin, 
2007), and in mothers with substance abuse problems (Miles, 2007). The aforementioned 
studies all found the PSI-SF to be a valid measure for determining parental stress in the 
South African population. 
 
3.2.6 Use of the PSI-SF as a measure of parenting stress in children with congenital 
heart disease  
 
Studies by Visootsak et al. (2015), Vrijmoet-Wiersma et al. (2009), Lee et al. (2007), Uzark 
and Jones (2003), Carey et al. (2002) and Goldberg et al. (1990) made use of the PSI-SF 
to determine levels of parenting stress in parents of children with CHD. These studies found 
the PSI-SF to be a valid measure for establishing parental stress in this population. 
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3.2.7 Permission to use the PSI-SF  
 
The distributor of the PSI, Psychological Assessment Resources Incorporated (PAR), 
granted the researcher permission to use the PSI-SF for this study. (See Appendix IV for 
user agreement with Psychological Assessment Resources, Inc.) 
 
3.2.8 Translation of the PSI-SF  
 
The PSI-SF is available in English and Sesotho. The complete PSI has been translated into 
Afrikaans. The distributor of the PSI, Psychological Assessment Resources Incorporated 
(PAR-Inc.), granted the researcher permission to extract the 36 items contained in the PSI-
SF from the full Afrikaans version of the PSI for the purpose of this study.   
 
3.3 Paediatric Quality of life Inventory™ (PedsQL™) 
 
3.3.1 Development of the Peds QL™ 
 
The PedsQL™ is a modular measure developed to measure HRQOL in healthy children, as 
well as those with chronic diseases. Disease-specific modules serve to determine the impact 
of disease and its treatment on the child’s function and ability to derive satisfaction in various 
aspects of life, including physical, psychological and social domains (Varni et al., 2011, Varni 
et al., 2007).  
 
3.3.2 Description of the PedsQL™ scales and modules used 
 
As children aged 36 months and younger were included in this study, the PedsQL™ Infant 
Scales (1-24 months) and PedsQL™ 3.0 Cardiac Module for toddlers (2-4 years) were 
chosen as the outcome measures for HRQOL. There is no PedsQLTM cardiac module 
available for children younger than two years. Uzark et al. (2003) however found that the 
PedsQL™ Generic Core Scales and the Cardiac Modules showed a significant correlation.  
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3.3.2.1 PedsQL™ Infant Scales 
 
The PedsQL™ Infant Scales contain two age-appropriate versions, namely for infants aged 
one to 12 months and infants aged 13 to 24 months. The PedsQL™ Infant Scale is proxy-
rated, and parents report on their perceptions of their child’s HRQOL (Varni et al., 2011, 
Goldbeck and Melches, 2005; Raat et al., 2006). The PedsQLTM Infant Scales contains 
items over five scales include physical functioning, physical symptoms, emotional 
functioning, social functioning, and cognitive functioning (Varni et al., 2011).  
 
3.3.2.2 PedsQL™ 3.0 Cardiac Module  
 
The Paediatric Quality of Life Inventory (PedsQL™) 3.0 Cardiac Module has been designed 
as a disease-specific module that serves to evaluate HRQOL in children with cardiac 
disease from the age of two years (Berkes et al., 2010; Uzark et al., 2003). The PedsQLTM 
3.0 Cardiac Module covers five scales relating to symptoms, perceived physical 
appearance, treatment anxiety, and cognitive and communication problems (Uzark et al., 
2003).  
 
3.3.3 Administration and scoring of the PedsQLTM 
 
No specific professional qualifications or training is required to administer the PedsQL™. In 
the case of parents completing the PedsQL™ questionnaire, administration should not 
exceed five minutes (Varni et al., 1999). Parents are asked how much of a problem each 
item has been during the past one month. A five-point Likert response scale is used, where 
0 is “never a problem”, 1 is “almost never a problem”, 2 is “sometimes a problem”, 3 is “often 
a problem”,  and 4 is “almost always a problem” (Varni et al., 2011; Uzark et al., 2003).  
 
3.3.3.1 Scoring of the PedsQL™ Infant Scales 
 
Items are reverse scored and linearly transformed to a 0 to 100 scale (0 = 100, 1 = 75, 2 = 
50, 3 = 25 and 4 = 0). Higher scores indicate better HRQOL. Scale scores are computed as 
the sum of the items divided by the number of items answered. The total scale score is 
computed as the sum of all the items on the PedsQL™ Infant Scales divided by the number 
of items answered (Varni et al., 2011). The physical health summary score is calculated as 
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the sum of the items over the number of items answered in the physical functioning and 
physical symptoms scales. The psychosocial health summary score is calculated as the 
sum of the items over the number of items answered in the emotional, social, and cognitive 
functioning scales (Varni et al., 2011).  
 
3.3.3.2 Scoring of the PedsQL™ 3.0 Cardiac Module 
 
Items are reverse scored and linearly transformed to a 0 to 100 scale (0 = 100, 1 = 75, 2 = 
50, 3 = 25 and 4 = 0). Higher scores indicate better HRQOL. Scale scores are computed as 
the sum of the items divided by the number of items answered. No total scaled score is 
computed for PedsQL™ Cardiac Module (Uzark et al., 2003).  
 
3.3.4 Standardisation and norming of the PedsQL™ 
 
PedsQLTM Infant Scales were tested in a stratified sample of 420 parents of infants aged 
one to 12 months, and in 263 parents of infants aged 13 to 24 months across the US (Varni 
et al., 2011). Uzark et al. (2003) administered the PedsQL Generic Core Scales and Cardiac 
Module to 250 children aged five to 18 years, and in 344 parents of children aged two to 18 
years with cardiac disease at the Cincinnati Children’s Hospital in the US. 
 
3.3.5 Reliability and validity of the PedsQL™ Infant Scales and Cardiac Module 
 
Varni et al. (2011) established that the PedsQLTM Infant Scales is a feasible measure to 
determine the HRQOL of infants. They found the measure showed very few missing item 
responses. The alpha reliability coefficient for the PedsQLTM Infant Scale is .92. The 
PedsQLTM Infant Scale was also shown to have good discriminative validity in that it could 
differentiate between healthy and ill infants.   
 
Uzark et al. (2003) established that the PedsQLTM 3.0 Cardiac Module is a feasible measure 
to determine HRQOL of toddlers with CHD. They found the measure showed few missing 
item responses. The alpha reliability coefficient for the PedsQLTM 3.0 Cardiac Module was 
.93. The PedsQLTM 3.0 Cardiac Module also showed good construct validity and scores 
across the five scales, and correlated with scores on the PedsQLTM 4.0 Generic Core Scale 
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scores. 
 
3.3.6 Use of the PedsQLTM as a measure of health-related quality of life in the South 
African population 
 
The PedsQLTM has only been used in a limited number of clinical studies in SA to investigate 
HRQOL in children with HIV (Goldberg, 2011), brain tumours (Penn, 2013) and post-burn 
(Weedon and Potterton, 2011). The aforementioned studies have shown the Peds-QL™ to 
be a feasible, reliable and valid measure for HRQOL outcomes in varied paediatric 
populations in SA.  
 
3.3.7 Use of the PedsQL™ as a measure of health-related quality of life in children 
with congenital heart disease 
  
No studies could be found that report on the HRQOL outcomes of children aged two years 
and younger with CHD using the PedsQL™ Infant Scales. However, the PedsQL™ infant 
modules have been successfully used to establish HRQOL in children younger than two 
years with other chronic diseases such as chronic liver disease (Mohammed et al., 2016).   
 
Studies by Uzark et al. (2003), Pike et al. (2007), Uzark et al. (2008), Berkes et al. 
(2010),Tahirović et al. (2010) and  Eagleson et al. (2013) have reported on the HRQOL 
outcomes of children aged two years and older with CHD using the PedsQL™ 3.0. Cardiac 
Module.  All of the aforementioned studies found the PedsQL™ 3.0 Cardiac Module to be a 
feasible, valid and reliable measure of HRQOL in children with CHD aged two years and 
older. No studies have however been conducted in SA using the Peds-QL™ as a measure 
of HRQOL outcomes in the paediatric cardiac population to date. 
 
3.3.8 Permission to use the PedsQL™ 
 
A user agreement was signed with Mapi Research Trust, Lyon, France, prior to use the 
questionnaires. This included the PedsQL™ Infant Scales (1-12 months) and (13-24 
months) and the PedsQLTM Cardiac Module (2-4 years). (See Appendix V for the user 
agreement with Mapi Research Trust).  
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3.3.9 Translation of the PedsQLTM 
 
The PedsQL™ Infant Scales (1-12 months) and the PedsQL™ Infant Scales (13-24 months) 
were available from the distributor in English, Afrikaans and Sesotho (Varni, 2013).  
 
The PedsQLTM Cardiac Module (2-4 years) was only available in English, and was translated 
into Afrikaans and Sesotho in line with the stipulated prescripts of the distributor prior to the 
commencement of the study (Varni, 2013). Further language validation of the translations 
was not possible as the translated questionnaires were not utilised during this study due to 
the age range of the participants and the caregiver’s language preferences, which failed to 
provide the opportunity to do so. 
 
3.4 Hollingshead Socioeconomic Index and Hollingshead Index of Social Position 
 
3.4.1 Determinants of Hollingshead’s Four Factor Index of Social Status 
 
Hollingshead’s Four Factor Index of Social Status calculates social status by collecting 
information on four factors, namely education, occupation, gender and marital status 
(Hollingshead, 1975).  
 
3.4.2 Calculation and interpretation of the Hollingshead indices 
 
3.4.2.1 Hollingshead Socioeconomic Index 
 
Each parent’s educational level is rated on a seven point scale according to the highest 
grade completed and each parent’s occupational level is rated on a nine-point scale 
(Hollingshead, 1975). The SES index score for each parent is calculated using a weighted 
formula where occupation is weighted 5 and education is weighted 4 (Hollingshead, 1975).  
 
Adding the status score of the mother and the status score of the father and dividing it by 
two calculates the socioeconomic status score for the family. This score is then used to 
determine the family’s social strata. Table 3.3 presents the socioeconomic index and social 
class equivalents of the Hollingshead Socioeconomic Index. 
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Table 3.3 Social class according to the Hollingshead Socioeconomic Index scores  
 
Socioeconomic index score Social class equivalent 
55 – 66 Major business or professional 
40 – 54 Medium business or minor professional 
30 – 39 Clerical worker or craftsman or sales worker 
20 – 29 Machinist or semi-skilled labourer 
9 -18 Unskilled labour or menial worker 
(Hollingshead, 1975, p 18) 
 
3.4.2.2 Hollingshead Index of Social Position  
 
The Hollingshead Index of Social Position (ISP) is a two-factor index calculated using a 
weighted formula where occupation is weighted 7 and education is weighted 4 (Lantos, 
2015).  A score for each parent is calculated. The score for each parent is added and divided 
by two to get the ISP score for the family. The score is then used to assign families to a 
social class category. Table 3.4 presents the ISP score and the social class equivalent of 
the Hollingshead ISP. 
 
Table 3.4 Social class categories for the Hollingshead Index of Social Position 
scores 
 
ISP score Social class equivalent 
11 – 17 Upper class 
18 – 31 Upper-middle class 
32 -  47 Middle class 
48 -  63 Lower –middle class 
64 -  77 Lower class 
(Lantos, 2015, p227) 
 
3.4.3 Reliability and validity of the Hollingshead Socioeconomic Index and 
Hollingshead Index of Social Position 
 
The Hollingshead Socioeconomic Index still lacks evidence of reliability and validity. 
However, according to experts in social stratification, it remains the index that other indices 
are benchmarked against (Cassedy et al., 2013). It remains the only outcome measure of 
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SES reported in the published CHD literature. Thus, this measure was still chosen for this 
study, despite its limitations, as it allowed for direct comparisons between studies. 
 
3.4.4 Use of the Hollingshead Socioeconomic Index and Hollingshead Index of Social 
Position as a measure of social status in the South African population 
 
The Hollingshead Socioeconomic Index, as a measure of socioeconomic and social status, 
has not been widely used in South African healthcare research. Two studies were identified 
to have used the Hollingshead Socioeconomic Index. Simelane (2015) studied the impact 
of SES on parenting autistic children in SA, while Bogart et al. (2013) investigated the role 
of parents in a HIV prevention programme in adolescents.  
 
3.4.5 The Hollingshead Socioeconomic Index and Hollingshead Index of Social 
Position as a measure of social status in families of children with congenital heart 
disease. 
 
Varni et al. (2007) included the Hollingshead Socioeconomic Index as a measure of social 
status in their family information form, contained in the PedsQLTM Generic Core Scales 
which is used to determine HRQOL in children. The Hollingshead Socioeconomic Index has 
been used in several paediatric cardiology studies to determine the SES of families including 
studies by Connor et al. (2010), Uzark et al. (2008) and Cassedy et al. (2013).  
 
3.4.6 Concerns regarding the Hollingshead Socioeconomic Index and the 
Hollingshead Index of Social Position 
 
Concerns have been expressed as to whether the Hollingshead Socioeconomic Index and 
the Hollingshead Index of Social Position are adequate measures of social status. The 
biggest concerns with the measure is that social status is determined by education and 
occupation. Occupational prestige might not only depend on the type of occupation, but the 
aspects of the occupation itself. Hollingshead also assumed that income was linked to 
education and occupation, which might not always be the case. Despite the possible 
limitations the Hollingshead Socioeconomic Index is still widely used in healthcare research 
(Cassedy et al., 2013; Weakliem and Adams, 2011).  
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3.4.7 Permission for use of the Hollingshead Socioeconomic Index and the 
Hollingshead Index of Social Position 
 
There is no restriction on the use of Hollingshead Socioeconomic Index and the Index of 
Social Position (ISP). The respective formulas for the calculations are freely available online 
in Hollingshead’s (1975) unpublished manuscript and from Lantos (2015) respectively. 
 
3.5 Pilot study 
 
The researcher performed multiple developmental assessments on high-risk children aged 
between one and 42 months in the months prior to the commencement of the study in order 
to familiarise herself with the subtests, testing and scoring procedures, and test items 
contained in the BSID-III. This served to improve the accuracy of the developmental 
assessments during the pilot study, as well as the main study. Once ethical clearance was 
attained, the study was piloted in line with the approved protocol (Refer to 4.6 for the study 
procedure followed). Six children meeting the inclusion criteria were included in the pilot 
study (10% of the anticipated study sample). 
 
The pilot study served multiple purposes, including the determination of the feasibility of this 
study. Another important purpose of the pilot study was to determine the suitability of the 
chosen outcome measures for the purpose of this study and in the identified population. 
Although all chosen outcome measures have been used in similar studies in young children 
with CHD in developed countries and in paediatric populations in SA, none had been used 
in the paediatric CHD population in SA before. All outcome measures were found to be 
suitable for use in the population of young children with CHD in central SA during the pilot 
study. 
 
The pilot study allowed for a review of the logistical aspects around the physical assessment 
of the children, and the interview and completion of the questionnaires with the parents in 
the paediatric cardiothoracic ward, cardiology unit and physiotherapy department at 
Universitas Academic Hospital in Bloemfontein, Free State. The researcher had not 
previously assessed and treated children with CHD in the cardiothoracic ward and 
cardiology unit. The cardiothoracic ward and cardiology unit were however chosen as the 
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site for the baseline assessments for logistical reasons, as the children needed to be 
accessible to both nursing staff and doctors for routine procedures on the afternoon of the 
day before their scheduled cardiac intervention.  
 
Performing the baseline assessments in the cardiothoracic ward and cardiology unit proved 
to be a challenge with regard to finding a quiet and private area or room in which to conduct 
the interviews with the parents, complete the self-administered questionnaires, and to do 
the children’s developmental assessment in a busy clinical setting. The pilot study allowed 
the researcher to identify the most suitable areas in each ward for this purpose, being either 
the consultation room or the patient’s own room. Unfortunately, as these were both busy 
clinical wards, the consultation room was at times in use by other clinicians, which required 
the need for improvisation and flexibility with regard to the assessment venue. Parent 
interviews were always conducted in a private consultation room to ensure confidentiality. 
The private consultation room was equipped with a table and chairs for the completion of 
the questionnaires and there was sufficient space to do the BSID-III assessment. If the 
consultation room was unavailable at the time of the developmental assessment, the 
assessment was done in the patient’s room. A therapy mat, child-sized table, chairs and a 
stairs were available in the ward for the developmental assessments.  
 
The physiotherapy department availed a private paediatric outpatient area with all the 
necessary equipment to the researcher for use by her for all the three-month and six-month 
follow-up assessments. The original plan was to do the follow-up assessments in the 
paediatric clinic at Universitas Academic Hospital where the cardiology clinic was held. 
However, this was not feasible due to the lack of space in the busy clinic. All follow-up visits 
were held in the physiotherapy department, and the researcher accompanied parents and 
children from the cardiology clinic to the physiotherapy department in order to ensure that 
they were not lost between the two sites.  
 
The pilot study showed the researcher to be proficient in the administration of the PSI-SF 
and PedsQL™. It came to light during the pilot study that parents lacked the confidence to 
complete the self-administered questionnaires on their own, preferring the researcher to sit 
with them during the completion so as to clarify any uncertainties. It was found that the 
suggested timeframes for the self-administered questionnaires greatly exceeded the 
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suggested five to ten minutes per questionnaire. This resulted in having to allow for closer 
to 20 minutes per questionnaire in the main study. In the case of Sotho-speaking mothers, 
a translator was also present to assist with translation and clarification when required. In 
cases where a translator was used, up to 25 minutes per questionnaire had to be allowed 
for in the main study. The developmental assessment took between 60 and 90 minutes, as 
suggested in the technical manual of the BSID-III, and the test duration was influenced by 
the child’s age, with older children taking longer to assess.  
 
The pilot study assisted the researcher in determining a logical sequence for the 
assessment. The administration guidelines for the self-administered questionnaire 
recommend that they be administered first before further assessments. This was however 
not found to be feasible in this study, in particular at baseline. Children undergoing cardiac 
surgery were in most cases admitted to the cardiothoracic ward after midday on the day 
before their surgery. Being admitted in the afternoon on the day before surgery posed a 
considerable challenge relating to time, in that these children still had to undergo multiple 
routine medical examinations and routine tests before their surgery. It was not possible to 
have the children admitted earlier as this would mean that they would have to have been 
admitted the previous week and remain in hospital over the weekend, resulting in an 
increase in hospital costs and inconvenience for the families. In most cases, this left the 
researcher with limited time available in which to complete the baseline assessment before 
the child became too tired and irritable. The priority at baseline was to complete the child’s 
physical examination and developmental assessments first; this included the neurological 
examination, measurement of head circumference and length, and the BSID-III. The self-
administered questionnaires were completed directly after the child’s assessment; and 
where not possible, the questionnaires could be completed in the morning on the day of the 
child’s surgery. It was decided that the same routine was to be followed at the three-month 
and six-month visits to ensure a consistent procedure for the children and parents. The time 
frame required for each assessment in total was determined to be between 90 and 120 
minutes. 
 
No changes were made to the study procedures, and the quality of the assessments done 
in the pilot study were such that the researcher included all the data collected in the pilot 
study in the main study.  
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3.6 Conclusion 
 
Based on the extensive literature review and the findings from the pilot study the BSID-III, 
PSI-SF, PedsQLTM and the Hollingshead Socioeconomic Index were deemed suitable 
outcome measures for use in this study.  
 
The method for Phase I and II of this study will be presented in Chapter four. 
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CHAPTER 4 
 
METHOD FOR PHASE I AND II 
_____________________________________________________ 
 
 
In this chapter, the methodology for Phase I and II of this study is presented. The study 
design and participant recruitment is described and the study procedure will be outlined. 
 
4.1 Study location 
 
The study was conducted at the Paediatric Cardiology Unit located at the Universitas 
Academic Hospital in Bloemfontein. 
 
The Paediatric Cardiology Unit at Universitas Academic Hospital services the population of 
central SA, estimated to be 4.2 million people. Central SA for the purpose of paediatric 
cardiology services in SA refers to the Free State and Northern Cape provinces, as well as 
the neighbouring country of Lesotho (Hoosen et al., 2010a). In addition, a number of children 
residing in the Eastern Cape are also treated at the Bloemfontein unit. Figure 4.1 provides 
a geographical view of the provinces of SA. The most frequently treated congenital heart 
defects at this unit include VSD, AVSD and PDA. 
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On average six to seven children, 30 months and younger, underwent cardiac surgery per 
month at Universitas Academic Hospital at the time of the study. Children only had access 
to mechanical ventilation as a form of mechanical circulatory support. ECMO and VAD 
mechanical circulatory support technologies were not available to these children. 
    
4.2 Ethical considerations 
 
Ethical clearance was obtained for this study from the Ethics Committee of the Faculty of 
Health Sciences, University of the Free State (clearance certificate number ECUFS 
177/2013) and the Committee for Research on Human Subjects, University of 
Witwatersrand (clearance certificate number M131056) prior to the commencement of the 
study. (See Appendix VI for the ethical clearance certificates). 
 
Permission to conduct the study was obtained from the relevant authorities at Universitas 
Academic Hospital, including the Clinical Manager, the Head of the Department of 
Cardiothoracic Surgery Department and the Head of the Department of Paediatric 
Cardiology. (See Appendix VII for the permission letters from the relevant authorities). The 
Figure 4.1 Map of the provinces of South Africa (Google images) 
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Physiotherapy Department at Universitas Academic Hospital granted permission for the use 
of a venue within the Department for all three-month and six month follow-up assessments.  
 
Participants in Phase I and Phase II of the study included both children and their parents. 
Parents were informed of the purpose of the study by means of an information letter, and 
the researcher provided further verbal explanation where necessary (a translator was used 
to assist in the case of Sesotho-speaking parents). Written informed consent was obtained 
from parents for their personal participation in the study. As the study also included their 
young children, who were incapable of providing informed consent, parents also provided 
written permission for their children’s participation in the study (PAREXEL International, 
2010; RSA-DoH, 2006). (Refer to Appendix VIII for the parent information letter and informed 
consent form for Phase I and II).  
 
A contribution was made towards the transportation costs incurred by the participants for 
their attendance of both the three-month and six-month follow-up visits. This was done in 
accordance with the National Human Research Ethics Council of SA (NHREC) guidelines 
(2012) on the payment of study participants in SA.  
 
The study was conducted in line with the approved protocol. Participation in this study was 
voluntary. Parents had the right to decline participation or withdraw from the study with their 
child at any point without reason or risk of penalty or discrimination. Children continued to 
receive standard cardiac care irrespective of their participation in the study. 
 
Cardiac neurodevelopmental follow-up is not offered as part of standard care at the 
Cardiology Unit at Universitas Academic Hospital. Where indicated, the researcher referred 
children who qualified for EI therapy services (included PT, OT and ST) based on their 
developmental performance to their nearest service point.  
 
4.3 Study design 
 
Phase I and II of the study made use of an observational descriptive study design. 
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4.4 Participants 
 
The study population consisted of young children with CHD and their parents who attended 
the Paediatric Cardiology Unit at Universitas Academic Hospital in Bloemfontein. For the 
purpose of this study, young children will refer to infants (1 month to 1 year) and toddlers  
(1 year to 3.5 years) (Marino et al., 2012).  
All children aged 30 months and younger, who met the inclusion criteria, were recruited into 
the study. Parents who granted written informed consent for their personal participation, as 
well as written permission for their child’s participation, were included in the study sample. 
 
The inclusion and exclusion criteria were set as follows: 
 
Inclusion criteria: 
 
§ Children 30 months and younger at the time of inclusion. 
§ Children diagnosed with a congenital heart defect that required cardiac surgery.  
§ Attended cardiac services with a parent who could speak English, Afrikaans or 
Sesotho. 
§ Parents had to be willing to attend scheduled follow-up visits with their child over a 
six-month period. 
 
Exclusion criteria: 
 
§ Children who were critically ill and could not be accurately and/or safely assessed.  
§ Neonates (children younger than 28 days). 
§ Children who had undergone previous or emergency cardiac surgery.  
§ Children who only underwent interventional cardiac catheterisation.  
§ Parents who declined to participate in the study, and/or were unwilling to grant 
permission for their child’s participation. 
§  
As congenital heart disease is a rare disease, a sample of convenience was used during 
Phase I and Phase II of the study due to the small study population. Forty consecutive 
participants were included in Phase I of the study and 22 participants exited the study at the 
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end of Phase II. Six participants died post-cardiac surgery (15% mortality rate) and a further 
twelve participants (30%) were lost to follow-up by the end of Phase II (Refer to Figure 4.2 
for a flow diagram depicting the study procedure).  
 
4.5 Materials and measurements 
 
The evidence-based guidelines for neurodevelopmental evaluation for infants and toddlers, 
provided in the scientific statement from the AHA on the evaluation and management of 
neurodevelopment in children with CHD (Marino et al., 2012), were taken into consideration 
when deciding upon the content of the neurodevelopmental assessment in this study. Based 
on their recommendation the BSID-III was chosen as the standardised developmental 
outcome measure. In addition growth parameters were measured (height, weight and head 
circumference) and a neuromotor examination (muscle tone and deep tendon reflexes) 
performed. 
 
4.5.1 Demographic information of the child and family 
 
Demographic information of the child with regards to age, gender, ethnicity and birth history 
(birth date, gestational age, birth weight and Apgar scores) was collected at baseline (See 
Appendix IX). Ethnic groups were identified in accordance with the 2011 South African 
Census as black African, Coloured, Indian or Asian, white and other (Statistics South Africa, 
2012). Parents selected the ethnic group with which they personally identified. 
 
Demographic information of the family with regards to the primary caregiver of the child, 
residence, mother’s age, number of siblings and teratogens was collected at baseline (See 
Appendix IX).  
 
4.5.2 Socioeconomic status of the family 
 
Information regarding educational attainment, occupation, employment status and marital 
status of both parents was collected at baseline (See Appendix IX). This information was 
used to calculate the SES status of each parent and family using the Hollingshead Four 
Factor Index of Socioeconomic Status. In addition, the Hollingshead Index of Social Position 
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(ISP) was calculated for each family in order to assign the family to a social class category 
(Lantos, 2015). 
 
4.5.3 Cardiac diagnosis and medical management information 
 
Information regarding the type of CHD, presence of genetic and extracardiac abnormalities, 
HIV status (recorded as HIV positive, HIV negative or unknown), complications, medication 
use and risks factors for CHD was collected from the patient’s medical record at baseline 
(See Appendix X).  
 
The children’s CHD was classified according to the nature of the defect as cyanotic or 
acyanotic (See Appendix I), and the medical severity of the cardiac disease was rated by a 
paediatric cardiologist using the Cardiologists Perception of Severity Scale (See Appendix 
II). 
 
4.5.4 Cardiovascular status  
 
Information regarding the children’s cardiovascular status, including vital signs (heart rate, 
respiratory rate and blood pressure) was collected from the patient record. Non-invasive 
pulse oximetry was used to assess the percutaneous oxygen saturation (SpO2) at baseline. 
A SpO2 of less than 85% on room air was considered to be indicative of cyanosis (Brown, 
2014; Kemper et al., 2011). This information was retrieved from the patient’s medical record 
at baseline (See Appendix XI). 
 
As vital signs and oxygen saturation (SpO2) was not routinely taken at the cardiology clinic, 
cardiovascular status at three-month and six-months post-cardiac intervention was 
established on the grounds of the presence of cyanosis at baseline and the need for multiple 
cardiac surgeries to optimise cardiovascular function (CHD severity).  
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4.5.5 Surgical intervention and post-operative medical course information 
 
Information regarding the child’s surgery including age at first surgery, aim of the surgery 
(palliation, staged correction or correction), surgical access, CPB time and aorta cross-
clamp time was collected from the child’s medical record post-operatively.  
 
In addition, information regarding the child’s post-operative medical course, including the 
presence of seizures, the need for cardiopulmonary resuscitation, prolonged mechanical 
ventilation, peri-operative and post-operative complications, cardiac ICU length of stay, 
post-surgery hospital length of stay and total length of hospital stay was also collected from 
the patient’s medical record (See Appendix X). 
 
4.5.6 Anthropometric measurements 
  
The scientific statement of AHA and AAP on the evaluation and management of children 
with CHD recommends that growth be carefully monitored. This includes weight, 
length/height and head circumference (Marino et al., 2012). 
 
At baseline, length (height) and weight was routinely measured on admission to either the 
cardiothoracic ward or cardiology unit by the nursing personnel, and documented in the 
patient’s file. At the three-month and six-month visits, length (height) and weight was 
routinely measured by the nursing personnel at the clinic and noted in the patient file and/or 
in the child’s Road to Health Booklet (RTHB) (See Appendix XI). 
 
Children were weighed using a digital baby scale and the measurement was noted in 
kilogram (kg) to a single decimal point. Length was determined by lying the child down on a 
firm surface. The child’s legs were straightened, and a tape measure was run alongside the 
child stretching from the crown of the head to the heels. Length was measured in centimetre 
(cm). The same digital scale available in the cardiothoracic ward and the paediatric clinic 
respectively, and the same procedure for measuring the children’s length, were used 
throughout the study. 
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Head circumference was not measured routinely by the nursing personnel and was 
measured by the researcher. A flexible non-stretchable measuring tape was used. The 
measuring tape was placed around the child’s head at the broadest part of the head above 
the ears and midway between the eyebrows and the hairline to the occipital prominence at 
the back of the head. Head circumference was recorded in centimetres (cm).  
 
The World Health Organization (WHO) child growth standards for length-for-age, weight-for-
age and head circumference-for-age for girls and boys were used to determine z-scores for 
the anthropometric measurements (WHO, 2006). It is known that children with genetic 
abnormalities such as DS follow different growth trajectories from children without genetic 
abnormalities. Children with DS have lower birth weights and grow slower. DS is also 
characterised by short stature (Zemel et al., 2015). It is recommended that specific growth 
charts for special populations be used to evaluate growth outcomes in children with 
disorders that interfere with their growth, such as DS (CDC, 2016b; Zemel et al., 2015; Van 
Gameren-Oosterom et al., 2011; Myrelid et al., 2002). Zemel et al. (2015) recommends the 
use of the latest published DS-specific growth charts as growth in the contemporary 
population of children with DS has improved considerably due to medical advances. For this 
study, the latest DS-specific growth charts published in the US in 2015 were used to 
calculate z-scores for growth parameters of children with CHD with DS in the current study 
(Zemel et al., 2015). No DS-specific growth standards are currently available for SA. 
 
4.5.7 Neurodevelopmental status 
 
The BSID-III was used to determine developmental outcome. The motor, cognitive and 
language scales of the BSID-III were administered by a physiotherapist with extensive 
paediatric experience (Bayley, 2006b). Administration of the test followed the guidelines as 
outlined in the administration manual (Bayley, 2006a). Due to test security concerns, Person 
Inc. does not permit the appending of any assessment products to this thesis. All Pearson 
Inc. assessment products are copyright protected. 
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4.5.8 Neurological status 
 
The AHA statement on the developmental assessment of young children with CHD 
recommends that a neurological assessment form part of the developmental assessment. 
This is to include the assessment of active and passive muscle tone and deep tendon 
reflexes (Marino et al., 2012). 
 
Muscle tone, deep tendon reflexes, clonus and Babinski were assessed by the researcher 
as part of the neurological examination at baseline, and at the three-month and six-month 
post-cardiac intervention follow-up visits. The neurological examination was done with the 
child positioned in supine (See Appendix XI). 
 
Muscle tone of the limbs was determined by moving the limb passively through the range of 
motion at different velocities whilst the resistance to movement was evaluated. Muscle tone 
was then classified as being increased, normal or decreased.   
 
Deep tendon reflexes (biceps-, triceps-, patellar- and Achilles tendon) were tested using a 
reflex hammer. Tendon reflexes were classified as increased, normal or decreased. 
Babinski and clonus were also tested as part of the reflexes, and test findings were reported 
as either positive or negative. 
 
4.5.9 Neurodevelopmental risk stratification 
 
The risk of adverse developmental outcome was classified as low or high. Data was 
collected regarding risk factors as part of the medical and surgical data.  
 
Children were deemed to be at high-risk of adverse neurodevelopmental outcome if they 
required surgery during infancy and if they had a cyanotic heart lesion. In addition, CHD with 
the following co-morbidities were considered to be at high-risk: prematurity, genetic 
syndromes associated with developmental difficulties, cardiopulmonary resuscitation at any 
point, prolonged hospitalisation post-surgery (> two weeks); peri-operative seizures, 
mechanical ventilation prior to cardiac surgery, significant neuroimaging abnormalities 
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and/or the presence of microcephaly (Marino et al., 2012). These variables (or risk factors) 
were also investigated for their association with developmental outcome (See Appendix X). 
 
4.5.10 Health-related quality of life 
 
The PedsQL™ was used to determine parents’ perception of the impact of CHD and its 
treatment on their child’s function and ability to derive satisfaction in various aspects of life, 
including physical, psychological and social domains. It is a multidimensional measure that 
is brief and easy to administer. 
 
As children 36 months and younger were included in this study the PedsQL™ Infant Scales 
(1-24 months) and PedsQL™ 3.0 Cardiac Module for toddlers (2-4 years) were used. As 
young children were included in the study, parents served as proxy-raters and completed 
the questionnaires (Raat et al., 2006; Goldbeck and Melches, 2005). Due to test security 
concerns, Mapi Research Trust does not permit the appending of their assessment products 
to this thesis. All Mapi Research Trust assessment products are copyright protected. 
 
4.5.11 Parenting stress  
 
The PSI-SF was used to measure the levels of stress experienced by parents parenting a 
child with CHD.  Parenting stress levels also served as a proxy for the burden of care. Due 
to test security concerns, Psychological Assessment Resources, Inc. (PAR) does not permit 
the appending of their assessment products to this thesis. All PSI-SF assessment products 
are copyright protected. 
 
4.5.12 Burden of Care  
 
Burden of care served to determine the impact of a child’s illness on family life. Information 
regarding the burden of care was included in the family information data sheet at baseline, 
and the family burden of care data sheet at three-month and six-month post-cardiac 
intervention (See Appendix IX and Appendix XII).  
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Data items relating to burden of care were adapted from the PedsQLTM Family Information 
Form developed by (Varni et al., 2007). Items on which data was collected included the 
number of times the child was hospitalised and the reasons for the hospitalisation (data was 
collected regarding admissions before cardiac surgery and between follow-up visits), the 
number of days the child was too ill to play or get up, and the number of days the child 
required special care as a result of his/her physical health. If the parent worked outside of 
the home, information was gathered on the number of days the parent missed work due to 
their child’s ill health, how often their child’s physical health affected their daily routine at 
work and how often their child’s physical health affected their ability to concentrate at work.  
 
4.6 Procedure for Phase I and Phase II 
 
Phase I  
 
The list of children scheduled for admission for cardiac surgery each week was e-mailed to 
the researcher by the Cardiothoracic Surgery Department on the Friday before, so that the 
researcher could review the surgery list to identify potential study participants. The 
researcher visited the cardiothoracic ward each Monday at midday to establish which 
children had been admitted, and to identify those who met the inclusion criteria for the study 
based on the information in their medical record. Then the updated surgery list for the week 
was reviewed to identify children going in for surgery either on a Tuesday, Wednesday or 
Thursday morning so that recruitment could be prioritised, and children who were included 
could be assessed before going in for surgery. This strategy was aimed at maximising the 
number of participants included in this study. The only feasible opportunity to do the baseline 
assessment was on the day of admission, which in most cases was the day before the child 
was scheduled to undergo cardiac surgery.  
 
Parents of children who met the inclusion criteria were approached in the cardiothoracic 
ward by the researcher after admission. The researcher informed the parents about the 
research study and invited them to participate. Parents who showed interested in 
participating were given an information letter, which was available in English, Afrikaans or 
Sesotho. Parents were provided with an opportunity to read through the document in their 
language of choice and ask questions. A translator was available, if needed. 
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Once written informed consent had been obtained from the parents, as well as written 
permission for their child’s participation, the family was included in the study sample. Upon 
inclusion in the study, the researcher gathered information regarding the nature and severity 
of the CHD and medical management of the child’s heart disease from the medical record 
and/or through consultation with the attending paediatric cardiologist. 
 
Baseline 
 
The child’s vital signs (heart rate, respiratory rate, and blood pressure), oxygen saturation, 
weight and height/length, as measured by the nursing personnel in the cardiothoracic ward 
on admission, was sourced from the child’s medical record and recorded. The child’s head 
circumference was measured by the researcher and recorded. 
 
The assessment took place in a doctor’s consultation office in the cardiothoracic ward to 
ensure privacy and a quiet environment with minimal distractions. The assessment started 
with the physical assessment of the child to ensure that all physical tests were completed 
before the child went in for surgery.  
 
The researcher administered the BSID-III. The test was administered with the child seated 
on the parent’s lap at a table or in the case of older children, it was performed with the child 
seated on a child-sized chair at a child-sized table. A therapy mat was available for testing 
of activities such as rolling and crawling, where age appropriate. The mental scale was 
administered before the motor scale, as recommended in the BSID III administration 
manual. Testing started at the child’s chronological age or where indicated at the child’s 
corrected age for the cognitive, language and motor scales (Bayley, 2006b). 
 
 Following the administration of the BSID III the researcher performed a neurological 
examination with the child positioned in supine on an examination table or on a therapy mat. 
The neurological examination included the testing of muscle tone, deep tendon reflexes, 
Babinski and clonus. 
 
Following the physical examination the researcher provided the parents with feedback on 
the child’s developmental performance on the BSID-III, identifying areas of strength and 
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weakness. In cases where there were developmental concerns, it was discussed with 
parents.  
 
The researcher interviewed the parents to gather demographic and socioeconomic 
information, as well as information regarding their current burden of care. The parents then 
completed two brief standardised questionnaires, the PedsQL™ which is a parent-proxy 
rated questionnaire that serves to measure parents’ perception of their child’s HRQOL, 
followed by the PSI-SF which serves to measure the levels of parenting stress. The 
questionnaires were available in English, Afrikaans and Sesotho. The researcher and a 
translator, if necessary, were present to answer any questions during the completion of the 
questionnaires.  
 
All children participating in the study then underwent cardiac intervention in the form of either 
cardiac surgery or percutaneous cardiac catheterisation. All parents were informed on 
assessment that they would be followed-up as part of the study at their routine post-cardiac 
intervention cardiology follow-up appointment.  
 
Phase II  
 
Three-month post cardiac intervention follow-up visit 
 
Upon discharge, the researcher established the child’s paediatric cardiology clinic follow-up 
date as booked by the cardiothoracic ward nursing. This appointment was scheduled at 
three-month post-cardiac intervention. The appointment date was then confirmed 
telephonically with the paediatric cardiology clinic by the researcher.  
 
Following discharge the researcher contacted the cardiothoracic department to retrieve the 
child’s surgical and post-operative medical course information from the child’s medical 
record. In cases of percutaneous cardiac catheterisation the cardiology department was 
contacted for procedure related information (See Appendix X on medical and peri-operative 
and post-operative information).  
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The researcher contacted parents telephonically and via Short Message Service (SMS) text 
message to remind them of their scheduled three-month study follow-up visit the week 
before and on the day before the scheduled appointment. Parents were accompanied from 
the cardiology clinic to the Physiotherapy Department for the three-month assessment.  
  
Nursing personnel at the paediatric cardiology clinic measured the weight and height/ length 
of the child. The values were retrieved from the clinic file or RTHB, and recorded by the 
researcher when the child was collected from the clinic. The child’s head circumference was 
measured by the researcher.  
 
All the measures done at baseline were repeated, namely the BSID-III, neurological 
assessment, interview regarding burden of care and the completion of the two standardised 
questionnaires, the PedsQLTM and PSI-SF. The same testing, interview and questionnaire 
procedures were followed, as described at baseline.  
 
Following the physical examination the researcher provided the parents with feedback on 
the child’s developmental performance on the BSID-III. Areas of strength and concern were 
highlighted. In cases where children were found to be developmentally at risk or presented 
with developmental delays based on their developmental performance on the BSID-III, 
parents were provided with suitable advice regarding developmental stimulation in line with 
the developmental items tested on the BSID-III. Children with developmental concerns were 
also referred to the indicated EI services (PT, OT and ST) at their nearest service point, if 
they were not already accessing services. Parents were also provided with feedback 
regarding their levels of parenting stress and their perception of their child’s HRQOL in 
relation to baseline scores.   
 
At the end of the follow-up visit, an appointment was made for their six-month post-cardiac 
intervention study follow-up. Where possible the researcher tried to combine the follow-up 
visit with other scheduled appointments at the hospital to decrease the burden placed on 
parents. 
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Six-month post-cardiac intervention follow-up visit 
 
The researcher contacted parents telephonically and via SMS text message to remind them 
of their scheduled six-month study follow-up visit the week before and the day before the 
scheduled appointment. The six-month follow-up again took place at the Physiotherapy 
Department, Universitas Academic Hospital. This was a venue already familiar to parents.  
 
Nursing personnel at the paediatric cardiology clinic or the child’s local clinic measured the 
weight and height/ length. The values were retrieved and captured by the researcher during 
the visit. The child’s head circumference was measured by the researcher.  
 
The same measures were repeated as done at baseline and at the three-month follow-up, 
namely the BSID-III, neurological assessment, interview regarding burden of care and the 
completion of the two standardised questionnaires, the PedsQLTM and PSI-SF. The same 
testing, interview and questionnaire procedures were followed as described for baseline and 
the three-month follow-up.  
 
Following the physical examination, the researcher provided the parents with feedback on 
the child’s performance on the BSID-III. Areas of strength and concern were highlighted. In 
cases where children were found to be developmentally at risk or presented with 
developmental delays based on their developmental performance on the BSID-III, parents 
were provided with suitable advice regarding developmental stimulation in line with the 
developmental items tested on the BSID-III. Children with developmental concerns were 
also referred to the indicated EI services (PT, OT and ST) at their nearest service point, if 
they were not already accessing services. Parents were also provided with feedback 
regarding their levels of parenting stress and their perception of their child’s HRQOL in 
relation to their baseline and three-month follow-up visit scores.   
 
Progress through Phase I and II of the study was monitored and data regarding mortality, 
loss to follow-up and non-compliance was captured (See Appendix XIII). Figure 4.2 below 
provides a flow diagram depicting the study procedure.  
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Figure 4.2 Flow diagram of the study procedure 
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Phase II: Six month follow- up  
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4.7 Measures to limit attrition 
 
Most of the children and their families treated at the cardiology unit at Universitas Academic 
Hospital are public sector patients, and families often come from poor socioeconomic 
circumstances. The majority of children and their families rely on inter-hospital or public 
transport to access cardiology services. Attendance of follow-up cardiology appointments in 
many cases is irregular and up to 45% of children do not attend their scheduled follow-up 
appointments (Brown, 2016).  
 
In order to reduce loss to follow-up, inconvenience and the financial burden on families, 
follow-up appointments were scheduled on the same dates that the children had their 
scheduled cardiology clinic follow-up visits.   
 
At baseline, a contact number was taken for the primary caregiver, which in most cases was 
the mother. Where there was an alternative contact number for an additional family member 
it was taken as well. The number of the primary caregiver was phoned in order to confirm 
that it was a valid number. Parents were contacted telephonically and via SMS text message 
one week before the scheduled study follow-up and the day before to remind them of the 
scheduled appointment. Studies by Leong et al. (2006), Downer et al. (2006) and Car et al. 
(2012) found that SMS text message reminders improved attendance of healthcare 
appointments. No confidential information was shared via SMS text message, only the date 
and time of the study follow-up. 
 
If children failed to arrive for scheduled follow-up appointments, the parents were contacted 
on the same day, and the appointments were rescheduled at the earliest possible 
convenience.  
 
A contribution was also made toward the travelling costs of participants to encourage the 
attendance of follow-up visits.  
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4.8 Statistical analysis 
 
A sample size of 40 children and their parents had a 90% power to detect a difference in 
means of 10 based on a standard deviation of 15, taking into account a possible 15% loss 
to follow-up and a 10% non-compliance based on the BSID III, as the main outcome 
measure. 
 
The data were not subjected to a test of normality as the sample size was not large enough 
for a proper test of normality. The assumption was that the data followed a normal 
distribution.  
 
Sample characteristics and clinical variables were presented as means with standard 
deviations and medians with ranges for continuous data and frequencies with percentages 
for categorical data.   
 
In addition to being treated as a numerical score, developmental outcomes within each 
developmental domain in the BSID-III (cognitive, language, and motor), growth parameters 
and parenting stress levels were classified at each assessment in accordance with each 
measure-specific classification system. Classification data was reported using frequencies 
with percentages. 
 
Within group changes over time, from baseline to both three-month and six-month post-
cardiac intervention, for growth parameters (length, height and head circumference), BSID-
III domain scores (cognitive, language and motor), neurological status, PedsQL™ total 
scores and PSI-SF total scores were calculated using a 95% confidence intervals on the 
difference between z-score means. Testing was done at the 0.05 level of significance.  
 
A paired T-test was used to assess difference between means of groups at baseline as part 
of the attrition analysis. Statistical significance was determined at a p-value of less than 
0.05.  
 
The association between identified variables and specific outcomes, including the BSID-III 
scores for each domain (cognitive, language and motor), PedsQL™ total score and PSI-SF 
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total scores at baseline, and three-months and six months post-cardiac intervention, was 
determined using analysis of variance (ANOVA). Mean values for variables significantly 
associated with key outcomes over time were analysed to determine upward or downward 
trends in associations.  In addition, a regression analysis was done to determine variables 
that were predictive of neurodevelopmental, HRQOL and parenting stress outcomes using 
ANOVAs. A linear regression model was used for each of the key outcome namely 
neurodevelopment (cognitive, motor and language), HRQOL and parenting stress. The 
effects used were the subcategories under each outcome. Interaction effects were also 
tested where appropriate.  The code for the ANOVA models used are presented in Appendix 
XIV. 
 
All data was entered into EXCEL spreadsheets. Descriptive statistics were calculated in 
EXCEL, while advanced statistical analysis was performed using R-Software in consultation 
with a Biostatistician. 
 
The results of this study are presented in Chapter five. 
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CHAPTER 5 
 
RESULTS OF PHASE I AND PHASE II 
 
 
 
The results for Phase I and II of this study will be presented in this chapter and will be briefly 
commented on. Study attrition will be outlined, and the reasons for attrition will be explained.  
 
Growth, neurodevelopmental, HRQOL, burden of care and parenting stress outcomes will 
be presented prior to cardiac surgery, and at three-month and six-month post-cardiac 
intervention. In addition, outcomes for neurodevelopment, HRQOL and parenting stress will 
be compared over time. The indication for early developmental intervention services will be 
established based on developmental performance on the BSID-III. Neurodevelopmental 
outcomes will further be used in the development of an appropriate home-based, parent-
driven developmental stimulation programme presented in Chapter seven. 
 
Variables associated with neurodevelopmental and HRQOL outcomes, as well as those 
variables associated with levels of parenting stress will be identified and briefly described.  
 
The purpose of routine cardiac neurodevelopmental follow-up is to cater for the entire 
spectrum of children presenting with CHD. For this reason, children who were diagnosed 
with a genetic comorbidity were not excluded from this study. The outcome of participants 
with a genetic comorbidity and cyanotic heart defects were of special interest, and key 
findings for these subgroups will also be presented. 
 
The findings and further implications of these findings will be discussed in depth in Chapter 
six. 
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5.1 Study attrition  
 
Forty-eight participants were recruited into the current study. Eight participants were 
subsequently lost to inclusion. Forty children were enrolled into this study at baseline (Refer 
to Figure 5.1). The study attrition for this study is presented in Figure 5.1 (on the following 
page). 
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Figure 5.1 Loss to follow-up over the study   
 
Cardiac surgery 
 (n=38) 
 
Recruited into study  
(n= 48) 
 
Included at baseline 
(n=40) 
 
Phase II: Three month post-cardiac 
intervention follow- up (n=25) 
 
Lost to follow-up (n=13)  
 
§ Deceased (n=6) 
§ Failed to arrive for scheduled 
follow-up appointment (n=7) 
Phase II: Six month post-cardiac 
intervention follow- up  
(n=22) 
 
Lost to follow-up (n=4)  
 
§ Failed to arrive for scheduled 
follow-up (n=3) 
§ Family relocated (n=1) 
 
Re-entered study (n=1) 
 
§ Re-entered study after 
missing three- month follow-
up (n=1) 
 
Lost to inclusion (n=8)  
 
§ Unplanned changes to 
surgery roster 
§ Surgery postponed due to the 
ill health of the child 
§ Researcher unavailable due 
work responsibilities   
Excluded (n=2) 
 
§ Underwent only interventional 
cardiac catheterisation (n=1) 
§ Surgery postponed 
indefinitely (n=1) 
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The mechanisms that were put in place to limit attrition in this study at the Paediatric 
Cardiology Unit, Universitas Academic Hospital in Bloemfontein were described in Chapter 
four (Refer to section 4.7). 
 
Forty children were included in this study at baseline following a recruitment period of 17 
months. Over the duration of the study, 19 participants were lost to follow-up, which equated 
to 47.5% of the sample being lost to follow-up at one or more point in time across this study.  
 
The reasons for attrition are outlined below.  
 
Excluded following baseline (n=2) 
 
Two participants had to be excluded from this study following their baseline assessment as 
they failed to undergo cardiac surgery. One participant only underwent interventional cardiac 
catheterisation but no surgery, whilst the other participant’s surgery was postponed 
indefinitely beyond the time frame of the current study due to the ill health of the child. 
 
Mortality (n=6) 
 
Six participants (15%) died following cardiac surgery. Three participants died in hospital 
following significant post-operative complications. Two participants died in the 
cardiothoracic ICU post-cardiac surgery after suffering a cardiac arrest and unsuccessful 
resuscitation. One participant survived a cardiac arrest but sustained a severe hypoxic brain 
injury, and died from respiratory-related complications following a three-month period of 
hospitalisation post-operatively.  
 
All three children who died post-operatively in the cardiothoracic ICU underwent cardiac 
surgery during infancy. Child one underwent an AVSD repair and had an accompanying 
genetic comorbidity; the CHD was further complicated in this case by PHTN. Child two 
underwent a coarctation repair and was also born prematurely. Child three underwent a 
VSD repair and had an accompanying genetic comorbidity. 
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Three participants died at home within three-months of hospital discharge following their first 
cardiac surgery. The reasons for mortality as reported by the mothers in all three cases were 
respiratory-related complications. 
  
Child one had undergone a VSD repair; the CHD was also complicated by PHTN. Child two 
had undergone a VSD repair and also had an accompanying genetic comorbidity. Child 
three had a DORV and AVSD and had undergone palliative surgery; the child also had an 
accompanying genetic comorbidity. 
 
The majority of the participants (66.7%) who died post-operatively had an accompanying 
genetic comorbidity. In all cases the genetic comorbidity was DS. The children who died 
were aged between two and 17 months. 
 
Non-compliance with scheduled follow-up visits (n=5) 
 
Five primary caregivers could be contacted via telephone and SMS text message, but still 
failed to comply with their scheduled follow-up appointments despite repeated efforts to 
encourage attendance and rescheduling of missed appointments.  
 
Three of the aforementioned primary caregivers and their children failed to arrive for both 
their three-month and six-month post-cardiac intervention follow-ups, whilst the other two 
caregivers and their children failed to arrive for only their six-month post-cardiac intervention 
follow-up. 
 
Untraceable (n=4)  
 
Three primary caregivers and their children were lost to both their three-month and six-
month post-cardiac intervention follow-up as they were untraceable. Contact numbers 
provided by the primary caregivers at the time of their baseline assessments were either no 
longer in service, switched off or belonged to another person resulting in the caregivers not 
being able to be contacted or traced. These caregivers and their children were also lost to 
cardiology services at Universitas Academic Hospital. 
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One primary caregiver and her child missed their three-month follow-up as well as their 
cardiology follow-up and could not be contacted or traced. The caregiver and child 
unexpectedly re-appeared at cardiology services and the six-month follow-up assessment 
could be done, despite being later than scheduled. One caregiver and child were 
untraceable by the time of their scheduled six-month post-cardiac intervention follow-up. 
The contact number provided was no longer in service and they could not be traced.  
 
Family relocation (n=1) 
 
One primary caregiver and her child relocated to another province in SA, and were unable 
to attend their six-month post-cardiac intervention follow-up.  
 
In the light of the high attrition rate, an attrition analysis was conducted for key variables at 
baseline for all the participants, those lost to follow-up, and those who remained in this study 
throughout. All participants were compared to those lost to follow-up and those remaining in 
the study, and those remaining in the study were compared to those lost to follow-up.  
 
The attrition analysis is presented in Table 5.1 for child-related variables and in Table 5.2 
for family-related variables. Any participant who missed one or more follow-up visit is 
represented in the lost to follow-up group, as were those who died and relocated. Values 
are reported as frequencies with percentages, medians with ranges, and means with 
standard deviations. P-values have been calculated for the difference between means 
between groups for relevant variables using paired T-tests. 
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Table 5.1 Attrition analysis for key child-related variables at baseline  
 
Baseline 
characteristics: 
Child-related 
variables  
All 
participants at 
baseline 
(n=40) 
Participants 
lost to 
follow-up 
(n=19) 
Participants 
remaining 
in study 
(n=21) 
P-values  
all versus 
those lost 
P-values 
all versus 
those 
remaining 
P-values 
lost versus 
those 
remaining 
Age baseline 
(months) 
Median  
Mean and SD 
 
 
7.4 
9.2 (± 5.4) 
 
 
7.3 
8.4 (± 5.1) 
 
 
8.8 
9.9 (± 5.7) 
 
 
 
0.676 
 
 
 
0.729 
 
 
 
0.509 
Gender  
Male  
Female 
 
15 (37.5%) 
25 (62.5%) 
 
7 (36%) 
12 (63.2%) 
 
8 (38%) 
13 (61.9%) 
 
0.960 
0.960 
 
0.960 
0.960 
 
0.963 
0.963 
 
Genetic 
comorbidity 
 
10 (25%) 
 
5 (26.3%) 
 
5 (23.8%) 
 
0.912 
 
0.920 
 
0.857 
Disease 
severity  
 
Moderate 
 
Moderate 
 
Moderate 
   
BSID composite 
cognitive score  
Median  
Mean and SD 
 
 
85 
84.9 (± 19.0) 
 
 
85 
82.6 (±19.6) 
 
 
95 
86.9 (±18.7) 
 
 
 
0.681 
 
 
 
0.691 
 
 
 
0.487 
BSID composite 
language score  
Median  
Mean and SD 
 
 
91 
90.5 (± 14.1) 
 
 
91 
88.5 (±13.7) 
 
 
91 
92.2 (±14.6) 
 
 
 
0.621 
 
 
 
0.657 
 
 
 
0.418 
BSID composite 
motor score  
Median  
Mean and SD 
 
 
82 
79.5 (± 17.5) 
 
 
79 
78.2 (±17.5) 
 
 
85 
80.7 (±17.8) 
 
 
 
0.793 
 
 
 
0.808 
 
 
 
0.663 
Weight-for-age 
Z-score  
Median  
Mean and SD 
 
 
-3.1 
-2.5 (±1.5) 
 
 
-3.1 
-2.9 (±7.7) 
 
 
-2.3 
-2.2 (±1.5) 
 
 
 
0.330 
 
 
 
0.367 
 
 
 
0.10 
Height-for-age 
z-score 
Median  
Mean and SD 
 
 
-1.9 
-2.2 (± 2.5) 
 
 
-2.2 
-2.7 (±1.8) 
 
 
-1.3 
-1.7 (±2.9) 
 
 
 
0.553 
 
 
 
0.223 
 
 
 
0.591 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
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Table 5.2 Attrition analysis for key family-related variables at baseline  
 
Baseline 
characteristics 
Family-related 
variables  
 
All participants 
(n=40) 
Participants 
lost to  
follow-up 
(n=19) 
Participants 
remaining in 
study 
(n=21) 
P-values 
all 
versus 
those 
lost 
P-values 
all versus 
those 
remaining 
P-values 
lost 
versus 
those 
remaining 
Age of mother 
(years) 
Median  
Mean and SD 
 
 
30 
29.6 (±8.04) 
 
 
32 
28.2 (±7.7) 
 
 
30 
30.9 (±8.3) 
 
 
 
0.519 
 
 
 
0.568 
 
 
 
0.294 
Maternal 
education  
 
Grade 9-11 
 
Grade 9-11 
 
Grade 9-11 
   
Mothers 
unemployed 
 
33 (83%) 
 
18 (94.7%) 
 
15 (71.4%) 
 
0.201 
 
0.317 
 
0.052 
SES  Lower class Lower class Lower class    
Parental stress 
Median  
Mean and SD 
 
90 
83.8 (± 19.2) 
 
90 
84.6 (±17.7) 
 
90 
83.1 (±20.8) 
 
 
0.833 
 
 
0.856 
 
 
0.734 
HRQOL 
Median  
Mean and SD 
 
80.6 
77.6 (± 12.4) 
 
85 
78.9 (±19.6) 
 
80.6 
76.5 (±10.9) 
 
 
0.735 
 
 
0.706 
 
 
0.544 
Distance to 
cardiac service 
(km) 
Median  
Mean and SD 
 
 
 
162.6 
202.8 (± 188.7) 
 
 
 
 
185.1 
162.4 (± 176.1) 
 
 
 
 
180.2 
218.7 (±202.3) 
 
 
 
 
 
0.728 
 
 
 
 
0.766 
 
 
 
 
0.578 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
There were no statistically significant differences for child-related or family-related variables 
between all participants at baseline and those participants remaining in the study 
throughout. Significant attrition bias was therefore not introduced in this study, and the 
participants remaining in the study could be considered to be representative of all 
participants at baseline. 
 
In addition, there were also no statistically significant differences for child-related and family-
related variables between all participants at baseline and those lost to follow-up. Neither 
was there any statistically significant difference between participants remaining in this study 
throughout and those lost to follow-up. Therefore, no specific child-related or family-related 
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variables could be assigned to contribute significantly to loss to follow-up in this study. 
 
5.2 Baseline sociodemographic information for all participants  
 
5.2.1 Demographic information  
 
Demographic information collected for all participants prior to cardiac intervention (baseline) 
is presented in Table 5.3 for child-related variables and in Table 5.4 for family-related 
variables. Relevant information was extracted from the family information data sheet that 
was completed at baseline. Values reported are frequencies with percentages, medians with 
ranges, and means with standard deviations. 
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Table 5.3 Demographic information of the child  
 
Child-related variables  Study sample (n=40) 
Age of child at baseline (months) 
 
Median (range) 
Mean and SD 
 
 
7.4 [1.4 – 20.9] 
9.2 (± 5.4) 
 
Gender  
 
Male  
Female 
 
 
15 (37.5%) 
25 (62.5%) 
 
Gestational age (weeks) 
 
Median (range) 
Mean and SD  
 
 
 
38 [31 – 41] 
37.5 (±2.0) 
Birth weight (grams) 
 
Median (range) 
Mean and SD  
 
 
 
2800 [1640 – 3950] 
2878.5 (±608.3) 
 
Ethnicity of the child 
 
Black African 
Mixed race 
White 
 
 
 
30 (75%) 
9 (22.5%) 
1 (2.5%) 
 
 
The majority of the participants in this study were of black African ethnicity, which is 
representative of the ethnic profile of the South African population. Although the median 
gestation age at birth for all participants was 38 weeks, nine participants (22.5%) were born 
preterm (< 37 weeks gestation) with a gestational age ranging from 31 to 36 weeks. Thirty 
participants (75%) had a birth weight within the normal range (2500- 4000 grams). Of these 
children categorised as having a normal birthweight, 23 (76.7%) had a birth weight under 
3000 grams. Therefore, despite the majority of the participants having been classified as 
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having a normal birth weight, most tended to have a birth weight on the lower side of the 
normal range.  
 
Table 5.4 Demographic information of the family  
 
Family-related variables Study sample (n=40) 
Primary caregiver 
 
Mother  
Father  
 
 
39 (97.5%) 
1 (2.5%) 
 
Age of the mother (years) 
 
Median (range) 
Mean and SD 
 
 
30 [16 – 43] 
29.6 (±8.0) 
 
Number of siblings  
 
Median (range) 
Mean and SD 
 
 
1 [0 – 4] 
1.2 (±1.1) 
 
 
 
Mothers were the primary caregiver in all but one instance, where the father fulfilled the role 
due to the mother’s mental health challenges. The age of the mothers varied considerably. 
Of the mothers, 15% were younger than 21 years, while 32.5% were 35 years or older.  
 
5.2.2 Socioeconomic status  
 
SES was reflected by the parents’ level of education, occupational prestige and employment 
status. The Hollingshead Index of Social Position was calculated to reflect the SES of each 
family. 
 
Most fathers were not present at the baseline assessment, and mothers were asked to 
report on the education level, occupation and employment status of the child’s father.  
 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
140 
 
The SES for all participants is presented in Table 5.5 (See table on the following page). 
Values reported are frequencies with percentages. 
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Table 5.5 Socioeconomic status of the families  
 
Variable  Study sample (n=40) 
Level of education of mothers 
 
University graduate 
Partial university or specialised training  
High school graduate 
Grade 9-11 
Grade 7-8 
Grade 6 or less 
 
 
 
1 (2.5%) 
5 (12.5%) 
10 (25%) 
18 (45%) 
5 (12.5%) 
1 (2.5%) 
Employment status of mothers 
 
Unemployed 
Part-time employment 
Full-time employment  
  
 
 
33 (82.5%) 
2 (5%) 
5 (12.5%) 
Level of education of fathers 
 
University graduate 
Partial university or specialised training  
High school graduate 
Grade 9-11 
Grade 7-8 
Unknown 
  
 
 
1 (2.5%) 
3 (7.5%) 
13 (32.5%) 
13 (32.5%) 
4 (10%) 
6 (15%) 
Employment status of fathers 
 
Unemployed 
Part-time employment 
Full-time employment  
 
 
 
13 (32.5%) 
6 (15%) 
21 (52.5%) 
 
Socioeconomic status of the family 
 
Lower class 
Lower-middle class 
Middle class 
Middle-upper class 
 
 
 
35 (87.5%) 
2 (5%) 
2 (5%) 
1 (2.5%) 
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The average level of education for both mothers and fathers was grade nine to 11 (median 
and mean values were determined to be the same). Of the 33 mothers who were 
unemployed, 29 mothers (87.9%) stayed at home in order to care for their child, or as a 
direct result of unemployment. The other four mothers (12.1%) were still learners or college 
students at the time of this study.  
 
The unemployment rate amongst fathers was high at 32.5%. Families in these cases tended 
to have no other source of income apart from child support grants provided by the 
government. More than half of the fathers (52.5%) were unskilled and worked as labourers 
or performed menial jobs. The majority of the families were from a low socioeconomic class. 
 
5.3 Cardiac diagnostic and medical management information  
 
The majority of the participants in this study resided in the Free State province (57.5%), with 
a large number of participants residing in the bordering Northern Cape Province (30%) of 
SA (Refer to Figure 4.1 under section 4.1 for a geographical representation of the provinces 
in SA).  
 
The catchment area for participants in this study covered a wide geographical area of SA. 
The distance travelled by families to access cardiac services at the Paediatric Cardiology 
Unit at Universitas Academic Hospital in Bloemfontein is shown in Table 5.6. Values 
reported are frequencies with percentages, medians with ranges and means with standard 
deviations.  
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Table 5.6 Distance travelled to the cardiac service point  
 
Variable All participants (n=40) 
Distance to cardiac service point (km) 
 
Median (range) 
Mean and SD  
 
 
 
162.4 [12 – 782.8] 
202.8 (±188.7) 
 
Distance to service point per category  
 
< 15 km 
Between 15 and 50 km 
Between 50 and 100 km 
>100 km  
 
 
10 (25%) 
0 (0%) 
4 (10%) 
26 (65%) 
 
The majority of the participants (65%) had to a travel a distance of over 100 kilometres to 
access cardiology services at the Universitas Academic Hospital in Bloemfontein. The 
majority of these families were dependent on the inter-hospital transport services provided 
by the RSA-DoH to commute to the cardiac centre. Only ten participants (25%) resided in 
Bloemfontein, where the cardiology service is located.  
 
A paediatric cardiologist was involved in the care of all participating children prior to cardiac 
intervention. The participants’ heart defects were classified according to the presence or 
absence of cyanosis. The majority of the participants (80%) in this study presented with 
acyanotic heart disease. The distribution of the study sample according to the type of 
congenital heart disease, based on the presence or absence of cyanosis is presented in 
Figure 5.2. 
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Figure 5.2 Classification of the type of congenital heart disease based on the 
presence of cyanosis (n=40) 
 
The primary cardiac diagnosis and CHD classification was sourced from the participants’ 
medical record and is presented in Table 5.7 (See table on the following page). Values 
reported are frequencies with percentages. 
20%
80%
Cyanotic (n=8)
Acyanotic (n=32)
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Table 5.7 Cardiac diagnosis and congenital heart disease classification 
 
Variable Study sample (n=40) 
Primary cardiac diagnosis 
 
Acyanotic defects (n=32) 
 
VSD 
AVSD 
PDA 
Coarctation of the aorta 
Aortic stenosis 
 
Cyanotic defects (n=8) 
 
DORV 
TGA  
TAPVD 
HLHS 
Tetralogy of Fallot 
Tricuspid atresia 
 
 
 
 
15 (37.5%) 
9 (22.5%)  
4 (10%) 
3 (7.5%) 
1 (2.5%) 
 
 
 
3 (7.5%) 
1 (2.5%) 
1 (2.5%) 
1 (2.5%) 
1 (2.5%) 
1 (2.5%) 
 
 
 Severity of the cardiac disease 
 
Mild 
Moderate 
Moderate to severe 
Severe 
 
Mean severity across all participants 
 
 
 
1 (2.5%) 
30 (75%) 
8 (20%) 
1 (2.5%) 
 
Moderate 
 Complicated CHD  
 
Uncomplicated  
Complicated by PHTN and/ or CCF 
 
 
12 (30%) 
28 (70%) 
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In the majority of cases, the cardiac disease was moderate in severity. The most commonly 
diagnosed congenital heart defects in this study sample were VSDs, followed by AVSDs. 
 
Of the 28 participants who presented with complicated CHD, six participants (21.4%) 
presented with PHTN, 17 participants (60.7%) with CCF, and five participants (17.9%) with 
both PHTN and CCF.   
 
Eighty-five percent of the participants were on prescription medications for their cardiac 
condition.  
 
Relevant medical information was also collected from the participants’ medical records and 
is presented in Table 5.8. Values reported are frequencies with percentages. 
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Table 5.8 Medical information of importance 
 
Variable  Study sample (n=40) 
Presence of a diagnosed genetic 
comorbidity  
 
No 
Yes 
 
 
 
 
30 (75%) 
10 (25%) 
Presence of extracardiac congenital 
abnormality 
 
No  
Yes  
 
 
 
 
37 (92.5%) 
3 (7.5%) 
HIV status of the child 
 
HIV negative 
HIV positive  
HIV status unknown  
 
 
28 (70%) 
0 (0%) 
12 (30%) 
 
Presence of known teratogens  
 
None  
Maternal Diabetes Mellitus  
Maternal hypertension  
 
 
36 (90%) 
3 (7.5%) 
1 (2.5%) 
 
 
Twenty-five percent of the participants were diagnosed with a genetic comorbidity; in all 
cases, the diagnosed genetic abnormality was DS. 
 
Four participants presented with extracardiac congenital abnormalities, two with 
musculoskeletal abnormalities, one with duodenal atresia and one with an umbilical hernia.  
 
No participants had tested HIV-positive at the time of their inclusion in this study. The HIV-
status of 30% of the participants was unknown.  
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Concerning cardiovascular status, 20% of the children were diagnosed with cyanotic heart 
defects and presented with cyanosis prior to cardiac intervention. Cyanosis was defined as 
a percutaneous oxygen saturation (SpO2) reading below 85%. Most of the children (87.5%) 
presenting with cyanosis before cardiac intervention, underwent either palliation or surgical 
procedures that would require further surgeries going forward to optimise their 
cardiovascular function.  
 
5.4 Surgical intervention and post-operative medical course 
 
Thirty-eight participants underwent cardiac surgery following their baseline assessment. The 
vast majority of these surgeries were elective in nature, and it was the first cardiac surgery 
for all the participants.  
 
Relevant information pertaining to the cardiac surgery was extracted from the participants’ 
surgical records and is presented in Table 5.9. Values reported are frequencies with 
percentages, medians with ranges, and means with standard deviations. 
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Table 5.9 Information pertaining to the cardiac surgery 
 
Variable Study sample (n=38) 
 Age at first cardiac surgery (months) 
 
Median (range) 
Mean and SD 
 
 
 
 
7.5 [1.4 – 20.9] 
9.4 (±5.5) 
 
 
Aim of the surgery 
 
Correction  
Staged correction 
Palliation 
 
 
28 (73.6%) 
5 (13.2%) 
5 (13.2%) 
 
Surgical access 
 
Median sternotomy 
Lateral thoracotomy 
 
 
 
31 (81.6%) 
7 (18.4%) 
Cardiopulmonary bypass time (min) 
 
Median (range) 
Mean and SD  
 
 
 
104 [41 – 300] 
111.8 (±54.8) 
Aorta cross-clamp time (min) 
 
Median (range) 
Mean and SD  
 
 
 
76 [15 – 132] 
70.3 (±35.4) 
 
The majority of the participants (68.4%) underwent their first cardiac surgery during infancy 
(< 12 months of age). However, the age at the time of first cardiac surgery ranged from 1.4 
month to 20.9 months.  
 
The majority of the participants underwent open-heart surgery with 68.4% of participants 
being placed on CPB during surgery. Twenty-seven participants (71%) had their aortas 
cross-clamped during surgery. CPB was done under relative hypothermia using cardioplegia 
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as the cardiac protection method.  
 
Information pertaining to the participants’ post-operative medical course following cardiac 
surgery was extracted from the participants’ medical records. This included information on 
peri-operative and post-operative complications, cardiothoracic ICU length of stay, hospital 
length of stay post-surgery and total hospital length of stay. Information on the medical 
course post-cardiac surgery is presented in Table 5.10 (See table on the following page). 
Values reported are frequencies with percentages, medians with ranges, and means with 
standard deviations. 
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Table 5.10 Medical course following surgery 
  
Variable  Study sample (n=38) 
Peri-operative complications  
 
Yes 
No  
 
 
 
 4 (10.5%) 
34 (89.5%) 
Cardiothoracic ICU length of stay  
(days) 
 
Median (range) 
Mean and SD 
 
 
 
6 [3 – 28] 
7.5 (±5.6) 
 
Post-operative complications 
 
Yes 
No 
 
 
 
7 (18.4%) 
31 (81.6%) 
Post-surgery hospital length 
 of stay (days) 
 
Median (range) 
Mean and SD  
  
 
 
 
9 [3 – 108] 
14.7 (±18.8) 
 
Total hospital length of stay  
(days) 
 
Median (range) 
Mean and SD  
 
 
 
 
11 [7 – 108] 
19.8 (±21.0) 
 
 
The majority of participants had an uncomplicated post-operative medical course. However, 
five participants (13.2%) were mechanically ventilated for longer than seven days, and 12 
participants (31.6%) had a cardiothoracic ICU length of stay extending beyond seven days. 
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Peri-operative complications occurred in four participants, three participants suffered a 
cardiac arrest and one participant presented with severe haemodynamic instability in the 
immediate post-operative period.  
 
Post-operative complications in the cardiothoracic ICU occurred in seven participants. 
Complications included respiratory infections (n=6), a hypoxic brain injury (n=1) and wound 
sepsis (n=1). 
 
Fifteen participants (39.5%) had a total hospital length of stay from the day of admission 
exceeding two weeks, while only eight participants (21.1%) had a total hospital length of 
stay exceeding two weeks from the day of surgery. The total hospital length of stay from 
admission is not always considered to be an accurate reflection of a complicated medical 
course in the current study setting. Many participants are admitted to hospital, and remain 
in hospital for extended periods prior to cardiac surgery due to surgeries being postponed 
or cancelled due to the illness of the child. The children are often kept in hospital rather than 
being discharged home for a short period, only having to return to hospital at great financial 
cost to the families. Keeping the children in hospital also curtails the risk of children not 
returning for rescheduled surgeries.  
 
5.5 Growth outcomes 
 
The WHO (2006) child growth standards and DS-specific growth charts (published in the 
US in 2015 by Zemel and colleagues) were used to determine z-scores for anthropometric 
measurements of children without and those with DS respectively.   
 
Anthropometric data is presented as z-scores for weight-for-age, height-for-age and head 
circumference-for-age at baseline, and for three-month and six-month post-cardiac 
intervention in Table 5.11. Values are reported as medians and means with standard 
deviations. 
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Table 5.11 Anthropometric data 
 
Variable Baseline 
(n=40) 
Three-months post-
cardiac intervention  
 (n=25) 
Six-months post-
cardiac intervention 
(n=22) 
 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
-2.6 
-2.5 (±1.5) 
 
 
 
-2.1 
-1.8 (±1,7) 
 
 
 
-1.5 
-1.5 (±1.8) 
Height-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.9 
-2.2 (±2.5) 
 
 
 
-0.8 
-1.3 (± 1.8) 
 
 
-1.6  
-1.8 (±1.6) 
Head circumference- 
for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.4 
-1.3 (±1.5) 
 
 
 
 
-1.0 
-0.9 (±1.7) 
 
 
 
-0.4 
-0.4 (±1.8) 
 
Z-scores for participants were used to identify malnutrition, stunting and microcephaly in 
participants. The WHO Global Database on Growth and Malnutrition uses a z-score cut off 
point of less than -2 standard deviations (SD) to classify low weight-for-age and height-for-
age as moderate malnutrition and stunting respectively, and z-scores of less than -3 SD as 
severe malnutrition and stunting respectively. A z-score cut-off point of less than -2 SD for 
head circumference-for-age is considered indicative of microcephaly. 
 
The classification of growth status according to the WHO z-score classification guidelines 
indicating suboptimal growth (characterised by a z-score of <-2) for weight-for-age, height-
for-age and head circumference-for-age is presented in Table 5.12. Values reported are 
frequencies with percentages.  
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Table 5.12 Participants with malnutrition, stunting and microcephaly  
 
Variable Baseline 
(n=40) 
Three-months post-
cardiac intervention 
(n=25) 
Six-months post-
cardiac intervention 
(n=22) 
 
Malnutrition  
 
27 (68%) 
 
14 (56%) 9 (40.9%) 
Stunting  
 
18 (45%) 9 (36%) 8 (36.4%) 
Microcephaly  
 
10 (25%) 5 (20%) 3 (13.6%) 
 
The majority (68%) of the participants presented with malnutrition prior to cardiac 
intervention, and of these participants with malnutrition 42.5% had severe malnutrition (z-
score <-3 SD). A large number of participants (45%) also presented with stunting prior to 
cardiac intervention indicating that growth failure was more chronic in nature. There was a 
high incidence of microcephaly (z-score <-3 SD) with up to a quarter of participants 
presenting with microcephaly (z-score < -2 SD).  
 
It is evident that growth was suboptimal in participants prior to cardiac intervention. The 
mean z-scores for all three growth parameters (weight, height and head circumference) at 
all three time points of assessment are presented graphically in Figure 5.3 for descriptive 
purposes. 
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Figure 5.3 Mean z-scores for growth parameters over the study  
 
Growth status across all growth parameters improved from before cardiac intervention to 
post-cardiac intervention, where at three-month and six-month post-cardiac intervention the 
mean z-scores for all parameters fell within the acceptable range (z-score > -2). The 
significance of the change in growth outcomes for all growth parameters over time is formally 
presented and commented on under 5.12. 
 
Complete catch-up growth however had not occurred by six-month post-cardiac 
intervention, as the mean and z-scores were still below the 50th percentile (Z-score of zero) 
across all growth parameters. Seven participants (31.8%) still presented with severe 
malnutrition at six-month post-cardiac intervention.  
 
Caregivers reported feeding difficulties in a quarter of the participants. Feeding difficulties 
reported included children struggling to suck, swallow and breathe during feeds due to 
respiratory distress, children tiring when feeding and GORD. Formal assessment of feeding 
skills however did not fall within the scope of this study.   
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5.6 Neurodevelopmental outcomes  
 
Neurodevelopment status was assessed at three time points across this study. These 
assessments took place at baseline (prior to cardiac intervention), and at three-month and 
six-month post-cardiac intervention respectively. The age of the participants at the three 
assessment time points is depicted in Table 5.13. Values reported are medians with ranges 
and means with standard deviations. 
 
Table 5.13 Age at neurodevelopmental assessment  
 
Variable  
 
Baseline 
(n=40) 
Three-months post-
cardiac intervention  
(n=25) 
Six-months post-
cardiac intervention 
(n=22) 
 
Age at assessment  
 (months) 
 
Median (range) 
Mean and SD 
 
 
 
 
7.4 [1.4 – 20.9] 
9.2 (±5.4)   
 
 
 
 
11.8 [4.6 – 25.5] 
 13.5 (±5.9) 
 
 
 
 
15 [7.4 – 30.4] 
16.7 (±6.4)  
 
 
Age corrected neurodevelopmental outcomes will be presented as composite scores for the 
three subscales of the BSID-III, namely the cognitive, language and motor subscale. The 
developmental status of the participants at baseline, and at three-month and six-month post-
cardiac intervention are presented in Table 5.14. Values reported are medians with ranges 
and means with standard deviations. The mean score on all three subscales of the BSID-III 
is 100. 
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Table 5.14 Cognitive, language and motor outcomes on the BSID-III  
 
BSID-III subscale Baseline 
(n=40) 
Three-month follow-up 
(n=25) 
Six-month follow-up 
(n=22) 
Cognitive subscale 
 
Median (range) 
Mean and SD 
 
 
85 [55 – 130] 
84.9 (± 19.03) 
 
 
 
90 [55 – 105] 
84.6 (±17.1) 
 
 
 
90 [55 – 110] 
83.4 (±18.3) 
 
Language subscale 
 
Median (range) 
Mean and SD 
 
 
 
91 [62 – 115] 
90.5 (±14.1) 
 
 
 
89 [50 – 112] 
88.4 (±15.9) 
 
 
81.5 [59 - 109] 
83.4 (± 15.5) 
Motor subscale 
 
Median (range) 
Mean and SD 
 
 
82 [46 - 112] 
79.5 (±17.5) 
 
 
88 [46 - 112] 
82.4 (± 19.8) 
 
 
 
89.5 [49 - 121] 
84.3 (±22.5) 
 
 
For descriptive purposes, the mean composite BSID-III scores for all of the BSID-III 
subscales (cognitive, language and motor) at all three time points of assessment are 
presented graphically in Figure 5.4 for descriptive purposes. 
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Figure 5.4 Mean composite BSID- III subscale scores across the study 
 
Mean cognitive, language and motor composite scores were below the mean score of 100 
across all three of the subscales of the BSID-III at all three of the time points of assessment.  
 
Motor development was the area of weakest developmental performance at baseline. There 
was improvement in the mean composite scores for motor performance from before to after 
cardiac intervention. To the contrary, developmental performance of the participants on the 
language and cognitive subscale declined from baseline to three-month and six-month post-
cardiac intervention. The significance of the change in neurodevelopmental performance 
over time is formally presented and commented on in section 5.11. 
 
Developmental outcomes at each assessment and within each subscale of the BSID-III 
(cognitive, language, and motor) were furthermore classified as “average” if they were within 
1 SD of the mean or higher (scores > 85), “at risk” if they were 1 to 2 SD below the mean 
(scores of 70–84), and “delayed” if they were >2 SD below the mean (scores <70).  
 
The classification of developmental performance for each of the subscales on the BSID-III 
is presented in Table 5.15. Values reported are frequencies with percentages. 
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Table 5.15 Classification of developmental performance 
 
Variable Baseline 
(n=40) 
Three-month follow-up 
(n=25) 
Six-month follow-up 
(n=22) 
COGNITIVE DEVELOPMENT  
 
Average or above 
 
23 (57.5%) 17 (68%) 14 (63.6%) 
At risk 
 
9 (22.5%) 3 (12%) 2 (9.1%) 
Developmentally delayed  
 
8 (20%) 5 (20%) 6 (27.3%) 
LANGUAGE DEVELOPMENT  
 
Average or above 
 
28 (70%) 
 
14 (56%) 9 (40.9%) 
At risk 
 
7 (17.5%) 9 (36%) 7 (31.8%) 
Developmentally delayed  
 
5 (12.5%) 2 (8%) 6 (27.3%) 
MOTOR DEVELOPMENT 
 
 Average or above 
 
 
19 (47.5%) 15 (60%) 12 (54.5%) 
 At risk 
 
 
10 (25%) 4 (16%) 4 (18.2%) 
Developmentally delayed  
 
11 (27.5%) 6 (24%) 6 (27.3%) 
 
According to the BSID-III criteria, a developmental delay is categorised at a composite score 
on any subscale below 2 SD of the mean score of 100 (score of less than 70). At baseline, 
14 participants (35%) presented with a developmental delay in at least one area of 
development. Of the participants with delayed development, five participants (12.5%) had 
delays in two or more areas of development. Motor delays were the most prevalent, with 11 
participants (27.5%) presenting with motor delays before cardiac intervention. The severity 
of the developmental delays was mild to moderate in most cases; however, four of the 
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participants’ with motor delays (36.4%) had severe delays scoring below 3 SD from the 
mean (a score of less than 55). Cognitive delays followed by language delays were less 
prevalent and moderate in severity. 
 
At three-months post-cardiac intervention, six participants (24%) presented with 
developmental delay in at least one area of development, of these participants with delayed 
development, four participants (16%) had delays in two or more areas of development. 
Motor delays remained the most prevalent delay; with six participants (24%) presenting with 
delayed motor development, and in four of the participants with motor delays (66.7%) the 
delay was found to be severe. Cognitive followed by language delays were less prevalent 
and moderate in severity. 
 
At six-month post-cardiac intervention, six participants (27.3%) presented with a 
developmental delay in at least one area of development. Of the participants with delayed 
development, five participants (22.7%) had delays in two or more areas of development. 
The prevalence of developmental delays at this time point was found to be the same across 
all three of the subscales of the BSID-III. An increase in the prevalence of cognitive and 
language delays was noted. The prevalence of motor delays remained consistent across 
study, at above 24%. Six participants presented with motor delays, 50% of who presented 
with moderate delays and the other 50% with severe delays. All cognitive and language 
delays were moderate in severity.  
 
A summary of the average prevalence of developmental delays across the study is 
presented in Figure 5.5. 
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Figure 5.5 Average prevalence of developmental delays across the study  
 
The median age at the time of first cardiac surgery was 7.4 months, making development in 
the prone position of particular interest in the current study participants, as typically-
developing children would start to crawl between the ages of seven and nine months 
(Bayley, 2006a). Twenty-three participants (57.5%) exhibited delayed prone development, 
especially with regards to crawling. A median sternotomy was used as the route of surgical 
access in 78.3% of the children who exhibited delayed prone development. Development in 
prone was delayed in all participants with DS.  
 
One participant suffered a thrombotic stroke post-cardiac surgery resulting in dense left 
hemiplegia. The neurological deficit significantly impaired the participant’s developmental 
performance across all three subscales of the BSID-III post-cardiac intervention. 
 
In addition, the BSID-III scores can be used to identify children who would qualify for EI 
services. This criteria for determining eligibility for EI services is applied in clinical practice 
in developed countries, as recommended by the AHA in their scientific statement regarding 
the management of children with CHD (Marino et al., 2012). Children who score below 1 SD 
of the mean (score of less than 85) on any of the BSID-III subscales (cognitive, language 
and motor) would qualify for referral to the appropriate EI services. This would therefore 
include both children at risk of, and those presenting with developmental delays.   
71%
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This analysis was deemed critical in identifying the need for EI services in this sample, and 
the type of therapeutic services that would be required. Information about participants 
qualifying for EI services based on BSID-III performance is presented in Table 5.16. Values 
reported are frequencies with percentages. 
 
Table 5.16 Children qualifying for early intervention services based on developmental 
performance 
 
  
Subscale  
Baseline 
(n=40) 
3-months post-cardiac 
intervention 
 (n=25) 
6-months post-cardiac 
intervention   
(n=22) 
Frequency 
(%) 
Frequency (%) Frequency (%) 
Cognitive 
(OT) 
17 (42.5%) 8 (32%) 8 (36.4%) 
Language 
(ST) 
12 (30%) 11 (44%) 13 (59%) 
Motor  
(PT) 
22 (55%)  10 (40%)  10 (45.5%) 
* Criteria for EI services is a subscale composite score > 1 SD below the mean score of 100 (Subscale score <85) 
 
The need for access to EI services varied at the various time points of assessment, and is 
shown in Table 5.16. Figure 5.6 provides a summary of the total need for access to and the 
type of EI services required. 
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Figure 5.6 Children qualifying for early intervention services  
 
Applying the eligibility criteria for referral to EI serviced based on developmental 
performance on the BSID-III, it was determined that up to 59% of participants would qualify 
for EI services over the study period. Of these children, up to 42.5% would require access 
to OT, 59% to ST, and 55% to PT services over the study period. In many instances, children 
would require access to multiple therapy services in order to address their risk of 
developmental delays or delays present in more than one area of development. It is also 
clear that over time the need for OT and PT services declined slightly; to the contrary, the 
need for ST services increased over time. 
 
Fifteen participants (37.5%) were referred to, or were accessing EI services to address 
identified developmental delays. Eight participants (20%) were referred to PT, ten 
participants (25%) to OT and three participants (7.5%) to ST services.  
 
Parents and children accessing EI services in this study reported that staff constraints within 
the RSA-DoH often resulted in infrequent therapy appointments and lack of access to 
specific therapy services, in particular ST. Furthermore, financial and time constraints on 
the part of parents prevented them from being able to access therapy services. This 
culminated in the ineffective provision of EI services to the most needy of participants in this 
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study. The development of a home-based parent-driven developmental stimulation 
programme to meet the developmental needs of children with CHD in central SA could serve 
to meet the needs in resource-poor setting. The development of the developmental activity 
programme, based on the developmental outcomes, is presented in Chapter seven. 
 
5.7 Neurological findings 
 
The only significant finding during the neurological examination at baseline, and at three-
month and six-month post-cardiac intervention was the presence of abnormal muscle tone. 
Findings regarding abnormal muscle tone are presented in Table 5.17. The values reported 
are frequencies with percentages. 
 
Table 5.17 Presence of abnormal muscle tone  
 
Distribution of muscle 
tone 
Baseline 
(n=40) 
Three-months post-cardiac 
intervention 
(n=25) 
Six-months post-
cardiac intervention  
(n=22) 
 
Hypotonia 18 (45%) 11 (44%) 7 (31.8%) 
 
Normal muscle tone 21 (52.5%) 14 (56%) 
 
15 (68.2%) 
Hypertonia 1 (2.5%) 
 
0 
 
0 
 
 
Forty-five percent and 44% of the participants presented with hypotonia at baseline and at 
three-month post-cardiac intervention respectively. All participants with DS presented with 
marked hypotonia at all three time points of assessment. Twenty percent of participants 
without genetic comorbidity presented with hypotonia at baseline, 24% at the three-month 
post-cardiac intervention and 9.1% at the six-month post-cardiac intervention. Hypotonia 
seemed to increase in the period initially following cardiac surgery, but in most cases tended 
to resolve over time in participants without DS.  
 
The single case of hypertonia noted at baseline appeared to be transient and resolved 
spontaneously post-cardiac intervention.  
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5.8 Parents’ perception of health-related quality of life 
 
HRQOL was determined using the PedsQLTM Infant Scales for children under the age of two 
years and the PedsQLTM Cardiac Module for participants older than two years. At baseline 
all participants were younger than two years and their HRQOL outcomes are reported for 
the PedsQLTM Infant Scales. 
 
At three-month post-cardiac intervention, one participant, and at six-months post-cardiac 
intervention four participants respectively were older than two years and their HRQOL 
outcomes were reported for the PedsQLTM Cardiac Module.  
 
HRQOL outcomes at baseline, and at three-month and six-month post-cardiac intervention 
for children younger than two years on the PedsQLTM Infant Scales are reported in Table 
5.18. Values reported are medians with ranges and means with standard deviations. The 
subscales of the PedsQLTM Infant Scales were used to calculate the summary scale score 
and the total score. Values are reflected as a score out of 100. Higher scores are indicative 
of better-perceived HRQOL.
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Table 5.18 Perceived health-related quality of life of children one to 24 months  
 
Subscales  Baseline 
(n=40) 
Three-months post-
cardiac intervention 
(n=24) 
Six-months post-
cardiac intervention 
(n=18) 
Physical functioning  
 
Median (range) 
Mean and SD  
 
 
83.3 [16.7 – 100] 
76.5 (± 21.4) 
 
 
 
100 [37.5 – 100] 
91.4 (±17.4) 
 
 
100 [33 – 100] 
88.5 (±18.7) 
Physical symptoms 
 
Median (range) 
Mean and SD 
 
 
 
80 [35 – 100] 
76.4 (± 15.9) 
 
 
90 [45 – 100] 
86.4 (± 13.6) 
 
 
88.8 [50 – 100] 
84.6 (±13.2) 
Emotional symptoms 
 
Median (range) 
Mean and SD 
 
 
 
75 [16.7 – 100] 
70.8 (±17.8)  
 
 
82.3 [25 – 100] 
77.3 (±20.3) 
 
 
81.5 [62.5 – 100] 
87.5 (± 10.9) 
 
Social functioning 
 
Median (range) 
Mean and SD 
 
 
 
100 [50 – 100] 
94.8 (± 12.4) 
 
 
100 [0 – 100] 
 90.9 (±23.04) 
 
 
100 [62.5 – 100] 
94.3 (±11.5) 
 
Cognitive functioning 
 
Median (range) 
Mean and SD 
 
 
 
100 [37.5 – 100] 
88.1 (±19.1) 
 
 
100 [0 -100] 
87.3 (±26.8) 
 
 
100 [25 – 100] 
 83.7 (± 23.4) 
 
SUMMARY SCALES FOR THE PEDSQL® INFANT MODULES AS CALCULATED FROM THE ABOVE 
SUBSCLAES 
Psychological health 
 
Median (range) 
Mean and SD 
 
 
 
78.2 [48.8 – 100] 
78.3 (±12.4) 
 
 
90.6 [20 – 100] 
82.6 (±19.9) 
 
 
84.7 [59.6 – 100] 
83.4 (± 11.7) 
 
Physical health 
 
Median (range) 
Mean and SD 
 
 
 
79.7 [29.7 – 97.4] 
76.8 (± 16.6) 
 
 
91.5 [42.2 – 100] 
88.3 (± 14.2) 
 
 
 
89.1 [42.1 – 100] 
86.0 (± 14.2) 
Total HRQOL score 
 
Median (range) 
Mean and SD 
 
 
 
80.6 [48.8 – 97.2] 
77.6 (± 12.4) 
 
 
89.6 [29.9 – 100] 
 85.2  (± 16.1) 
 
 
87.9 [52.2 – 100] 
85.1 (±11.2) 
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Parents of children younger than two years perceived their child’s HRQOL as good at all 
three of the assessment time points. Parents’ perception of their children’s HRQOL 
improved post-cardiac intervention, as reflected by both the mean and median total scores. 
At baseline, parents perceived their children’s physical health as being poorer than their 
psychosocial health, whereas post-cardiac intervention the converse tended to be true.  
 
HRQOL outcomes at baseline, and three-month and six-month post-cardiac intervention for 
children older than two years as reported on the PedsQLTM Cardiac Module are presented 
in Table 5.19. Values reported are medians with ranges and means with standard 
deviations.  
 
The PedsQLTM Cardiac Module does not formally report calculating a total score, total 
scores have been calculated in previous studies using the PedsQLTM cardiac module for 
example Sand et al. (2013). The same principle as applied by Sand et al. (2013) has been 
applied in this study to generate a total score. A total score was calculated for determining 
HRQOL across all participants in this study sample across the three modules of the 
PedsQLTM that were used. The Subscales were used to calculate the total score on the 
PedsQLTM Cardiac Module. Values are reflected as a score out of 100. Higher scores are 
indicative of better-perceived HRQOL. 
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Table 5.19 Perceived health-related quality of life of children older than two years 
 
Subscales  Three-months post-cardiac 
intervention  
 (n=1) 
Six –months post-cardiac 
intervention 
(n=4) 
Heart symptoms 
 
Median (range) 
Mean and SD 
 
 
 
95  
 
 
 
100 [95 – 100] 
98.8 (±2.5) 
 
Perceived physical 
appearance 
 
Median (range) 
Mean and SD 
 
 
 
 
100  
 
 
 
 
100 [83.3 – 100] 
95.8 (± 8.4) 
 
 
Treatment anxiety 
 
Median (range) 
Mean and SD 
 
 
 
100  
 
 
 
62.5 [0 – 100] 
56.3 (±50.5) 
 
Cognitive problems  
 
Median (range) 
Mean and SD 
 
 
 
100  
 
 
 
100 [16.3 – 100] 
79.1 (±41.8) 
Communication 
 
Median (range) 
Mean and SD 
 
 
 
100  
 
 
 
100 [0 – 100] 
75.0 (±50.0) 
 
Total score  
 
Median (range) 
Mean and SD 
 
 
 
97.8  
 
 
 
82.6 [76.1 – 100] 
85.3 (± 10.4) 
 
 
Parents of children aged two years and older perceived their children’s post-cardiac 
intervention HRQOL as good at both time points the measure was utilised. For some older 
children, treatment anxiety became a concern as they became older. Similar to the findings 
on the PedsQLTM Infant Modules post-cardiac intervention levels of cognitive and language 
functioning became of greater concern to parents than physical functioning over time.  
 
The PedsQLTM Infant Module and the PedsQLTM Cardiac Module outcomes are comparable 
as measures of perceived HRQOL in children with CHD. Total scores across the PedsQLTM 
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Infant Modules and the PedsQLTM Cardiac Module were combined and analysed to reflect 
the perceived HRQOL for all participants. Values reported are reflected as a score out of 
100. Higher scores are indicative of better-perceived HRQOL. The perceived HRQOL for all 
participants is presented in Table 5.20. Values reported are medians with ranges and means 
with standard deviations. 
 
Table 5.20 Perceived health-related quality of life for all children  
 
Variable  Baseline 
(n=40) 
Three-months post-
cardiac intervention 
(n=25) 
Six-months post-
cardiac intervention 
(n=22) 
 
Total score  
 
Median (range) 
Mean and SD 
 
 
80.6 [48.6 – 97.2] 
77.6 (±12.4) 
 
 
90.3 [29.9 – 100] 
85.7(±15.9) 
 
 
86.7 [52.2 – 100] 
85.1 (±10.8) 
 
 
Figure 5.7 shows a graphical representation of the mean total HRQOL scores at all three 
time-points of assessment for descriptive purposes.   
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Figure 5.7 Mean PedsQLTM total scores across the study 
 
Parents of all participants perceived their children’s HRQOL as good at all three time points 
of assessment, both before and after cardiac intervention. Parent’s perception of their 
children’s HRQOL improved after cardiac intervention as indicated by both mean and 
median total HRQOL scores. Perceived HRQOL remained similar at three-month and six-
month post-cardiac intervention. The significance of the change in HRQOL over time is 
formally presented and commented on in section 5.11. 
 
Parents however had wide ranging perceptions of their children’s HRQOL at all three 
assessment time points, both before and after cardiac intervention. Some parents viewed 
their children’s HRQOL as exceptionally poor whilst others viewed it as excellent. 
 
5.9 Parenting stress outcomes 
 
Parenting stress of the primary caregivers was established for all participants using the PSI-
SF. Parenting stress was reported by mothers with the exception of a single case where the 
father fulfilled the role of primary caregiver. 
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Parenting stress is reported across three subscales, namely parenting distress, parent-child-
dysfunction and difficult child. A total stress score was also calculated. Parenting stress 
scores for the subscales and total stress scores are reflected as percentiles. Values 
provided are medians with ranges and means with SD. Levels of distress experienced by 
primary caregivers are reflected in Table 5.21. 
 
Table 5.21 Parenting stress of the primary caregivers 
 
PSI-SF Scales Baseline 
(n=40) 
Three-month post-
cardiac intervention 
(n=25) 
Six-months post-
cardiac intervention 
(n=22) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
90 [10-99] 
83.3 (±19.9) 
 
 
75 [1 – 95]  
63.8 (±31.9) 
 
 
65 [1 – 95] 
57.8 (±31.9) 
 
Parent-child dysfunction 
 
Median (range) 
Mean and SD 
 
 
 
90 [40 – 99] 
80 (±19.8) 
 
 
85 [5 – 99] 
72.8 (±27.2) 
 
 
80 [5 – 99] 
63.5 (±34.2) 
Difficult child 
 
Median (range) 
Mean and SD 
 
  
 
77.5 [1 – 99] 
67.1 (±26.3) 
 
 
55 [1 – 95] 
52.6 (±27.6) 
 
 
47.5 [1 – 95] 
47.6 (±35.5) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
90 [5 – 99] 
83.8 (±19.2) 
 
 
 
80 [1 – 99] 
69 (±28.5) 
 
 
 
67.5 [1 – 99] 
57.8 (±34.8) 
 
Percentile scores over all three subscales and for the total stress can be used to classify the 
extent to which parents are experiencing stress. Scores across all subscales above the 85th 
percentile are considered to be high. For the parent-child dysfunctional interaction, a 
subscale score above the 85th percentile is considered clinically significant and for the other 
subscales of parental distress, difficult child and the total stress scores above the 90th 
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percentile are considered clinically significant. Normal scores lie between the 15th and 80th 
percentile, and scores are considered low if below the 15th percentile.  
 
The classification of the levels of parenting stress experienced by parents in this study 
sample is presented in Table 5.22 (see table on the following page). 
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Table 5.22 Classification of the levels of parenting stress  
 
Subscales of the PSI-SF Baseline 
(n=40) 
Three-months 
post-cardiac 
intervention 
(n=25) 
Six-months  
post-cardiac 
intervention 
(n=22) 
Parenting distress 
 
Clinically significant  
 
24 (60%) 7 (28%) 5 (22.7%) 
 High  
 
31 (77.5%) 11 (44%) 7 (31%) 
 Normal  
 
8 (20%) 11 (44%) 12 (54.4%) 
Low 
 
1 (2.5%) 3 (12%) 3 (13.7%) 
Parent-child dysfunction 
 
Clinically significant  
 
22 (55%) 11 (44%) 9 (40.9%) 
 High  
 
22 (55%) 13 (52%) 
 
9 (40.9%) 
 Normal  
 
 
18 (45%) 11 (44%) 10 (45.5%) 
Low 
 
0 (0%) 1 (4%) 3 (13.6%) 
Difficult child 
 
Clinically significant  
 
7 (17.5%) 3 (12%) 3 (13.6%) 
 High  
 
14 (35%) 4 (16%) 5 (22.7%) 
 Normal  
 
24 (60%) 19 (76%) 11 (50%) 
Low 
 
2 (5%) 2 (8%) 6 (27.3%) 
Total stress  
 
Clinically significant  
 
24 (60%) 6 (24%) 7 (31.8%) 
 High   
 
27 (67.5%) 9 (36%) 7 (31.8%) 
 Normal  
 
12 (30%) 14 (56%) 11 (50%) 
Low 
 
1 (2.5%) 2 (8%) 4 (18.2%) 
> 85th percentile (high), >90th percentile clinically significant, 15th – 80th percentile (normal), <15th percentile (low) 
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The mean total stress scores at all time points of assessment are presented graphically in 
Figure 5.8 for descriptive purposes. 
 
 
Figure 5.8 Mean total stress scores across the study 
 
The majority of primary caregivers (60%) experienced clinically significant levels of stress in 
their parenting role at baseline as reflected by the scores on the PSI-SF scales and the total 
stress score. More than half of the primary caregivers felt that their child failed to meet their 
expectations (reflected by scores on the parent-child dysfunction subscale). Most parents 
however felt that their children were not difficult to parent (reflected by scores on the difficult 
child subscale). Several parents of children older than two years noted concerns about their 
child’s behaviour. These concerns included tantrums, inattention and hyperactivity. 
However, behaviour was not formally assessed as part of the neurodevelopmental 
assessment due to the age profile of this study’s participants. 
 
The levels of parenting distress and role stress declined post-cardiac intervention, and 
continued to decline over time; most parents then experienced normal levels of stress. 
Dysfunction in parent-child interaction also improved over time, but it remained the aspect 
that continued to contribute most to the levels of parenting stress over time. The significance 
of the change in the levels of parenting stress over time is formally presented and 
commented on in section 5.11. 
0
10
20
30
40
50
60
70
80
90
Baseline 3-month 6-month
P
e
rc
e
n
ti
le
 s
c
o
re
s
 
Time points of assessment Total stress score
(p<0.001)
(p<0.001)
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
175 
 
The PSI-SF only reflects levels of parenting stress directly related to the primary caregiver’s 
parenting role. Anecdotal reports provided by many of the primary caregivers in this study 
indicate that unemployment, low SES, low levels of education and a lack of social support 
may further exacerbate the stress they are already experiencing in their parenting role. 
 
5.10 Burden of care  
 
Parents reporting on the number of times their child was hospitalised determined the burden 
of care placed on the primary caregiver, and the effect their child’s health had on their work 
life and daily routine. This descriptive information served as a reflection of the magnitude of 
the care burden experienced by primary caregivers in this study sample. The burden of care 
experienced by the primary caregivers across the study is summarised in Table 5.23. Values 
reported are medians with ranges and means with standard deviations.  
 
Table 5.23 Burden of care across the study 
 
Variables Before cardiac 
intervention 
 (n=40) 
Between hospital 
discharge and three-
month follow-up 
(n=25) 
Between three-month 
and six-month follow-
up 
(n=22) 
Number of hospital 
admissions  
 
Median (range) 
Mean and SD  
 
 
 
2 [0 – 5] 
2. 02 (±1.31) 
 
 
 
0 [0 – 2] 
0.2 (±0.5) 
 
 
 
0 [0  - 1] 
0.2 (±0.4) 
 
Number of days child too 
ill to play 
 
Median (range) 
Mean and SD 
 
 
 
 
0 [0 – 21] 
1.5 (±3.7) 
 
 
 
0 [0 – 5] 
0.4 (±1.2) 
 
 
 
0 [0 – 14] 
1.2 (±3.3) 
Number of days child 
required special care 
 
Median (range) 
Mean and SD 
 
  
 
 
0 [0 -31] 
5 (±9.6) 
 
 
 
0 [0 -3] 
0.3 (±0.9 ) 
 
 
 
0 [0 – 14] 
1.2 (± 3.3) 
* Hospitalisations excluded the admission for cardiac intervention 
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The majority of the participating children (87.5%) had at least one hospital admission prior 
to cardiac intervention. Participants tended to have far fewer hospital admissions post-
cardiac intervention. The main reason for hospital admissions both before and after cardiac 
intervention was respiratory-related complications.  
 
Twenty percent of the primary caregivers were employed at the time of their child’s first 
cardiac intervention. In some instances, primary caregivers reported having to miss work 
due to their child’s ill health. For the majority of employed primary caregivers, their child’s 
health did not affect their work routine and ability to concentrate at work as a carer looked 
after the child during the workday. In the case of working mothers, the grandmothers carried 
a heavy burden of care.  
 
Ten percent of the primary caregivers were either learners or students at the time of their 
children’s first cardiac surgery. They reported that their children’s ill health affected their 
school and class attendance prior to cardiac intervention, but this was no longer the case 
post-cardiac intervention. Grandmothers carried a heavy caregiving burden in cases where 
the mother was a learner, student or teenager, or where the father was the primary 
caregiver.  
 
The majority of primary caregivers were housewives at the time of their child’s first cardiac 
intervention, either out of choice to care for their child, or due to the inability to find gainful 
employment. They reported that their child’s health affected their ability to continue with daily 
chores within the home prior to cardiac intervention, but this was seldom the case post-
cardiac intervention.  
 
Two mothers and one father gave up their employment post-cardiac intervention to play a 
more active role in the caregiving of their children. However, this came at a financial cost to 
the families. Many mothers reported a desire to seek gainful employment after their child’s 
cardiac intervention as a result of their children’s improved health and the diminished care 
burden. 
 
It is therefore evident that caring for a child with CHD heightened the financial, emotional 
and physical burden of care for both parents and grandparents, in many instances. The 
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burden of care predominantly fell on mothers in this study sample.  The burden of care was 
greater prior to cardiac intervention, and declined post-cardiac intervention and over time as 
the children’s health status improved. 
 
5.11 Changes in key outcomes over time 
 
Within the group, changes in key outcomes over time, including growth, neurodevelopment, 
HRQOL and parenting stress over time were calculated using a 95% confidence intervals 
for the difference between the z-score means. Testing was done at the 0.05 level of 
significance. Data from all participants assessed at the various time-points was included in 
the analysis. 
 
 The changes in key outcomes over time are presented in Table 5.24. 
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Statistically significant changes were seen in three of the four key outcomes, including 
growth, HRQOL and parenting stress from before cardiac intervention to post-cardiac 
intervention.  
 
Significant catch-up growth was seen for both weight and head circumference at six-month 
post-cardiac intervention when compared to growth prior to cardiac intervention. The 
significant improvement in head circumference suggests that the small head size was 
related to the growth failure rather than small brain volume. There was also a significant 
improvement in parents’ perception of their children’s HRQOL at three-month post-cardiac 
intervention when compared with their perceived HRQOL prior to cardiac intervention.  
 
Levels of parenting stress were found to have declined significantly from before cardiac 
surgery at both three-month and six-months post-cardiac intervention when compared to 
levels of parenting stress prior to cardiac intervention.  
 
Change in neurodevelopmental outcomes and muscle tone over time were not found to be 
significant. 
 
5.12 Variables associated with key outcomes  
 
Variables known to be risk factors for adverse developmental outcome and poorer HRQOL, 
as well as those associated with increased levels of parental distress were analysed for 
various sub-categories for their association with key outcomes by means of ANOVAs. The 
results of the variables analysed as main effects for each of the key outcomes, namely 
neurodevelopment, HRQOL and parenting stress, are presented below. The main effects in 
the model represent the multiple factors influencing the response in each of the named 
categories. 
 
A regression analysis was also done using ANOVAs to determine variables predictive of key 
outcomes. Only the findings for associations will be presented in the results section.  
The results of the regression analysis can be referenced in Appendix XIV.  
  
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
180 
 
5.12.1 Variables associated with neurodevelopmental outcome 
 
Variables that demonstrated an association with neurodevelopmental outcome were 
determined for individual variable sub-categories at baseline, and at three-month and six-
month post-cardiac intervention. 
 
Variables associated with each of subscales of the BSID-III (cognitive, language and motor) 
are presented in Table 5.25 to 5.27 (See tables on the pages to follow). These variables 
were set as main effects in the ANOVA models.  
D
e
ve
lo
p
m
e
nt
, 
H
R
Q
O
L
 a
n
d 
b
ur
d
e
n
 o
f 
ca
re
 o
f 
yo
u
ng
 c
h
ild
re
n
 w
ith
 C
H
D
  
_
__
_
_
__
_
__
_
_
_
__
_
__
_
__
_
_
__
_
_
__
_
__
_
_
_
__
_
__
_
__
_
_
__
_
_
__
_
__
_
_
_
__
_
__
_
__
_
_
__
_
_
__
_
 
 
 
_
__
_
_
__
_
__
_
_
_
__
_
__
_
_
_
_
_
__
_
_
__
_
__
_
_
_
__
_
__
_
__
_
_
__
_
_
__
_
__
_
_
_
__
_
_
_
_
__
_
_
__
_
_
__
_
   
  
  
  
  
  
   
  
  
   
 
1
8
1
 
 T
a
b
le
 5
.2
5
 V
a
ri
a
b
le
s
 a
s
s
o
c
ia
te
d
 w
it
h
 t
h
e
 B
S
ID
-I
II
 c
o
g
n
it
iv
e
 s
c
o
re
s
  
 
V
a
ri
a
b
le
s
 f
o
r 
B
S
ID
-I
II
 c
o
g
n
it
iv
e
 
s
c
o
re
s
  
P
-v
a
lu
e
s
 
C
h
a
n
g
e
 i
n
 z
-s
c
o
re
 m
e
a
n
s
 f
o
r 
 B
S
ID
-I
II
 c
o
g
n
it
iv
e
 s
c
o
re
s
 f
o
r 
s
ig
n
if
ic
a
n
t 
a
s
s
o
c
ia
ti
o
n
s
 
B
a
s
e
li
n
e
 
T
h
re
e
-m
o
n
th
s
 
p
o
s
t-
c
a
rd
ia
c
 
in
te
rv
e
n
ti
o
n
 
S
ix
-m
o
n
th
s
 
p
o
s
t-
c
a
rd
ia
c
 
in
te
rv
e
n
ti
o
n
  
B
a
s
e
li
n
e
 
T
h
re
e
-m
o
n
th
s
 
p
o
s
t-
c
a
rd
ia
c
 
in
te
rv
e
n
ti
o
n
 
S
ix
-m
o
n
th
s
 
p
o
s
t-
c
a
rd
ia
c
 
in
te
rv
e
n
ti
o
n
 
T
re
n
d
 
d
ir
e
c
ti
o
n
 
T
y
p
e
 a
n
d
 s
e
v
e
ri
ty
 o
f 
C
H
D
 
8
4
.1
 
6
.9
 
6
.7
 
D
e
cr
e
as
in
g
 
co
gn
iti
ve
 
sc
o
re
s 
D
is
e
as
e
 s
e
ve
ri
ty
  
0
.0
2
* 
0
.9
6
 
0
.9
6
 
T
yp
e 
C
H
D
  
0
.2
4
 
0
.4
1
 
0
.0
8
 
S
u
rg
e
ry
 a
n
d
 m
e
d
ic
a
l 
c
o
u
rs
e
 
A
g
e 
a
t t
im
e
 o
f 
fir
st
 s
u
rg
e
ry
 
0
.1
5
 
0
.2
4
 
0
.7
0
 
C
P
B
 t
im
e
 
0
.5
3
 
0
.8
9
 
0
.3
7
 
P
o
st
-o
p
e
ra
tiv
e
 c
o
m
p
lic
a
tio
n
s 
0
.9
1
 
0
.4
9
 
 
0
.2
0
 
D
u
ra
tio
n 
o
f m
e
ch
an
ic
a
l v
e
n
til
a
tio
n
 
0
.6
2
 
0
.1
3
 
0
.1
5
 
H
o
s
p
it
a
l 
a
n
d
 I
C
U
 l
e
n
g
th
 o
f 
s
ta
y
 
IC
U
 le
ng
th
 o
f 
st
a
y 
0
.2
3
 
0
.2
3
 
0
.2
4
 
H
o
sp
ita
l l
e
n
g
th
 o
f 
st
a
y 
p
o
st
-s
u
rg
e
ry
 
0
.7
0
 
0
.6
7
 
0
.7
1
 
P
a
ti
e
n
t 
fa
c
to
rs
 
G
e
nd
er
 
0
.9
9
 
0
.6
8
 
0
.5
7
 
P
re
m
a
tu
rit
y 
 
0
.2
3
 
0
.6
2
 
0
.6
3
 
L
o
w
 b
irt
h
 w
e
ig
ht
 
0
.1
7
 
0
.8
9
 
0
.9
5
 
G
e
ne
tic
 c
o
m
o
rb
id
ity
 (
D
S
) 
0
.0
0
**
* 
0
.0
0
**
* 
0
.0
0
**
**
 
G
ro
w
th
  (
w
e
ig
h
t-
fo
r-
a
g
e
) 
0
.3
2
 
0
.4
9
 
0
.2
6
 
S
o
ci
o
d
em
o
gr
a
ph
ic
 f
a
ct
o
rs
 
D
is
ta
nc
e
 t
o
 c
a
rd
ia
c 
se
rv
ic
e
 p
oi
n
t 
0
.2
5
 
0
.4
0
 
0
.5
4
 
A
g
e 
o
f 
m
o
th
e
r 
0
.0
1
* 
0
.0
1
**
 
0
.0
1
**
 
L
ev
e
l o
f 
e
du
ca
tio
n
 o
f 
m
o
th
e
r 
0
.6
9
 
0
.0
5
 
0
.3
0
 
S
o
ci
o
e
co
n
o
m
ic
 s
ta
tu
s 
 
0
.8
9
 
0
.9
5
 
0
.7
5
 
In
di
ca
tio
n 
of
 s
ta
tis
tic
al
 s
ig
ni
fic
an
ce
: 
* 
P
 <
 0
.0
5,
 *
* 
P
 <
 0
.0
1 
an
d 
**
* 
P
 <
 0
.0
01
 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
182 
 
Disease severity only showed a significant association with cognitive outcome prior to 
cardiac intervention. The presence of a genetic comorbidity (DS) and maternal age were 
significantly associated with cognitive developmental outcome prior to cardiac intervention, 
as well as at three-month and six-month post-cardiac intervention. All significant values are 
due to a decrease in cognitive scores. 
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The presence of a genetic comorbidity (DS) was shown to be the variable significantly 
associated with language development outcomes both prior to and after cardiac 
intervention. Age at the time of first cardiac intervention was also significantly associated 
with language development outcomes prior to cardiac intervention and at three-month post-
cardiac intervention. All significant values are due to a decrease in language scores.
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Growth prior to cardiac intervention was significantly associated with motor performance at 
baseline. The presence of DS and maternal age were significantly associated with motor 
development outcomes both before and after cardiac surgery. All significant values are due 
to a decrease in motor scores. 
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5.12.2 Variables associated with parents’ perception of health-related quality of life 
  
Variables that demonstrated an association with parent perceived HRQOL were determined 
for individual variable sub-categories at baseline, and at three-month and six-month post-
cardiac intervention. 
 
Variables associated with PedsQLTM total scores are presented in Table 5.28. These 
variables were set as main effects in the ANOVA models.  
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Motor developmental performance and levels of parenting stress prior to cardiac intervention 
were shown to have a significant association with parental perception of their child’s 
HRQOL. None of the categories of variables were shown to be predictive of HRQOL after 
cardiac intervention. All significant values are due to an increase in PedsQLTM total scores. 
 
5.12.3 Variables associated with levels of parenting stress 
 
Variables that demonstrated an association with levels of parenting stress were determined 
for individual variable sub-categories at baseline, and at three-month and six-month post-
cardiac intervention. 
 
Variables associated with PSI-SF total scores are presented in Table 5.29. These variables 
were set as main effects in the ANOVA models.  
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Neurodevelopmental outcome, in particular language developmental performance, was 
significantly associated with levels of parenting stress prior to cardiac intervention and at 
three-month post-cardiac intervention. Parents’ perception of their child’s HRQOL prior to 
cardiac intervention was also found to be significantly associated with levels of parenting 
stress. In addition, the age of the child at the time of the first cardiac intervention, and the 
age of the mother, was also associated with levels of parenting stress at three-month post-
cardiac intervention. All significant values are due to a decrease in PSI-SF total scores. 
 
It became evident from the analysis that parents’ perception of their child’s HRQOL was 
closely related with the level of parenting stress experienced prior to the child undergoing 
cardiac surgery.  
 
5.13 Key outcomes for groups of special interest  
 
This study aimed to report on outcomes for all participants; however, the outcomes of 
participants with genetic comorbidity (DS in this study) and those with cyanotic heart defects 
were still considered to be of special interest.  
 
The limited sample size resulted in small subgroups, which were not sufficiently powered to 
be able to draw meaningful conclusions from formal statistical analyses of between group 
differences. Despite this limitation, it was still deemed important to investigate tendencies 
and trends in outcomes between participants with CHD with DS compared to those with 
CHD without DS, as well as those with cyanotic heart defects compared to those with 
acyanotic heart defects for descriptive purposes.  
 
A summary of the most important findings of between group differences for subgroups of 
special interest will be highlighted in this section. Additional tables of outcomes between 
subgroups of special interest, namely CHD with DS compared to CHD without DS, and for 
the cyanotic heart defects compared to acyanotic heart defects can be referenced in 
Appendix XV and Appendix XVI respectively. 
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5.13.1 Outcomes for children with CHD with Down syndrome compared to those with 
CHD without Down syndrome 
 
A quarter of the participants in this study were diagnosed with a genetic comorbidity in 
addition to their diagnosis of CHD. In all cases, the diagnosed genetic abnormality was DS. 
The proportion of participants with genetic comorbidity in this study sample is shown in 
Figure 5.9. 
 
 
Figure 5.9 Prevalence of Down syndrome in this study sample (n=40) 
 
5.13.1.1 Sociodemographic information  
 
Sociodemographic variables for participants in the subgroup with CHD and DS were similar 
to that in the group with CHD without DS, apart from maternal age that was more advanced 
in the group of CHD with DS. The median age was 37 years compared to only 27.5 years in 
the group with CHD without DS.  
 
5.13.1.2 Cardiology diagnostic information  
 
The type and severity of cardiac disease was similar in both groups. The profile of CHD 
however varied between groups. AVSDs were the most common primary cardiac diagnosis 
25%
75%
CHD with DS (n=10)
CHD without DS (n=30)
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in the group of CHD with DS (60%), whilst VSDs were most common in the CHD without DS 
group (43.3%).   
 
5.13.1.3 Surgical intervention and post-operative medical course 
 
Children in the group of CHD with DS tended to be slightly older at the time of their first 
cardiac intervention. Surgical variables with regards to duration of CPB, aorta cross-clamp 
time, length of cardiothoracic ICU stay and post-surgery hospital length of stay were similar 
in both groups. Post-operative mortality was higher in the group of CHD with DS. Sixty-
seven percent of participants who died post operatively had CHD with DS. 
 
5.13.1.4 Growth outcomes 
 
Anthropometric data using the z-score system for weight-for-age, height-for-age and head 
circumference-for-age at baseline and for the three-month and six month post-cardiac 
intervention is presented in Table 5.30. Values reported are medians with ranges and means 
with standard deviations. 
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Table 5.30 Growth outcomes in children with CHD with DS compared to those with 
CHD without DS 
 
Growth parameter CHD and DS  CHD without DS  
Baseline 
 
(n=10) (n=30) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-2.6 
-2.3 (±1.6) 
 
 
-2.6 
-2.6 (±1.5) 
 
Height-or-age z-score 
 
Median  
Mean and SD 
 
 
 
-0.9 
-1.5 (±3.0) 
 
 
-2.0 
-2.4 (±2.3) 
 
Head circumference-for-age z-score 
 
Median  
Mean and SD 
 
 
-1.7 
-1.6 (±0.9) 
 
 
-1.4 
-1.3 (±1.7) 
 
Three-months post-cardiac 
intervention  
 
(n=5) (n=20) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.1 
-1.1 (±2.6) 
 
 
-2.2 
-2.0 (±1.4) 
 
Height-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.1 
-2.2 (±2.5) 
 
 
-0.7 
-1.1 (±1.5) 
 
Head circumference-for-age z-score 
 
Median  
Mean and SD 
 
 
-0.9 
-1.8 (±1.9) 
 
 
 
-1.0 
-0.6 (±1.7) 
 
Six-months post-cardiac intervention (n=5) (n=17) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
-1.2 
-0.9 (± 2.1) 
 
 
 
-1.7 
-1.8 (±1.8) 
 
Height-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.6 
-2.1 (±1.4) 
 
 
-1.5 
-1.7 (±1.7) 
Head circumference for age z-score 
 
Median  
Mean and SD 
 
 
-1.6  
-2.1 (±1.4) 
 
 
 
-1.5 
-1.7 (±1.7) 
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Growth outcomes for participants in the group of CHD with DS and those in the group of 
CHD without DS were similar when the growth of participants with DS was determined using 
the DS-specific growth charts, which allowed for fair comparison with their peers.   
 
The majority of participants in both groups (more than 60%) presented with malnutrition prior 
to cardiac intervention, a large number of participants in both groups (more than 40%) were 
also stunted. The prevalence of microcephaly was also high in both groups (more than 20%). 
Growth across all growth parameters improved in both groups post-cardiac intervention. 
 
5.13.1.5 Neurodevelopmental outcomes  
 
Composite scores for cognitive, language and motor subscales of the BSID-III for both 
groups are reported in Table 5.31. Values reported are medians with ranges and means 
with standard deviations. 
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Table 5.31 Developmental outcomes on the BSID-III for children with CHD with DS 
compared to those with CHD without DS 
 
Variable CHD with DS CHD without DS 
Baseline (n=10) (n=30) 
Cognitive subscale 
 
Median  
Mean and SD 
 
 
60 [55 – 90] 
65 (±10.5) 
 
 
95 [55 – 130] 
91.5 (±16.5) 
 
Language subscale 
 
Median  
Mean and SD 
 
 
 
75.5 [62 - 112] 
78.2 (±15.2) 
 
 
94 [65 – 115] 
94.5 (±11.3) 
Motor subscale 
 
Median  
Mean and SD 
 
 
58 [46 - 88] 
61 (±14.1) 
 
 
86.5 [58 – 112] 
85.7 (±13.8) 
 
Three-months post-
cardiac intervention 
(n=5) (n=20) 
Cognitive subscale 
 
Median  
Mean and SD 
 
 
55 [55 – 70] 
60 (±7.1) 
 
 
90 [55 -105] 
90.8 (±12.7) 
 
Language subscale 
 
Median  
Mean and SD 
 
 
 
71 [50 – 83] 
69.2 (±12.1) 
 
 
92.5 [71 – 112] 
93.2 (±13.1) 
Motor subscale 
Median  
Mean and SD 
 
46 [46 -73] 
55 (±12.7) 
 
 
91 [46 – 112] 
89.3 (±14.7) 
Six-months post-
cardiac intervention 
 
(n=5) (n=17) 
Cognitive subscale 
 
Median  
Mean and SD 
 
 
55 [55 – 65] 
58 (±4.5) 
 
 
90 [55 -100] 
90.9 (±13.3) 
 
Language subscale 
Median  
Mean and SD 
 
 
65 [57 – 79] 
66.2 (±6.9) 
 
91 [65 – 109] 
88.8 (±13.5) 
Motor subscale 
 
Median  
Mean and SD 
 
 
55 [49 – 70] 
57.4 (±8.3) 
 
 
97 [49 -121] 
92.3 (±18.9) 
 
* Scores < 70 = delayed, 70-84 at risk and >85 normal 
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Mean scores for all three of the sub-categories of the BSID-III were below the mean score 
of 100 in both groups at all three time-points of assessment. The mean scores for all the 
subscales in the group of CHD without DS were all within 1SD of the mean at all assessment 
time points. The scores on all of the subscales for the group with CHD with DS were 
considerably lower than the group with CHD without DS at all three time points of 
assessment.  
 
At baseline, 90% of the participants in the group of CHD with DS were at risk of, or had 
delayed motor development, compared to only 40% in the CHD without DS group. By six-
month post-cardiac intervention risk of, and delays in motor development in the group of 
CHD without DS had declined to 29.4%.  Where motor delays were present in this group 
they were mild or moderate in nature. In contrast, by six-month post-cardiac intervention 
100% of the children in the CHD with DS group were at risk of, or presented with delayed 
motor development. Where motor delays were present in this group the majority (60%) were 
severe in nature. 
 
At baseline, 90% of the participants in the group of CHD with DS were at risk of, or presented 
with delayed cognitive development, compared to only 27% in the CHD without DS groups. 
By six-month post-cardiac intervention risk of, and delayed cognitive development had 
declined in the group of CHD without DS to 17.2%. In contrast, by six-month post-cardiac 
intervention 100% of participants in the group of CHD with DS were at risk of, or presented 
with delayed cognitive development.  
 
At baseline, 80% of the participants in the group of CHD with DS were at risk of, or presented 
delayed language development, compared to only 13.3% in the CHD without DS group. By 
six-month post-cardiac intervention risk of, and delayed cognitive development had 
increased in the group of CHD without DS group to 47.2% and to 100% in the CHD with DS 
group.  
 
Developmental outcomes were therefore to be considered considerably poorer for 
participants with CHD who had DS, when compared to those without DS across all areas of 
development both before and after cardiac intervention.  
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Hypotonia was marked in all participants (100%) in the group of CHD with DS both before 
and after cardiac intervention. Hypotonia was present in 26.7% of participants in the CHD 
without DS group before cardiac intervention and tended to resolve over time. 
 
5.13.1.6 Parents’ perception of health related quality of life  
 
Parents’ perception of their children’s HRQOL reflected as a total score out of a 100 is 
presented in Table 5.32. Values indicated are medians with ranges and means with standard 
deviations. 
 
Table 5.32 Perceived health-related quality of life outcomes of children with CHD with 
DS compared to those with CHD without DS 
 
PedsQLTM total score CHD with DS CHD without DS 
Baseline  
 
Median (range) 
Mean and SD 
(n=10) 
 
77.5 [63.9 – 88.2] 
75.5 (±8.1) 
 
(n=30) 
 
81.3 [48.6 – 97.2] 
78.4 (±13.6) 
 
Three-month post-cardiac 
intervention 
 
Median (range) 
Mean and SD 
 
(n=5) 
 
 
77.8 [29.2 – 93.3] 
69.7 (±29.8) 
(n=20) 
 
 
90.3 [64.4 – 100] 
87.9 (±11.2) 
Six-month post-cardiac 
intervention  
 
Median (range) 
Mean and SD 
 
(n=5) 
 
 
76.1 [74.4 -79.4] 
76.5 (±2.1) 
(n=17) 
 
 
89.5 [52.2 – 100] 
87.3 (±11.3) 
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Parents in both groups perceived their children’s HRQOL as good at all time points of 
assessment over the study. However, parents of participants in the group of CHD with DS 
viewed their children as having a poorer HRQOL than those of children with CHD without 
DS both before and after cardiac intervention. Parents of children with CHD without DS were 
of the view that their children’s HRQOL improved to a greater extent post-cardiac 
intervention than those parents of children with CHD with DS.   
 
5.13.1.7 Parenting stress outcomes  
 
Parenting stress outcomes, reflected as a percentile score, are presented in Table 5.33. 
Values reported are medians with ranges and means with standard deviations. 
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Table 5.33 Levels of parenting stress in children with CHD with DS compared to those 
with CHD without DS 
 
Subscales of the PSI-SF CHD with DS CHD without DS 
Baseline (n=10) (n=30) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
87.5 [35 – 99] 
74.4 (±24.9) 
 
 
 
90 [10 – 99] 
86.4 (±17.3) 
Parent-child dysfunction 
 
Median (mean) 
Mean and SD 
 
 
 
95 [40 – 99] 
86.7 (±19.2) 
 
 
 
80 [40 – 99] 
77.8 (±19.8) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
75 [25 – 95] 
73 (±20.8) 
 
 
77.5 [1 – 99] 
65.2 (±27.9) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
92.5  [40 – 99] 
82.4 (±20.9) 
 
 
90 [5 - 99] 
84.3 (±18.9) 
 
Subscales of the PSI-SF CHD with DS CHD without DS 
Three-months post-cardiac 
intervention 
(n=5) (n=20) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
80 [30 – 95] 
68 (±30.9) 
 
 
 
 
75 [1 – 95] 
62.8 (±32.9) 
Parent-child dysfunction 
 
Median (range) 
Mean and SD 
 
 
 
95  [85 - 99] 
(93.6 (±6.1) 
 
 
 
70 [5 – 99] 
67 (±27.9) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
75  [50 - 95] 
75 (±18.4) 
 
 
52.5  [1 – 95] 
47.1 (±26.9) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
90 [60 - 99] 
84.6 (±16.9) 
 
 
77.5  [1 – 99] 
65.1 (±29.8) 
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Subscales of the PSI-SF CHD with DS CHD without DS 
Six-months post-cardiac 
intervention 
(n=5) (n=17) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
65 [35 – 95] 
62 (±24.9) 
 
 
 
65 [1 – 95] 
56.5 (±34.3) 
Parent-child dysfunction 
 
Median (range) 
Mean and SD 
 
 
 
95 [80 – 99] 
91 (±7.3) 
 
 
 
55 [5 – 97] 
55.1 (±34.6) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
80 [35 – 99] 
(76.8 (±24.7) 
 
 
40 [1 – 90] 
39.1 (±34) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
80 [55 – 99] 
81.8 (±17.3) 
 
 
 
50 [1 – 95] 
50.8 (±35.8) 
 
Before cardiac intervention, parents of participants with CHD with DS felt that their children 
did not live up to their expectations to a greater extent than those with CHD without DS. 
Stress experienced by parents in both groups was comparable prior cardiac intervention. 
The majority of parents in both groups experienced clinically significant levels of stress 
(stress scores above the 90th percentile considered to be clinically significant) before their 
children underwent cardiac intervention. 
 
At both three-months and six-months post-cardiac intervention, parents of participants with 
CHD with DS felt that their children did not live up to their expectations to a greater extent, 
and were more difficult to parent, than children without DS. At both three-and six-month 
post-cardiac intervention the stress experienced by parents in their parenting role was far 
greater for the parents of children with CHD with DS. 
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5.13.2 Outcomes for cyanotic versus acyanotic heart defects  
 
The majority (80%) of the participants in this study were diagnosed with acyanotic heart 
defects. Differences in key outcomes of participants with cyanotic heart defects compared 
to acyanotic heart defects will be presented in the following section. The proportion of this 
sample with cyanotic heart defects is shown in Figure 5.10.  
 
 
Figure 5.10 Prevalence of cyanotic heart defects in this study sample (n=40) 
 
5.13.2.1 Sociodemographic information  
 
Sociodemographic information was similar for both the cyanotic and acyanotic groups.  
 
5.13.2.2 Cardiology diagnostic information  
 
The mean cardiac disease severity in the cyanotic heart defect group was moderate to 
severe, while the mean severity in acyanotic group was moderate. The children in the 
cyanotic group tended to have more severe CHD than the acyanotic group.  
The most prevalent congenital heart defect in the cyanotic group was DORVs (30%), whilst 
VSDs (50%) were the most common defect in the acyanotic group.  
 
20%
80%
Cyanotic heart defects (n=8)
Acyanotic heart defects (n=32)
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5.13.2.3 Surgical intervention and post-operative medical course 
 
Those participants with cyanotic heart defects in the current study underwent their first 
cardiac surgery at a slightly younger age than those participants with acyanotic heart 
defects.  
 
The duration of CPB tended to be longer in the case of children with cyanotic heart defects 
compared to acyanotic heart defects, but the aorta cross-clamp times were similar for both 
groups. The cardiothoracic ICU length of stay and hospital length of stay post-surgery 
tended to be slightly longer for children with cyanotic heart defects.  
 
5.13.2.4 Growth outcomes 
 
Anthropometric data using the z-score system for weight-for-age, height-for-age and head 
circumference-for-age at baseline and for the three-month and six month post-cardiac 
intervention are presented in Table 5.34. Values reported are reported as medians and 
means with standard deviations. 
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Table 5.34 Growth outcomes for children with cyanotic heart defects compared to 
those with acyanotic heart defects 
 
Growth parameter Cyanotic Acyanotic 
 
Baseline (n=8) (n=32) 
 
Weight for age z-score 
Median  
Mean and SD 
 
-2.8 
-2.5 (±1.4) 
 
 
-2.6 
-2.5 (±1.5) 
Height for age z-score 
Median  
Mean and SD 
 
 
-2.5 
-3.3 (±2.8) 
 
-1.6 
-1.9 (±2.3) 
Head circumference for age 
 z-score 
Median  
Mean and SD 
 
 
-1.4 
-1.5 (±2.2) 
 
 
 
-1.4 
-1.3 (±1.4) 
Three-months post cardiac 
intervention 
(n=4) (n=21) 
Weight for age z-score 
Median  
Mean and SD 
 
-2.9 
-3.0 (±0.8) 
 
-1.7 
-1.6 (±1.7) 
 
Height for age z-score 
Median  
Mean and SD 
 
 
-1.0 
-1.2 (±1.6) 
 
-1.2 
-1.6  (±1.9) 
Head circumference for age  
z-score 
Median  
Mean and SD 
 
 
0.3 
0.2 (±1.7) 
 
 
 
-1.2 
-1.1 (±1.7) 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Weight for age z-score 
Median  
Mean and SD 
 
-2.2 
-1.8 (±2.5) 
 
 
-1.8 
-1.6 (±1.7) 
Height for age z-score 
Median  
Mean and SD 
 
 
-1.8 
-1.7 (±1.8) 
 
 
-1.6 
-1.8 (±1.6) 
 
Head circumference for age  
z-score 
Median  
Mean and SD 
 
 
0.3 
0.5 (±1.3) 
 
 
 
-0.6 
-0.5 (±1.9) 
 
The majority of the participants in both groups (65.6% and higher) had suboptimal growth 
prior to cardiac intervention. A higher percentage of children in the cyanotic group had 
malnutrition (75%) and stunting (62.5%), and the extent of the growth failure in this group 
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tended to be greater prior to cardiac intervention. The prevalence of microcephaly was found 
to be high in both groups.  
 
Growth across all growth parameters improved in both groups post-cardiac intervention, and 
growth trends tended to be comparable by six-month post-cardiac intervention. However, 
the weight catch-up post-cardiac intervention tended to be slower in children in the cyanotic 
group.  
 
5.13.2.5 Neurodevelopmental outcomes  
 
Composite scores for cognitive, language and motor subscales of the BSID-III for both 
groups are reported in Table 5.35 (See table on the following page). Values indicated are 
medians with ranges and means with standard deviations. 
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Table 5.35 Developmental outcomes on the BSID-III for children with cyanotic heart 
defects compared to those with acyanotic heart defects 
 
Variable Cyanotic Acyanotic  
 
Baseline (n=8) (n=32) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD 
 
 
92.5 [55 – 105] 
89.4 (±17) 
 
 
 
85 [55 – 130] 
83.8 (±19.6) 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
100 [65 – 112] 
93.9 (±17.5) 
 
 
91 [62 – 115] 
89.6 (±13.3) 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
85 [46 – 112] 
82.8 (±18.8) 
 
 
 
82 [49 – 110] 
78.7 (±17.3) 
 
Three-month post cardiac 
intervention 
(n=4) (n=21) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD 
 
 
90 [85 – 95] 
90 (±4.1) 
 
 
90 [55 – 105] 
83.6 (±18.5) 
 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
106 [ 91 – 109] 
103 (±8.5) 
 
 
83 [50 – 112] 
85.6 (±15.7) 
 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
85 [82 – 94] 
86.5 (±5.7) 
 
 
 
91 [46 – 112] 
81.6 (±21.5) 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD 
 
 
95 [80 – 110] 
95 (±12.2) 
 
 
 
87.5 [55 – 110] 
80.8 (±18.7) 
 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
90 [65 – 103] 
87 (±17.9) 
 
 
81 [59- 109] 
82.6 (±15.4) 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
89.5 [73 – 121] 
93.3 (±21.8) 
 
 
 
89.5 [49 – 121] 
82.3 (±22.8) 
* score < 70 = delayed,  70-84 at risk and >85 normal, >85 normal 
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Developmental performance across all the subscales of the BSID-III (cognitive, language 
and motor) tended to be similar at all time points of assessment, both before and after 
cardiac intervention, when the BSID-III score ranges of the participants were compared.  
 
5.13.2.6 Parents’ perception of health-related quality of life  
 
Perceived HRQOL as reflected as a total score out of 100 is reflected in Table 5.35. Values 
indicated are medians with ranges and means with standard deviations. 
 
The perceived HRQOL outcomes for children with cyanotic and acyanotic heart defects are 
presented in Table 5.36.  
 
Table 5.36 Perceived health-related quality of life outcomes for children with cyanotic 
heart defects compared to acyanotic heart defects 
 
PedsQLTM total score Cyanotic  Acyanotic  
Baseline  
 
Median (range) 
Mean and SD 
 
(n=8) 
 
79.5 [48.6 – 93.3] 
75 (±16.2) 
 
(n=32) 
 
81 [49.3 – 97.2] 
78.3 (±11.5) 
Three-months post cardiac 
intervention 
 
Median (range) 
Mean and SD 
 
(n=4) 
 
 
91.7 [88.9 – 99.3] 
92.9 (±4.6) 
 
(n=21) 
 
 
88.2 [29.9 – 100] 
84.3 (±17) 
Six-months post cardiac 
intervention  
 
Median (range) 
Mean and SD 
 
(n=4) 
 
 
87.9 [84.8 – 90] 
87.6 (±2.3) 
(n=18) 
 
 
86.4 [52.2 – 100] 
84.6 (±11.9) 
 
HRQOL was good in both groups at all assessment time points. Perceived HRQOL was 
similar in both groups at all assessment time points both before and after cardiac surgery. 
Parents in both groups perceived their children’s HRQOL to have improved post-cardiac 
intervention. 
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5.13.2.7 Parenting stress outcomes 
 
Levels of parenting stress reflected as a percentile are presented in Table 5.37. Values 
reported are medians with ranges and means with standard deviations. 
 
Table 5.37 Levels of parenting stress for children with cyanotic heart defects 
compared to acyanotic heart defects 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
 
Baseline 
 
(n=8) (n=32) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
80 [50 -99] 
78.5 (±19.1) 
 
 
 
90 [5 – 99] 
85.2 (±19.3) 
 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
 
Three-months post 
cardiac intervention 
(n=4) (n=21) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
75 [15-80] 
61.3 (±31) 
 
 
80 [1 – 99] 
70.5 (±28.6) 
 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
25 [5 - 90] 
36.3 (±37.1) 
 
 
72.5 [1-99] 
62.6 (±33.4) 
 
A high number of the parents (37.5% and higher) in both groups experienced clinically 
significant levels of stress (total stress score higher than the 90th percentile) before their 
child underwent cardiac intervention. Parenting stress declined in both groups after cardiac 
intervention and over time. Levels of parenting stress tended to be similar in both groups at 
all three of the time-points of assessment when the PSI-SF total score ranges of the 
participants were compared. 
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5.14 Summary  
 
The majority of participants in this study were diagnosed with acyanotic heart defects, and 
in most cases, the disease severity was moderate. A quarter of the participants presented 
with genetic comorbidity in the form of DS. The majority of participants had at least one 
hospital admission prior to cardiac intervention, mostly for respiratory-related complications. 
Most underwent open-heart surgery in infancy and were placed on CPB. Most children had 
an uncomplicated medical course post-cardiac surgery. The mortality rate was 15%, which 
contributed to the loss to follow-up of 47.5% over the course of this study.  
 
The majority of families had to travel distances of greater than 100 km to access cardiac 
services. Both mothers and fathers had low levels of education and most families were from 
a low socioeconomic class.  
  
The findings of this study confirm that young children with CHD are at risk of developmental 
delay across all areas of development as measured by the BSID-III. Younger children initially 
showed the greatest risk of, and delays in motor development followed by cognitive 
development. Language delays became more prevalent with increasing age and with 
increasing skill complexity. In the most cases developmental delays were mild to moderate 
in severity. However, there were no significant changes in developmental outcome over time 
and post-cardiac intervention. Children with CHD with DS had worse developmental 
outcomes across all areas of development compared to children without DS, whilst the 
developmental outcome in children with cyanotic and acyanotic heart defects was found to 
be similar. Variables most strongly associated with developmental outcomes included the 
presence of DS and maternal age. Other variables found to be associated with 
developmental outcome include age at first surgery and disease severity.  
 
Hypotonia was the most significant abnormal finding on neurological examination, and was 
marked in all participants with DS. Hypotonia resolved in participants with CHD without DS 
over time.  
 
The majority of the participants had suboptimal growth prior to cardiac intervention. A quarter 
of the participants also presented with microcephaly related to their growth failure. Growth 
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(weight and head circumference) improved significantly over time and post-cardiac 
intervention. The growth trends of children with CHD with DS were similar to those with CHD 
without DS. Growth in children with cyanotic heart defects tended to be poorer than those 
with acyanotic heart defects both before and after cardiac intervention. 
 
Parents perceived their children’s HRQOL as good at all assessment time points. However, 
parents’ perception of their children’s HRQOL improved significantly post-cardiac 
intervention. Perceived HRQOL was similar in participants with cyanotic and acyanotic heart 
defects. Parents of children with CHD with DS perceived their children’s HRQOL as poorer 
than those with CHD without DS. The variables that were associated with parental 
perception of their child’s HRQOL prior to cardiac intervention included motor developmental 
performance and levels of parenting stress. No variables were found to be significantly 
associated with HRQOL outcomes at either three-month or six-month post-cardiac 
intervention.  
 
The majority of parents experienced clinically significant levels of stress in their parenting 
role prior to cardiac intervention. More than half of the caregivers felt that their child failed 
to meet their expectations. Levels of parenting stress declined significantly post-cardiac 
intervention and over time. Although dysfunction in the parent-child interaction improved 
after cardiac intervention, this continued to be the aspect that contributed most to parenting 
stress. Parents of children with cyanotic and acyanotic heart defects experienced similar 
levels of stress. However, parents of children with CHD with DS tended to continue to 
experienced higher levels of stress than parents of children with CHD without DS after 
cardiac intervention. They found that their children failed to live up to their expectations to a 
greater extent than those with children with CHD without DS after cardiac intervention. 
Variables associated with levels of parenting stress included language developmental 
performance, perceived HRQOL, age of the child at first cardiac surgery and maternal age. 
Parents’ perception of their child’s HRQOL and parenting stress levels were found to be 
closely interlinked, especially prior to cardiac intervention. 
 
The findings will be discussed in more detail and in the context of the published literature in 
Chapter six.  
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CHAPTER 6 
 
DISCUSSION 
 
 
 
The results of this study will be discussed in more detail in this chapter. A discussion of the 
sample size and study attrition will be presented. The sociodemographic, diagnostic 
cardiology and surgical management information will also be discussed.  
 
Each of the main outcomes that were assessed will be discussed in the context of the 
available research, and where indicated, possible reasons for the outcomes and changes 
seen over time will be provided. The most important outcomes for subgroups will be 
discussed briefly. These are to include the outcomes for children with CHD with DS and 
those with cyanotic heart defects. 
 
The strengths of the study and challenges faced during this study, as well as the limitations, 
will be discussed. A number of recommendations for clinical management and future 
research will be presented.  
 
6.1 Recruitment, sample size and study attrition 
 
Recruiting participants into this study posed a challenge at the outset, in part due to the fact 
that cardiac neurodevelopmental follow-up did not form part of standard cardiac care offered 
at the Universitas Academic Hospital Cardiac Unit. This is not a problem unique to cardiac 
clinical practice in SA. Despite routine cardiac neurodevelopmental follow-up being 
recommended as part of standard cardiac clinical care in the AHA guidelines (Marino et al., 
2012), most cardiac centres in developed countries fail to assess neurodevelopment 
routinely as part of standard cardiac care (Brosig Soto et al., 2011). Long et al. (2015) and 
Kendall et al. (2003) similarly reported that cardiac neurodevelopmental follow-up did not 
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form part of routine cardiac care in either Australia or the UK respectively. To date 
longitudinal neurodevelopmental follow-up in children with CHD in developed countries has 
mostly been done in the context of clinical cardiac outcome-based research (Brosig Soto et 
al., 2011).  
 
The fact that cardiac neurodevelopmental follow-up did not form part of standard cardiac 
care at the Universitas Academic Hospital Cardiac Unit resulted in challenges in establishing 
referral and recruitment systems for this study. Medical and nursing personnel in both the 
Cardiology Department and Cardiothoracic Department were unfamiliar with the processes 
involved in performing neurodevelopmental assessment as part of patients’ standard care. 
Putting systems in place to access the surgery lists in advance to identify potential 
participants for inclusion and allowing for sufficient time for recruitment and baseline 
assessment took time. Integrating neurodevelopmental follow-up into routine clinical care, 
both in the ward and busy outpatient clinic setting posed several logistical and time-related 
challenges. Referral systems became more established over time and recruitment into the 
study became easier as collaborative working relationships were established with medical 
and nursing personnel.  
 
Challenges in establishing referral and recruitment systems in a clinical setting where 
cardiac neurodevelopmental follow-up is not well established and does not form part of 
standard cardiac care are not unique to this study. Brosig Soto et al. (2011) reported similar 
challenges in their study done in the US as did Long et al. (2015) in their early developmental 
intervention study done in Australia.  
 
A further challenge in recruiting participants into this study was that all participants had to 
undergo a mandatory comprehensive neurodevelopmental assessment on the BSID-III prior 
to cardiac intervention. Only two neurodevelopmental follow-up studies by Majnemer et al. 
(2009) and Dittrich et al. (2003) have reported including a neurodevelopmental assessment 
prior to cardiac intervention in their research protocols. Their developmental assessments 
were similarly conducted on the day prior to cardiac surgery. Only Majnemer et al. (2009) 
mandated neurodevelopmental assessment prior to surgery. Dittrich et al. (2003) on the 
other hand, reported only being able to perform neurodevelopmental assessment on 68.7% 
of their participants prior to cardiac intervention. 
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Mandating a baseline neurodevelopmental assessment resulted in the exclusion of 
medically unstable and critically ill children and those children having to undergo emergency 
cardiac surgery. This in effect limited the sample size to some extent. Majnemer et al. (2009) 
and Dittrich et al. (2003) also noted similar participant exclusions from their pre-operative 
assessments.   
 
This aforementioned factor may also have resulted in an under-representation of children 
with more severe cardiac defects in the current study sample, as the children who were 
medically unstable or required emergency surgery were most likely to have been those 
children with more severe forms of CHD. 
 
More recently published studies where multiple neurodevelopmental assessments took 
place only assessed participants’ neurodevelopmental status after cardiac intervention 
(Medoff-Cooper et al., 2016; Mussatto et al., 2015; Mussatto et al., 2014; Chock et al., 2012; 
Long et al., 2012a; Sananes et al., 2012; and Joynt et al., 2009). Furthermore, the AHA 
guidelines fail to provide clarity on developmental assessment during infancy in relation to 
cardiac intervention (Marino et al., 2012).  
 
Gaynor et al. (2015) noted that one of the greatest challenges facing cardiac 
neurodevelopmental follow-up studies is that they are limited by small sample sizes and that 
they are usually single centre-based. Even though the sample size in the current study was 
small at 40 participants, recruited over a 17-month period, the participant numbers are still 
comparable with those reported in other neurodevelopmental outcome studies conducted at 
major cardiac centres in developed countries when sample sizes are broken down into the 
average number of participants recruited per annum. Recent cardiac neurodevelopmental 
outcome studies using the BSID-III as the outcome measure recruited between 16 and 32 
participants per annum (Mussatto et al., 2015; Mussatto et al., 2014; Beca et al., 2013; Long 
et al., 2012a; Acton et al., 2011; Brosig Soto et al., 2011).  
 
The attrition rate in the current study was high at 47.5%, yet it remained comparable with 
the rates reported in the literature. Gaynor et al. (2015) highlighted the fact that longitudinal 
cardiac clinical follow-up studies are challenged by loss to follow-up. The reported loss to 
follow-up in multiple assessment neurodevelopmental follow-up studies in the developed 
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world varies considerably. Long et al. (2015) reported a loss to follow-up of 44%. Hoskoppel 
et al. (2010) reported a loss to follow-up of 35% at their second follow-up visit, which 
escalated to 64% by their third follow-up visit. Chock et al. (2012) reported a loss to follow-
up of 43% over the duration of their study. 
 
Despite patients surviving and recovering from cardiac surgery, many require long-term 
follow-up, but adherence with cardiac follow-up has been found to be poor in Africa 
(Tantchou Tchoumi et al., 2011) and in SA (Van Deventer et al., 2015; Lee, 2014). Lee 
(2014) reported a 28.8% loss to follow-up in their study of cardiac patients conducted in 
Cape Town, SA; whilst Van Deventer et al. (2015) reported that the loss to follow-up at a 
tertiary cardiac unit in the Western Cape province of SA was 44%. In a study of cardiac 
patients in Cameroon, Tantchou Tchoumi et al. (2011) reported an early loss to follow-up of 
32%, and a late loss to follow-up of 40%.  
 
In the current study, the attendance rate of follow-up visits at three-month post-cardiac 
intervention was 62.5%, which declined to 55% by the time of the six-month post-cardiac 
intervention follow-up. Loss to follow-up was found to increase over time despite families 
being reminded of follow-up appointments and being remunerated for their travelling 
expenses. A possible reason for the decline in participation over time in this study could 
have been that the six-month follow-up did not always coincide with a routine cardiology 
follow-up appointment. This meant that the attendance of the six-month post-cardiac 
intervention neurodevelopmental follow-up on its own required a special effort on the part of 
the families. Both Hoskoppel et al. (2010) and Tantchou Tchoumi et al. (2011) noted a 
similar decline in adherence with follow-up appointments over time. Tantchou Tchoumi et 
al. (2011) suggested that poverty and the distance that had to be travelled by families to 
access cardiac services discouraged compliance with follow-up appointments. Hoskoppel 
et al. (2010) failed to provide reasons for their loss to follow-up over time.  
 
Reasons for loss to follow-up in the current study were found to be multiple. Mortality 
contributed to study attrition. The mortality rate in the current study was 15%. This aligns 
with the survival rate of 85% for children with CHD reported in current literature (Marino et 
al., 2012; The Lancet, 2012; Hoosen et al., 2010b). 
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Other factors contributed to the loss to follow-up including distance to be travelled to access 
cardiac services, unreliable inter-hospital transport services, financial difficulties on the part 
of families and a lack of understanding of primary caregivers of the importance of 
neurodevelopmental follow-up.  
 
The majority (65%) of the participants in the current study lived more than 100 kilometres 
from the cardiac service point. Long et al. (2015), Steiber et al. (2012) and Kendall et al. 
(2003) all identified that geographical constraints posed a significant challenge to the 
provision of cardiac services post-cardiac intervention in developed countries. These 
authors further suggested that the distance to be travelled to follow-up needed to be 
considered a potential limitation to the implementation of cardiac neurodevelopmental 
programmes, as well as EI programmes. Brosig et al. (2014) and Brosig Soto et al. (2011) 
agreed, that families who lived a considerable distance from the cardiac service point often 
failed to participate in cardiac neurodevelopmental follow-up.   
 
Most families (87.5%) in this study had a low SES, and the costs of travel, as well as parents 
who were employed not wanting to miss work due to the potential loss of income, and 
availability of inter-hospital transport affected adherence to follow-up appointments. Van 
Deventer et al. (2015), Lee (2014), Amakali and Small (2013), Mocumbi et al. (2011) and 
Tantchou Tchoumi et al. (2011) all similarly found that the costs and time associated with 
cardiac follow-up deterred families from complying with follow-up appointments.  Lee (2014) 
reported that in a study done in Cape Town, one-third of the patients lost to cardiac follow-
up resided in distant provinces in SA or in neighbouring countries. Furthermore, Amakali 
and Small (2013) noted that a lack of access to inter-hospital transport made the facilitation 
of follow-up cardiac care difficult in resource-poor settings. 
 
Anecdotally, most parents’ knowledge and understanding of the importance of cardiac 
neurodevelopmental follow-up was found to be lacking in the current study. The reason for 
this could be that cardiac neurodevelopmental follow-up did not form part of routine cardiac 
care, and that parents were not provided with adequate information on the risk CHD poses 
to their child’s developmental outcome (this will be addressed in Chapter seven through the 
development of the family information document and home-based developmental activity 
programme). Mocumbi et al. (2011) and Van Deventer et al. (2015) both commented on the 
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fact that families knowledge and understanding of their child’s health condition influenced 
adherence to follow-up. Brosig Soto et al. (2011) and Long et al. (2015) suggested that the 
decline in post-operative compliance with neurodevelopmental follow-up could be as a result 
of parents feeling that their child was “doing well”, or that the child was seeing a rehabilitation 
therapist closer to home (Brosig Soto et al., 2011). Long et al. (2015) also reported parents 
not attending follow-up as they felt it was “unnecessary”. Brosig et al. (2014) were of the 
opinion that getting the buy-in and commitment of parents to comply with follow-up was 
critical to the success of cardiac neurodevelopment follow-up. 
 
Ten percent of participants were lost to follow-up as they became untraceable, and could 
no longer be contacted via cellular phone at the number provided. Van der Meer and Loock 
(2008) similarly found that the limited methods of distance communication available to most 
South Africans, such as telephone and e-mail services, was an important reason why 
patients were lost to medical follow-up. Ninety percent of South Africans make use of cellular 
phones for communication, with SMS text messaging being the most common form of 
cellular phone use in Africa (Pew Research Centre, 2015). There are still challenges with 
cellular phone communication in Africa as most cellular phone owners are on “pay as you 
go” and frequently change phones and phone numbers. In addition, unreliable network 
coverage, the cost of charging cellular phones, and the purchasing of airtime are still 
considerable hurdles for families with financial constraints, and those residing in rural areas 
(Dobush, 2015).   
 
Confirming follow-up appointments via telephone appears to be problematic not only in 
developing countries. Brosig Soto et al. (2011) also reported that 17% of their study 
participants in the US did not respond to telephone calls and were subsequently lost to 
follow-up. 
 
6.2 Sociodemographic information  
 
The majority of children in the current study were female. Consecutive sampling and the 
relatively small sample size may have contributed to the coincidental gender profile. 
Okoromah et al. (2011) noted the ratio of males to females born with CHD as being 1.4:1. 
In most other comparable neurodevelopmental outcome studies, males were found to be in 
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the slight majority (Medoff-Cooper et al., 2016; Brosig Soto et al., 2011; Beca et al., 2013; 
Mussatto et al., 2014; Acton et al., 2011; Long et al., 2012a). 
 
The results of the current study indicated that 22.5% of the children were born prematurely 
and 25% had a low birth weight. Goff et al. (2011) reported that approximately 15% of 
children with CHD are born either prematurely and/or with a low birth weight. The higher 
prevalence of low birth weight in the current study population could possibly be attributed to 
the low SES of the families and the gestational age of the child (Kader and Perera, 2014; 
Taylor and Sarathchandra, 2014). The low birth weight of children in this study could also 
be the result of growth being restricted in utero due to the abnormal foetal blood flow caused 
by the heart defect (Roman, 2011; Knirsch et al., 2010). 
  
The average gestational age of participants was 38 weeks, with a range of 31 to 41 weeks. 
This compares favourably with the average gestational age reported in other outcome 
studies (Gaynor et al., 2015; Mussatto et al., 2014; Beca et al., 2013; Chock et al., 2012; 
Goff et al., 2011; Simons et al., 2010). 
 
The mean birth weight in this study was 2878.5 grams. The average birth weights in Knirsch 
et al. (2010), Matsuzaki et al. (2010) and Simons et al.’s (2010) studies were under 3000 
grams. However, most of the studies report an average birth weight ranging between 3000 
and 3500 grams (Gaynor et al., 2015; Schaefer et al., 2013; Beca et al., 2013; Chock et al., 
2012; Goff et al., 2011; Bellinger et al., 2009). 
 
The inclusion of premature infants in neurodevelopmental outcome studies is variable. 
Prematurity was considered an exclusion criterion in some studies, whilst other studies 
included children irrespective of gestational age. Both Mussatto et al. (2014) and Brosig 
Soto et al. (2011) reported that 20% of the participants in their respective studies were born 
prematurely. Exclusion of premature infants from some studies may be the result of 
prematurity being considered an independent risk factor for developmental delay (McGowan 
et al., 2011). 
 
The median age of the mothers in this study was 30 years, but ranged from 16 to 43 years. 
The median age of mothers in SA at the age of the birth of their first child is 22.5 years 
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(Statistics South Africa, 2012). There were a large number of mothers over the age of 30 
years, in particular the mothers of children with CHD with DS in this study were found to be 
older with a median age of 37 years.  
 
The level of education for mothers and fathers in this study was low, averaging grade nine 
to 11. According to the General Household Survey (2014), only 28.7% of South African’s 
have attained grade 12 as their highest level of education (Statistics South Africa, 2015). In 
the South African context, black African women are at a disadvantage with regards to 
educational opportunities (Statistics South Africa, 2013). This is in stark contrast with the 
educational attainment of parents reported in outcome studies from developed countries, 
where the level of parental education at a minimum was a high school graduate, with many 
parents reporting some level of tertiary education (Gaynor et al., 2015; Mussatto et al., 2015; 
Acton et al., 2011). 
 
Consistent with the population served by the Universitas Academic Hospital Cardiac Unit, 
the majority of the participants’ ethnicity was black African (75%), followed by mixed race 
(22.5%), and then white (2.5%). The ethnic profile of this study differed from other outcome-
based studies, where the majority of the participants were white. It is important to be 
cognisant of the fact that most of these studies were done in North America and Europe. 
Looking at the study with the largest reported sample of 1770 participants from 22 
institutions, Gaynor et al. (2015) reported that 84% of the cohort in their study was white. 
This would make this the first study where the majority of the sample consisted of black 
African children. 
 
The majority of the parents in this study were from a low socioeconomic class. To the 
contrary, most families represented in CHD outcome-based research done in developed 
countries were from a middle socioeconomic class (Mussatto et al., 2014; Brosig Soto et al., 
2011; Acton et al., 2011). Low levels of education and high rates of unemployment amongst 
parents contributed to the low SES of the families in this sample. In most instances, the 
fathers were the primary breadwinners; however, only 52% reported having full-time 
employment. The employment rate is reflective of the South African economic climate where 
the unemployment rate is high. In 2015, it was reported that 26.4% of potentially 
economically active South Africans were unemployed (ENCA, 2015).  
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The majority of the caregivers were mothers and most did not work outside the home. The 
unemployment rate amongst women in SA remains higher than that of men (Statistics South 
Africa, 2013), which was similar to the findings in the current study. Additional factors that 
may have contributed to the women in this study not working outside of the home may be 
the burden of caring for a child with a chronic health condition. 
 
6.3 Congenital heart disease profile 
 
The profile of the type of CHD, based on the presence or absence of cyanosis in this study, 
was comparable to that reported in the literature (Hanson, 2015; Starr and Tucker, 2005). 
Acyanotic heart defects were diagnosed in 80% of the participants, with cyanotic heart 
defects present in 20% of the participants. There may have been a slight under-
representation of cyanotic heart defects in this study due to the fact that critically ill children 
and those requiring emergency surgery were excluded. These children were more likely to 
have had cyanotic heart defects.  
 
The profile of congenital heart defects in this study sample was comparable to that reported 
in the literature. The most common acyanotic defects reported in the current study sample 
were VSDs, followed by AVSDs and then PDAs (Hanson, 2015; Nousi and Christou, 2010). 
Similarly, the most common cyanotic defects were DORVs and TGAs, followed by TOFs 
(Hanson, 2015; Nousi and Christou, 2010).  
 
The majority of the participants in this study had moderate or moderate to severe CHD. 
Yildiz et al. (2009), who applied the same severity classification system in their study, also 
reported that the majority of the participants in their study had disease of moderate severity. 
However, the current study reported far fewer cases of mild CHD, at only 2.5%, compared 
to the 36.1% reported by Yildiz et al. (2009). In addition, the current study also reported far 
fewer cases of severe CHD at only 2.5%, compared to the 8.1% reported by Yildiz et al. 
(2009).  
 
The low number of children presenting with mild CHD in the current study could be explained 
by the lack of neonatal screening and missed diagnoses in the case of asymptomatic CHD 
in SA as a result of service delivery failures and an overburdened public health system 
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(Brown, 2014; Hoosen et al., 2010a; Hoosen et al., 2010b). In addition, cardiac defects may 
have gone undiagnosed as a result of poverty and low socio-economic status limiting access 
of families to specialist healthcare services (Ataguba et al., 2011), resulting in a large 
number of children with CHD in SA not being diagnosed (Reuters South Africa, 2015). 
 
The low number of children with severe CHD represented in this study could be attributed 
to critically ill and medically unstable children and those requiring emergency surgery being 
excluded. These children would most likely have been those with more severe forms of CHD 
(Gaynor et al., 2015). In addition, children with the severest forms of CHD such as HLHS 
often do not survive long enough in SA to undergo palliation (Brown, 2016). 
 
Twenty-five percent of the participants in this study were diagnosed with a genetic 
comorbidity. In all cases, the genetic abnormality diagnosed was DS. Neurodevelopmental 
outcome studies that included children with genetic comorbidity reported that between 8.7 
and 22% of study participants were diagnosed with a genetic abnormality or syndrome 
(Gaynor et al. 2015; Goff et al., 2011; Brosig Soto et al., 2011).   
 
6.4 Surgical intervention and post-operative medical course 
 
The majority of the participants in this study underwent cardiac surgery in infancy. The 
median age at first surgery was 7.5 months with a mean age of 9.4 (±5.5) months. Most 
children included in neurodevelopmental outcome research underwent their first cardiac 
surgery in early infancy (Gaynor et al., 2015; Mussatto et al., 2015; Mussatto et al., 2014; 
Beca et al., 2013; Long et al., 2012a; Sananes et al., 2012; Brosig Soto et al., 2011; Bellinger 
et al., 2009; Joynt et al., 2009; Majnemer et al., 2009). However, there were isolated studies 
that included participants where the age at first cardiac surgery was over one year (Schaefer 
et al., 2013; Von Rhein et al., 2011; Simons et al., 2010). 
 
The age at first cardiac intervention in this study was older than reported in the majority of 
the outcome studies. Older age at the time of first cardiac surgery could be attributed to 
delayed diagnosis of the child’s CHD. Many children in this study lived in rural areas and 
may not have had access to specialist care. In addition, bottlenecks in the referral system 
and problematic inter-hospital transport services within the public health sector may have 
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resulted in delayed access to care (Van Deventer et al., 2015; Lee, 2014; Robertson, 2006). 
Overburdened cardiac services may also have resulted in children requiring elective surgical 
intervention having to wait for surgery (Hoosen et al., 2010a; Hoosen et al., 2010b). As 
discussed previously, neonates, critically ill children and those requiring emergency surgery 
were excluded from this study. This could also have contributed to the older age of included 
children at the time of first cardiac surgery in this study.  
 
The majority of the participants in this study underwent open-heart surgery with CPB. The 
median duration of CPB in this study was 104 minutes and an average duration of 111.8 
minutes. Considerable variation in CPB time is reported in the literature. Reported median 
CPB duration ranged from 49 minutes to 215 minutes (Mussatto et al., 2015; Mussatto et 
al., 2014; Long et al., 2012a; Von Rhein et al., 2012; Goff et al., 2011; Brosig Soto et al., 
2011; Joynt et al., 2009); whilst the reported average CPB duration ranged from 85 minutes 
to 249 minutes (Mussatto et al., 2014; Beca et al., 2013; Brosig Soto et al., 2011; Acton et 
al., 2011; Hoskoppel et al., 2010; Knirsch et al., 2010; Matsuzaki et al., 2010; Joynt et al., 
2009). It was evident in reviewing these studies that the duration of CBP was longer in 
studies including participants with more severe CHD undergoing complex cardiac surgeries. 
Both the median and average duration of CPB in this study fell within the ranges reported in 
the literature.  
 
The median aorta cross-clamp time in this study was 76 minutes and the average cross-
clamp time was 70.3 minutes. Cross-clamp time was reported less frequently in the 
literature. Median cross-clamp times reported range from 40 minutes to 81 minutes 
(Schaefer et al., 2013; Long et al., 2012a; Long et al., 2012b; Von Rhein et al., 2012; Joynt 
et al., 2009). Whilst average cross-clamp times reported range from 53.6 minutes to 82.3 
minutes (Acton et al., 2011; Joynt et al., 2009; Knirsch et al., 2010). The mean and median 
aorta cross-clamp times in this study fell within the ranges reported in the literature.  
 
The majority of the participants in this study had a cardiothoracic ICU length of stay of one 
week or less. The median cardiothoracic ICU length of stay was six days, and the average 
length of stay was 7.5 days. ICU length of stay ranged between three and 28 days. The ICU 
length of stay in this study is comparable to the ICU length of stay reported in the literature, 
which ranged from two to seven days (Beca et al., 2013; Long et al., 2012a; Von Rhein et 
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al., 2012; Matsuzaki et al., 2010; Simons et al., 2010). 
 
Post-operative hospital length of stay in this study exceeded two weeks in 21.1% of children. 
The median hospital length of stay post-surgery was nine days, with the average hospital 
length of stay 14.7 days. Making direct comparisons with hospital length of stay reported in 
the literature was complicated by the fact that the criteria for calculating hospital length of 
stay varied considerably between studies. Total hospital length of stay from admission was 
also not considered an accurate reflection of a complicated medical course in the current 
study setting, as many of these children may have had an extended period of hospitalisation 
prior to cardiac intervention due to social rather than medical reasons. 
 
Reported median hospital length of stay in the literature ranged between 16 and 43 days 
(Mussatto et al., 2015; Mussatto et al., 2014; Schaefer et al., 2013; Long et al., 2012a; Brosig 
Soto et al., 2011; Joynt et al., 2009); whilst the average reported length of hospital stay 
reported ranged between 18 and 67 days (Mussatto et al., 2014; Acton et al., 2011; Brosig 
Soto et al., 2011; Knirsch et al., 2010; Matsuzaki et al., 2010; Joynt et al., 2009). It is evident 
that both the median and mean hospital length of stay in the current study was shorter than 
the duration of hospital stay reported in the literature. Possible reasons for the difference in 
duration of hospital stay may be attributed to the fact that the other studies included more 
children with severe CHD, which may have required a longer period of hospitalisation both 
before and after surgery due to a complicated medical course. Children represented in 
studies in developed countries may also have been admitted to hospital a few days earlier 
for surgery and kept in hospital slightly longer before being discharged. The overburdened 
healthcare system in SA makes bed capacity a limited resource. Consequently, children are 
discharged from hospital as soon as their medical condition allows (Alper et al., 2016).  
 
 In this study, cardiopulmonary resuscitation was required in 7.5% of children after surgery. 
This is comparable to the reported need for cardiopulmonary resuscitation reported in the 
literature, which ranged from 7 to 8.5% (Beca et al., 2013; Von Rhein et al., 2012). Other 
post-operative complications reported in the current study included respiratory infections, 
wound sepsis and hypoxic brain injury. Majnemer et al. (2009) also reported similar post-
operative complications. 
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From the aforementioned discussion, it can be concluded that the CHD profile and surgical 
outcomes of the children in the current study are similar to those reported in the literature 
for children in developed countries.  
 
6.5 Growth outcomes 
 
6.5.1 Growth outcomes as reflected by z-scores  
 
Growth failure and feeding difficulties are common in children with CHD, especially prior to 
cardiac intervention (Medoff-Cooper et al., 2016). This was affirmed by the findings in the 
current study where the majority of children (68%) had suboptimal growth (z-score < -2) at 
one or more of the time-points of assessment. 
 
In addition, caregivers reported feeding difficulties in a quarter of participants. Feeding 
difficulties in this study could be attributable to CCF, DS and GORD. Similar reasons for 
feeding difficulties in children with CHD were put forward by Medoff-Cooper et al. (2016). 
Formal feeding assessment was not a study objective, and it is very likely that the 
prevalence of feeding difficulties was underreported in the current study. None of the 
children in the current study received supplemental tube feeding prior to cardiac 
intervention, nor were any children discharged home on tube feeds. 
 
Growth was suboptimal in the majority of children in the current study prior to cardiac 
intervention, with 68% presenting with malnutrition. Of the children presenting with 
malnutrition, 43.5% had severe malnutrition. Stunting also occurred in 45% of the children. 
Growth outcomes improved post-cardiac intervention and over the study period. However, 
at six months post-cardiac intervention 40.9% of the children still had malnutrition, and 
36.4% were still stunted. 
 
The prevalence of malnutrition and stunting in children with CHD in developing countries 
has been reported to be high. Okoromah et al. (2011), in a study done in Nigeria, reported 
the prevalence of malnutrition as 90.4% in their study, with 61.2% having severe 
malnutrition. Stunting occurred in 20.5% of participants. Lata et al. (2015), in a study done 
India, reported that 57.3% of their study participants presented with significant growth failure 
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prior cardiac intervention. Vaidyanathan et al. (2008) similarly reported significant growth 
failure in children awaiting cardiac intervention in India. Varan et al. (1999), in their study in 
Turkey, also found malnutrition to be prevalent, with 65.2% of children in their study being 
malnourished and 52% stunted. Reported growth failure in children with CHD in developed 
countries ranges between 20 and 50% (Medoff-Cooper et al., 2016; Costello et al., 2015; 
Irving, 2011).   
 
Rates of growth failure in children in the current study were higher than those reported for 
developed countries, but comparable to the growth outcomes published for children with 
CHD living in developing countries. Reasons for growth failure in the current study are 
similar to those reported in other studies done in developing countries, and are related to 
both SES and level of maternal education. Walker et al. (2007) suggested that poverty was 
associated with growth failure in children in developing countries, estimating that a third of 
children younger than five years in developing countries had growth retardation or stunting. 
In support of the aforementioned conclusion Amakali and Small (2013) similarly found that 
in Namibia the low SES of families of children with CHD, and low levels of maternal 
education, resulted in a lack of knowledge regarding a suitable cardiac diet. Insufficient 
financial resources also resulted in caregivers being unable to purchase adequate foods of 
high nutritional value. Undiagnosed and untreated feeding dysfunction may also have 
contributed to growth failure in the current study (Medoff-Cooper et al., 2016).  
 
Vaidyanathan et al. (2008) also suggested that growth failure prior to cardiac intervention in 
children with CHD could also be attributed to haemodynamic factors related to the CHD, the 
presence of CCF, recurrent respiratory infections, reduced potential for growth (low birth 
weight) and older age at corrective surgery. Similar contributing factors were identified in 
the current study prior to cardiac intervention. Participants in the current study were not 
operated on in the neonatal period, 55% of the participants presented with CCF, 62.5% of 
the participants were hospitalised with respiratory-related illnesses prior to cardiac 
intervention and 25% had low birth weights. 
 
Daymont et al. (2013) reported decreased growth trajectories for weight, height, as well as 
head circumference, identifying that children with CHD were more likely to present with 
microcephaly. Twenty-five percent of the participants in the current study had z-scores for 
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head circumference-for-age of lower than -2 prior to cardiac intervention. Possible reasons 
for the poor head circumference growth in the children in the current study could include 
malnutrition, genetic comorbidity and the cardiac disease itself. Reports on the prevalence 
of microcephaly in children with CHD before cardiac intervention vary in the literature, and 
ranges from 8 to 36% (Marino et al., 2012; Brosig Soto et al., 2011; Goldberg et al., 2011; 
Long et al., 2011; Hoskoppel et al., 2010; Majnemer et al., 2009). The occurrence of 
microcephaly in the current study was within the range reported in the literature. The 
prevalence of microcephaly declined over the study period, and by the six-month post-
cardiac intervention 13.6% of the children still presented with microcephaly. Majnemer et al. 
(2009) similarly reported that microcephaly continued to persist in some children after 
cardiac intervention.  
 
6.5.2 Change in growth outcomes over time  
 
In the current study, growth outcomes improved post-cardiac intervention and over time. 
There was a significant positive change in weight (p= 0.04) and head circumference (p= 
0.02) from baseline to the six-month post-cardiac intervention. By the six-month post-cardiac 
intervention, median and mean z-scores for all growth parameters fell within the acceptable 
range. However, complete catch-up growth had not yet occurred by the six-month post-
cardiac intervention, as mean and median z-scores for all growth parameters still fell below 
the 50th percentile. In addition, 31.8% of the children still presented with severe malnutrition 
at the six-month post-cardiac intervention.  
 
Daymont et al. (2013), Knirsch et al. (2010) and Vaidyanathan et al. (2008) similarly reported 
that significant catch-up growth took place after cardiac surgery. Daymont et al. (2013) also 
established that despite significant catch-up growth, complete catch-up growth had not yet 
taken place by 36 months of age in children requiring cardiac intervention, indicating a 
sustained decrease in the growth trajectories in children with CHD when compared to their 
healthy same-aged peers. 
 
Several authors reported growth failure in children with CHD post-cardiac intervention, as 
was the case in the current study. Brosig Soto et al. (2011) reported growth failure to be 
considerably more than expected post-cardiac surgery, reporting malnutrition in 22.1% and 
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stunting in 15.9% of their study participants. Medoff-Copper et al. (2016) noted that 30% of 
their participants presented with growth failure at three-month post-cardiac intervention. 
Mussatto et al. (2014) reported that 54% of their study participants presented with growth 
failure at any of their visits. Vaidyanathan et al. (2008) noted that despite improvement in 
growth post-cardiac intervention 59% of the children in their study were found to be 
malnourished and 24.2% stunted. Malnutrition and stunting were found to be severe in 
27.7% and 24.2% of cases respectively. 
 
6.5.3 Relationship between growth and neurodevelopmental outcomes 
 
Growth (weight) prior to cardiac intervention was significantly associated with motor 
developmental outcome before cardiac intervention (p= 0.04) in the current study. However, 
growth was not found to be strongly associated with neurodevelopmental outcome after 
cardiac surgery at either three-month or six-month post-cardiac intervention. Growth failure 
has been identified as a risk factor for poor developmental outcome (Lata et al., 2015; Irving, 
2011). The strong association between growth failure and motor developmental outcomes 
before cardiac intervention in the current study could be explained by the fact that 
malnutrition was most profound prior to cardiac intervention and was likely to have resulted 
in muscle weakness and a lack of energy required by these children for typical age–related 
developmental activities. Children were likely to tire easily and this may have negatively 
affected the achievement of age-appropriate motor milestones before cardiac surgery. Long 
et al. (2011) cited similar reasons for the lack of achievement of gross motor milestones in 
their study on the motor developmental outcomes of children with CHD.  
 
Knirsch et al. (2010) found that the pre-operative weight was not associated with 
neurodevelopmental outcome post-cardiac intervention at one year of age, which is in line 
with the findings in the current study. Medoff-Cooper et al. (2016) contradicted these 
findings, reporting a significant association between growth after cardiac intervention before 
the age of 30 days and neurodevelopmental outcomes at both six months and twelve 
months of age post-cardiac intervention. The difference in findings could possibly be 
attributed to the fact that the study sample of Medoff-Cooper et al. (2016) contained 
considerably more children with single ventricle physiologies. This is consistent with the 
report by Ravishankar et al. (2013) from the Paediatric Heart Network Infant Single Ventricle 
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Trial where growth in the first year of life was associated with neurodevelopmental outcomes 
at 12 months of age.  
 
6.6 Neurodevelopmental outcomes 
 
Developmental outcomes in the current study will only be directly compared to studies that 
made use of the BSID-III as their measure of neurodevelopmental outcome. It is 
acknowledged that there are only a limited number of neurodevelopmental outcome studies 
that can be used for direct comparison. Where indicated broader comparisons will be made 
to neurodevelopmental outcomes established by other measures. 
 
6.6.1 Developmental performance on the BSID-III 
 
The median age of participants at baseline was 7.4 months (mean age of 9.2 ± 5.4 months) 
and by the six-month post-cardiac intervention assessment 15 months (mean 16.7± 6.4 
months). The age of participants and the time points of neurodevelopmental assessment in 
other comparable neurodevelopmental outcome studies varied considerably. The average 
age of children at assessment ranged from 7.2 to 27.6 months (Alsaied et al., 2016; 
Mussatto et al., 2015; Mussatto et al., 2014; Beca et al., 2013; Long et al., 2012a; Acton et 
al., 2011; Brosig Soto et al., 2011; Visootsak et al., 2011). 
 
Mean composite cognitive, language and motor scores in the current study were below one 
SD (score <85)  from the test mean subscale score of 100  across all three subscales of the 
BSID-III, at all three of the time points of assessment, apart from the language subscale at 
baseline and three-month post-cardiac intervention. Mean composite scores in this study 
across the three time points of assessment ranged between 83.4 and 84.9 (with scores 
ranging between 55 and 130) for the cognitive subscale, 83.4 and 90.5 (with scores ranging 
between 50 and 115) for the language subscale, and 79.5 and 84.3 (with scores ranging 
between 46 and 121) for the motor subscale. It is evident from the wide range of composite 
scores on all three subscales that there was considerable variation in the developmental 
performance of the children in the current study. Similarly Mussatto et al. (2015) and Acton 
et al. (2011) reported a wide variation in developmental performance of children with CHD 
despite them having similar clinical backgrounds. It must also be acknowledged that there 
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is considerable variability in skill acquisition in typically developing children, perhaps further 
suggesting that this variation in developmental outcome may be magnified in children with 
CHD (Snookes et al., 2010).  
 
Comparing mean composite scores in the current study with those reported in the literature, 
Brosig Soto and colleagues (2011) in their study in the US reported mean composite 
cognitive scores of 100.8 ±11.9, language scores of 96 ±12.7, and motor scores of 88.6 
±18.6. They included participants with genetic comorbidity, and developmental assessment 
took place in infancy. Children in their study scored higher mean composite scores across 
all developmental domains compared to the children in the current study.  
 
Acton and colleagues (2011) in their study in Canada, reported mean composite cognitive 
scores of 95.9 ±14.1, language scores of 90.8 ±18.1 and motor scores of 93.7 ±14.2. Their 
study excluded children with genetic comorbidity. Children in their study also scored higher 
mean composite scores across all developmental domains compared to the children in the 
current study. 
 
Beca and colleagues (2013), in their study in New Zealand, reported mean composite 
cognitive scores of 94 ±15, language 94 ±16, and motor 97 ±12 Their study excluded 
children with genetic comorbidity. Participants were nearing two years of age in their study 
at the time of their assessment. Similar to the finding in the current study, language scores 
were lowest in their study at the six-month post-cardiac intervention where children were 
older. Children in their study also scored higher mean composite scores across all 
developmental domains compared to the children in the current study. 
 
Long and colleagues (2012a), in their study in Australia, failed to report specific mean 
composite score values, but reported median composite cognitive score of 105 (with a range 
of 65 to 105), and language score of 106 (with a range of 65 to135). Motor composite scores 
were not reported. However, it was noted that the median composite scores for all three of 
the subscales of the BSID-III were within one SD of the test mean, which is similar to the 
findings noted in the aforementioned studies. More than 80% of their study participants 
scored within the normal limits on each of the three subscales of the BSID-III. Their study 
excluded children with genetic comorbidity. Participants were nearing two years of age in 
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their study at the time of assessment. Median scores here were higher than the mean scores 
reported in any of the other studies. Children in their study scored higher mean composite 
scores across all developmental domains compared to the children in the current study. 
 
The current study and studies by Mussatto et al. (2015) and Mussatto et al. (2014) were the 
only studies where multiple assessments were performed with at least three assessments 
on the BSID-III. The studies by Mussatto et al. (2015) and Mussatto et al. (2014) however 
only reported categories of outcome, and no specific mean composite scores for these 
samples were reported. They did however indicate that the children in their study with CHD 
had stable developmental trajectories with performance in the low average range. This 
would also mean that children in the current study’s developmental performance was poorer 
across all developmental domains. 
 
It is important to highlight that children in the current study consistently attained lower scores 
for cognition, language and motor performance than reported in any of the other studies  on 
the BSID-III However, mean composite scores reported in most of the other studies need to 
be interpreted with caution as most of these studies excluded participants with genetic 
comorbidity. Mussatto et al. (2015), Mussatto et al. (2014) and Brosig Soto et al. (2011) 
included children with CHD with genetic comorbidity and reported them to score significantly 
lower across all subscales of the BSID-III when compared to children with CHD without 
genetic comorbidity. It would therefore stand to reason that including children with genetic 
comorbidity in one’s sample would most likely lower the mean composite scores across all 
developmental domains. It therefore makes only the mean composite scores reported in the 
study by Brosig Soto and colleagues (2011) truly suitable for direct comparison. Even if the 
BSID-III scores of the current study are exclusively compared to those reported by Brosig 
Soto et al. (2011), mean composite scores across all of the three subscales of the BSID-III 
in the current study are still lower. A valid conclusion can therefore be drawn that the 
developmental performance of children with CHD in SA is poorer than that of children in 
developed countries. 
 
Poorer developmental performance across all domains of development would suggest that 
other factors, apart from the cardiac disease itself and the treatment thereof, contributed to 
the developmental outcome of the children in this sample. As no comparative BSID-III 
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outcome data is available for children with CHD in developing countries, the difference in 
outcomes are most likely attributable to factors widely reported in the literature to have a 
detrimental effect on childhood development in developing countries.  
 
It is therefore plausible to consider that low SES and poverty, malnutrition, low levels of 
maternal education and increased levels of parenting stress contributed to the extent of the 
developmental delays in the children in the current study. This aligns with the multiple risks 
identified by Grantham-McGregor et al. (2007) and Walker et al. (2007) in The Lancet (2007) 
series on childhood development in developing countries. This view is strengthened by a 
recent publication by Sena Leal and colleagues (2016) who found that low levels of maternal 
education and low SES negatively impact the motor development in children with CHD in 
Brazil.  
 
Intrinsic and individual characteristics’ of the child such as genetic make-up, motivation 
personality and gender, could also have had an impact on the development of the children 
in the current study (Aubert, 2015; Rademeyer and Jacklin, 2013). Although none of the 
children in this study were known to be HIV-positive the HIV-status of nearly a third of the 
children was unknown. It is possible that there were children with undiagnosed HIV co-
infection in the current sample. It would therefore be important to note that HIV infection 
could have contributed to the extent of the developmental delays in this sample. HIV-
infection in infancy can lead to encephalopathy and an increased risk of developmental 
delays (Rademeyer and Jackline, 2013; Potterton et al., 2010; Baillieu and Potterton, 2008; 
Walker et al., 2007).  
 
6.6.2 Prevalence of developmental delays 
 
In the current study, 59% of the children scored below one standard deviation of the mean 
(score < 85) on at least one of the BSID-III subscales across the study period, indicating 
that they were either at risk of, or presented with developmental delays. Prior to cardiac 
intervention, 35% of the children in the current study presented with a developmental delay 
(score <70) in at least one area of development, and by the six-month post-cardiac 
intervention this had declined to 27.3%. There were however several participants who 
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presented with delays in more than one area of development both before and after cardiac 
intervention.   
 
The number of children at risk and those presenting with developmental delays in the current 
study sample was high when compared to the prevalence of developmental delays in 
healthy children, which is estimated at around 16% (Mussatto et al., 2014). Reports on the 
prevalence of developmental delays in children with CHD vary considerably. The variable 
prevalence could in part be accounted for by the varying criteria used to classify 
developmental delay, as well as the heterogeneity of the study samples and different 
methodologies used in the research studies. The current study made use of the criteria set 
out in the BSID-III manual where scores of 70-84 were considered to be “at risk” and scores 
less than 70 were considered as “delayed”. Mussatto et al. (2015) and Mussatto et al. (2014) 
reported using a similar classification system for identifying children in need of EI referral. 
  
Mussatto et al. (2014) reported a high prevalence in their study cohort of children being 
either at risk of, or presenting with delayed development, finding 75% of their participants 
had scored less than one standard deviation from the test mean; whilst Mussatto et al. 
(2015) reported delayed development in at least one domain in 34% of their study 
participants. Brosig Soto et al. (2011) reported that 44% of their participants scored below 
one standard deviation of the test mean on at least one of the Bayley subscales. Long et al. 
(2012a) found that only 19.1% of their participants scored below one standard deviation of 
the test mean in at least one area of development. The prevalence of children at risk of and 
those with developmental delays in the current study fell within the range reported in the 
literature, and was similar to that reported by Mussatto et al. (2015) and Mussatto et al. 
(2014) using the same classification system.  
 
In the current study, developmental delays were mild to moderate in nature in most cases; 
however, severe delays were noted in some children, most especially in those with DS. The 
nature of the developmental delays were similar to reports by Mussatto et al. (2015) and 
Long et al. (2012a).  
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6.6.3 Developmental profile  
 
The area of weakest developmental performance was motor development, followed by 
cognitive development. Language development was found to be within the norm for age 
prior to cardiac intervention. The current study’s findings regarding the nature of the 
developmental delays were consistent with those reported in the literature (Long et al., 2015; 
Mussatto et al., 2014; Tabbutt, 2013; Sananes et al., 2012; Long et al., 2012a; Long et al., 
2012b; Snookes et al., 2010).  
 
Poor motor performance prior to cardiac intervention in the current study could be attributed 
to muscle weakness due to malnutrition, hypotonia, cardiovascular compromise, 
immobilisation, maternal overprotection and DS. Long et al. (2011) noted similar risk factors 
for gross motor dysfunction in their study. As also suggested by Long et al. (2012b), 
cardiovascular compromise likely limited the physical endurance of the children in the 
current study compromising their gross motor skill acquisition.  
 
Motor development was found to improve over time and after cardiac intervention in the 
current sample of children. This was also consistent with the findings of Mussatto et al. 
(2014) and Hoskoppel et al. (2010). Possible reasons for the improvement in motor 
performance post-cardiac intervention could include improved strength due to increased 
activity and growth catch-up, resolution of the hypotonia, improved cardiovascular 
endurance, and less maternal over-protection.  
 
Cognitive function was relatively unimpaired in the younger children in the current study, 
which was similar to the finding of Hoskoppel et al. (2010). The profile of the developmental 
problems in the current sample changed over time. Cognitive, but especially language, 
performance of children in this sample declined over time and with increasing age. This 
compared to the findings of Mussatto et al. (2014), Long et al. (2012a), Acton et al. (2011), 
and Brosig Soto et al. (2011). Increasing language skill complexity with age could provide 
an explanation for this finding in current as well as in the other studies.  
 
Long et al. (2015) and Mussatto et al. (2014) raised a valid concern over the predictive value 
of early developmental findings of later developmental outcomes based on the changing 
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developmental expectations. Based on the findings in the current study one would have to 
agree as the developmental profile of the children in this study clearly changed over time 
and with increasing age.  
 
Similar patterns of developmental delay were reported in studies using the BSID-II. Medoff-
Cooper et al. (2016), Gaynor et al. (2015), Sananes et al (2012), Hoskoppel et al. (2010), 
Matsuzaki et al. (2010) and Snookes et al. (2010) all noted that motor delays were more 
prevalent than cognitive and language delays in young children with CHD. In most instances, 
the delays noted were mild in severity. Long et al. (2012b) found that up to 62% of children 
with CHD had atypical gross motor development in the first year of life. Sananes et al. (2012) 
similarly noted an improvement in motor performance over time. 
 
Outcomes established by measures other than the BSID also reported that motor delay was 
greater than cognitive delay in young children with CHD (Lata et al., 2015; Chock et al. 2012; 
Majnemer et al., 2009).   
 
It can therefore be concluded that the developmental profile of the children in the current 
study was similar to that of children with CHD in developed countries. 
 
6.6.4 Gross motor developmental performance in prone 
 
The median age of 7.4 months of the children in the current study at the time of their first 
cardiac surgery resulted in prone development being of particular interest as typically 
developing children would start to crawl between the ages of seven and nine months 
(Bayley, 2006a). Twenty-three participants (57.5%) exhibited delayed prone development, 
especially concerning crawling. Of the participants with delayed prone development, a 
median sternotomy was used as the surgical access route in 78.3% of these children. 
Development in prone was delayed in all of the children with DS in this study.  
 
Only Long et al. (2012b) have specifically investigated gross motor development outcomes 
in young children with CHD who have undergone cardiac surgery in infancy. They reported 
atypical gross motor development in 62% of the children in their study during the first year 
Development, HRQOL and burden of care of young children with CHD  
__________________________________________________________________________ 
 
 
__________________________________________________________________________                        
234 
 
of life. Unfortunately, no descriptive information was provided on the attainment of specific 
milestones or functioning in the various developmental positions.  
 
A possible explanation for delayed prone development could be that parents may have failed 
to place their children in prone due to respiratory compromise and fear. Post-cardiac surgery 
sternal precautions are limiting and often parents are uninformed of when they can start 
placing their child in prone again following cardiac surgery. Even when safe to do so, 
discomfort and irritability of the child when placed in prone may have prevented parents from 
placing their child in this position. Long et al. (2011) agreed, having found that pain sensitivity 
and discomfort over the sternum after open-heart surgery resulted in the failure to position 
infants with CHD in prone, resulting in delayed acquisition of motor milestones. 
 
Motor development may also have been influenced by cultural practices (Rademeyer and 
Jacklin, 2013; Angulo-Barroso et al., 2011) African cultural practices such as carrying a baby 
on the mother’s body may have influenced the time these children spent in prone. According 
to Russel et al. (2009) nearly three-quarters of the African babies in their study spent less 
than 10 minutes awake time in prone each day. Although cultural differences are well 
accepted for gross motor development, it is suggested gross motor milestones requiring 
more coordination and greater motor control, such as crawling, are least affected by cultural 
practiceces (WHO Multicentre Growth Reference Study Group, 2006). Despite cultural 
practices precocity of motor development has been reported in African cultures (Angulo-
Barroso et al., 2011). Rademeyer and Jacklin (2013) found that typically developing black 
African urban infants in Gauteng, South Africa, performed better than their American peers 
on the BSID-III. Their findings support previous claims of African infant developmental 
precocity. 
 
Despite the lack of information on specific gross motor milestone outcomes, prone is 
considered an extremely important developmental position. The value of “tummy time” and 
achieving developmental milestones in prone in children with CHD was affirmed by Long et 
al. (2015), who used age-inappropriate prone development as a criteria for referral to EI 
physiotherapy services.   
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6.6.5 Significant neurological sequelae  
 
In the current study, one participant suffered a thrombotic stroke post-cardiac surgery 
resulting in a dense left hemiplegia. This significantly impaired developmental performance 
across all areas post-cardiac intervention. Long et al. (2015) and Beca et al. (2013) reported 
similar findings.  
 
6.6.6 Qualification for access to early intervention services based on developmental 
performance 
 
BSID-III scores can be used to identify children who would qualify for EI services. This 
criterion for determining eligibility for EI services is applied in clinical practice in developed 
countries, and is recommended in the AHA guidelines on the management of development 
in children with CHD (Mussatto et al., 2014; Marino et al., 2012; Brosig Soto et al., 2011). 
Children who score below one SD of the test mean on any of the BSID-III subscales 
(cognitive, language and motor) would qualify for referral to the appropriate EI services. This 
would therefore include children at risk of- and those presenting with developmental delays 
(Mussatto et al., 2014; Brosig Soto et al., 2011).   
 
It was determined that 59% of the participants in the current study would qualify for EI 
services based on the set criteria; with 42.5% requiring OT, 59% ST, and 55% PT services. 
In many instances, children would need to access multiple therapy services to address 
concerns in more than one area of development.  
 
Parents in the current study were asked to report on the referral to, and accessing of EI 
services. Several children were referred to EI services based on their developmental 
performance. It was determined that 37.5% had been referred to, or were accessing EI 
services to address identified developmental delays. Twenty percent had been referred to 
PT, 25% to OT, and 7.5% to ST services.  
 
The identified need for and access to EI services for children with CHD varied in the 
literature. Brosig Soto et al. (2011) reported that 51.6% of children in their study were 
accessing EI services. Hoskoppel et al. (2010) reported a referral rate of 54% to EI services. 
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Kendall et al. (2003) and Lewin et al. (2002) noted that the rehabilitation needs were being 
discussed in only 41% of children with CHD in the UK. Mussatto et al. (2014) noted that 74% 
of children in their study had or were receiving EI services.  
 
In the current study, 80% of the children with CHD with DS were accessing EI services, 
which in most cases was only OT. Brosig Soto et al. (2011) reported that in their study 100% 
of children with CHD with genetic comorbidity were accessing EI services. A possible 
explanation for the disparity in the accessing of EI services between children with CHD 
without and with genetic comorbidity (such as DS) could be explained by the fact that the 
developmental needs of children with DS, as was also shown in the current study, are 
greater. The specific developmental needs of children with DS are perhaps also better 
known to healthcare professionals, and referral systems and services for children with DS 
are better established within the healthcare sector than those for children with CHD without 
DS.  
 
Applying the same criteria for the accessing of EI services as applied in developed countries 
assisted in quantifying the need for EI services in the current study population in central SA. 
Even developed countries with considerable healthcare resources such as the US have 
reported that EI programmes are extremely costly to run and that current staffing levels 
cannot meet the service needs (Johnson et al., 2014; Rosenberg et al., 2013; Brosig Soto 
et al., 2011).  
 
Children with CHD and their families in SA are likely to face several barriers in accessing EI 
services. In developing countries there is insufficient health funding to provide adequate 
services (WHO, 2015). Furthermore, human resources for the provision of rehabilitation 
services are often a neglected component of healthcare services in developing countries, 
despite the considerable need based on the burden of disease (Gupta at al., 2011). There 
is also a significant disparity in access to rehabilitation services between the public and 
private healthcare sector in SA (Mars, 2011). 
 
Mars (2011) reported in the South African public health sector there are 2.5 physiotherapists 
and two occupational therapists per 100 000 people. Similarly, speech therapists are also 
in short supply (Republic of South Africa, 2014). There is a significant disparity in access to 
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rehabilitation services between the public and private healthcare sector in SA. In the private 
health sector, there are 53 physiotherapists and 30 occupational therapists per 100 000 
people served respectively; this being similar to ratios reported in developed countries 
(Mars, 2011). 
 
6.6.7 Change in developmental outcomes over time  
 
There were no significant changes noted in neurodevelopmental outcomes before and after 
cardiac intervention and over time (by three-month and six-month post-cardiac intervention) 
in the current study. Motor performance tended to improve over time and post-cardiac 
intervention, whereas cognitive and language performance tended to decline. Reasons for 
the lack of significant changes seen in developmental outcome over the study duration could 
be attributed to the relatively short time frame of the follow-up of only six-months and the 
relatively small sample size. A further reason could be that the developmental trajectory of 
most of the participants continued to be average or slightly below average over the duration 
of the study. This is in line with the reported average developmental trajectories over time 
by Mussatto et al. (2015).  
  
6.6.8 Variables associated with neurodevelopmental outcomes 
 
Disease severity was found to be significantly (p= 0.02) associated with cognitive 
development prior to cardiac intervention. This is similar to the findings in the literature as 
reported by Gaynor et al. (2015), Mussatto et al. (2015), Marino (2013), Martinez-Biarge et 
al. (2013), Long et al. (2012b), Sananes et al. (2012), Tabbutt et al. (2012), Goldberg et al. 
(2011), Long et al. (2011), Hoskoppel et al. (2010) and Simons et al. (2010). They all 
indicated the more severe forms of the disease were associated with poorer cognitive 
development. 
 
Age at first surgery was found to be significantly associated with language development 
prior to cardiac intervention (p< 0.001) and at three-month post-cardiac intervention 
(p=0.04). The majority of children in this study underwent their first cardiac surgery in infancy 
at a median age of 7.5 months. These findings are in agreement with the literature, indicating 
that cardiac surgery in infancy is associated with poorer developmental outcomes (Gaynor 
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et al., 2015; Marino, 2013; Marino et al., 2012; Long et al., 2011; Donofrio and Massaro, 
2010; Snookes et al., 2010; Majnemer et al., 2009; Dittrich et al., 2003). To the contrary 
Mussatto et al. (2014) did not report age at first open-heart surgery to be significantly 
associated with developmental outcome. No clear reason could be established to explain 
the difference in their reported finding. 
 
In the current study, a diagnosis of DS in addition to CHD was found to be significantly   
(p<0.001) associated with poorer developmental outcome across all developmental 
domains, both before and after cardiac intervention. These findings are consistent with 
reports in the literature that indicate that the presence of a genetic abnormality is a significant 
and independent risk factor for adverse neurodevelopmental outcome in children with CHD 
(Alsaied et al., 2016; Medoff-Cooper et al., 2016; Gaynor et al., 2015; Mussatto et al., 2015; 
Naguib et al., 2015; Mussatto et al., 2014; Martinez-Biarge et al., 2013; Marino et al., 2012; 
Tabbutt et al., 2012; Brosig Soto et al., 2011; Goldberg et al., 2011; Long et al., 2011; 
Visootsak et al., 2011; Fuller et al., 2009; Joynt et al., 2009). 
 
Growth (weight) was found to be significantly associated (p= 0.04) with motor development 
prior to cardiac intervention. The association between growth retardation and gross motor 
development can be explained by the same reasons put forward by Long et al. (2011) in 
that children presenting with malnutrition are also likely to be too tired and too weak, and 
have too little energy to engage in typical age-appropriate developmental activities, which 
then results in the delayed acquisition of motor skills. Similarly, Medoff-Cooper et al. (2016), 
Mussatto et al. (2015), Lata et al. (2015), Ravishankar et al. (2013), Brosig et al. (2014) and 
Long et al. (2011) all reported growth failure to be associated with poorer developmental 
outcomes, especially prior to cardiac intervention. Similar to Knirsch et al. (2010) and 
Mussatto et al. (2015), the current study found that growth (weight) was not significantly 
associated with developmental outcome after cardiac intervention and over time. This could 
be explained by the significant catch-up growth that occurred post-cardiac intervention in 
the children in the current study.  
 
In the current study, maternal age was found to significantly associated with cognitive 
development (p=0.01) and motor development (p<0.001) before and after cardiac surgery, 
and over time. Maternal age has not previously been reported in the literature as a risk factor 
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for poorer neurodevelopmental outcome. The association between older maternal age and 
poorer developmental outcome in the current study could be explained by the fact that 
children with the poorest developmental outcome were those with DS. The mothers of the 
children with CHD with DS in the current study tended to be older than the mothers of the 
children with CHD without DS. In addition, the association may not have previously been 
made, because the majority of the outcome-based studies excluded children with genetic 
abnormalities. 
 
The level of maternal education, which may also serve as a proxy for SES, showed a near 
significant (p=0.05) association with cognitive development after cardiac intervention in the 
current study. This would be consistent with the findings by Gaynor et al. (2015), Mussatto 
et al. (2015), Tabbutt et al. (2012) and Majnemer et al. (2009) who found lower levels of 
maternal education to be associated with poorer cognitive development. Low levels of 
maternal education and poor SES could negatively affect cognitive development through 
the lack of suitable stimulation in the home environment and lack of responsive parenting 
(Engle et al., 2007; Walker et al., 2007). To the contrary, Mussatto et al. (2014) found the 
level of maternal education and SES not to be a strong predictor of developmental outcome. 
The finding of Mussato et al. (2014) could possibly be explained by the fact that the majority 
of their study participants came from a middle-class or affluent communities, and parents 
were generally well educated. The lack of variability in SES in their study might not have 
reflected the impact of low SES and low levels of maternal education on developmental 
outcome. 
   
In the current study, SES itself was not found to be significantly associated with 
developmental outcome. These findings are contrary to the findings of Gaynor et al. (2015), 
Mussatto et al. (2015), Naguib et al. (2015), Sarrechia et al. (2015), Sananes et al. (2012), 
Tabbutt et al. (2012), Von Rhein et al. (2011) and Majnemer et al. (2009) who all found lower 
SES to be associated with worse developmental outcomes. The lack of association shown 
between SES and developmental outcome in the current study could perhaps be attributed 
to the fact that almost all families were from the same socioeconomic class (low class). Thus 
the true impact of varying SES could not be captured in the current study sample. 
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Increased cardiac ICU length of stay, increased duration of mechanical ventilation, and 
increased hospital length of stay served as proxy for a complicated medical disease course. 
None of the aforementioned factors were found to be significantly associated with 
developmental outcome in the current study. This is contradicted by the findings of Medoff-
Cooper et al. (2016), Mussatto et al. (2015), Ravishankar et al. (2013), Long et al. (2012b), 
Marino et al. (2012), Sananes et al. (2012), Von Rhein et al. (2012) and Long et al. (2011) 
which indicated that a prolonged hospital length of stay and a complicated medical course 
were associated with worse developmental outcomes. It is important to note that these 
studies included a high proportion of children with cyanotic heart defects, and many included 
complex lesions involving single ventricle physiologies. The contradictory findings may 
therefore be explained by the fact that the majority of the children in the current study had 
acyanotic lesions and disease severity in most cases was moderate. It is therefore 
reasonable to conclude that the children in the current study were less likely to have followed 
a complicated medical course requiring prolonged ICU and hospital length of stay.  
 
Duration of CPB was also not found to be significantly associated with developmental 
outcome in the current study. This is contradicted by the findings of Mussatto et al. (2015), 
Mussatto et al. (2014), Marino et al. (2012), Sananes et al. (2012), Tabbutt et al. (2012), 
Bellinger et al. (2011), Hoskoppel et al. (2010) and Simons et al. (2010) which indicated that 
a longer duration of CBP was associated with worse developmental outcome. A possible 
explanation for the contrasting findings could be that the aforementioned studies included a 
large number of children with severe disease who were likely to require complex cardiac 
surgeries and longer durations on CPB than the children in the current study.  
  
The current study did not find gestational age at birth or birth weight to be significantly 
associated with developmental outcome. To the contrary, Chock et al. (2012), Sananes et 
al. (2012) and Goff et al. (2011) all noted prematurity and low birth weight to be associated 
with worse developmental outcomes. Both Gaynor et al. (2015) and Mussatto et al. (2014) 
similarly found that gestational age was not strongly associated with neurodevelopmental 
outcome. A possible explanation for the contradictory findings could have been the varying 
patient profiles of the children included in the aforementioned studies. The birth weight and 
gestational age at birth of most the children in the current study were within the normal 
range, perhaps explaining the lack of association between these variables and 
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developmental outcome. 
 
Gender was not found to be strongly associated with developmental outcome in the current 
study. Few studies have reported on the association of gender with developmental outcome; 
however, Gaynor et al. (2015), Sananes et al. (2012) and Majnemer et al. (2012) reported 
that male gender was associated with poorer developmental outcome, especially relating to 
cognitive and fine motor skills. The difference in findings in the current study could potentially 
be explained by the small sample size and the fact that there were more female than male 
participants.  
 
6.7 Neurological findings 
 
Hypotonia was the only significant abnormal neurological finding in the current study. This 
was consistent with reports in the literature by Lata et al. (2015), Majnemer et al. (2009) and 
Limperopoulos et al. (2000). 
 
Forty-five percent of the participants in the current study presented with hypotonia at 
baseline and at three-month post-cardiac intervention. This was comparable with Marino et 
al., (2012), Tabbutt et al. (2012), Donofrio et al. (2011) and Majnemer et al. (2009) who all 
reported the prevalence of abnormal neurological finding to range between 36 and 52% prior 
to cardiac intervention. A possible explanation for the tendency of the hypotonia to resolve 
over time could be that the hypotonia in most cases was secondary to muscle weakness 
that resulted from the considerable under-nutrition of most participants prior to cardiac 
intervention. The resolution of hypotonia in participants in the current study coincided with 
considerable improvements in growth status (weight) and motor development post-cardiac 
intervention, would support this hypothesis.  
 
All children in the current study with CHD with DS presented with marked hypotonia over 
the duration of the study (Refer to 6.10.3) 
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6.8 Parents’ perception of health-related quality of life 
 
Very few studies have been done to establish HRQOL in toddlers, and even fewer in infants 
with CHD, which somewhat limits comparisons with the published literature. Findings from 
the current study will not be compared to the HRQOL outcomes of older children and 
adolescents, as age and developmental stage influence HRQOL, thus making these findings 
unsuitable for comparison.  
 
6.8.1 Parents’ perception of HRQOL outcomes as reflected by the PedsQL® scores  
 
6.8.1.1 Health-related quality of life outcomes for children younger than two years 
 
Parents’ perception of the HRQOL outcomes of children under the age of two years in the 
current study was found to be good at all three time points of assessment (the total mean 
PedsQL TM scores ranged from 77.6 to 85.2 over the current study). The PedsQLTM total 
scores at all three times of assessment in the current study were within the range of the 
mean scores reported by Varni et al. (2011) for healthy children aged one to 12 months 
(82.47 ±9.95) and children aged 13 to 24 months (85.55 ±8.74) (see Appendix XVII for tables 
of the results for the individual scales of the PedsQLTM). Mean total PedsQLTM scores in the 
current study were higher than those reported by Varni et al. (2011) for children with chronic 
illness aged one to 12 months (68.02 ± 13.92) and children aged 13 to 24 months (69.87 
±10.37). It can therefore be concluded that HRQOL outcomes of the children in the current 
study to be similar to that of their healthy same-aged peers.   
 
In the current study, parents’ perceived their children’s HRQOL as being similar to that of 
their healthy same-aged peers. This could be explained by the fact that the majority of the 
children in the current study had moderate disease severity. This would make it unlikely that 
their physical, cognitive or social-emotional functioning would be significantly impaired; 
therefore, their HRQOL would likely be perceived by parents to be good.  
 
Parents viewed their children’s physical health as being poorer than their psychological 
health prior to cardiac intervention in the current study. This would align with the 
developmental outcomes in the current study that found motor development to be most 
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affected prior to cardiac intervention. After cardiac surgery, and as the children became 
older, parents reported their psychological functioning to be more problematic than their 
physical functioning. This would also align with the developmental outcomes in the current 
study in that deficits in cognitive and language development became more apparent over 
time, and with increasing age and developmental skill complexity.  
 
Werner et al. (2014) reported better overall HRQOL in children with CHD at the age of one 
year compared to their healthy peers, the reason being that younger children exhibited fewer 
behavioural problems and parents were simply glad that their child was active despite their 
CHD.  
 
6.8.1.2 Health-related quality of life outcomes for children older than two years 
 
Fewer heart-related symptoms were reported for children in the current study (mean scores 
ranged from 95 to 98.8) compared to Eagleson et al.’s (2013) study (mean scores ranged 
from 76.14 to 85.5). Possible reasons for this could be that most of the children in the current 
study had moderate disease severity, and that heart symptoms were likely to have resolved 
or improved considerably post-cardiac intervention. The Cardiac Module was only 
administered post-operatively, as all children were under the age of two years when 
undergoing their first cardiac surgery, so no comparison could be made on the cardiac 
module from before to after cardiac intervention.  
 
Children in the current study (mean score of 56.3 ±50.5) displayed greater treatment anxiety 
post-cardiac intervention compared to that reported by Eagleson et al. (2013) (mean score 
of 87.1 ±19.1) and in other studies conducted in children aged two to 18 years using the 
Cardiac Module (mean score ranged from 61.08 to 87.1)(Sand et al., 2013; Uzark et al., 
2013; Berkes et al., 2010; Tahiroviċ et al., 2010; Uzark et al., 2008; Mussatto and Tweddell, 
2005). This could be explained by a possible post-cardiac intervention aversion to and fear 
of healthcare personnel due to their association with painful procedures and other negative 
experiences related to cardiac care and surgery.  
 
HRQOL outcomes in the current study relating to physical appearance (mean scores ranged 
from 95.8. to 100) were comparable to those established by Eagleson et al. (2013)(mean 
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score of 87.1 ±19.1) and in other studies conducted in children aged two to 18 years using 
the Cardiac Module (mean scores ranged 80.37 to 87.1) )(Sand et al., 2013; Uzark et al., 
2013; Berkes et al., 2010; Tahiroviċ et al., 2010; Uzark et al., 2008; Mussatto and Tweddell, 
2005). Cognition outcomes in the current study (mean score ranged from 79.1 to 100) were 
comparable to those established by Eagleson et al. (2013) (mean score of 81.5 ±12.3) and 
in other studies conducted in children aged two to 18 years using the Cardiac Module (mean 
scores ranged from 67.06 to 81.5)(Sand et al., 2013; Uzark et al., 2013; Berkes et al., 2010; 
Tahiroviċ et al., 2010; Uzark et al., 2008; Mussatto and Tweddell, 2005). Communication 
outcomes in the current study (mean scores ranged from 75 to 100) were comparable to 
those reported by Eagleson et al. (2013) (mean score of 100) and in other studies conducted 
in children aged two to 18 years using the Cardiac Module (mean scores ranged from 71.58 
to 80.08)(Sand et al., 2013; Uzark et al., 2013; Berkes et al., 2010; Tahiroviċ et al., 2010; 
Uzark et al., 2008; Mussatto and Tweddell, 2005).  
 
The findings in the current study were aligned with the findings of all the comparable studies 
reviewed, in that treatment anxiety, cognitive function, and communication ability impacted 
most negatively on parents’ perception of their child’s HRQOL in children aged two years 
and older. The negative impact of cognitive and language deficits on HRQOL are consistent 
with the developmental outcome findings in the current study, where cognitive and language 
delays emerged over time and with the increasing age of the child and increasing skill 
complexity.  
 
The overall HRQOL of two to three year olds in the current study was comparable to HRQOL 
of other children with CHD aged two years and older. This was determined by the 
comparison of the total mean score for the PedsQLTM Cardiac Module in the current study 
(mean score ranged from 85.3 to 97.8) with the total mean scores reported for the Cardiac 
Module by Uzark et al. (2008) (mean score of 86.66 ±12.19) and Sand et al. (2013) (mean 
score of 80.08 ±17).  
 
Furthermore, the HRQOL of two to three year olds with CHD in the current study was found 
to be comparable to that of their healthy same-aged peers. This was determined through 
the comparison of total mean scores on the PedsQLTM Cardiac Module with the total mean 
score for healthy peers on the PedsQLTM Generic Core Scales which were reported by Uzark 
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et al. (2008) as 87.86 ±12.19 and Berkes et al. (2010) as 79 ±15.  
 
6.8.1.3 Health-related quality of life outcomes for all children 
 
Parents’ perception of their children’s HRQOL in the current study was good, and 
comparable with other children with CHD as well as their healthy same-aged peers. 
Improved scores on the PedsQLTM post-cardiac intervention are likely to reflect the improved 
physical and psychosocial functioning of the children in the current study after cardiac 
intervention. The parents’ had wide-ranging perceptions of their children’s HRQOL, and 
across the study there were some children whose physical and psychosocial functioning 
negatively affected their health and wellbeing. 
 
In general, the positive HRQOL outcomes of the children in the current study are similar to 
those reported by numerous investigators who found the HRQOL of children with CHD to 
be largely unaffected and similar to that of their same-aged healthy peers (Schaefer et al., 
2013; Berkes et al., 2010; Uzark et al., 2008; Hövels-Gürich et al., 2007; Birks et al., 2006; 
Majnemer et al., 2006b; Goldbeck and Melches, 2005). The majority of participants in the 
current study had moderate disease severity, and it is reasonable to anticipate that children 
with more severe disease may have poorer HRQOL outcomes, based on the findings in the 
literature. In addition, by virtue of the fact that HRQOL is a subjective measure in young 
children with CHD, reflecting parents’ perceptions of their child’s HRQOL, could also serve 
to explain some of the variability in outcomes.  
 
6.8.2 Changes in parents’ perception of health-related quality of life over time   
 
There was a significant improvement (p=0.04) in parents’ perception of their children’s 
HRQOL in the current study at three-month post cardiac-intervention when compared to 
before cardiac intervention. Improved perception of their children’s HRQOL post-cardiac 
intervention could be attributed to a decrease in cardiac symptoms, and the improved 
physical and psychosocial functioning shown by many of the children in the current study 
after cardiac intervention. It was to be anticipated that parents would experience high levels 
of stress shortly before their child was to undergo cardiac surgery which might have 
influenced their perception of their child’s HRQOL at that point in time. Decreased levels of 
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parental stress following cardiac intervention might therefore also have favourably changed 
parents’ perceptions of their children’s HRQOL. The current study’s findings are consistent 
with the findings of Bertoletti et al. (2015), Marino et al. (2009) and Birks et al. (2006).  
 
In the current study, parenting stress and parents perception of their child’s HRQOL were 
closely linked before cardiac intervention. Parents found their child’s CHD to be a source of 
considerable stress prior to cardiac intervention and their perception of the impact of the 
CHD, irrespective of the disease severity, had a considerable effect on the way they 
perceived their child’s HRQOL. This was consistent with the findings of Bertoletti et al. 
(2015), Dulfer͒et al. (2015), Knowles et al. (2014), Eagleson et al. (2013), Spijkerboer et al. 
(2010), Miatton et al. (2007), Majnemer et al. (2006b) and Mussatto et al. (2006).  
 
6.8.3 Variables associated with health-related quality of life outcomes  
 
In the current study, motor development was significantly (p=0.01) associated with parental 
perceptions of their child’s HRQOL prior to cardiac intervention. The reason for this finding 
could be that parents’ felt that the limitations the cardiac disease placed on their child’s 
physical activity, as well as other environmental restrictions, might have prevented their child 
from being able to perform the same age-appropriate motor activities as their healthy peers. 
This was consistent with reports by Bertoletti et al. (2015), Nousi and Christou (2010), 
Miatton et al. (2007) and Birks et al. (2006) in that CHD led to physical activity limitations.  
 
Levels of parenting stress in the current study, prior to cardiac intervention, were also 
significantly (p= 0.02) associated with parents’ perceptions of their child’s HRQOL at the 
same time point.  This is similar to reports by Dulfer͒et al. (2015), Eagleson et al. (2013), 
Spijkerboer et al. (2010), Miatton et al. (2007) and Majnemer et al. (2006b). As discussed 
under 6.8.2 parents found their child’s CHD to be a source of considerable stress and their 
perception of the impact of the CHD on their child had a considerable effect on the way they 
perceived their child’s HRQOL. It could be speculated that additional stressors including low 
SES, uncertainty about the child’s health outcomes, and the increased burden of care, 
especially prior to cardiac intervention might also have influenced parents perception of their 
child’s HRQOL. In agreement with Nousi and Christou (2010) parents may have projected 
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their own personal distress onto their child, negatively influencing their perception of their 
child’s HRQOL.  
 
Disease severity was not shown to have a significant association with parents’ perception 
of their child’s HRQOL. This is similar to the reported findings of Amedro et al. (2015), 
Bertoletti et al. (2015), Latal et al. (2009) and Majnemer et al. (2006b). It is acknowledged 
that the impact of disease severity on parents’ perception of their child’s HRQOL remains 
controversial. Disease severity itself has proven an unreliable predictor of HRQOL outcomes 
in young children with CHD, and perhaps rather, as Mussatto (2006) suggests, parental 
perception of the impact of the CHD on their child might play a more important role in 
determining parents’ perception of their child’s HRQOL.  
 
The current study’s findings however, contradict those of Eagleson et al. (2013), Sand et al. 
(2013), Tahirović et al. (2010) and Uzark et al. (2008) who all found disease severity to be 
significantly associated with parents’ perception of their child’s HRQOL. Macran et al. 
(2006), in turn, only found disease severity to influence HRQOL outcomes in younger 
children. The reason for the contradictory findings most likely lies in the participant profile of 
the aforementioned studies with regard to disease severity and age of the children.  
 
Similar to Hövels-Gürich et al. (2007), the current study did not find the type of CHD 
(presence of cyanosis) to be significantly associated with HRQOL outcomes. The current 
study’s finding contradict the findings of Schaefer et al. (2013), Tahirović et al. (2010) and 
Birks et al. (2006) who found that the presence of cyanosis negatively influenced HRQOL 
outcomes. The contradictory findings with regards to the impact of cyanosis on HRQOL 
could be attributed to the varying patient profiles reflected in the aforementioned studies. A 
possible reason for the lack of association shown between cyanotic heart disease and 
HRQOL outcomes in the current study could be ascribed to the fact that the majority of the 
children in the current study had acyanotic heart defects. 
 
In the current study, surgical variables including age at first cardiac surgery and duration of 
CPB were found not to be significantly associated with HRQOL outcomes. This study’s 
findings regarding the association of age at first cardiac surgery with HRQOL outcomes 
contradicts the findings of Latal et al. (2009) who found that older age at first cardiac surgery 
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was associated with worse HRQOL outcomes. The contradictory findings could be 
explained by the fact that Latal et al. (2009) included children of a far wider age range and 
older age at their first cardiac surgery. Similar to the findings in the current study, Majenemer 
et al. (2006) found that surgical factors were not strong predictors of HRQOL outcomes in 
children with CHD. This study’s findings are contradicted by the findings of Schaefer et al. 
(2013), Latal et al. (2009) and Hövels-Gürich et al. (2007) who reported a significant 
association between the duration of CPB and HRQOL outcomes. A possible explanation for 
the contradictory findings could be the varying patient profiles represented in the 
aforementioned studies, in particular relating to disease severity. It is possible that children 
with more severe disease in the other study samples may have required surgeries that were 
more complex, thus requiring a longer duration of CBP. These children could have had 
different HRQOL outcomes compared to children in the current study, where most children 
had moderate disease severity and less complex defects resulting in surgeries requiring 
shorter durations of CPB.   
 
In the current study, patient variables including growth failure, feeding problems and the 
presence of DS were found not to be strongly associated with parents’ perception of their 
child’s HRQOL. This study’s findings contradict those of Nousi and Christou (2010) who 
found growth failure in children with CHD to be significantly associated with poor HRQOL 
outcomes. This study’s findings also contradict those of Werner et al. (2014) who reported 
poorer HRQOL outcomes in children with genetic abnormalities. Similarly, Garcia Guerra et 
al. (2014) reported significantly worse HRQOL in children with CHD with genetic 
abnormalities compared to both their healthy same-aged peers as well as other children with 
CHD without genetic abnormalities. Possible explanations for the contradictory finding in the 
current study regarding the association of  both growth failure and genetic abnormalities 
with HRQOL outcomes could possibly be that parents might have viewed their child as either 
having a medical problem that affected their health or not.  Additional problems apart from 
the cardiac disease, including growth, failure, poor feeding and DS might then not 
significantly have altered their view of their child’s HRQOL. 
 
Socioeconomic factors including SES and level of maternal education were not found to be 
strongly associated with parents’ perception of their child’s HRQOL. The findings on the 
association between SES and HRQOL have proven inconsistent in the literature (Uzark et 
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al., 2008; Mussatto, 2006). Amedro et al. (2015), Eagleson et al. (2013), Latal et al. (2009) 
and Nousi and Christou (2010) reported that SES was associated with the HRQOL 
outcomes in children with CHD. A possible reason for the contradictory findings in the 
current study could be that the majority of the parents had the same level of education, and 
were from the same socioeconomic class, thus limiting the ability to make strong 
associations between variable SES and educational attainment and parental perceptions of 
their children’s HRQOL.  
 
The association between the child’s age and parents’ perception of their HRQOL was not 
specifically investigated in the current study; however, it was evident that HRQOL improved 
post-cardiac intervention and over time with increasing age. This is consistent with reports 
by Sand et al. (2013). Eagleson et al. (2013) however found age not to be associated with 
HRQOL outcomes. No clear reason for the difference in findings could be identified.  
 
6.9 Parenting stress and burden of care 
 
Very few studies have established parenting stress in parents of infants and toddlers living 
with CHD. Parenting stress reported in the current study is predominantly a reflection of the 
parenting stress experienced by mothers. In most instances the child was accompanied by 
only the mother on admission and for healthcare visits; therefore the parenting stress of the 
fathers could not be established consistently in the current study. 
 
6.9.1 Parenting stress outcomes  
 
The majority of primary caregivers (60%) in the current study experienced clinically 
significant levels of stress in their parenting role just prior to their child undergoing cardiac 
surgery, This is consistent with the findings of Wei et al., (2016), Harvey et al. (2013), Landolt 
et al. (2011), Solberg et al. (2011) and Franck et al. (2010).  
 
Some parents of children with chronic health conditions experience ongoing stress 
(Golfenshtein et al., 2016), this was also found to be the case in the current study. Even 
though total stress scores declined over time in the current study, just more than a third of 
parents experienced ongoing stress after their child’s cardiac intervention. This is consistent 
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with the findings of Wei et al. (2016), Hearps et al. (2014), Grønning Dale et al. (2013), 
Harvey et al. (2013) and Goldberg et al. (1990) in that parents of children with CHD 
experience higher levels of stress than parents of children with other chronic health 
conditions, and parents of healthy children. This however contradicts the findings of 
Vrijmoet-Wiersma et al. (2009) that parents of children with CHD experienced similar levels 
of stress to parents of healthy children. Whilst, Brosig et al. (2007) provides even further 
contradiction by suggesting that some parents may even experience lower levels of stress 
compared to parents of healthy children due to the fact that they develop a higher tolerance 
for what is perceived to be stressful because of their experiences relating to their child’s 
CHD.  
 
6.9.2 Changes in parenting stress over time  
 
Parenting stress levels in the current study declined significantly from before cardiac 
intervention at both three-month (p< 0.001) and six-month (p< 0.001) post-cardiac 
intervention. The significant decline in the levels of parenting stress can be explained by the 
resolution or improvement in cardiac symptoms and the improved health and wellbeing of 
the children after cardiac intervention. It was to be anticipated that parents would experience 
high levels of stress shortly before their child was to undergo cardiac intervention, this might 
also have contributed to the significant decrease in parenting stress post cardiac 
intervention. This is consistent with previous findings ( Wei et al.; 2016; Grønning Dale et 
al., 2013). In addition, a large number of children in the current study underwent definitive 
corrective surgery (73.6%), leaving minimal lasting deficits (Goldberg et al., 1990). Despite 
the significant decrease in parenting stress over the time-span of study, it is important to 
note that just over a third of parents continued to experience high levels of stress after their 
child’s cardiac intervention (Refer to discussion under 6.9.2). 
 
6.9.3 Burden of care and parent stressors 
 
Several stressors were identified to contribute to parenting stress and the burden of care 
experienced by parents in the current study. A limitation of the PSI-SF is that it only 
measures stressors directly related to a parent’s parenting role, yet many factors outside of 
the parenting role may contribute to parenting stress. To negate the limitations of the PSI-
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SF, parents were asked to provide information on their experience of the impact of their 
child’s health status and medical care, socioeconomic circumstances and burden of care on 
the stress they experienced.   
 
6.9.3.1 Illness-related stressors  
 
The majority of parents found seeing their child in the cardiac ICU after cardiac surgery 
attached to machines and with drainage tubes to be the most stressful experience. This is 
consistent with the findings of Wei et al. (2016), Harvey et al. (2013), Landolt et al. (2011), 
Solberg et al. (2011) and Franck et al. (2010).  
 
6.9.3.2 Parent-related stressors 
 
Parent-related stressors included the burden of caring for a child with CHD. Mothers fulfilled 
the role of primary caregiver in most instances in the current study, and as a result 
shouldered most of the burden of care. This is consistent with the findings of Bruce et al. 
(2014), Grønning Dale et al. (2013), Fonseca et al. (2012), Yildiz et al. (2009), Lan et al. 
(2007) and Lawoko and Soares (2006). In the current study, grandmothers carried a 
considerable burden of care in the case of teenage mothers or where the child’s mother 
could not fulfil the role of primary caregiver. Several mothers were unmarried and headed 
single-parent households. Most mothers also did not work outside of the home. This is 
similar to findings reported by Amakali and Small (2013) for mothers of children with CHD 
in Namibia. Roman et al. (2016) concurred that the burden of childcare in sub-Saharan 
Africa predominantly fell on mothers due to cultural practices where black African men tend 
not to be involved in the day-to-day care of the children.  
 
In the current study, hospital admissions prior to cardiac intervention for respiratory 
complaints and employed parents having to miss work to due to their child’s ill health  added 
to the burden of care experienced by mothers in the current study.  
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6.9.3.3 Child-related stressors 
 
More than half of the parents’ felt that their child failed to meet their expectations. Although 
dysfunction in parent-child interaction improved over the time-span of the study, it remained 
the stressor that most contributed to parenting stress. Similar indications that parental 
perception of their child and acceptance of the child affect levels of parenting stress have 
been noted (Golfenshtein et al., 2016).  
 
The majority of parents in the current study did not find their children demanding or difficult 
to parent. Parenting styles and cultural perceptions may have contributed to this view 
(Roman et al., 2016). In addition, the majority of children in the current study had moderate 
disease severity and were unlikely to be overly irritable, possibly explaining the contradictory 
findings of Golfenshtein et al. (2016), Soulvie et al. (2012), Torowicz et al. (2010) and Uzark 
and Jones (2003).  
 
6.9.3.4 Socioeconomic-related stressors 
 
Many of the parents in the current study highlighted the impact their current socioeconomic 
circumstances had on their psychosocial wellbeing. It can be speculated that 
unemployment, low SES, low levels of maternal education and a lack of social support 
exacerbated the stress parents’ were already experiencing in their parenting role. This is in 
agreement with reports by Amakali and Small (2013), Engle et al. (2007) and Walker et al. 
(2007) who noted that financial strain increased levels of parenting stress in developing 
countries. Golfenshtein et al. (2016), Bruce et al. (2014), Harvey et al. (2013), Grønning 
Dale et al. (2013), Soulvie et al. (2012) and Connor et al. (2010) reported similar findings in 
developed countries.  
 
6.9.4 Variables associated with levels of parenting stress 
 
Neurodevelopmental outcome, and in particular language development, was found to be 
significantly associated with parenting stress prior to cardiac intervention (p=0.04), as well 
as at three-month post-cardiac intervention (p=0.03). One may speculate that a lack of 
communication and social interaction on the part of the child with a parent is likely to increase 
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parental anxiety and negatively affected the parent-child relationship. Similarly, several 
other investigators in developed countries have indicated that parenting stress negatively 
impacts on the quality and responsiveness of caregiving, ultimately having a detrimental 
effect on the child’s social-emotional, motor, cognitive and language development (Soulvie 
et al., 2012; Landolt et al., 2011; Laing et al., 2010; Torowicz et al., 2010; McCusker et al., 
2009; Fulbright Sumpter, 2009). Engle et al.’s (2007) findings in developing countries proved 
to be similar in this regard. 
 
Parents’ perception of their child’s HRQOL was significantly (p=0.02) associated with levels 
of parenting stress before cardiac intervention. Parental perception of their child’s HRQOL 
may be closely linked to their perception of their child’s level of functioning and their view of 
the parent-child relationship. If parents perceive their child as having a poor ability to function 
in everyday situations, their stress levels are likely to increase (Mussatto, 2006). 
 
The age of the child at first cardiac surgery (p=0.03) and the age of the mother (p=0.04) 
were found to be significantly associated with parenting stress at three-month post-cardiac 
intervention. A possible reason for this finding in this study could be the young age of the 
children and that the cardiac intervention was recent, which were both factors that were 
likely to contribute to the burden of care and therefore the level of parenting stress 
experienced. This is consistent with findings of Soulvie et al. (2012) and Lee et al. (2007) 
that parenting toddlers and pre-schoolers with CHD resulted in higher levels of parenting 
stress by virtue of the higher burden of caregiving in children of these ages.  
 
Disease type and severity were not found to be significantly associated with levels of 
parenting stress. Parenting stress tended to be similar for the parents of the children with 
cyanotic and acyanotic heart defects in the current study. This is likely due to the fact that 
patient characteristics were similar for both groups, and the disease severity was only 
marginally worse in the cyanotic group. This is consistent with the reported findings of 
Hartman and Medoff-Cooper et al. (2012), Vrijmoet-Wiersma et al. (2009) and Mussatto et 
al. (2006). The current study findings contradict those of Grønning Dale et al. (2013), 
Torowicz et al. (2010), Connor et al. (2010), Majnemer et al. (2006b), Mörelius et al. (2002) 
and Goldberg et al. (1990) who reported parenting a child with severe CHD to be more 
stressful. The difference in findings is possibly attributable to varying participant profiles of 
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the aforementioned studies with regard to disease severity. Disease severity has however 
failed to explain parents’ psychological morbidity over time (Grønning Dale, 2013). Rather, 
parents’ perception of the impact of the CHD on their child and family may have proven to 
be a powerful predictor of long-term psychological morbidity in the current study, than 
disease severity, as  has been suggested by Rempel et al. (2013). 
 
In the current study, patient-specific factors, including DS and growth failure, were not found 
to be significantly associated with levels of parenting stress. This contradicts the finding of 
Torowicz et al. (2010) that growth failure increased the burden of care and level of parenting 
stress, and Visootsak et al. (2015) that the presence CHD with DS was associated with 
greater levels of parenting stress. The lack of association between these variables and 
levels of parenting stress may be a reflection on the fact that parents viewed their children 
as either having a medical problems or not, irrespective of the number of problems. 
 
SES and maternal education were not found to be strongly associated with levels of 
parenting stress in the current study.  Possible reasons for the lack of a strong association 
being shown may relate to the fact that the PSI-SF does not measure the impact of factors 
that are unrelated to the parenting role. In addition, similar SES and levels of maternal 
education levels across the sample, and the small sample size may also have limited the 
ability to show a strong associations between SES and levels of parenting stress.  
 
6.10 Outcomes in children with Down syndrome  
 
6.10.1 Introduction   
 
Twenty-five percent of the children in the current study were diagnosed with DS. The 
representation of children with genetic abnormalities in this study are similar to that reported 
by Gaynor et al. (2015), Mussatto et al. (2014) and Brosig Soto et al. (2011). The median 
age of the mothers of children with CHD with DS in the current study was advanced at 37 
years. Visootsak et al. (2011) reported a comparable maternal age. Advanced maternal age 
is known to be associated with an increased risk of DS (Bertoti and Schreiner, 2015; 
Elmagrpy et al., 2011; Murphy et al., 2006). 
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Due to the small sample size, no further statistical analysis was done to determine inter-
group differences, as subgroups were insufficiently powered to be able to draw reasonable 
conclusions. However, it was deemed important to identify trends in outcomes between 
groups. Apart from the current study, very few studies have reported on the outcomes of 
children with CHD with DS. This serves to highlight the uniqueness of the current study.  
 
6.10.2 Growth outcomes 
 
In the current study, growth outcomes for children with CHD with DS were found to be similar 
to those with CHD without DS when the DS-specific growth standards were used to 
determine the growth outcomes of children with DS, allowing for fair comparison with their 
peers. The prevalence of malnutrition prior to cardiac intervention was similar for the children 
with CHD with and without DS. The majority of the children (60%) with CHD with DS 
presented with malnutrition prior to cardiac intervention, and a large number were stunted. 
Twenty percent of the children with CHD with DS had microcephaly. The reasons for 
suboptimal growth in children with CHD with and without DS in the current study are likely 
to be similar (Refer to 6.5.1). It is difficult to compare growth outcomes in children with CHD 
with DS with the published literature as available studies by Knirsch et al. (2010) and Bravo-
Valenzuela et al. (2011) made use of standard growth charts to determine growth outcomes, 
which could mean that the extent of the growth failure reported in these studies may be 
overestimated.  
 
The children with CHD with DS in the current study showed considerable catch-up growth 
following cardiac intervention, but complete catch up growth had not occurred by the six-
month post cardiac intervention. Despite median z-scores for growth parameters falling 
within the acceptable range by the six-month post-cardiac intervention, the z-scores were 
still below the 50th percentile. This is in agreement with the findings of Bravo-Valenzuela et 
al. (2011). To the contrary, Knirsch et al. (2010) found the presence of a genetic abnormality 
to be the single most significant predictor of poor catch-up growth post-surgery. Again, 
possible reasons for the variable findings could be attributed to the use of standard growth 
charts and population means, as well as varying patient profiles with regard to disease 
severity. 
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6.10.3 Developmental outcomes 
 
In the current study, composite scores across all three BSID-III subscales (cognitive, 
language and motor) at all three time-points of assessment tended to be much lower for the 
children with CHD with DS when compared with the children with CHD alone. This is 
consistent with the findings of Alsaied et al. (2016), Mussatto et al. (2014), Brosig Soto et 
al. (2011) and Visootsak et al. (2011).  
 
Language and cognitive development for the children with CHD with DS in the current study 
declined over the course of the study, and motor development remained poor over the study 
duration. This is consistent with the findings of Mussatto et al. (2014). Declining cognitive 
and language performance over time, and with increasing age may be explained by the 
heightened skill complexity with increasing age and the impact of the intellectual impairment 
characteristic of DS (Alsaied et al., 2016; Visootsak et al., 2013; Van Gameren-Oosterom et 
al., 2011;Visootsak et al., 2011; Marino et al., 2012). In addition, children with DS are limited 
in their ability to explore their environment due to their motor impairments, which in turn may 
result in secondary impairments related to cognition (Bertoti and Schreiner, 2015; Visootsak 
et al., 2011). This study’s findings are also consistent with the findings of Alsaied et al. 
(2016), Visootsak et al. (2013) and Visootsak et al. (2011) that children with DS present with 
delayed expressive and receptive language.  
 
The extent of the motor delays in children with CHD with DS may be attributed to the marked 
hypotonia, joint laxity, lack of postural- and antigravity control, and deficits in both balance 
and coordination. These would be consistent with the reasons for poor motor performance 
in children with DS as suggested by Bertoti and Schreiner (2015) and Visootsak and 
colleagues (2011). The aforementioned causes are likely to be superimposed on other 
contributing factors for motor delay in children with CHD as discussed under section 6.6.3 
and 6.6.4. The above-mentioned would perhaps go on to explain the greater extent and 
severity of the motor delays seen in the children with CHD with DS in the current study, as 
well as in the studies by Alsaied et al. (2016) and Visootsak et al. (2011), when compared 
with children with either DS alone or CHD alone. 
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All children with CHD with DS presented with marked hypotonia at all time points of 
assessment, whilst hypotonia in children with CHD without DS tended to resolve by the six-
month post cardiac intervention. The marked hypotonia in children with CHD with DS is 
characteristic of DS (Visootsak et al., 2013). 
 
6.10.4 Parents’ perception of health-related quality of life outcomes 
  
In the current study, when comparing the total PedsQLTM scores with the normative values 
published by Varni et al. (2011) for healthy and chronically ill children, it is apparent that 
parents of children with CHD with DS perceived their children’s HRQOL to be reasonably 
good compared to their healthy peers and marginally better than that of children with other 
chronic conditions. There was however a tendency of parents of children with CHD with DS 
to perceive their children’s HRQOL as poorer than that of parents of children with CHD 
without DS. Parents of children with CHD with DS perceived their children’s HRQOL to be 
largely unchanged over the time-span of the study.  
 
Very little has been published on the HRQOL outcomes of children with CHD with DS, and 
there are no reported studies in children as young as the participants in the current study. 
Most HRQOL studies have excluded children with genetic abnormalities, as it is considered 
an independent risk factor for worse HRQOL. However, Garcia Guerra et al. (2014) and 
Werner et al. (2014) reported poorer HRQOL outcomes in slightly older children with CHD 
with genetic abnormalities compared to children with CHD alone. Van Gameren-Oosterom 
et al. (2011) found children with DS alone to have impaired HRQOL with regard to 
developmental functioning and autonomy. 
 
6.10.5 Parenting stress outcomes  
 
In the current study, half of the parents of the children with DS experienced clinically 
significant levels of stress just before their children underwent cardiac intervention. This was 
comparable to parents of children with CHD without DS, which was to be anticipated in that 
stress in both groups at this specific point in time was largely driven by the anxiety and fear 
of the impending cardiac intervention.  
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At both three-months and six-month post-cardiac intervention parenting stress levels tended 
to be considerably higher for the parents of the children with DS. This could potentially be 
explained by the fact that for many parents of children with CHD without DS their child’s 
medical problem was either resolved completely or there was a significant improvement in 
the child’s clinical picture after cardiac intervention.  However, for the parents of the children 
with DS, despite having seen a considerable improvement in their child’s cardiac symptoms, 
they continued to experience stress related to parenting a child with DS. This is consistent 
with the findings of Visootsak et al. (2015) that having a child with CHD with DS provided 
parents with additional stress. Parents of children with CHD with DS were found to have 
consistently reported higher levels of parenting stress, compared to parents of children with 
only DS.  
 
6.11 Outcomes in children with cyanotic heart defects 
 
6.11.1 Growth outcomes 
 
Only 20% of participants in the current study were diagnosed with cyanotic heart defects. 
Of the children with cyanotic defects 87.5% would require further surgeries. More children 
with cyanotic heart defects presented with growth failure both before and after cardiac 
intervention compared with the children with acyanotic heart defects, and the extent of the 
growth retardation tended to be greater. A reason for this finding is that cyanosis results in 
chronic hypoxia causing dyspnoea and tachypnoea during feeding. Breathing difficulties 
cause the child to tire easily during feeding resulting in inadequate food and calorie intake 
(Roman, 2011; Da Rosa Pereira et al., 2015). Furthermore, these children are likely to be in 
a state of constant metabolic stress resulting in increased energy expenditure (Lata et al., 
2015; Daymont et al., 2013; Knirsch et al., 2010; Wheat, 2002; Varan et al., 1999). The 
finding in the current study are consistent with the findings of Al-Asy et al. (2014), Daymont 
et al. (2013), Irving, (2011) and Varan et al. (1999) that the extent of the malnutrition is 
related to the characteristics of the CHD, including the presence of cyanosis. Daymont et al. 
(2013) found that children with severe CHD showed large, early, and sustained decreases 
in growth trajectories. Costello et al. (2015) however found no relationship between cyanotic 
CHD and growth failure prior to cardiac surgery. They suggested the reason for their 
contradictory findings was that their cohort of children did not include children with severe 
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forms of CHD such as HLHS. Though the current study had only a single participants with 
severe CHD, additional factors relating to socioeconomic disadvantage in the current 
sample are believed to have contributed to the extent of growth failure in both children with 
cyanotic and acyanotic heart defects.  
 
Post-cardiac intervention growth outcomes tended to remain poorer for children with 
cyanotic heart defects, especially regarding weight. Both groups however showed significant 
catch-up growth by the six-month post-cardiac intervention. The largely comparable growth 
trajectories by six-month post-cardiac intervention is likely due to the fact that most of the 
children in the current study had moderate (75%) or moderate to severe (20%) disease 
severity and the majority of the children (75%) in the current study underwent corrective 
surgery resulting in a considerable improvement in cardiac symptoms.  
 
6.11.2 Developmental outcomes 
 
This study noted no tendency towards different neurodevelopmental outcomes between 
children with cyanotic heart defects and those with acyanotic defects. Brosig Soto et al. 
(2011) similarly noted no significant differences in developmental outcomes between 
cyanotic and acyanotic heart defects. Lata et al. (2015) contradicted these findings by 
reporting a higher occurrence of developmental delays in children with cyanotic heart 
defects. The contradictory findings are likely to be explained by the different patient profiles 
of the respective studies. Half of the children in Lata et al.’s (2015) study had severe disease, 
whilst only 28.4% of the children in Brosig Soto et al.’s (2011) study had severe disease, 
compared to  only 2.5%  of children in the current study having severe disease. This would 
possibly explain why Lata et al. (2015) found that children with more complex cyanotic heart 
defects had poorer developmental outcomes. 
 
6.11.3 Parents’ perception of health-related quality of life outcomes 
 
In the current study HRQOL outcomes tended to be similar for the children with cyanotic 
and acyanotic heart defects, with relatively good HRQOL being experienced by the children 
in both groups. This is consistent with the findings of Hövels-Gürich et al. (2007). This 
however, contradicts the findings of Mellion et al. (2014) and Schaefer et al. (2013) that 
more severe CHD and cyanotic lesions are associated with worse HRQOL outcomes. The 
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reason for these differences can likely be attributed to the difference in the patient profiles 
of the respective studies.  
 
6.11.4 Parenting stress outcomes  
 
Parenting stress tended to be similar for the parents of the children with cyanotic and 
acyanotic heart defects in the current study. This is likely due to the fact that patient 
characteristics were similar for both groups, and the disease severity was only marginally 
worse in the cyanotic group. No specific reference is made in the published literature to the 
effect of cyanotic heart defects per se on parenting stress. If the severity of the cardiac 
disease is used as a proxy for cyanosis the outcomes in the literature are contradictory 
(Refer to section 6.9.5). It is reasonable to draw this conclusion, as cyanotic heart defects 
are likely to be more severe. 
 
6.12 Strengths of this study 
 
The current study has several strengths, not only within the South African and African 
context, but also within the context of global CHD outcome-based research. It must be 
emphasised that this was a single-centre study and that the findings are relevant to and 
representative of the population of young children with CHD living in central SA. The findings 
of this study may however not be generalizable to the entire population of young children 
living with CHD in SA or on the African continent. Findings may also not be generalizable to 
young children living with CHD in developed countries. 
 
Perhaps the most important strength of this study lies in the fact that it is the first study in 
SA, and on the African continent, to have determined the developmental outcome of young 
children with CHD undergoing cardiac intervention. It is also the first neurodevelopmental 
outcome study in children with CHD where the majority of the sample consisted of black 
African children. The majority of participants in the neurodevelopmental outcome studies 
done in developed countries were white. This is the first study in SA, and one of only a few 
studies on the African continent to have established the growth and parenting stress 
outcomes of young children with CHD who have undergone cardiac intervention. This is also 
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the first study on the African continent to have established the HRQOL outcomes in young 
children with CHD.  
 
This study included the entire spectrum of children with CHD who would require cardiac 
neurodevelopmental follow-up, including children with DS. This is also the first study in SA 
and in Africa to describe the outcomes of children with CHD who also have DS. This study 
adds to the global body of very limited data on the neurodevelopmental, growth, HRQOL 
and parenting stress outcomes of children with DS who also have CHD.  
 
This is the first study to  provide a detailed description of the rationale behind and 
development of a home-based parent-driven developmental stimulation programme aimed 
at addressing the developmental needs, not only of children with CHD in SA, but of children 
worldwide. The complete programme has been compiled, presented and is ready for further 
testing and validation.  
 
Furthermore, this study contributes to the limited body of global data on developmental 
outcomes for children with CHD using the BSID-III. It is the first study to report on HRQOL 
outcomes for children with CHD using the infant modules of the PedsQLTM.  
 
In addition, this study continues to add to the global body of data on the growth, 
development, HRQOL and parenting stress outcomes for children with CHD. This study is 
one of only three studies to have reported on neurodevelopmental outcomes prior to cardiac 
intervention, allowing for comparison of developmental outcomes before and after cardiac 
intervention.  
 
6.13 Challenges encountered during the study 
 
6.13.1 Logistical challenges 
 
Several logistical challenges were encountered during this study, and were discussed in 
detail under the pilot study (Refer to section 3.5). Following the pilot study several additional 
measures were put in place to limit study attrition. These measures where highlighted under 
section 4.7.  
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There were a number of logistical challenges experienced prior to cardiac intervention. 
These included establishing a consistent referral system in the absence of routine cardiac 
neurodevelopmental follow-up, adapting to changes and cancellations in the cardiac surgery 
list. A further challenge was completing the baseline assessments the day before cardiac 
intervention amidst routine medical procedures and investigations, and finding a designated 
private area in a busy ward to conduct the assessments. The aforementioned could possibly 
have influenced the child’s developmental performance during testing. Assessing parent 
stress just before their child undergoes cardiac surgery is likely to be reflected in the parents 
stress scores at baseline. The considerable stress experienced by parents just before their 
child’s cardiac surgery may also have influenced their perception of their child HRQOL at 
this time point. Findings of this study at baseline needs to be interpreted taking this 
consideration. It would have been preferable to have done an earlier baseline assessment 
at another routine hospital visit but in the context of the study site this option was unfeasible.   
 
There were also logistical challenges faced post-cardiac intervention at the follow-up visits. 
These included not being able to assess the children in the cardiology out-patient clinic due 
to space constraints, children missing scheduled appointments due to irregular inter-hospital 
transport and financial challenges on the part of the parents, and children arriving late for 
their appointments and having to wait until their cardiology follow-up was complete before 
being able to perform the assessments which resulted in some of them being irritable while 
being assessment.  
 
6.13.2 Loss to follow-up 
 
Retaining participants in the current longitudinal clinical follow-up study in SA posed difficult, 
despite concerted efforts to encourage adherence through parent education, SMS text 
messages and verbal telephonic reminders, and the reimbursement of travelling expenses. 
Attrition was discussed at length under section 6.1.  
 
Factors contributing to loss to follow-up in the current study included distance to follow-up, 
unreliable inter-hospital transport services, and socioeconomic disadvantage. Additionally a 
lack of understanding on the part of the parents regarding the importance of cardiac 
neurodevelopmental follow-up, even if their children were doing well post-cardiac 
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intervention, may have contributed to the loss to follow-up. The six-month study visit failed 
to coincide with a routine cardiology visit, and attendance would have required special effort 
on the part of the families.  
 
Contacting families to confirm appointments via distance communication methods, including 
cellular phone calls and SMS text messages, was problematic due to unreliable network 
coverage in rural areas, the frequent changing of cellular phone numbers, and the inability 
of parents to afford airtime. 
 
6.13.3 Assessment measures 
 
In regards to the assessment measures, parents lacked confidence in completing the 
PedsQLTM and PSI-SF unaccompanied, resulting in these measures taking longer than 
initially anticipated to complete, especially when a translator was required. This perhaps 
also served as reflection of the low level of maternal education identified in this study.  
 
The BSID-III test items were not found to always be culturally sensitive, despite the reported 
use of the BSID-III for developmental assessments in SA. The BSID-III contains test items 
that proved unfamiliar to children living in rural areas and who did not have access to 
educational toys and storybooks. The standardised storybook item in the BSID-III was in 
English, yet the home language of the majority of the children in this study was Sesotho. 
The children’s lack of familiarity with several of the test items may have been a reflection on 
the social disadvantage faced by many South African families that could have resulted in a 
lack of receptive parenting and suitable age-appropriate stimulation being provided within 
the home. 
 
Several parents seemed confused by the PSI-SF question six “I am unhappy with the last 
purchase of clothing I made for myself”. The confusion was likely caused by mothers not 
being able to afford new clothing items due to their low SES. Question 33 also caused 
confusion, “Think carefully and count the number of things that your child does to bother 
you”.  The answer options state “1-3” things as the lowest score-option and does not provide 
the option of zero.  Scoring posed problematic as some caregivers felt their child did nothing 
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that bothered them. Other parents were unsure of how to count items that bothered them. 
These two questions of the PSI-SF had to be carefully explained to a number of parents.  
 
In some cases, it was difficult to build a comprehensive picture of the SES of families beyond 
the primary caregiver, which in most cases was the mother. On completing the Hollingshead 
Socioeconomic Index, mothers could not always provide as comprehensive a picture of the 
father’s educational attainment and occupational prestige as would have been liked. This 
was partly due to the fact that fathers were not present at the assessments and, in some 
cases, were uninvolved in the child’s care.   
 
6.14 Study limitations 
 
The results of the current study need to be interpreted against the background of several 
limitations. This study represents the outcomes of a single cardiac-centre in SA making the 
results specific to this study population. This means that the findings from this study may 
not be generalizable to the entire population of children with CHD and their parents as a 
whole.  
 
There was a high attrition rate in this study,  and the limited number of participants available 
for evaluation at both three-month and six-month post-cardiac intervention may have 
influenced the analysis of variance findings used to determine associations between multiple 
variables and developmental, HRQOL and parenting stress outcomes.  
 
The study was also limited by a small sample size. Although the sample was small, it was 
considered to be representative of the population of young children with CHD served by the 
Cardiac Unit at Universitas Academic Hospital. Subgroups were small and were 
inadequately powered to draw definite conclusions on between group differences.  
 
Due to the study methodology, neonates, children who were critically ill and those who had 
undergone previous or emergency cardiac surgery were excluded from the study sample. 
This excluded some children with more severe cardiac disease from the study sample.  
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Despite the AHA’s recommendation of the BSID-III as the outcome measure of choice for 
developmental assessment in children with CHD younger than 42 months, it needs to be 
considered that it may have potentially underestimated the prevalence and severity of the 
developmental delays in this population. It is therefore recommend that BSID-III scores be 
interpreted cautiously in this high-risk population. 
 
Only a disease-specific measure was used to determine HRQOL in children older than two 
years. Despite HRQOL outcomes being comparable between disease specific and generic 
HRQOL modules of the PedsQLTM it would be advisable to use a generic module, in 
combination with a disease-specific measure in future studies, to make comparisons easier 
with same-aged healthy peers and children with other health conditions. It is also unfortunate 
that there is no cardiac disease-specific measure available for use when assessing HRQOL 
in children younger than two years.  
 
The researcher performing the developmental assessments at all time points had the 
potential to introduced bias.  
 
6.15 Clinical recommendations  
 
Clinical recommendations will be made based on the four key outcomes of the study. 
Relevant suggestions will be provided for each of the outcomes in the following section. 
 
Growth  
 
The monitoring of growth is particularly important in young children with CHD considering 
they are at high risk of growth failure, as is evident in this study. A diagnosis of CHD warrants 
the regular and careful monitoring of all growth parameters, including weight, height, and 
head circumference, to help identify children at risk of or presenting with suboptimal growth. 
When indicated, children should be referred to a dietician who can implement strategies to 
limit growth failure and enhance catch-up growth post-cardiac intervention. A number of 
parents reported feeding difficulties in the current study. It is therefore also recommended 
that feeding skills be closely monitored and assessed by a speech therapist when indicated, 
and suitable therapy initiated if needed.  
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Development  
 
Young children with CHD are at high risk of developmental delays across all developmental 
domains, as is evident in this study. It is therefore a strong recommendation that routine 
cardiac neurodevelopmental follow-up be integrated into standard cardiac care in SA. It is 
further recommended that clinicians implement the AHA (Marino, 2012) developmental 
screening and evaluation guidelines for children CHD. There is an urgent need to mobilise 
awareness and initiate dialogue amongst cardiac services in SA regarding the importance 
of collaborating with allied health professionals to establish CNP programmes within the 
country’s cardiac units, despite the considerable human resource and financial constraints.  
 
Children identified as being at risk or those presenting with developmental delays should be 
referred to appropriate EI services, and families should be assisted in accessing these 
services in order to optimise functional ability and participation of the child within the home 
and community. In the light of the challenges faced in adhering to hospital-based EI services 
in SA, it is recommended that innovative strategies be explored to provide early 
developmental stimulation within the home and in the community. Such innovations would 
include the implementation of a home-based parent-driven developmental stimulation 
programme (see Chapter 7). In the current setting it is recommended that parents be 
provided with an education session and be issued with the programme during their hospital 
stay post-cardiac intervention as this is the only certain point of contact based on the poor 
adherence of follow-up appointments.  
 
In this study, several parents reported inattention and hyperactivity in children older than 
two years. Therefore, it would be recommended that children in this population be monitored 
for attention-deficits, hyperactivity, autistic spectrum disorders and behavioural problems as 
they enter their preschool and school years.  
 
The tendency of children with CHD with DS to have considerably poorer developmental 
outcomes warrants that children who present with CHD with DS be specifically targeted for 
regular neurodevelopmental follow-up and intensive EI therapy in order to optimise 
developmental outcomes in this subgroup of children with CHD. 
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Health-related quality of life  
 
Although the HRQOL of the children in this study was good, it is recommended that HRQOL 
be established for all children with CHD as part of standard cardiac care and holistic patient 
management, taking into consideration the International Classification of Functioning, 
Disability and Health for Children and Youth (ICF-CY) framework. Mechanisms need to be 
put in place in cardiac units in SA to provide adequate psychosocial and developmental 
support to children with CHD so as to optimise their HRQOL.  
 
Parenting stress  
 
Regular routine screening of families for risk of psychosocial morbidity across the cardiac 
care continuum will assist in identifying families who would benefit from both psychological 
and education interventions. It is recommended that cardiac parent support groups be 
established, as they could prove beneficial in providing emotional support to these parents 
and assist in mediating parenting stress.  
 
6.16 Research implications  
 
Moving past the goalpost of survival, and attending to the promotion of optimal outcomes in 
at-risk children with CHD and their families, it is of critical importance that studies with larger 
samples (through multicentre research collaborations) and long-term follow-up be 
conducted so as to identify ways in which to best assist these children and their families. 
Against the aforementioned background ssuggestions for further research is provided in the 
following section for each of the key areas of focus. 
 
Growth  
 
Based on the high prevalence and the extent of the growth failure identified in children in 
this study, further research is needed to further investigate the growth outcomes of children 
with CHD more comprehensively over time. Research is also needed to determine the 
prevalence and nature of feeding difficulties in this population.  
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The best ways of providing appropriate nutritional support, in conjunction with medical care, 
for children with CHD in resource-poor settings needs investigation. The effectiveness of 
feeding interventions, including growth monitoring, nutritional advice, and nutritional 
supplementation, will need to be established.  
 
Neurodevelopment  
 
Further collaborative research is necessary to establish the developmental outcome of 
children serviced by cardiac units across SA.  
 
Further research is also indicated to more comprehensively investigate the combined impact 
of CHD and DS in a larger sample of children.  
 
Considering the high burden of HIV in sub-Saharan Africa it is important for clinicians to 
keep record of the HIV status of all children with CHD, including those children who are HIV 
infected, HIV exposed but uninfected and those HIV unexposed, to allow future studies to 
investigate the neurodevelopmental outcomes for these subgroups of the children. 
 
The developmental screening, evaluation and referral practices of clinicians treating children 
with CHD in SA (including paediatricians, cardiologists and cardiothoracic surgeons) needs 
to be determined, as does their awareness of- and implementation of the AHA 
developmental evaluation and management guidelines for children with CHD. 
 
In addition, further research is required to determine the most appropriate cardiac 
neurodevelopmental follow-up programme model for implementation in resource-
constrained settings, such as SA. The feasibility of running cardiac neurodevelopmental 
follow-up programmes in SA, and their ability to identify and refer children in need of 
developmental support, needs to be investigated.  
 
Based on the preliminary findings of this study, research also needs to be done to identify 
the specific EI service requirements of children with CHD in SA. 
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Furthermore, research is needed regarding the feasibility and suitability of implementing the 
home-based parent-driven developmental stimulation programme as an innovative 
alternative for the provision of early developmental intervention in children with CHD in a 
geographically challenged and resource-constrained environment.   
 
A suitable developmental screening tool for use in a busy clinical setting in SA also needs 
to be identified and tested in children with CHD to evaluate its effectiveness in identifying 
children with CHD who are at risk of developmental delay, and who are in need of more 
comprehensive developmental assessment.  
 
It is further suggested that children in this sample be followed up into their preschool and 
school-going years as part of longitudinal research into outcomes in this population.  
 
Health-related Quality of Life  
 
Further qualitative research is recommended to explore in more detail and depth the 
perceptions of parents of their children’s HRQOL and the physical and psychosocial factors 
affecting HRQOL. 
 
Longitudinal research is also needed to establish changes in HRQOL over time and with the 
changing developmental age of the child. In older children, child self-reported and parent 
and healthcare practitioner reported HRQOL outcomes should be compared and seen in 
combination to provide a complete picture. 
 
In addition, suitable interventions need to be identified and explored that will enhance the 
health and wellbeing of children with CHD. 
 
Parenting stress  
 
Studying parenting stress outcomes is complex, as there are multiple factors that may 
influence individual stress outcomes. Factors that need to be taken into consideration 
include a genetic predisposition to anxiety and depression, personality and temperament, 
life stressors in play at the time and resiliency factors. Identifying specific factors that impact 
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on individual parenting stress outcomes will require testing in a larger sample using multiple 
methods of data collection. It would be recommended that when investigating parenting 
stress both self-administered questionnaires and semi-structure interviews (qualitative) be 
included to adequately explore the factors influencing parenting stress.  
 
Research is required to investigate the stress experienced by parents in the cardiac ICU, 
identifying the stressors at play in this environment.  
 
In addition, longitudinal research is needed in SA to establish changes in parenting stress 
over time and with the changing developmental age of the child.  
 
Further research is also necessary to determine the true impact of social disadvantage, 
including variables such as SES and level of parent education on resilience and the ability 
of parents to cope with caring for a child with CHD in SA. 
  
Additional research is required to determine the effect of educational interventions in 
reducing parenting stress. 
 
Further research is also needed to determine the effectiveness of cardiac parent support 
groups in mediating parenting stress in parents of children with CHD.  
 
16.17 Conclusion 
 
The majority of the children in the current study had acyanotic heart disease and most of 
the children had moderate disease severity. Most of the families were from a low 
socioeconomic class and the parents had low levels of education. This is in contrast with 
most of the outcome studies done in developed countries where many more children in the 
cohorts studied had cyanotic heart defects and severe cardiac disease, including HLHS. 
Most families represented in studies performed in developed countries were from middle 
class socioeconomic backgrounds and parents were better educated. Differences in patient 
and family profiles, as well as methodological differences and varying outcome measures 
used, largely accounted for the difference in findings. However, it is encouraging to note that 
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the surgical outcomes of children in the current study were comparable with those in 
developed countries.  
 
Suboptimal growth was prevalent in the majority of the children in the current study prior to 
cardiac surgery. The children with cyanotic disease tended to have poorer growth both prior 
to and after cardiac intervention due to poor feeding and increased metabolic demands. 
Growth retardation prior to cardiac intervention was also associated with poorer motor 
development prior to cardiac surgery due to lack of energy, and secondary muscle 
weakness and hypotonia preventing them from engaging in typical age-related physical 
activities. The extent of the growth retardation in the current study was greater than that 
reported for children in developed countries, but similar to reports for developing countries. 
Growth retardation in children with CHD in developing countries is likely to be exacerbated 
by poverty and possible HIV co-infection. Consistent with the literature significant catch-up 
growth for both weight and head circumference took place in the children in the current study 
after cardiac intervention, but complete catch up growth had not yet occurred by the six-
month post-cardiac intervention. The growth trajectories for the children with DS were similar 
to the children without DS. 
 
The developmental profile and prevalence of developmental delays in the current study was 
comparable to those of children with CHD in developed countries. Consistent with the 
literature, motor development was the area of development most affected in younger 
children before cardiac intervention in the current study. Motor outcomes improved post-
cardiac intervention and with increasing age. Cognitive and language development declined 
with increasing age and skill complexity. The presence of DS was consistently associated 
with poorer developmental outcomes across all developmental domains. The developmental 
outcomes of the children with cyanotic and acyanotic heart defects were similar, most likely 
due to the moderate severity of most of the cyanotic heart defects in the current study. 
Despite the majority of the children in the current study having moderate disease severity, 
the extent of developmental delays was found to be greater. It is probable that social 
disadvantage exacerbated the extent of the developmental delays in the current study. The 
lack of significant changes in developmental outcome over the duration of the study can be 
attributed to the low average trajectories that characterise development in children with 
CHD, and the relatively short duration of follow-up. 
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The parents in the current study perceived their children as having a good QOL, comparable 
to their same-aged healthy peers. The children with cyanotic and acyanotic heart defects 
had a similar HRQOL, likely due to the fact that most of the cyanotic defects included in the 
current study were moderate in nature. Children with DS however tended to have a poorer 
HRQOL than the children without DS. Motor development was significantly associated with 
HRQOL prior to cardiac intervention in the current study. Physical activity limitations and 
delayed motor skill acquisition were likely to influence the parents’ perceptions of their child’s 
HRQOL. Parenting stress was also significantly associated with HRQOL prior to cardiac 
intervention. Parents’ perception of their child’s developmental status and general health 
was likely to have influenced their perception of their child’s HRQOL. In the current study, 
there was a significant improvement in parental perception of their child’s HRQOL at three-
month post-cardiac intervention, which remained relatively consistent at six-month post-
cardiac intervention. This is comparable to the findings in the literature. Improved perception 
of their children’s HRQOL is likely due to the resolution or improvement in the child’s cardiac 
symptoms and their improved physical abilities. HRQOL outcomes for the children with 
cyanotic and acyanotic disease were similar, because most cyanotic defects in the current 
study were not severe. The children with DS tended toward poorer HRQOL outcomes than 
the children without DS. 
 
The majority of parents in the current study reported clinically significant levels of stress in 
the period immediately before cardiac intervention, and found the surgery and ICU stay 
particularly stressful. This is consistent with the literature. Even though parenting stress 
declined significantly at both three-month and six-month post-cardiac intervention, a number 
of parents continued to experience clinically significant stress. Consistent with the literature, 
mothers in the current study reported a high burden of care prior to cardiac intervention and 
financial problems aggravated the stress they already experienced in their parenting role. 
Perceived HRQOL before cardiac intervention, language development, age of the mother, 
and age at surgery were significantly associated with levels of parenting stress.  
 
The developmental findings were used to develop a home-based parent-driven 
developmental activity programme to meet the developmental needs identified from the 
results of the study presented in Chapter five and the discussion of the findings in Chapter 
six. The development of the home-based developmental activity programme will be 
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presented in Chapter seven. The final conclusions drawn from this study will be presented 
in Chapter eight.  
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CHAPTER 7 
 
DEVELOPMENT OF A HOME-BASED DEVELOPMENTAL ACTIVITY 
PROGRAMME (PHASE III) 
__________________________________________________________________ 
 
 
This chapter describes the processes involved in the development of a home-based 
developmental activity programme and the supplemental information document. Results 
indicating the nature of the developmental delay in the current study population will also be 
highlighted.  
 
This chapter is divided into two sections. In Section I, relevant literature on early 
developmental intervention programmes and home programmes implemented in paediatric 
populations at risk of or who present with developmental delay will be presented in support 
of the rationale behind the design, development, content and proposed implementation of 
the programme developed as part of Phase III of this study. Early developmental intervention 
programmes and cardiac rehabilitation programmes conducted in young children with CHD 
will be reviewed to determine the feasibility of such programmes in this population.  
 
Section II will present Phase III of this research study. Development of the programme took 
place within the context of two important theoretical frameworks applied widely in paediatric 
therapeutic clinical practice, namely family-centred care and the International Classification 
of Functioning, Disability and Health (ICF). A detailed description of the rationale, design 
and content of the developmental home activity programme and supplemental information 
document will be presented. The methods employed to validate the content of the home-
based developmental activity programme via an expert panel of experienced EI therapists 
and a focus group of selected parents who participated in the current study will be outlined. 
Key findings from the expert panel and focus group will be highlighted, and the final home-
based developmental activity programme and information document will be presented. 
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7.1 Introduction 
 
It is well established that children with CHD are at risk of developmental delay. Prospective 
longitudinal research studies have demonstrated that this risk does in fact become a reality 
(Long et al., 2015). The patterns of development in the young children with CHD included in 
this study are in keeping with the patterns of development described in global scientific 
literature in that motor delays are most common in young children with CHD (Long et al., 
2015; Mussatto et al., 2014; Long et al., 2012a; Snookes et al., 2010), and that language 
and cognitive deficits emerge over time and with increasing age (Mussatto et al., 2014; Long 
et al., 2012a; Brosig Soto et al., 2011). Developmental delay was also greater in children 
with genetic abnormalities, including DS (Alsaied et al., 2016; Mussatto et al., 2014; Brosig 
Soto et al., 2011; Visootsak et al., 2011). 
 
Developmental outcomes in the current study sample affirms the view that 
neurodevelopmental follow-up and early therapeutic intervention need to be incorporated 
into routine cardiac care in SA, as in developed countries, in order to optimise developmental 
outcome and the HRQOL of young children living with CHD. How best to implement 
developmental follow-up and intervention in the cardiac population in SA is yet to be 
determined. Limited human resources within the healthcare sector and the social 
disadvantage faced by many families living in the country need to be taken into account in 
the design, content and mode of delivery of developmental intervention programmes, if such 
programmes are in any way to be feasible (Potterton et al., 2010). 
 
7.2 Literature Review  
 
7.2.1 Theoretical frameworks 
 
Family-centred care and the International Classification of Functioning, Disability and Health 
(ICF) are theoretical frameworks that are widely applied in paediatric clinical therapeutic 
practice. Family-centred care used in combination with the ICF serves to identify the 
dimensions of health and wellbeing that should be addressed in early developmental 
intervention. Both frameworks provide valuable insights into the design and content of early 
developmental intervention programmes, where there is a focus on enhancing activity and 
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participation, as well as the facilitation of environmental modifications. In addition, these 
frameworks support the rationale of why home programmes are considered a desirable 
means of providing therapeutic intervention (Novak and Cusick, 2006).   
 
7.2.1.1 Family-centred care  
 
Family-centred care is an approach that follows the philosophy that the family plays an 
imperative role in the health and wellbeing of its members. Family-centred care serves to 
empower the family to be able to participate in the planning, delivery and evaluation of 
healthcare services provided to their child (Spearing, 2015; Novak and Cusick, 2006). 
  
In a family-centred approach, parents are viewed as experts in determining the needs of 
their child (Novak et al., 2007; Novak and Cusick, 2006). As the child lives at home in the 
care of their family, intervention should be planned and designed in partnership with parents 
in order to reflect the individual family’s priorities (Novak and Cusick, 2006). In clinical 
practice, this would imply that parents have the right to define the priorities for therapeutic 
intervention and, in collaboration with the therapist, help direct and implement the 
intervention so that services meet the family’s needs (Novak and Cusick, 2006). Today the 
involvement of parents in the provision of EI services, including home programmes, is 
considered to be critical to the success of these services (Novak et al., 2007; Novak and 
Cusick, 2006; Blauw-Hospers et al., 2011). Home programmes are routinely used as part of 
family-centred practice as they inherently recognise the expert caregiving abilities of the 
family (Novak and Cusick, 2006).  
 
7.2.1.2 International Classification of Functioning, Disability and Health (ICF) 
  
The World Health Organisation (2001) developed the International Classification of 
Functioning, Disability and Health (ICF) in order to provide a scientific basis for  
understanding health and health-related states (Palisano et al., 2012; WHO, 2001). The ICF 
serves to define components of health, as well as health-related aspects such as wellbeing 
(Versaw-Barnes and Wood, 2015; WHO, 2001).  
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The ICF-CY version is derived from the ICF (WHO, 2001). It was designed with the purpose 
of better describing the characteristics of the developing child relevant to aspects of health 
and functioning (WHO, 2007). The ICF-CY includes the same content as the ICF, but has 
additional content covering the developmental characteristics of children from birth up to 18 
years (WHO, 2007). The domains contained within the ICF and ICF-CY include body 
functions and structures, activities and participation (Versaw-Barnes and Wood, 2015; 
Palisano et al., 2012; WHO, 2007; WHO, 2001). The WHO model also takes contextual 
factors into account, including the interaction between the three components of the ICF and 
the child’s own environmental and personal factors (Versaw-Barnes and Wood, 2015; 
Palisano et al., 2012).  
 
Figure 7.1 provides a schematic representation of the ICF-CY model (WHO, 2007). 
 
Figure 7.1 The ICF-CY model (WHO, 2007).  
 
To provide a practical example, when applying the ICF framework in the young child living 
with CHD, it could be postulated that the child could present with various impairments of 
body function and structure, including musculoskeletal impairments (muscle weakness), 
cardiopulmonary impairments (poor cardiac function, exercise intolerance and recurrent 
respiratory tract infections), neuromuscular impairments (low muscle tone, poor motor 
control and poor coordination), and pain. Activity limitations could include delayed milestone 
achievement and poor endurance during physical activity. Participation will reflect how the 
above-mentioned impairments of body structure and function, as well as the activity 
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limitations, affect the child’s participation at home during daily activities or during play 
(Gocha-Marchese, 2015). Participation in life situations in turn is considered an important 
aspect of HRQOL (Palisano et al., 2012). In addition, childhood development is a dynamic 
process and the functioning of the child is dependent on the continued interaction with family 
and other caregivers. Therefore, the functioning of the child cannot be seen in isolation, but 
rather in the context of the family system. Family interactions, as well as the quality of the 
social and physical environment are considered to have a significant impact on childhood 
development (WHO, 2007). The environment and quality of stimulation can be influenced 
through early developmental intervention and home programmes (Versaw-Barnes and 
Wood, 2015; Novak and Cusick, 2006).  
 
7.2.2 Early developmental intervention  
 
Childhood development is an important determinant of health across the lifespan, and early 
developmental opportunities create a critical foundation for a child’s later academic success 
and general wellbeing (Anderson et al., 2003). The term “early developmental intervention” 
refers to educational and neuroprotective strategies that aim to enhance brain development 
and optimise developmental and functional outcome. Early educational strategies seek to 
take advantage of cerebral plasticity, while neuroprotective strategies include interventions 
that promote typical development and prevent disability. Neuroprotective strategies would 
include therapeutic intervention and environmental modifications that aim to provide early, 
appropriate developmental stimulation (Bonnier, 2008; Spittle et al., 2007). It is generally 
accepted that early developmental intervention programmes should be initiated during the 
first year of life, and may continue through toddlerhood and the preschool years (Spittle et 
al., 2007). 
 
Initially, early developmental intervention programmes were developed for children at risk of 
developmental delays. These included children at high developmental risk because of 
poverty, children with disorders associated with developmental delay including DS and 
cerebral palsy, and children at risk as a result of being born preterm or at a low birth weight 
(Bonnier, 2008). Available scientific literature on EI relates to programmes implemented in 
the aforementioned populations.  
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7.2.2.1 Components of early intervention programmes 
 
A problem encountered when reviewing available EI studies is that most studies provide 
some information on the intervention, but none provide sufficient detail of the intervention to 
enable replication of the programme (Benzies et al., 2013). Mothers were involved in the 
delivery of all documented EI programmes by virtue of their role as primary caregiver 
(Benzies et al., 2013).  
 
Benzies et al. (2013) performed a systematic review of the published literature on early 
developmental intervention programmes in preterm infants. They aimed to identify key 
components of EI programmes.  From their review, they identified four key components. 
These were (i) providing support to parents through advice, anticipatory guidance and/or 
emotional support; (ii) parent education through information, demonstration, discussion, 
active engagement and feedback from a healthcare professional; (iii) increasing parental 
awareness of their influence on their child’s development, and (iv) the promotion of parental 
wellbeing. Similarly, Blauw-Hospers et al. (2011) implemented an EI programme that made 
use of an approach that included family involvement, parental education, therapeutic 
handling and providing the infant with the opportunity for repeated practice and play. 
 
There is a growing body of evidence that early developmental intervention programmes 
should be aimed at enhancing the parent-child relationship and the provision of an optimal 
environment with appropriate stimulation for learning and development. Such programmes 
will be best suited and most likely to promote motor, cognitive and social development 
(Colditz et al., 2015; Blauw-Hospers et al., 2011; Bonnier, 2008; Spittle et al., 2007). 
Parenting practices have been shown to have a significant influence on a child’s 
development (Colditz et al., 2015). Therefore there should be emphasis on parent education 
regarding developmental milestones and appropriate stimulation, empowering them to 
support their child’s skills development. Play should also form an important part of any early 
developmental intervention programmes (Colditz et al., 2015; Blauw-Hosper et al., 2011; 
Spittle et al., 2007).  
 
The content of home-based early developmental intervention programmes should be based 
on clinical assessment findings (Spittle et al., 2007). Home programmes provided to parents 
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are to include activities, exercises and suggestions for toys (Spittle et al., 2007). Blauw-
Hospers et al. (2011) further advise that the activities provided should challenge the child to 
the limit of their capabilities, and that development may be best promoted by providing the 
child with opportunities to explore their environment by means of trial and error practice. 
 
7.2.2.2 Effectiveness of early intervention programmes  
 
Most children at risk of, or presenting with developmental delay are referred to EI services 
(Spittle et al., 2007), despite the lack of scientific evidence supporting their effectiveness 
(Blauw-Hospers et al., 2011; Bonnier, 2008; Blauw-Hospers et al., 2007; Spittle et al., 2007). 
Additional research is required to determine best practice regarding the design, content and 
implementation of early developmental intervention programmes (Spittle et al., 2007). 
 
Spittle et al. (2007) reviewed the effectiveness of early developmental intervention provided 
to infants born preterm post-hospital discharge. They found that there was no standardised 
protocol for the provision of intervention and that the programmes described in the literature 
varied greatly. There is also a paucity of information on intervention frequency and dosage. 
It has been suggested that for home-based developmental intervention, the programme 
should be implemented daily or at least five days per week for at least 20 minutes per day 
(Spittle et al., 2007). The optimal timing and duration of EI programmes however remains 
undetermined (Bonnier, 2008).  
 
There are noted challenges in implementing early developmental intervention programmes 
in at-risk populations. Hospital-based, therapist-driven programmes face challenges relating 
to the accessibility of the services to families, and the availability of adequate financing and 
human resources within the healthcare sector to provide therapeutic interventions services 
(Colditz et al., 2015; Spittle et al., 2007).   
 
7.2.3 Home programmes  
 
Home programmes are therapeutic interventions specifically designed for implementation 
within the home, and in the context of daily family life. These programmes are driven by and 
evaluated by families through interactions with therapists (Engle et al., 2007; Novak and 
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Cusick, 2006). Therapists working in paediatrics often make use of home-based 
developmental activity programmes to assist parents in caring for children at risk of, or who 
present with developmental delay. Home-based, parent-driven intervention needs to be 
considered as a viable alternative to hospital-based therapist-driven intervention, in that it 
provides the possibility of sustained exposure to intervention at a low cost (Colditz et al., 
2015). Home programmes may therefore hold the greatest potential to impact development 
over the long-term in at-risk populations (McConnell et al., 2014; Spittle et al., 2007; 
Tétreault et al., 2003).  
 
There are several advantages to implementing home-based programmes. Home 
programmes are more convenient and offer more flexibility to families (Novak et al., 2009). 
In addition, home programmes present an attractive option in an overburdened healthcare 
system with a shortage of therapists and long waiting times to access therapy. It also 
provides access to intervention for families who cannot access hospital-based, direct 
interventions due to geographical and financial constraints (Novak et al., 2009; Tétreault et 
al., 2003).  
  
7.2.3.1 Components of home programmes 
 
Home programmes are widely used, despite the lack of clinical guidelines to inform 
therapists’ decision-making regarding the design, development, implementation and 
evaluation of these programmes (Novak et al., 2009; Novak and Cusick, 2006). In an attempt 
to address the lack of directives on home programmes, Novak and Cusick (2006) developed 
a model for home programmes containing tasks and strategies therapists can employ when 
developing and implementing home programmes within the context of the ICF and family-
centred care. The model includes five phases namely (i) establishing a collaborative 
relationship with the family, (ii) collaborative goals setting, (iii) development of the home 
programme, (iv) delivery of the home programme and supporting implementation, and (v) 
evaluating the effectiveness and outcome of the programme (Novak et al., 2009; Novak and 
Cusick, 2006).  
 
Home programmes are considered to play a vital role in assisting families in achieving the 
desired health outcomes for their child (Novak and Cusick, 2006). Therapists serve as expert 
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partners in home programmes, working with parents to support their child’s development. 
This is achieved by enhancing caregiver competency and providing the necessary 
knowledge, skills and resources to enable the family to address the child’s developmental 
needs within the context of their daily life and meaningful participation at home, and during 
daily activities such as bathing, feeding, dressing and play (Potterton et al., 2010; Engle et 
al., 2007; Novak and Cusick, 2006). 
 
Home programme development should be based on assessment findings and the concerns 
and priorities identified by the family (Potterton et al., 2010; Novak and Cusick, 2006; 
Tėtreault et al., 2003). Activities contained in home programmes should form part of the 
daily routine and fit into the family’s lifestyle. Activities should preferably be embedded in 
functional activities and skills. In addition the programme should be flexible, providing 
alternative activities that provide parents with a variety of activities they could do (Potterton 
et al., 2010; Novak et al., 2009; Novak and Cusick, 2006; Tėtreault et al., 2003). Suggested 
activities should be playful and easy to do (Potterton et al., 2010; Novak and Cusick, 2006). 
When prescribing home programmes, parents should also be advised on how to create a 
stimulating home environment (Tėtreault et al., 2003).  
 
Home programmes work best for parents if they are documented. Parents are more likely to 
engage in the activities at home if they can be referenced. It has been found that written 
information, supplemented by pictorials work best (Novak and Cusick, 2006). Home 
programmes should be disseminated in brochure or booklet form and where indicated the 
programme activities may be demonstrated to enhance execution at home (Novak and 
Cusick, 2006).  
 
Parents often find it difficult to maintain momentum with home programme implementation 
over the long-term (Novak, 2011); and adherence to home programmes varies. Adherence 
may be affected by the burden the intervention places on families with respect to effort and 
time (Spittle et al., 2007). The literature highlights several other reasons for non-adherence. 
These reasons include busy family life, family maladjustment to the child’s health condition, 
difficulties within the home situation, tedious activities often contained in home programmes, 
poor parental perception of the value of the activities contained in home programmes, and 
difficulties in the parent-child relationship (McConnell et al., 2014; Novak and Cusick, 2006; 
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Tétreault et al., 2003). Other noted challenges include marital status, family size, SES and 
the child’s age (Tétreault et al., 2003). Even when parents adhere to home activity 
programmes, it may come at a personal cost. Caring for a child with greater needs is more 
demanding and time consuming, and home programmes may further contribute to parental 
strain and fatigue. Therapists need to be cognisant of this when prescribing home 
programmes to families (McConnell et al., 2014; Tėtreault et al., 2003). The families’ 
perception of the value of the home programme will determine whether therapy is viewed 
as important, and ultimately successful (Novak and Cusick, 2006). Furthermore, parents’ 
satisfaction with the programme provided to them also affects adherence (Spittle et al., 
2007). Providing parents with an appropriate home programme has been found to increase 
parents’ satisfaction with therapy services (Novak et al., 2009). 
 
7.2.3.2 Effectiveness of home programmes 
 
There is overwhelming support for home programmes, and their importance is well 
recognised; however, their effectiveness in improving function and participation has not 
been proven (Novak and Cusick, 2006; Tėtreault et al., 2003). There is also a lack of 
guidelines to inform therapists of the frequency, intensity and duration of home programme 
implementation (Novak and Cusick, 2006). 
 
Novak et al. (2009) investigated the implementation of home programmes in children with 
cerebral palsy and found that median programme implementation time of 15 minutes per 
session at a frequency of at least four times per week was adequate to bring about 
improvements in function and participation. Longer periods or ongoing intervention via home 
programmes are more likely to effect change (Novak et al., 2009). Novak (2011) suggested 
that interdisciplinary home programmes might be more effective than numerous individual 
programmes. It would be easier for parents to implement a single integrated programme 
addressing all the domains of development at home rather than multiple individual 
programmes provided by several therapists.  
 
Further research is needed into the effectiveness of home programmes. Therapists need to 
establish more clearly the burden that home programmes place on families in order to adapt 
programmes to enhance participation, and thus ultimately their effectiveness, but also 
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promote the wellbeing of the family (Tėtreault et al., 2003). 
 
Potterton et al. (2010) investigated the effectiveness of a basic home stimulation programme 
in improving the developmental outcome of young HIV-infected children in SA. They found 
that empowering mothers with a basic home stimulation programme had the potential to 
significantly improve development outcomes. 
 
It has been recommended that adherence to home programmes can be encouraged and 
monitored via telephone or SMS text message (Novak et al., 2009). Where parents have 
access to electronic devices and the internet, advanced video technologies such as Skype 
can be used as a means of evaluating outcome and adapting home programmes (Rhodan, 
2013). However, in developing countries where many parents do not have access to such 
technologies follow-up by telephone or SMS text message is the best available option. 
Evaluation of the effectiveness and updating of home programmes in developing countries 
is likely best done in person at appointments that are scheduled to coincide with other 
hospital-based appointments (Potterton et al., 2010). 
 
7.2.4 Developmental intervention in children with congenital heart disease 
 
To date there has been minimal investigation into the feasibility and effectiveness of early 
developmental intervention and home programmes in young children living with CHD who 
are at risk of or who present with developmental delays (Long et al., 2015; Steiber et al., 
2012; Brosig Soto et al., 2011). In addition to developmental delay, children with CHD are 
also known to present with exercise intolerance and decreased physical endurance during 
activity (Tikkanen et al., 2012). Despite this, there are no available guidelines for cardiac 
rehabilitation or physical activity prescription in young children with CHD (Tikkanen et al., 
2012). 
 
7.2.4.1 Evidence-based approach to developmental intervention in children with 
congenital heart disease  
 
The specific guideline published by the American Heart Association (2012) targets the early 
identification and management of developmental delays and disorders in children with CHD, 
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with the goal of optimising developmental outcome (Marino et al., 2012). The guidelines 
provided on developmental screening and evaluation are expansive, but there is a lack of 
information on the management of developmental delays once identified. The guideline 
simply states that a collaborative interdisciplinary approach should be followed with the 
referral of the child  and family to EI therapy services to address the areas of development 
in which the child is having difficulty. EI therapy services include PT, ST and OT. No further 
information is provided on the design, content and dosage of these developmental 
interventions. The guideline also makes no mention of physical activity prescription or 
cardiac rehabilitation as part of intervention. Given the possibility that the early appropriate 
intervention may potentially alter the long-term neurodevelopmental outcome and HRQOL 
of children living with CHD (Knutson et al., 2016), further clarification on the nature of the 
intervention is therefore required as part of the  management guideline. 
 
7.2.4.2 Early developmental intervention for children with congenital heart disease 
 
Despite evidence regarding the occurrence of neurodevelopmental delays in children with 
CHD, little research has been done to examine intervention programmes to address these 
developmental delays (Long et al., 2015; Steiber et al., 2012; Brosig Soto et al., 2011). Both 
of the documented programmes implemented by Long et al. (2015) and Steiber et al. (2012) 
failed to follow an interdisciplinary approach and addressed only a single area of 
development. Both programmes were developed and presented by physiotherapists in an 
attempt to improve motor development outcomes (Long et al., 2015; Steiber et al., 2012).  
 
Kendall et al. (2003) and Lewin et al. (2002) investigated the extent to which rehabilitation 
services were provided to young children with CHD in the UK. Eighty-two percent of the 
participants in their study, who were all healthcare practitioners directly involved in paediatric 
cardiac care, indicated that there was a need for rehabilitation services. Contrary to the 
identified need, children’s rehabilitation priorities were only discussed by the cardiac team 
in 41% of cases. Brosig Soto et al. (2011) reported that only 51.6% of children with CHD 
were referred to EI services. These findings were similar to the referral rates to EI services 
reported in a study by Hoskoppel et al. (2010). More concerning is that 31% of children 
meeting the criteria for EI did not receive these services (Brosig Soto et al., 2011).   
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The timing of initiating intervention in children with CHD proved to be a challenge as noted 
in the studies by Long et al. (2015), Steiber et al. (2012) and Brosig Soto et al. (2011). The 
perception of families’ of the need for developmental intervention posed a considerable 
hurdle. Placing a high priority on early therapeutic intervention to address developmental 
concerns may seem inappropriate to families who are to face or have just faced a major 
cardiac surgery or even a life-and-death situation. As children recover post-intervention and 
do better, parents may feel that there is no longer any need for developmental intervention. 
This may contribute to families failing to access EI services despite referral. The 
aforementioned studies however remain unclear on whether the lack of EI services being 
accessed by families is because of family factors, such as interest and availability of time, 
or a lack of access to EI services due to human resource and financial constraints within the 
healthcare sector. According to Long et al. (2015) a large number of families staying a 
considerable distance from service points are lost to follow-up; and this would also need to 
be factored into the timing of implementing early developmental intervention in this 
population. 
 
There are only two reported studies to date that have investigated the feasibility of early 
developmental intervention in children with CHD. Long et al. (2015) investigated the efficacy 
of a physiotherapy EI programme on the gross motor development of infants with CHD using 
both a hospital-based and home-based-intervention approach in Australia. Home-based 
intervention was provided to participants who resided a considerable distance from the 
service point; while hospital-based EI appointments were scheduled for local families to 
coincide with other hospital appointments in an attempt to improve compliance. Intervention 
was provided on a needs basis. The frequency of the intervention sessions was weekly, bi-
weekly or monthly, based on the extent of the developmental delay. The participants who 
received the home-based intervention were provided with a single physiotherapy session 
prior to hospital discharge following cardiac intervention. Parents were provided with home-
based strategies to address identified gross motor delays. The study intake was stopped 
after ten months as the hospital-based intervention strategy proved to be infeasible. 
 
Steiber et al. (2012) investigated the feasibility of a ten-week, play-based, parent-delivered 
home-based EI programme on motor development in children aged 12 to 26 months with 
CHD in Canada. Play-based activities were individualised in accordance with each child’s 
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developmental age. Two motor development goals were selected as the target activities for 
each two-week period. For each target activity, the parents were provided with four to six 
play-based activity options using games and songs. Parents were asked to engage their 
child in one or more of the options for a total of ten minutes or more each day so that the 
total intervention time per day was 20 minutes. Adherence to the home-based rehabilitation 
programme ranged from 0 to 100%, with only two families reporting complete adherence to 
the prescribed programme.  
 
Long et al. (2015) and Steiber et al. (2012) both noted that the distance parents had to travel 
to access hospital-based services posed a significant hindrance to the implementation of 
early developmental intervention programmes. As cardiac surgery is usually performed at a 
cardiac centre located in a large city, patients often come from a wide geographical 
catchment area. Long et al. (2015) made the clear determination that hospital-based EI 
services were impracticable and poorly suited to address the developmental needs of young 
children with CHD. 
 
The implementation of home-based developmental intervention programmes in young 
children with CHD is however in itself not without its challenges. When parents within the 
home setting administer an intervention programme, adherence and the effectiveness of the 
intervention provided become extremely hard to measure (Steiber et al., 2012).   
 
Family education should be provided as part of EI programmes, and should include 
information on sternal precautions to be adhered to post-operatively and age-appropriate 
developmental positioning. The importance of physical activity and early developmental 
intervention should also be emphasised (Hanson, 2015). 
 
Evidence suggests that the developmental needs of children with CHD are for the most part 
not being met globally. Convincing both parents and the cardiac community that early 
therapeutic intervention improves developmental outcome, prevents morbidity and improves 
HRQOL requires scientific evidence that is not currently available. According to Long et al. 
(2015) the required evidence can only be gathered through ongoing scientific research 
where the early developmental intervention programme design, content and method of 
delivery are well documented. The frequency and dosage of intervention also needs to be 
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assessed objectively in order to determine the dosage required to bring about changes in 
developmental outcome. Clinical guidelines for early developmental intervention in young 
children with CHD can only then be compiled and put into practice (Long et al., 2015).  
 
7.2.4.3 Use of prone positioning as a developmental position in children with 
congenital heart disease  
 
Play provides a vehicle for exploration of the environment. The child awaiting cardiac 
surgery often has very little opportunity for play and physical exploration (Hanson, 2015). 
Despite environmental limitations pre-operatively and post-operatively, children with CHD 
should be exposed to, and parents should encourage all developmental positions, including 
prone if tolerated. If not tolerated parents should try to make use of modified prone 
positioning over a towel roll, cushion or over the mother’s shoulder (Hanson, 2015). If 
children are not regularly placed in prone while awake they may become intolerant of the 
position (Dudek-Shriber and Zelazny, 2007). Prone is considered an important 
developmental position as it is considered a forerunner for other developmental positions 
including crawling and weight bearing on the upper limbs (Du et al., 2015; Hanson, 2015). 
In addition, prone development has been found to influence milestone achievement in other 
developmental positions such as supine and sitting (Dudek-Shriber and Zelazny, 2007).  
Prone is seldom contraindicated in children with CHD, apart from in the immediate post-
operative period following a median sternotomy. Parents should be advised to encourage 
“tummy time” from two weeks after sternal closure, depending on tolerance, with a goal of 
40 minutes per day, which can alternatively be broken down into four ten minute sessions 
(Lucile Packard Children’s Hospital, 2015).  
 
7.2.4.4 Physical activity prescription in young children with congenital heart disease 
 
Physical activity is considered a basic requirement for childhood development. Perceptual 
and motor experiences determine physical and motor development, and also affect 
emotional, psychosocial and cognitive development (Müller et al., 2013; Bjarnason-Wehrens 
et al., 2007a). Survivors of CHD often present with comorbidities that impair their physical 
abilities. On top of physical impairments, development is often negatively impacted by 
environmental factors, such as parental overprotection, which may further predispose the 
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child to physical inactivity and exercise intolerance. This may potentially have serious long-
term development and HRQOL implications for CHD survivors (Du et al., 2015; Müller et al., 
2013; Tikkanen et al., 2012; Bjarnason-Wehrens et al., 2007a).   
 
The impact of parental overprotection on development and physical endurance cannot be 
underestimated. Parents unnecessarily restrict their child’s physical activity, and are often 
uninformed about the potential benefits of physical activity (Müller et al., 2013; Bjarnason-
Wehrens et al., 2007a). Children with CHD require no restriction of physical activity unless 
there is significant cardiovascular compromise. Therefore, most children with CHD can and 
should participate in the same physical activities as their same-aged healthy peers (Hanson, 
2015; Tikkanen et al., 2012; Bjarnason-Wehrens et al., 2007a). 
 
The benefits of physical activity are not restricted to the cardiovascular system alone, but 
may also address comorbidities in other systems affected by CHD. Cardiorespiratory 
complications may limit the capacity for physical activity, but mobilisation and physical 
activity on the other hand may serve to improve cardiorespiratory function. Increased 
physical activity may also in turn address neurodevelopmental concerns such as 
developmental delays, musculoskeletal problems and low muscle tone. A strong relationship 
exists between muscle strength and physical endurance and exercise tolerance; therefore, 
improving muscle strength would prove beneficial in improving physical endurance (Hanson, 
2015; Riner and Hunt Selhorst, 2013; Tikkanen et al., 2012; Bjarnason-Wehrens et al., 
2007a). 
 
One would anticipate that the benefits associated with exercise training in adults with 
cardiovascular disease would be transferable to even young children with heart disease, but 
to date there has been limited published research into paediatric cardiac rehabilitation. 
There is no published research on cardiac rehabilitation and activity prescription in children 
with CHD under the age of four years. The findings in the few published studies in children 
aged four years and older strongly support the benefits of incorporating physical activity in 
rehabilitation programmes for children with CHD (Tikkanen et al., 2012).  
 
There are no clear guidelines available on physical activity prescription in young children 
with CHD (Du et al., 2015). There is insufficient evidence to recommend formal exercise 
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programmes in infants and toddlers as a means of increasing physical activity (AAP, 2006). 
The American Academy of Paediatrics (AAP) (2006) does however encourage parents to 
provide a safe, nurturing and minimally structured play environment for infants and toddlers. 
Similarly, Hanson (2015) and Bjarnason-Wehrens et al. (2007a) suggest that parents should 
allow their toddlers or pre-schoolers with CHD to partake in unrestricted physical activity and 
participatory activities, such as play to enhance the physical, emotional, psychosocial and 
cognitive development, ultimately improving their  child’s HRQOL. 
 
The aforementioned recommendations provided by the American Academy of Paediatrics 
(2006), Hanson (2015) and Bjarnason-Wehrens et al. (2007a) are very broad, and parents 
are likely to require more specific instruction regarding physical activity and play to 
encourage adherence. It would be an oversight not to also consider the application of the 
FITT (frequency, intensity, type and timing) principles of exercise prescription, as 
recommended in the American College of Sports Medicine (ACSM) (2006) guideline, when 
considering the prescription of a home-based developmental activity programme for young 
children with CHD (Haskell et al., 2007).  
 
The FITT principles are outlined in Figure 7.2.  
 
 
Figure 7.2 FITT principles of exercise prescription (American College of Sports 
Medicine, 2006) 
Frequency:
3-5/week  
Intensity:
Moderate   
Type: 
Activities that 
promote strength, 
endurance and 
flexibility 
Time:
150 
minutes/week  
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Applying the FITT principles in physical activity prescription for infants and toddlers with 
CHD, where physical activity is focused on age-appropriate developmental activities and 
play, requires some innovative adaptation. The following recommendations can be made, 
taking into consideration the activity prescription guideline proposed by Du et al. (2015) for 
their prospective study on exercise intervention (passive movement and active exercise) in 
infants with CHD. 
 
Frequency 
 
It has been suggested in children aged four years and older that physical activity provided 
five days a week would suffice in improving physical endurance and exercise tolerance (Du 
et al., 2015). This is in line with the ACSM guideline (2006), and therefore it could be 
recommended that young children with CHD should engage in daily physical activity.  
 
Intensity  
 
Though the ACSM guidelines recommend physical activity of moderate intensity, how 
exactly this translates into dosage in young children is yet unclear. Du et al. (2015) 
suggested that a short duration, low-dose intervention programme of physical activity as 
developmentally appropriate as possible, would be best-suited (Du et al., 2015). 
 
Time (duration) 
 
It has been suggested in children aged four years and older that physical activity provided 
for 25 minutes per day, will suffice in improving endurance and physical activity (Du et al., 
2015). This aligns with the suggested 20 minute duration of home-based developmental 
intervention proposed by Steiber et al. (2012), Novak (2009) and Spittle et al. (2007). 
 
Type  
 
Du et al. (2015) noted that physical activities should include developmental activities that 
are appropriate for the child’s age. This aligns with intervention activities used by Long et al. 
(2015) and Steiber et al. (2012) as part of EI programmes in children with CHD. 
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In conclusion, there is a clear need for therapeutic intervention that includes age-appropriate 
physical activity in order to adequately address physical endurance and exercise intolerance 
concerns in children with CHD (Hanson, 2015; Tikkanen et al., 2012; Bjarnason-Wehrens 
et al., 2007a). As evidenced, the use of developmentally appropriate physical activity to 
improve physical endurance and exercise tolerance in young children with CHD is 
undervalued and underutilised as part of therapeutic intervention. The best design of 
physical activity programmes in young children with CHD remains unclear. From a parent-
centred care perspective, it is recommended that physical activity programmes be home-
based and parent driven (Tikkanen et al., 2012; Bjarnason-Wehrens et al., 2007a; 
Bjarnason-Wehrens et al., 2007b). As parental fear may be a barrier to children partaking in 
physical activities (Bjarnason-Wehrens et al., 2007a; Bjarnason-Wehrens et al., 2007b), 
parent education on the benefits of physical activity and the provision of clear physical 
activity guidelines are to be considered an important component of home-based 
developmental activity programmes (Tikkanen et al., 2012). 
 
7.3 Rationale and development of the home-based parent-driven developmental 
activity programme 
 
7.3.1 Introduction  
 
Scant information is currently available in the literature on parent-driven, home-based EI for 
young children with CHD. The strongest scientific evidence, as presented above, was used 
to determine the framework for the development of the home-based developmental activity 
programme. Long et al. (2015) strongly recommended that future research into home-based 
developmental intervention in children with CHD should clearly define the design, content, 
dosage and implementation strategy used so as to determine best practice. In light of this, 
the process for the development of this home-based developmental intervention will be 
described comprehensively.   
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7.3.2 Rationale behind the home-based parent-driven developmental activity 
programme 
 
In keeping with current best practice evidence, it was decided to develop the programme 
within the framework of family-centred care and the ICF-CY. Thus it was decided that the 
programme should be home-based and parent-driven to optimise the child’s functional 
abilities and enhance participation in his/her own home environment and community. 
Further motivation for designing a home-based, parent-driven programme was the 
consideration that families face considerable challenges in accessing hospital-based 
services due to geographical and financial constraints. The aforementioned challenges as 
relevant to the current study population were discussed in Chapter 6.  
 
There is an extreme shortage of experienced neurodevelopmental therapists throughout the 
public health sector in the SA. In addition, cardiac centres do not have the funding available 
to appoint therapists to run CNPs and provide EI therapy services to these children. A 
community-based service will also likely be impracticable. Community rehabilitation services 
are understaffed and tend to be provided by recently qualified and inexperienced therapists. 
Therefore the only practicable option of providing high quality, sustainable, long-term early 
developmental intervention in this population would be that EI therapy services be initiated 
at specialist cardiac units by experienced therapists, but be home-based and parent-driven. 
 
After the determination that the best-suited mode of programme delivery would be home-
based and parent-driven it was decided that Novak and Cusick’s (2006) model for home 
programmes would serve as a suitable framework from which to develop this programme.  
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7.3.3 Development of the home-based parent-driven developmental activity 
programme  
 
The steps taken in the development of this home-based, parent-driven developmental 
stimulation programme are presented below: 
 
Step1: Establishing a collaborative relationship with key stakeholders 
 
The researcher established a collaborative relationship with the families recruited into the 
study over the six-month period during which their children were followed-up after cardiac 
intervention. Parents often provided invaluable insights into their fears, concerns, wishes 
and needs during these assessments. This anecdotal information proved extremely valuable 
when determining the format and content of the programme.  
 
Satisfaction regarding the proposed content of the developmental home activity programme 
was established with key stakeholders, including parents who would have to execute and 
participate in the programme at home with their child, as well as rehabilitation therapists who 
would be responsible for providing the programme. This was done via a focus group of 
parents who took part in this study and an expert panel of rehabilitation therapists working 
in early childhood development (this included occupational therapists, physiotherapists and 
speech therapists). 
 
Step 2: Goal Setting  
 
Developmental aspects that would need to be addressed in the programme were identified 
from the developmental outcomes of the participants in Phase I and Phase II of the current 
study where cognitive, language and motor performance was determined using the BSID-
III. The goal was to develop a single, interdisciplinary programme that would address all 
developmental domains including cognition, receptive and expressive language and fine 
and gross motor function. A single interdisciplinary programme allowed for implementation 
by a single therapist if need be; this taking into consideration the shortage of experienced 
neurodevelopmental therapists in the country.  
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The programme had to be suitable for all children with CHD, including those at risk of or 
presenting with developmental delays. Considering the high loss to follow-up and the large 
number of parents who are unlikely to access EI services post-intervention, the issuing of 
this programme prior to discharge would provide parents with a developmental activity 
guide, which they could reference, and use over time. It would also be suggested that 
children and their parents be seen as part of a CNP at routine cardiology follow-up visits so 
that any development concerns can be addressed and the implementation of the 
developmental activity programme supported.  
 
Step 3: Design and content of the programme 
 
The programme is a home-based parent-driven developmental activity programme. 
 
Parental education is deemed critical to the implementation of the home programme. 
During this study, several aspects were identified that would need to be addressed as part 
of parent information in this population. It was identified that parents needed information on 
the relationship between CHD and developmental risk, developmental milestones, the 
importance of providing suitable developmental stimulation and encouraging physical 
activities at home, as well as the importance of adequate nutrition. A number of the children 
in this study had CHD with DS and parents required additional information on the unique 
developmental challenges facing their children. Another important gap identified during 
Phase I of this study was that parents were not being provided with any information 
regarding sternum precautions, appropriate developmental positioning (especially 
concerning prone positioning), and activity restriction post-cardiac surgery. In addition, no 
information was provided on wound care prior to hospital discharge. 
 
The content of the home programme was based on developmental outcomes and 
expected developmental skills. Bedford et al. (2013) aptly describes childhood development 
as a measure of abilities and aptitude, making comparisons with same-aged children. 
Developmental performance is usually described in terms of the developmental tasks the 
child can or cannot perform. Based on these grounds, the current EI literature strongly 
recommends that early developmental intervention and home programme content be based 
on assessment findings and that the child should be provided the opportunity to master skills 
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he/she is struggling with (Long et al., 2015; Steiber et al., 2012; Potterton et al., 2010; Spittle 
et al., 2007; Novak and Cusick, 2006). 
 
From clinical experience, it is to be considered likely that therapists will provide advice and 
prescribe developmental activities for a home programme based on skills that the child 
struggled with or could not do during assessment. Aligning an intervention and home 
programme with the assessment findings provides continuity and increases parental 
acceptability of the assessment test (Bedford et al., 2013). The age-appropriate 
developmental skills tested under the various domains of the BSID-III were determined 
through an extensive literature review process to determine age-expected skills (Bayley, 
2006a). The developmental skills contained in the BSID-III are not unique to the BSID-III 
alone. Similar skills are tested by 13 other developmental outcome measures, which cover 
all the developmental domains of interest. These measures include the Denver II, Battelle 
Developmental Inventory Second Edition (BDI-2), Child Development Inventory (CDI), Child 
Development Review (CDR), Mullen Scales of Early Learning (MSEL), Brigance Early 
Childhood Screens, Griffiths Mental Development Scales-Extended revised (GMDS-ER), 
Schedule of Growing Skills-II and the Ages and Stages Questionnaire (ASQ-3). All of these 
measures assess universal developmental skills across key developmental domains 
(Bedford et al., 2013). 
  
Thus, the skills identified for age can be considered typical of childhood development and 
not specific to an individual measure. The BSID-III is viewed as the gold standard measure 
of development (Bedford et al., 2013; Marino et al., 2012). In the light of its high standing 
and strong psychometric properties the age expectations for skills development were 
considered a valid guide.  
 
ADL related to bathing, eating, playing and bedtime were considered important for parents 
to participate in. Suggestions were also included for age-appropriate toys and low-cost toy 
options for parents who could not afford expensive educational toys. The programme was 
to provide parents with a “resource toolbox” of developmental stimulation activities they 
could do at home. The array of activities offered parents flexibility and a variety of activities 
that could be changed on a daily basis.  
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A progressive programme of physical activities would be encouraged to improve physical 
endurance and exercise tolerance, as appropriate for age. Time for free play would also 
assist in this regard. The treatment dosage would be aligned with current suggestions for 
developmental intervention and physical activity prescription in young children. The 
recommended frequency for implementation of the home programme would be five times a 
week, with a minimum of at least three times per week. The target duration of the intervention 
should be at least 20 minutes per day. It would be recommended that the duration of physical 
activity be progressed incrementally to improve physical endurance and exercise tolerance.  
The programme would be issued to families in writing, and in colour, using an A5 booklet 
format. The booklet is supplemented by illustrations of developmental activities. In addition, 
parents would be provided with a written information document containing relevant parent 
education information. 
 
7.4 Method for Phase III 
 
Key stakeholders, including parents and rehabilitation therapists, were to be consulted to 
assess the validity and the suitability of the content of the home-based developmental 
activity programme that was developed in order to enhance the quality and validity thereof.   
 
7.4.1 Location 
 
The focus group of selected mothers who participated in Phase I and II of this study was 
held at the Physiotherapy Department at the Universitas Academic Hospital in Bloemfontein. 
The expert panel members were contacted electronically via e-mail and telephone due to 
the geographical diversity and busy schedules of the healthcare professionals involved. 
 
7.4.2 Ethical considerations 
 
Ethical clearance was obtained for Phase III of this study (together with Phase I and II) from 
the Ethics Committee of the Faculty of Health Sciences, University of the Free State 
(clearance certificate number ECUFS 177/2013) and the Committee for Research on 
Human Subjects, University of Witwatersrand (clearance certificate number M131056). 
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Participants in Phase III of this study included a select group of mothers, who participated 
in Phase I and II, and rehabilitation experts. All participants were informed of the purpose of 
Phase III of this study by means of an information letter; further verbal explanation was 
provided by the researcher upon request. Parents provided written informed consent (See 
Appendix XVIII) before the focus group commenced, and therapists consented to 
participation by reviewing the home activity programme sent to them electronically and 
submitting their feedback (See Appendix XIX).   
 
A contribution was made towards the transportation costs incurred by the mothers for their 
attendance of the focus group. No remuneration was provided to the rehabilitation therapists 
for their participation. The study was conducted in line with the approved protocol. 
Participation in this, Phase III of this study, was voluntary. Parents and rehabilitation experts 
had the right to decline participation or withdraw at any point without reason or risk of 
penalty. 
 
7.4.3 Study design 
 
Phase III made use of a qualitative study design.  
 
7.4.4 Participants 
 
Phase III of this study consisted of two groups of participants, namely the focus group of 
mothers and a panel of rehabilitation experts.   
 
7.4.4.1 Focus group 
 
Six mothers, who had exited Phase II of the study, were invited to participate in the focus 
group to gain consensus on the content of the home developmental activity programme. 
They were selected due to their personal knowledge of caring for a child living with CHD, 
and had been through the process of the three developmental assessments on the BSID-III 
that formed part of Phase I and Phase II of this study.  
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It was decided that including six mothers in the focus group would be sufficient in the 
consensus-gaining process on the home-based developmental activity programme in this 
study. The focus group size was aligned with the group size recommended in the literature. 
According to Sagoe (2012), Wong (2008), Lakshman et al. (2000) and Kitzinger (1995), a 
focus group in medical research should typically be between four and 12 people.  
 
Mothers were selected for the focus group if they met the following inclusion criteria: 
§ Had to have taken part in Phase I and II of the study, and exited the study at the end 
of Phase II. 
§ Had to be English literate. 
§ Resided in and around Bloemfontein and could easily commute to Universitas 
Academic Hospital for the session. 
§ Provided written informed consent for their participation in Phase III. 
§ We’re willing and able to attend the scheduled group session. 
 
7.4.4.2 Expert panel  
 
A panel of six rehabilitation experts including physiotherapists, occupational therapists and 
speech therapists, were selected for their experience in working in early developmental 
intervention services in SA. Representation of all three of the therapeutic allied health 
professions was decided upon, based on the multiple domains of development contained in 
the developmental home activity programme, as well as the goal of the programme being 
able to be presented in clinical practice by any member of the rehabilitation team.  
 
The following inclusion criteria were applied for the expert panel of rehabilitation therapists: 
§ Were practising at the time of the study as a physiotherapist, occupational therapist 
or speech therapist in SA. 
§ Had neurodevelopmental therapy (NDT) certification as a minimum requirement, but 
having advanced NDT certification in early intervention was considered beneficial. 
§ Had at least five years’ working experience in early childhood intervention services. 
Experience working with children with CHD was considered advantageous. 
§ Provided consent to participate in the expert panel during Phase III of the study by 
reviewing the programme and submitting feedback. 
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Due to the qualitative nature of the research, a purposive sampling method was used to 
identify six rehabilitation experts who met the inclusion criteria. The aim of the expert panel 
was to gain consensus about the content of the home-based developmental activity 
programme. It was decided that six rehabilitation experts would be sufficient in the 
consensus-gaining process on the developmental home activity programme in this study.  
 
The size of the expert panel was within the recommendations provided in the literature. 
According to Jones and Hunter (1995) it is recommended that a medical expert panel consist 
of up to a maximum of 12 members. The number of participants in an expert panel to gain 
consensus varies considerably in medical consensus studies done to date and depends 
largely on the topic of investigation.  
 
7.5 Procedure for Phase III 
 
Following the final six-month post-cardiac intervention follow-up all developmental 
assessments on the BSID-III for Phase I and II were scored and the data analysed to 
establish the prevalence and nature of the developmental problems faced by children with 
CHD in this sample. It was found that children with CHD presented with developmental 
delays following the patterns described in chapter 5 (Refer to section 5.7). Motor delays 
were most prevalent before cardiac intervention and during infancy, and language and 
cognitive delays became more apparent with age. Children with DS presented with more 
significant delays in all developmental domains, compared with children with CHD without 
DS. Developmental outcome findings and a comprehensive literature review were used in 
the development of the developmental home activity programme, as already described.  
 
Following the compilation of the home-based developmental activity programme, consensus 
about the content of the programme amongst the key stakeholders was established (CDC, 
2006). Key stakeholders were considered to be the rehabilitation professionals who would 
be providing the programme to families, as well as parents who would be encouraged to 
participate in the programme at home. Phase III took approximately four months to 
complete. The focus group and the expert panel ran in parallel. 
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The procedure for both the focus group and expert panel will be described below: 
 
7.5.1 Focus Group 
 
A focus group discussion is a qualitative research method whereby a small group of 
participants gather to discuss a specific topic in order to generate data. Characteristic of a 
focus group is the interaction between the facilitator and the group, as well as the interaction 
between the group members. The main objective of a focus group is to gain an 
understanding of the participants’ perspective on the topic of discussion (Wong, 2008).  
 
Seven mothers met the aforementioned inclusion criteria, and were identified for potential 
participation in the focus group. These mothers were contacted via telephone and SMS text 
message to invite them to participate in the focus group. Two of the mothers were 
subsequently found to be untraceable at the contact numbers previously provided, despite 
repeated attempts. Two mothers were unable to attend the scheduled group session as they 
had subsequently been employed after exiting the study and could not afford to miss a day’s 
work. However, they were willing to review the programme in their own time and provided 
their input when contacted telephonically afterwards. Three of the mothers contacted were 
willing to participate in the focus group session.  
 
In an attempt to increase and enhance the quality of the feedback provided by parents from 
this study, the researcher reviewed the clinic appointments for March 2016 to see if any 
families who had participated in the study, but resided outside of Bloemfontein, were 
scheduled for a cardiology follow-up visit. Two mothers were identified and contacted at the 
clinic, and were willing to review the programme in their own time. They were contacted 
telephonically for feedback on the programme afterwards.  
 
A date was identified for the focus group and the details were communicated to the three 
participating parents. They were reminded telephonically and via text message of the 
session by the researcher three days before the scheduled session and on the day before 
the session. One of the three mothers who participated in the focus group had a child with 
DS. The focus group was held in the committee room at the Department of Physiotherapy 
at Universitas Hospital. This provided comfortable seating and a table at which to write. 
Refreshments were provided. The researcher served as the facilitator (interviewer) of the 
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group. At the session, the facilitator explained the aim of the session and orientated the 
parents in regards to the procedures. Written informed consent was obtained from each 
participant before starting. Parents were provided with a pen, as well as a copy of the 
information document (See Appendix XX) and the developmental activity programme (See 
Appendix XXI) printed in colour and in A5 booklet form. Parents were given 40 minutes to 
read through and review the documents provided to them. Any additional comments could 
be noted on the documents with the pen provided. A discussion followed regarding their 
experiences, as well as the comments and suggestions provided.  
 
Parents were sent home with the home programme and encouraged to think about the 
document again and were followed up 10 days later to find out if there were any additional 
comments. Parents who reviewed the programme outside of the group context were 
contacted via telephone for their input.  
 
7.5.2 Expert Panel   
 
According to Jones and Hunter (1995) the use of an expert panel in medical research is a 
qualitative method applied in order to gain consensus and synthesise information. An expert 
panel is to be considered invaluable in areas of medical research where published 
information is inadequate or not available, providing a method of gaining information and 
the insights of appropriate experts to enable decision-making. As very little published 
information is available on the content of developmental home programmes, it proved the 
most suitable means of gaining consensus on the content of the developmental activity 
programme.  
 
Two physiotherapists, two occupational therapists and two speech therapists who met the 
inclusion criteria, were identified and selected for the expert panel. These therapists were 
contacted via e-mail inviting them to participate in this study. An information letter was 
included in the e-mail sent out to them. The developmental activity programme was sent to 
the therapists electronically to review. By reviewing the programme and providing feedback, 
the expert was agreeing to participate. A clear deadline was provided for submission in all 
feedback. Reminders were sent out every ten days via e-mail and SMS text message.  
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7.6 Interpretation of the findings from the focus group and expert panel 
 
7.6.1 Focus group  
 
It proved more logistically challenging than anticipated to get local mothers to attend the 
focus group, and only three mothers were able to attend.  An additional three mothers 
reviewed the programme independently and provided feedback over the phone. In total, 
feedback on the home-based developmental activity programme was received from six 
mothers.  
 
Anecdotal comments provided by parents during Phase I and II of the study were an 
important consideration in the development of the parent information document and the 
home-based developmental activity programme. Key areas parents commented on were 
listed for more in depth discussion during the focus group. These included the need for 
information on nutrition, developmental milestones, and signs for concern regarding 
developmental performance, suitable developmental stimulation within the home, and 
sternum precautions and activity restrictions post-cardiac surgery.  
 
Following the in-depth discussion of the tabled discussion points and their feedback on the 
home-based activity programme, parents indicated that they were satisfied with the content 
of the information document and home-based developmental activity programme and 
suggested no further additions. They indicated that they felt it would be important that these 
documents be issued on admission, as this would allow sufficient time for parents to read 
through them and ask questions before being discharged home. They were also of the 
opinion that an information session with the therapist to discuss the programme prior to 
discharge would be beneficial in encouraging adherence. They reported finding the 
precautions and activity limitation guidelines particularly important to have explained to them 
before discharge, as they were unsure of any precautions that needed to be applied.   
 
Parents felt the milestones as documented in the developmental activity programme were 
easy to read and understand. They particularly liked the activities that incorporated play and 
daily activities, and felt that the activities would be doable in their daily routine. The mothers 
also approved of the toy adaptations for low-income situations and found the advice 
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regarding toys to be important. They thought it feasible to issue the developmental activity 
programme in a two-hour education session post-cardiac intervention, but prior to discharge. 
The majority of the mothers were also of the opinion that they would like to have 
developmental activities explained to them, and where necessary, demonstrated. They also 
suggested that parents should be informed to come in earlier on the day of admission for 
cardiac surgery so that routine developmental assessment could be done in the morning 
before the child was admitted to the ward.  
 
Additional issues that came out in the discussion that were of importance included parents 
being satisfied with the information provided by the cardiac surgeon regarding the surgery 
beforehand, however all of them felt completely unprepared for seeing their child in the 
cardiac ICU. They found the experience was overwhelming and incredibly stressful. They 
voiced the need for better orientation to the cardiac ICU beforehand and the need to be 
informed about the drains, endotracheal tube and indwelling devices. Their child’s 
discomfort and pain was hard for them to witness, and they felt unable to care for or comfort 
their child in that situation.  
 
Parents’ valued the regular developmental assessments and follow-up. They felt that it 
reinforced that their children were progressing well, and allowed for questions and advice. 
They also indicated that they were in favour of the fact that that advice provided on 
developmental stimulation was aligned with the items that were tested during the 
developmental assessments. 
 
Parents indicated that they experienced very high levels of stress after their child’s CHD 
diagnosis. This stress was exacerbated by their experiences in the healthcare system. They 
viewed the most stressful time as being the period being just before cardiac surgery and 
when their child was in the cardiac ICU. All the parents were of the opinion that they would 
have benefited from additional psychological support and counselling during this period, in 
particular. They felt that the study follow-up visits provided additional support to them, and 
they enjoyed the regular sessions. They expressed the need for their children’s development 
to be followed up over the long-term. They were also of the opinion that the SMS text 
message reminders for follow-up appointments contributed to their adherence.  
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The mothers unanimously motivated for the establishment of a support group for parents of 
children with CHD at the Cardiac Unit at Universitas Academic Hospital. They were of the 
opinion that parents going through the same experiences could share their experiences, and 
that they could support each other. Mothers whose children had already been through 
cardiac surgery could provide valuable insights to other parents regarding their lived 
experiences.   
 
7.6.2 Expert panel  
 
All the therapists were pleased with the home-based developmental activity programme 
provided to them for review, and were of the opinion that it would be a valuable resource 
tool for families in the SA context. There were several comments made by the therapists 
that were carefully considered and weighed-up, where appropriate, minor amendments 
were made to the programme. The comments provided by panel members deemed to be 
important, will be discussed hereafter.  
 
A single therapist noted concern that some activities, skills and tasks contained in the home-
based developmental activity programme were similar to those tested on the BSID-III. The 
therapist also expressed concern that the stimulation items and toys were similar to the 
testing items used in the BSID-III. In order to address this concern, it was deemed important 
to explain the rationale behind the choice of activities and toys under the rationale and 
development of the programme, supported by the relevant literature (See 7.3.3). The use of 
similar items can therefore be justified in that the programme aimed to align the home 
programme with the assessment findings to provide continuity and to make the test more 
acceptable to parents (Bedford et al., 2013).  Furthermore, the developmental skills 
contained in the BSID-III are not unique, but represent universal childhood developmental 
skills across key developmental domains (Bedford et al., 2013). 
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Based on the panel’s suggestions a few additions were made to the programme regarding 
the development of motor skills: 
 
§ Alternatives were to be provided for prone positioning flat on the floor. This included 
modified prone positioning over angled cushions or on the mothers chest when she 
was is reclined in a chair or lying down (Hanson, 2015). 
§ The age at the emergence of hand preference was noted under fine motor skills. 
Dominance starts to emerge from the age of two to three years of age, but however 
will be unreliable until the age of five or six years (Scharoun and Bryden, 2014). 
 
Based on the panel’s suggestions a few additions were made to the programme regarding 
the development of motor development skills: 
 
§ In the 7-9 month age category: child understands tone of voice was added. 
§ In the 10-12 month category: child is able to wave bye-bye, shakes head for no and 
uses sound combinations to refer to an object or person for example “wawa” for a 
dog was added. 
 
Both speech therapists were of the opinion that more feeding information could be included 
in the programme. Although feeding is considered an extremely important aspect to address 
in children with CHD, in light of the frequent occurrence of feeding difficulties and growth 
failure, care had to be taken not to “overburden” the activity programme and keep it true to 
its intended purpose. The main aim of the home programme was to promote physical activity 
and encourage the acquisition of age-appropriate developmental skills within the main 
domains of development including cognition, socialisation, language and motor skills. From 
this point of departure it was deemed inappropriate to add any additional information on 
feeding. In addition, addressing feeding concerns would require the expert assessment and 
input of a qualified speech therapist.  
 
As the aim of the home programme was also to improve physical endurance and activity 
tolerance in children with CHD, the researcher deemed it critical to develop guidelines for 
programme dosage regarding frequency, intensity time (duration) and type of activities 
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based on the available literature recommendations, as outlined under the rationale and 
development of the programme (See 7.3.1). 
 
7.7 Presentation of the parent information document  
 
The parent information document is presented in Appendix XX.   
 
7.8. Presentation of the home-based parent-driven developmental activity programme  
 
The home-based, parent-driven developmental activity programme is presented in Appendix 
XXI. The home programme has also been included in the booklet to provide a tangible 
experience of the booklet as it will be issued to parents going forward.  
 
7.9 Suggested model for implementation of the homed-based parent-driven 
developmental activity programme  
 
The final home-based developmental activity programme is ready for piloting and 
implementation. Based on the clinical experience of the researcher in this population the 
only viable time for implementation would be on admission for cardiac intervention and prior 
to discharge.  
 
A proposed model for the implementation of the home-based parent-driven developmental 
activity programme’s implementation for young children with CHD in central SA has been 
compiled (Refer to Appendix XXII).  
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CHAPTER 8 
 
CONCLUSION 
 
 
 
Over recent decades medical and surgical advances have significantly lowered the mortality 
rate for children born with congenital heart defects. CHD survivors are at high-risk of growth 
retardation and developmental morbidity that negatively affect their health-related quality of 
life (HRQOL). In addition, caring for a child with a chronic health condition such as CHD 
places a considerable financial and emotional burden on parents, putting them at risk of 
ongoing stress and psychosocial morbidity including anxiety and depression. The outcomes 
of children living with CHD and their families in South Africa (SA) are unknown. 
 
The aim of this study was to determine the pre-cardiac intervention and three-month and 
six-month post-cardiac intervention development, growth, HRQOL and burden of care 
outcomes of young children with CHD in central SA. Levels of parenting stress served as a 
proxy for burden of care. Additional objectives included comparing growth, development, 
HRQOL and parenting stress outcomes over time. The association between numerous 
variables and developmental, HRQOL and parenting stress outcomes determined. In 
addition, the developmental needs of young children living with CHD in central SA were to 
be identified, and a home-based developmental activity programme developed to meet 
these needs.  
  
In order to meet the Phase I and II objectives, an observational descriptive study was 
conducted. Forty-eight children aged 30 months and younger and their parents, who met 
the inclusion criteria, were recruited into the study prior to cardiac intervention at the 
Universitas Academic Hospital Paediatric Cardiac Unit in Bloemfontein. Development was 
established by means of the BSID-III, HRQOL by means of the PedsQLTM, and parenting 
stress by means of the PSI-SF. Growth outcomes were determined by calculating z-scores 
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for growth parameters using the WHO child growth standards and DS-specific growth charts. 
Sociodemographic information including maternal age, parental educational attainment and 
occupational status was collected using a self-developed questionnaire. Medical severity of 
the child’s cardiac disease was rated using the Cardiologists Perception of Medical Severity 
Scale. Socioeconomic status was determined using the Hollingshead Index of Social 
Position. 
 
Baseline data was collected for 40 children and their parents. Two children and their parents 
were excluded following baseline as the children failed to undergo cardiac surgery. In 
addition, loss to follow-up resulted in data only being collected for 25 parents at three-month 
and 22 parents at six-month post-cardiac intervention. The attrition rate was high with 47.5% 
of the children and their families missing at least one follow-up visit. 
 
The majority (75%) of the children in the current study were of black African ethnicity. The 
median age of the children at baseline was 7.4 months (with a range of 1.4 to 20.9 months). 
The majority of children (n=26) underwent open-heart surgery in infancy with 
cardiopulmonary bypass. Most children (n=30) had moderate disease severity, with 20% 
(n=8) having cyanotic lesions. A quarter of the children (n=10) were also diagnosed with DS. 
The median age of the mothers at baseline was 30 years (with a range of 16 to 43 years) 
and the average level of education for both mothers and fathers was grade nine to 11. Most 
mothers (n=33) did not work outside the home, and the majority of families (n=35) were from 
a low socioeconomic class. In most instances (97.5%) mothers fulfilled the role of primary 
caregiver. 
 
The majority (68%) of children had suboptimal growth prior to cardiac intervention. There 
was significant catch-up growth for both weight (p=0.04) and head circumference (p= 0.02) 
by the six-month post-cardiac intervention. Complete catch-up growth had not yet taken 
place by the six-month post-cardiac intervention, with 40.9% of the children still presenting 
with malnutrition. It is also most likely that small head circumference prior to cardiac-
intervention was growth related. The growth trends of children with CHD with DS were found 
to be similar to those of children with CHD without DS. Growth in children with cyanotic heart 
defects tended to be poorer both before and after cardiac intervention, but were comparable 
by six-month post cardiac intervention.  
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There was a high prevalence of mild to moderate developmental delay across all 
development domains. Over the study 29% of the children presented with delayed 
development. On average over the study period 12% of children presented with a delay in 
at least one area of development, whilst 17% presented with delays in two or more areas of 
development. Motor delays (27.5%) were most prevalent in younger children, prior cardiac 
intervention. Motor performance improved with age and post-cardiac intervention, but 
language and cognitive performance declined with age and increasing skill complexity. 
There was not a  significant change  in the developmental outcome of the children over time. 
The developmental outcome for children with cyanotic and acyanotic heart defects tended 
to be similar. The presence of DS was the variable found to be most significantly (p< 0.001) 
associated with the developmental outcome of the children across all developmental 
domains, and at all time points of assessment. Children with CHD with DS tended to have 
considerably poorer developmental outcomes compared to children with CHD without DS. 
Disease severity (p=0.02) and maternal age (p=0.01) were significantly associated with 
cognitive development. Age at first cardiac surgery was found to be significantly associated 
with language development both before cardiac intervention (p <0.01) and at three-months 
post-cardiac intervention (p=0.04). Suboptimal growth prior to cardiac intervention (p=0.04) 
and maternal age (p < 0.001) were significantly associated with motor development. 
 
 Although the patterns of development, and the prevalence of developmental delays, in the 
current studies were similar to those reported in developed countries, children living with 
CHD in central SA performed below the expected developmental levels for children with 
CHD when assessed on the BSID-III. Hypotonia was the most significant abnormal 
neurologic finding, with 45% of the children presenting with hypotonia prior to cardiac 
intervention. The hypotonia resolved in all children without DS by the six-month post-cardiac 
intervention. 
 
Overall parents perceived their children’s HRQOL as being relatively good, and similar to 
that of their healthy same-aged peers and other children with CHD in developed countries. 
Parents’ perception of their children’s HRQOL improved significantly after cardiac 
intervention (p= 0.04). Perceived HRQOL tended to be similar for children with cyanotic and 
acyanotic heart defects. Parents of children with CHD with DS tended to perceive their 
children’s HRQOL as poorer than that of children with CHD without DS. Motor development 
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(p=0.01) and levels of parenting stress (p=0.02) were significantly associated with parental 
perception of their children’s HRQOL prior to cardiac intervention.  
 
The majority of parents’ (60%) experienced clinically significant levels of stress prior to their 
children undergoing cardiac intervention. Parenting stress decreased significantly from pre-
cardiac intervention levels at both at three-months (p<0.001) and six-months (p<0.001) post-
cardiac intervention as the child’s cardiac symptoms resolved or declined, and their health 
status improved. Parents of children with cyanotic and acyanotic heart defects tended to 
experience similar levels of stress. Parents of children with CHD with DS tended to 
experience higher levels of ongoing stress compared with parents of children with CHD 
without DS. Parenting stress prior to cardiac intervention was significantly associated with 
parents’ perception of their child’s HRQOL (p=0.02) and language development (p=0.04). 
Parenting stress at three-month post-cardiac intervention was significantly associated with 
age at first cardiac surgery (p=0.03), language development (p=0.03) and level of maternal 
education (p=0.04). HRQOL and parenting stress outcomes were closely linked before 
cardiac intervention. Parents who perceived their child as having a poor ability to function in 
everyday situations showed increased levels of stress. 
 
Based on developmental performance on the BSID-III (subscale scores below 85), 59% of 
the children in this study would qualify for referral to EI; with many children requiring access 
to more than one service. A home-based parent-driven developmental activity programme 
would likely be best suited to meet the developmental needs of children with CHD living in 
central SA taking into account the need for services, the high rates of loss to follow-up,  the 
long distances to be travelled to the cardiac centres to access services, and the service 
delivery challenges faced within the public health sector in SA.  
 
Phase III resulted in the development of a home-based developmental activity programme 
to meet the identified developmental needs of children with CHD in central SA. Qualitative 
methods, including an expert panel of rehabilitation professionals and a focus group of 
parents, were used to gain consensus on the content of the developmental activity 
programme. 
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It was encouraging that the longer-term outcomes of children with CHD in central SA were 
not vastly different from those of children in developed countries. The greater extent of the 
growth retardation and developmental delay of children in the current study is however of 
concern, and likely attributable to social disadvantage. The findings in this study strongly 
support the implementation of a CNP as part of standard cardiac care in SA. Moving past 
the goalpost of survival, and attending to the promotion of optimal outcomes in at-risk 
children with CHD and their families, it is of critical importance that larger studies with long 
term follow-up be conducted to identify ways in which to best assist these children and their 
families. A home-based parent-driven developmental stimulation programme presents an 
innovative approach to meeting the developmental needs of young children living with CHD 
in a financial and human resource-constrained environment, challenged by geography.  
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APPENDIX I  
CLASSIFICATION OF CONGENITAL HEART DISEASE 
BASED ON THE NATURE OF THE DEFECT 
 
APPENDIX I  
CLASSIFICATION OF CONGENTIAL HEART DISEASE BASED ON 
THE NATURE OF THE DEFECT 
 
 
Table I.1 Classification of acyanotic congenital heart disease 
 
Diagnosis Nature of defect  Intervention required Outcome  
Acyanotic cardiac defects 
PDA The vascular connection between the 
pulmonary truncus and the aorta fails to 
close after birth. 
Cardiac catheterisation or 
cardiac surgery for repair.  
Excellent.  
ASD Abnormal opening in the atrial septum 
allowing the communication of blood 
between the left and right atrium. 
Cardiac catheterisation or 
cardiac heart surgery for 
repair. 
Excellent. 
VSD Abnormal opening in ventricular septum 
allowing the communication of blood 
between the left and right ventricle. 
Cardiac catheterisation or 
cardiac surgery for repair. 
Excellent. 
AVSD Central defect in the atrioventricular septum 
due to incomplete fusion of the tendocardial 
cushions, the membranous portion of the 
ventricular septum and the septal leaflets of 
the tricuspid and mitral valves. 
Cardiac surgery for repair. Excellent.   
AS Narrowing of the aortic valve resulting in 
obstruction to blood flow from the left 
ventricle. 
Cardiac catheterisation or 
cardiac surgery for repair.  
Excellent. 
PS Narrowing of the pulmonary valve resulting 
in obstruction to blood flow from the right 
ventricle 
Cardiac catheterisation or 
cardiac surgery for repair. 
Excellent. 
Coarctation 
of the aorta 
Congenital narrowing of the aorta as it 
leaves the heart in the segment of the aorta 
just after the arteries to the head and upper 
limb branch off 
Cardiac surgery for repair. Excellent. 
(Adapted from Hanson, 2015; Morrow, 2012; Starr and Tucker, 2005). 
Table I.2 Classification of cyanotic congenital heart disease 
 
Diagnosis Nature of lesion  Intervention required Outcome  
CYANOTIC CARDIAC DEFECTS 
 TOF 
 
Characterised by a high riding VSD, right 
ventricular hypertrophy, and pulmonary 
stenosis anomalous position of aorta. 
Staged cardiac surgery. 
 Early palliation and staged 
repair. 
Excellent. 
 HLHS Hypoplasia or absence of the left ventricle, 
and hypoplasia of the ascending aorta. 
Staged cardiac surgery for 
palliation Early palliation 
and later repair. If palliation 
fails will require cardiac 
transplant. 
Poorest of all 
defects. 
TGA and 
DORV 
Aorta arises from the right ventricle and the 
pulmonary artery from the left ventricle. In 
the case of DORV, the aorta and pulmonary 
artery both arise from the right ventricle. 
Staged cardiac surgery for 
palliation in the neonatal 
phase and early surgical 
correction via arterial switch 
procedure. 
Excellent. 
Interrupted 
aortic arch 
Faulty development of aortic arch system, 
the segment between left common carotid 
artery and the subclavian artery is absent. 
Usually associated with VSD shunting. 
Cardiac surgery to 
reconstruct and reconnect 
the aortic arch and close 
VSD. 
Excellent. 
 TAPVR Pulmonary venous blood return is to the 
right atrium or systemic veins instead of the 
left atrium. 
Cardiac surgery for repair. Excellent. 
Tricuspid 
atresia 
The tricuspid valve fails to develop. Staged cardiac surgery for 
palliation then surgery for 
repair. 
Excellent. 
Pulmonary 
atresia 
The pulmonary valve fails to develop Cardiac catherisation and 
staged cardiac surgery for 
palliation and later repair.  
Excellent. 
Truncus 
arteriosus 
Combined pulmonary artery and aorta, often 
accompanied by a VSD. 
Cardiac surgery. Excellent. 
(Adapted from Hanson, 2015; Morrow, 2012; Starr and Tucker, 2005). 
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APPENDIX II  
CLASSIFICATION OF CONGENITAL HEART DISEASE BASED ON 
MEDICAL SEVERITY 
 
Table II.1 Cardiologists perception of medical severity scale  
 
Grading Description  
1 Mild disorder requiring no therapy or effectively treated without surgery 
via cardiac catheterisation. 
Long-term follow up indicated. 
2 
 
 
Moderate disorder, the child is asymptomatic. 
Requires surgical correction (curative) or requires no therapy. The 
defect is easily repaired. 
3 Marked disorder, and the child is symptomatic. 
Surgical repair, which is often difficult, will be required (one or more 
procedures). Often-significant residual effects or need for further 
surgery. 
4 Severe disorder that is not correctable or requires complex palliative 
repair. 
(Yildiz et al., 2009; Uzark et al., 2003; DeMaso et al., 1991). 
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USER AGREEMENT FOR THE BSID-III 
 
 
Dear Robyn,  
 
Permission to use a Pearson assessment is inherent in the qualified purchase of the 
test materials in sufficient quantity to meet your research goals. In any event, Pearson 
has no objection to you using the Bayley Scales of Infant and Toddler Development, 
Third Edition (Bayley-III) and you may take this email response as formal 
permission from Pearson to use the test in its as-published formats in your 
student research.  
 
If you do not yet qualify to purchase the test, your professor or faculty supervisor may 
be able to assist you by lending their qualifications and supervising your use of the 
test. 
 
The BAYLEY-III is a sensitive clinical assessment that requires a high degree (CL2) to 
purchase, administer, score and interpret. It also represents Pearson copyright and 
trade secret material. As such, Pearson does not permit photocopying or other 
reproduction of our test materials by any means and for any purpose when they 
are readily available in our catalog. Consequently, you may not simply 
reproduce the Bayley-III test forms. 
 
Long term license agreements with our Test Authors prohibit Pearson from providing 
or licensing our test materials at no charge/gratis for any purpose. As a resident of 
South Africa, to qualify for and purchase additional Bayley-III test materials, please 
visit the following link to the product page in our Pearson Assessment UK online 
catalog: 
http://www.pearsonclinical.co.uk/Psychology/ChildCognitionNeuropsychologyandLang
uage/ChildGeneralAbilities/BayleyScalesofInfantandToddlerDevelopmentThirdEdition(
Bayley-III)/BayleyScalesofInfantandToddlerDevelopmentThirdEdition(Bayley-III).aspx  
 Finally, because of test security concerns, permission is not granted for appending 
tests to theses, dissertations, or reports of any kind. You may not include any actual 
assessment test items, discussion of any actual test items or inclusion of the actual 
assessment product in the body or appendix of your dissertation or thesis. You are 
only permitted to describe the test, its function and how it is administered and discuss 
the fact that you used the Test, your analysis, summary statistics, and the results. 
 
 
Regards, 
William H. Schryver 
 
William H. Schryver 
Senior Licensing Specialist 
Pearson  
Always Learning 
Learn more at www.psychorp.com 
Please respond only to pas.licensing@pearson.com 
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USER AGREEMENT FOR THE PEDSQLTM 
 
 
Dear Robyn, 
 
Thanks a lot for sending the signed documents. You will consequently find attached to 
this email the Infant scale module in US English, Afrikaans and Sesotho as well as the 
template and the linguistic validation guidelines for the translation of the Cardiac 
Module. I am also attaching the Scoring Manual for this Questionnaire.  
 
I would be most grateful if you could please kindly confirm safe reception. Many 
anticipated thanks. Please note that the backward translations of the cardiac module 
must by reviewed by the author for approval. Therefore ready I invite you to provide 
Mapi with them.  
 
You can consider this message as an authorization to use the PedsQL Questionnaire 
in your study. Please do not hesitate to get back to me should you have any question 
or need anything else. 
 
Kind regards, 
Piero 
 
Piero Bindi 
Information Resources Specialist 
PROs & ClinROs Information Support Unit 
 
Mapi Research Trust 
27 rue de la Villette | 69003 LYON | FRANCE  
Tel: +33 (0) 4 72 13 65 75 | Tel: +33 (0) 4 72 13 59 86 (Direct Line) 
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ETHICAL CLEARANCE FROM THE ETHICS COMMITTEE OF THE FACULTY 
OF HEALTH SCIENCES, UNIVERSITY OF THE FREE STATE 
 
  
  
  
 
 
 
 
 
 
 
 
 
  
ETHICAL CLEARANCE FROM THE HUMAN RESEARCH ETHICS (MEDICAL) 
COMMITTTE, UNIVERSITY OF THE WITWATERSRAND 
  
 
  
 
 
APPENDIX VII 
PERMISSION LETTERS FROM RELEVANT AUTHORITIES  
 
APPENDIX VII 
PERMISSION LETTERS FROM RELEVANT AUTHORITIES 
 
  


  
 
 
APPENDIX VIII  
PARENT INFORMATION LETTER AND INFORMED 
CONSENT FORM: 
PHASE I AND II  
 
APPENDIX VIII 
PARENT INFORMATION LETTER AND INFORMED CONSENT FORM:  
PHASE I AND II 
 
 
 
NEURODEVELOPMENT, QUALITY OF LIFE AND BURDEN OF CARE OF YOUNG 
CHILDREN WHO HAVE UNDERGONE CARDIAC INTERVENTIONS IN CENTRAL 
SOUTH AFRICA:  
THREE-MONTH AND SIX-MONTH POST CARDIAC INTERVENTION OUTCOMES  
 
 
Dear parent(s)/caregiver, 
 
My name is Robyn Smith and I am a physiotherapist. I am currently doing research as 
part of my Doctorate of Philosophy (PhD) studies at the University of the 
Witwatersrand (WITS). Research is simply the process by which one finds the answers 
to a question. 
 
Background and motivation 
 
Congenital heart defects are the most common birth defect affecting children. It is a 
serious condition, and depending on how severe the defect is, it can hold the risk of 
associated problems including delayed development and neurological problems.  
 
The ability to identify heart defects, and treat them at a young age has significantly 
improved over recent years. This has resulted in many more children now surviving 
and living into adulthood. It is becoming increasingly important to look at how children 
surviving heart defects are growing, developing and functioning in their everyday lives 
over time. It is also important to look at the quality of life of both the child and that of 
their family. This information is important to healthcare professionals in order for us to 
evaluate the standard of our services and to continue to improve the care we provide 
to children with heart conditions.  
 
To date very little research has been done, particularly in South Africa, regarding how 
children surviving heart defects are doing over time. There has also been no research 
regarding the benefit of early and continued developmental evaluation and the 
implementation of a home-based, parent-driven developmental stimulation programme 
in improving developmental outcome of children with congenital heart defects. 
 
Aim of the study 
 
I wish to determine your childs development and quality of life before their cardiac 
intervention, at three months after their cardiac intervention and again at six months 
after their cardiac intervention. I will be looking at changes in your childs development 
and quality of life over this period of time.   
 
I also wish to look at identifying possible risk factors for poor developmental outcome 
in South African children. I am also extremely interested in finding out how caring for a 
child with a congenital heart defect affects you and your family life, and how this 
contributes to the level of stress you are experiencing.  
 
Finally I hope to use the information I gather about the developmental difficulties 
experienced by children with congenital heart defects, to help me develop a home-
based, parent-driven developmental stimulation programme that will best address the 
needs of children with congenital heart defects.  
 
If your child meets the necessary inclusion criteria, I would like to invite you and your 
child to participate in this study. 
 
Format of the study 
 
After you consent to participate in the study and provide permission for your childs 
participation an initial assessment will be scheduled to take place at one of your 
routine cardiology clinic visits before any cardiac-intervention procedures take place. 
This baseline assessment will provide important information about your childs growth, 
development and quality of life before any cardiac intervention.   
 
I will consult your childs medical record and talk to your cardiologist to gather 
information about your childs condition and treatment. I will then interview you, the 
parent(s)/caregiver, in order to gather important information about your family and how 
caring for your child is impacting on your life. You will also be asked to complete two 
(2) brief questionnaires, one relating to the levels of stress you are currently 
experiencing, and one regarding your view of your childs quality of life.  
 
I will then do a physical assessment which will include looking at your childs vital signs 
(heart rate, breathing rate, blood pressure and levels of oxygen in their blood), growth 
(length, weight and head circumference) as well as doing a comprehensive 
assessment of your childs development.  The first assessment will take approximately 
one to one and a half hours to complete.  
 
 Your child will then undergo cardiac intervention which may be open heart surgery or 
an interventional catheter-based cardiology procedure. Upon discharge following the 
intervention I will schedule a follow-up appointment for three months after the 
procedure. I will contact you telephonically three days beforehand to remind you of 
your appointment.  
 
At your three-month follow-up visit I will again assess your childs vital signs, growth 
and development. You will again be asked to complete the same two (2) brief 
questionnaires as with the first assessment, and I will again ask about the burden of 
care. This visit will take approximately one hour. At the end of this visit I will schedule a 
follow-up appointment for six months after your childs initial cardiac intervention. I will 
contact you telephonically three days beforehand to remind you of your appointment. 
 
At your six month follow-up I will again assess your childs vital signs, growth and 
development. You will again be asked to complete the same two (2) brief 
questionnaires as with the first assessment, and I will again ask about the burden of 
care. This visit will take approximately one hour.  
 
Where ever possible follow-up appointments will be scheduled to coincide with your 
normal clinic visits to minimise any inconvenience, or as suitable to your schedule. If 
you are unable to attend a scheduled appointment I will request that you telephonically 
contact the researcher to reschedule your appointment as soon as is possible for you. 
 
The information gathered from these assessments will be used to determine the type 
of developmental problems experienced by children with congenital heart defects. I will 
then use this information to assist me in developing guidelines for a developmental 
stimulation programme aimed at addressing these specific needs. 
 
 After the completion of the initial part of the study you may subsequently be invited to 
participate in a group session aimed at evaluating whether such a home-based 
developmental stimulation programme would adequately meet your needs.  
 
Benefit of participating in the study  
 
Your child may not directly benefit from their participation in this study. Participation in 
this study will in no way influence the standard care your child receives.  
 
You will however have the benefits of regular, comprehensive assessment of your 
childs development and quality of life. 
 
Your participation will help determine the developmental needs of young children living 
with congenital heart disease in central South Africa. This information will assist me 
developing a home-based, parent-driven developmental stimulation programme that 
specifically addresses the needs of these children.  
 
Following the completion of the study if I identified any developmental concerns or your 
child requires any neurodevelopmental therapy your child will be referred accordingly 
to early intervention rehabilitation services. 
Ethical considerations 
 
This study holds no anticipated risk to you or your child. The assessments will be done 
in the Cardiology Department, Universitas Academic Hospital where medical personnel 
will be present. The physiotherapist is also experienced in working with children. 
 
Your participation as well as that of your child in this study is voluntary, you may 
decline to participate or withdraw yourself and your child from the study at any point 
without the risk of discrimination or penalty. Your child will continue to receive standard 
care irrespective of your participation in the study. 
 
You will not be remunerated for your participation in the study, but the researcher will 
reimburse you for your travelling costs for visits directly related to your participation in 
this study. An amount of R150 per visit will be provided per visit for transport. There 
are no additional costs to you personally for participating in the study. 
 
All information about you and your child will be treated as confidential, only the 
researcher and your doctors will have access to this information. Complete 
confidentiality cannot however be guaranteed, as this information may be required to 
be disclosed if requested by a court of law or an ethics committee review. 
 
Feedback on study outcome 
 
The results of the study can be requested from the researcher following the completion 
of the study.  
 
Presentation and publication of research findings 
 
The results of the study may be used in presentations at academic congresses or in 
print in the form in an accredited journal. In the above cases all data pertaining to 
participants will be presented in an anonymous manner and no individual will be 
identifiable. 
 
Ethical inquiries 
 
This protocol has been reviewed by two ethics committee. If you have any questions or 
concerns pertaining to the ethical aspects of the study you may contact the researcher 
or the secretariats of the following ethics committees: 
 
Ethics Committee of the Faculty of Health Sciences, University of Free State 
Office of secretariat  051-4052812 
    StraussHS@ufs.ac.za 
 
Medical Human Research Ethics Committee, University of Witwatersrand 
Office of secretariat  011-7171234  
    anisa.keshav@wits.ac.za 
 
If you have any inquiries, questions or concerns the researcher can be 
contacted at the following numbers: 
 
Robyn Smith       051- 4013303 (w) 
Lecturer /Physiotherapist     082 925 9367 (cell) 
Department of Physiotherapy 
University Free State 
 
INFORMED CONSENT 
 
I .........................................................................., have been informed about the study 
by the researcher, Mrs. Robyn Smith.  
 
I  ....................................................... agree to participate in this study.  
 
I hereby also grant permission that my child................................................................. 
may participate in this study.  
 
 I am aware that our participation is voluntary, and that we can decline participation or 
withdraw from the study at any point without risk of penalty. I am aware that my child 
will continue to receive standard care irrespective of our participation. 
 
 I hereby agree that Robyn Smith may assess my child and have access to his/her 
medical information.   
 
I am aware that I will only receive compensation of R150 per visit for our travelling 
costs for visits directly relating to our participation in this study.  
 
I agree to attend the visits with my child as scheduled by Mrs. Smith.  
 
I am aware that if any developmental concerns or problems are identified by Mrs. 
Smith during the course of the study my child will be referred to the appropriate 
rehabilitation services. 
 
 I have been informed that I may enquire about the study if I feel it is indicated, from 
either the researcher, Ms Smith or the secretariat of the ethics committees at the 
numbers provided in the information letter. 
 
I am aware that I can request the results of the study upon its completion. 
I am aware that the results of the study may be presented at academic congresses or 
in print in the form in a journal. I am aware that all our personal information will be 
treated as confidential and all results will be presented in an anonymous manner. 
 
I am aware that following my participation in this the first part of the study I may later 
be invited to participate in parent/caregiver group sessions to evaluate whether the 
home-based, parent-driven developmental stimulation programme that is going to be 
developed will meet my specific needs as a parent/caregiver. 
 
I am aware that I will be provided with a copy of the information letter and the 
signed copy of the informed consent for personal reference. 
 
Signature of the parent/caregiver  _______________________ 
Name in print     _______________________ 
Date      _______________________ 
 
Signature of the researcher   _______________________ 
Name in print     _______________________ 
Date      _______________________ 
 
Signature of a witness   _______________________ 
Name in print    _______________________ 
Date      _______________________ 
 
Signature of a translator    _______________________ 
(If applicable) 
Name in print    _______________________ 
Date      _______________________ 
  
 
 
APPENDIX IX 
DATA FORM: 
DEMOGRAPHIC INFORMATION OF THE CHILD AND 
FAMILY  
 
Subject number C
Demographic data parent/caregiver
Maternal age at birth of the child 
y y
Number of siblings
Do any of your other children also have heart defects?
Yes
No
Not applicable
If you are the child's mother please indicate if you had any of the following
conditions during your pregnancy
Diabetes mellitus
Overweight/obesity
Infections e.g. Rubella, toxoplasmosis
Unknown
Residence of Parent/ Caregiver where child resides
Bloemfontein 
Kimberley
Maseru 
Other 
If other, specify ______________________________
Ethnicity of the child
Black 
White
Coloured 
Asian
If other, specify _____________________________
What is your relationship with this child?
Mother/ stepmother/ foster mother
Father/ stepfather/ foster father
Grandmother 
Grandfather
Guardian 
If other , specify ___________________________
APPENDIX IX
DATA FORM: DEMOGRAPHIC INFORMATION OF THE CHILD AND FAMILY
What is your relationship with this child? (if a second person present)
Mother/ stepmother/ foster mother
Father/ stepfather/ foster father
Grandmother 
Grandfather
Guardian 
If other , specify ___________________________
What language is spoken primarily in the home?
English 
Afrikaans
Sesotho
Other, specify ___________________________
Socio-economic status of the family
Highest level of education of mother/caregiver
7 Graduate of a professional degree
6 University graduate
5 Partial university/at one year specialised training 
4 High school graduate 
3 Grade 9-11
2 Grade 7- 8
1 Grade 6 and less
0 Not applicable/ unknown 
Employment status of mother
Employed full time 
Part-time employment
Unemployed
Occupation/ job title mother ________________________________
Occupational score mother
9 Executive, owner of large business, major professional
8 Administrators, lesser professionals, owner medium size business
7 Small business owner, owner farm, managers, minor professional
6 Technicians, small business owner, semi-professional
5 Clerical and sales worker, small farm and business owner
4 Smaller business, skilled labourer, craftsmen, tenant farmer
3 Machine operator, semi-skilled labourer
2 Unskilled worker
1 Farm labourer, menial worker, student, housewife
0 Not applicable/unknown
Highest level of education of father  
7 Graduate of a professional degree
6 University graduate
5 Partial university/ one year specialised training 
4 High school graduate 
3 Grade 9-11
2 Grade 7- 8
1 Grade 6 and less
0 Not applicable/ unknown 
Employment status of father
Employed full time 
Part-time employment
Unemployed
Occupation/ job title father ________________________________
Occupational score mother /caregiver
9 Executive, owner of large business, major professional
8 Administrators, lesser professionals, owner medium size business
7 Small business owner, owner farm, managers, minor professional
6 Technicians, small business owner, semi-professional
5 Clerical and sales worker, small farm and business owner
4 Smaller business, skilled labourer, craftsmen, tenant farmer
3 Machine operator, semi-skilled labourer
2 Unskilled worker
1 Farm labourer, menial worker, student, housewife
0 Not applicable/unknown
Hollingshead socioeconomic status index  mother/caregiver
Hollingshead socioeconomic status index  father
Hollingshead socioeconomic status index  family
Social strata for the family
55-66 major business and professional
40-54 medium business, minor professional
30-39 clerical, craftsmen, sales worker
20-29 machinist, semi-skilled
9-18 unskilled labour, menial worker
Birth history of child
Date of birth 
y y m m d d
Birthweight grams
Gestation weeks
Apgar Scores /10 /10
Impact of CHD on the family (burden of care)
In the last year has your child been hospitalised? Yes No
If so how many times 
Reason for these admissions ______________________________
______________________________
______________________________
In the past month on how many days has your child been too ill to play/get up?
days
In the past month on how many days did your child require special  care? 
due to his/her physical health days
If you work outside the home please answer the following questions
in the past month
How many days did you miss work due to your child's physical health?
days 
How often does your child's physical health affect your daily routine at work?
Never 
Seldom 
Often 
Always 
How often does your child's health affect your ability to concentrate at work?
Never 
Seldom 
Often 
Always 
References:
Hollingshead, AA.1975. Four factor index of social status. Unpublished manuscript, 
Yale University, New Haven, Conneticut
Varni, JW. 2008. PedsQL Family information form
  
 
 
APPENDIX X 
DATA FORM: 
CARDIAC DIAGNOSIS, AND MEDICAL AND SURGICAL 
MANAGEMENT 
Subject number C
Congenital heart defect Diagnostic information 
Primary diagnosis _____________________________
_____________________________
_____________________________
Diagnostic ICD-10-CM coding 
Child's HIV status 
Unknown
HIV positive
HIV negative
CHD classification 
Cyanotic
Acyanotic
Severity of the heart defect 
Mild (requiring no therapy/effectively treated without surgery)
Moderate (surgically corrected (curative) no therapy
Moderate to severe (one or more surgery repair) 
Complex or severe disease uncorrectable or palliated 
Age at which the defect was diagnosed? months
Age when treatment commenced? months
Mangement of the CHD  to date (mark more than one option if indicated)
No treatment required
Conservative management including cardioactive drugs 
Cardiac catheterisation 
Surgery
Other
If other, specify ________________________________________________
DATA FORM: CARDIAC DIAGNOSIS, AND MEDICAL AND SURGICAL 
MANAGEMENT 
APPENDIX X
Presence of any known extracardiac associations
Presence of known genetic syndromes associated with CHD
None DiGeorge
Down Williams
Edward Noonan
Patau Marfan
Turner Kabuki
Holt-oram Goldenhar
Alagille Mitochondrial
Duchenne Pompes disease
Barth Hurler
Long QT Other 
If other, specify ____________________________________________
Presence of structural malformations associated with CHD
None Tracheo-oesophageal fistula
CHARGE Renal abnormalities
VACTERL Congenital diaphragmatic hernia
Anorectal malformation Muskuloskeletal abnormalities
Omphalocele Other 
Gastrochisis
If other, specify ____________________________________________
Presence of any known teratogens (environmental risks) associated with CHD
None Vitamin A (acne treatment)
Rubella Maternal alcohol consumption
Maternal diabestes Smoking
Maternal obesity Phenylketonuria
Smoking Other
If other, specify ____________________________________________
Does the child have any central nervous system abnormalities?
Yes
No 
If yes, specify the nature of abnormality
______________________________________________________________
______________________________________________________________
______________________________________________________________
Peri-operative Data  (first surgery)
Did the child undergo any surgical intervention? 
Yes 
No
If yes, please complete the information below
Age at first surgery months
Date of the surgery 
y y m m d d
Aim of the surgery 
Palliation 
Staged correction
Complete correction
Nature of the surgery/interventional procedure
___________________________________________________________
___________________________________________________________
___________________________________________________________
Surgical approach used
Median sternotomy 
Thoracotomy 
Other 
If other, specify _____________________________
Surgical information: 
Cardiopulmonary bypass time 
Cross clamping aorta time 
Hypothermic circulatory arrest time 
Temperature during circulatory arrest degrees Celsius
Haematocrit 
Intensive Care admission
Did the child require pre-operative intubation and MV Yes No
If yes, specify reason(s) _______________________________
_______________________________
Known neuromuscular weakness Yes No
prior to ICU admission 
If so, specify the nature of weakness ______________________________
_______________________________
Duration of invasive ventilation days
Did child require resuscitation at any point Yes No
Did child have any seizures Yes No
Number of days hospitalised upon discharge days
Was additional surgical intervention indicated at a later point in time Yes No
Peri-operative Data  (second surgery)
Did the child undergo a second surgical procedure during the study period?
Yes
No 
In summary, indicate if the child is at low or high  risk for developmental
delays  or disorder based on the  medical information gathered
High risk (need to meet the understated risk criteria)
Neonates or infants requiring open heart surgery
(cyanotic or acyanotic lesions)
Children with cyanotic lesions not requiring open heart surgery
Any combination of CHD and any of the following co-morbidities
Prematurity
Developmental dealy recognised in infancy
Genetic syndrome associated with developmental difficulties
Cardiopulmonary resuscitation at any point
Prolonged hospitalisation (> 2 weeks) postoperatively
Perioperative seizures
Significant neuroimaging abnormalities or microcephaly
history of mechanical support  
Low risk (none of the above mentioned risk criteria)
during infancy
  
 
 
APPENDIX XI 
DATA FORM: 
CARDIOVASCULAR, GROWTH AND NEUROMOTOR 
STATUS 
Subject number C
ASSESSMENT 1: BASELINE 
Cardiovascular status (vital signs)
Heart rate /min
Respiratory rate /min
Oxygen saturation %
Blood pressure mmHg
Growth parameters  
Weight g
Height cm 
Head circumference cm
Neuromotor status
Muscle tone 
Hypotonic 
Normal 
Increased 
Babinski Left postive 
negative
Right postive 
negative
Clonus Left postive 
negative
Right postive 
negative
DATA FORM: CARDIOVASCULAR, GROWTH AND 
APPENDIX XI
NEUROMOTOR STATUS
ASSESSMENT 2: PHASE II (THREE-MONTHS POST INTERVENTION)
Cardiovascular status 
Need for further cardiac interventions Yes No
Growth parameters  
Weight g
Height cm 
Head circumference cm
Neuromotor status
Muscle tone 
Hypotonic 
Normal 
Increased 
Babinski Left postive 
negative
Right postive 
negative
Clonus Left postive 
negative
Right postive 
negative
ASSESSMENT 3: PHASE II (SIX-MONTHS POST INTERVENTION)
Yes No
Growth parameters  
Weight g
Height cm 
Head circumference cm
Neuromotor status
Muscle tone 
Hypotonic 
Normal 
Increased 
Babinski Left postive 
negative
Right postive 
negative
Clonus Left postive 
negative
Right postive 
negative
Cardiovascular status 
Need for further cardiac interventions 
  
 
 
APPENDIX XII 
DATA FORM: 
BURDEN OF CARE INFORMATION AT THREE-MONTH AND 
SIX-MONTH POST CARDIAC INTERVENTION 
 
Subject number P
Since your  discharge following the cardiac intervention procedure, 
has your child been hospitalised? Yes No
If so how many times 
Reason for these admissions ______________________________
______________________________
______________________________
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
until now how many days has your child been too ill to play/get up?
days
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
how many days did your child require special  care due to his/her physical health? 
days
If you work outside the home please answer the following questions
in the past month
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How many days did you miss work due to your child's physical health?
days 
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How often does your child's physical health affect your daily routine at work?
Never 
Seldom 
Often 
Always 
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How often does your child's health affect your abilty to concentrate at work?
Never 
Seldom 
Often 
Always 
DATA FORM: BURDEN OF CARE INFORMATION AT
 THREE-MONTH  AND SIX-MONTH POST CARDIAC INTERVENTION 
APPENDIX XII 
BURDEN OF CARE THREE MONTHS POST CARDIAC INTERVENTION
Since your  discharge following the cardiac intervention procedure, 
has your child been hospitalised? Yes No
If so how many times 
Reason for these admissions ______________________________
______________________________
______________________________
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
until now how many days has your child been too ill to play/get up?
days
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
how many days did your child require special  care due to his/her physical health? 
days
If you work outside the home please answer the following questions
in the past month
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How many days did you miss work due to your child's physical health?
days 
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How often does your child's physical health affect your daily routine at work?
Never 
Seldom 
Often 
Always 
Since your discharge following your child's cardiac intervention procedure 6 weeks ago, 
How often does your child's health affect your abilty to concentrate at work?
Never 
Seldom 
Often 
Always 
References:
Varni, JW. 2008. PedsQL Family information form
BURDEN OF CARE SIX MONTHS POST CARDIAC INTERVENTION
  
 
 
APPENDIX XIII 
DATA FORM: 
PATH THROUGH THE STUDY 
 
Subject number C
Phase I  : Pre- cardiac intervention status (baseline)
Interview and assessment done Yes
No
Date  of assessment 
d d m m y y
If you indicated No, why did the assessment not take place ?
Loss to follow-up ___________________________________________
Non-compliance ___________________________________________
Mortality ___________________________________________
Critical illness ___________________________________________
Other
If other, specify ___________________________________________
___________________________________________
___________________________________________
Phase II: Three-month follow-up
Interview and assessment done Yes
No
Date of assessment 
d d m m y y
If you indicated No, why did the assessment not take place ?
Loss to follow-up ___________________________________________
Non-compliance ___________________________________________
Mortality ___________________________________________
Critical illness ___________________________________________
Other
APPENDIX  XIII
DATA FORM: PATH THROUGH THE STUDY
If other, specify ___________________________________________
___________________________________________
___________________________________________
Phase II: Six month follow-up
Interview and assessment done Yes
No
Date of assessment 
d d m m y y
If you indicated No, why did the assessment not take place ?
Loss to follow-up ___________________________________________
Non-compliance ___________________________________________
Mortality ___________________________________________
Critical illness ___________________________________________
Other
If other, specify ___________________________________________
___________________________________________
___________________________________________
  
 
 
APPENDIX XIV 
REGRESSION ANALYSIS: 
VARIABLES PREDICITIVE OF KEY OUTCOMES 
APPENDIX XIV  
REGRESSION ANALYSIS: 
VARIABLES PREDICTIVE OF KEY OUTCOMES 
 
A regression analysis was done to determine variables that were predictive of key 
outcomes in development (cognitive, language and motor), HRQOL and parenting 
stress at all three time points of assessment (baseline, and three-months and six 
months post cardiac intervention). The regression analysis was done using two-way 
analysis of variance (ANOVAs). The regression analysis provides t-statistics and 
probabilities for coefficients, and only one F-statistic and probability for the 
regression. The coefficient of determination is listed as adjusted R-squared (R2) and 
indicates the percentage of the variable on the left side of the equation that can be 
explained by the predictors. The-F-statistic tests whether the combination of 
predictors explains variation in the variable on the left side of the equation in a 
manner that is unlikely to occur by chance if the null hypothesis is true.  P-values are 
provided for the F-test. 
 
A linear regression model was used for each of the key outcome namely 
neurodevelopment (cognitive, motor and language), HRQOL and parenting stress. 
The effects used were the subcategories under each outcome. Interaction effects 
were also tested where appropriate.  The code for the Anova models used was as 
follows: 
 
 
General format: Variable (base, 3 months, 6 month) ~ Effect1 + Effect2 +....  
Type and severity of CHD:  Score ~ Severity + CHDtype + interaction of 
Severity:CHDtype 
Surgery and medical course: Score ~ Age + CPBtime + POComplication + 
mechanic ventilation 
Hospital and ICU length of stay: Score ~ ICU stay + Hospital stay 
Patient factors: Score ~ Gender + Premature + Weight + DS + Growth 
Sociodemographic factors: Score ~ Distance + Age + Education + SE status 
 
 
VARIABLES PREDICTIVE OF NEURODEVELOPMENTAL OUTCOME 
 
Cognitive development 
 
Table XIV.1: Variables predictive of BSID-III cognitive scores at baseline  
 
BSID-III cognitive 
scores (Baseline) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared㻌
p-value 
Type and severity of CHD 
Disease severity  -48.5 17.46 -2.79 0.01 ** 0.19 0.03* 
Type CHD  -23.33 12.51 -1.87 0.07 
Surgery an medical course 
Age at first surgery -1.01 0.63 -1.63 0.12 -0.05 0.59 
CPB time 0.05 0.65 0.70 0.49 
Postop complications -2.61 10.55 -0.25 0.81 
Duration of MV 7.09 13.97 0.51 0.62 
Hospital and ICU length of stay  
ICU LOS 1.32 1.09 1.21 0.23 -0.01 0.45 
Hospital LOS  -0.40 0.32 -1.25 0.22 
Patient factors 
Gender -0.06 4.85 -0.01 0.99 0.37 0.00*** 
Prematurity  7.04 6.90 1.02 0.32 
Low birth weight 0.00 0.00 1.13 0.27 
Down syndrome -24.30 5.49 -4.42 0.00*** 
Growth  (weight-for-
age) 
1.64 1.63 1.00 0.32 
Socio-demographic factors 
Distance service point 0.03 0.02 1.74 0.09 0.11 0.08 
Age of mother -1.03 0.39 -2.67 0.01* 
Maternal education 0.18 2.21 0.08 0.94 
Socioeconomic status  1.32 9.10 0.15 0.89 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
Table XIV.2: Variables predictive of BSID-III cognitive scores at three-months 
post cardiac intervention  
 
BSID-III cognitive 
scores  
(3-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted  
R-squared  
p-value 
Type and severity of CHD 
Disease severity  4.03 2.24 0.00 1.00 -0.10 0.84 
Type CHD  2.33 2.68 0.87 0.39 
Surgery an medical course 
Age at first surgery -0.12 0.15 -0.82 0.43 0.04 0.37 
CPB time 0.03 0.03 1.07 0.31 
Postop complications -4.56 2.70 -1.69 0.12 
Duration of MV 5.83 3.57 1.63 0.13 
Hospital and ICU length of stay  
ICU LOS 0.44 0.35 1.25 0.23 -0.01 0.43 
Hospital LOS  -0.11 -0.12 -0.89 0.38 
Patient factors 
Gender 0.47 1.10 0.42 0.68 0.45 0.00*** 
Prematurity  0.57 1.80 0.32 0.76 
Low birth weight -0.00 0.00 -0.28 0.79 
 Down syndrome -6.20 1.30 -4.77 0.00*** 
Growth (weight-for-
age) 
0.23 0.43 0.54 0.59 
Socio-demographic factors 
Distance service point 0.01 0.00 2.14 0.04* 0.28 0.03* 
Age of mother -0.22 0.07 -3.00 0.01** 
Maternal education 0.50 0.48 1.04 0.31 
Socioeconomic status  -0.14 2.25 -0.06 0.95 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
 
Table XIV.3: Variables predictive of BSID-III cognitive scores at six-months 
post cardiac intervention 
 
 
BSID-III cognitive 
scores  
(6-months) 
Estimates Standard 
error 
t-value P>| t | Adjusted 
R-squared  
p-value 
Type and severity of CHD    
Disease severity  -1.27 2.30 -0.55 0.59 0.01 0.37 
Type CHD  3.77 2.74 1.36 0.19 
Surgery an medical course 
Age at first surgery -0.14 0.16 -0.89 0.40 0.09 0.32 
CPB time 0.02 0.02 1.49 0.17 
Postop complications -5.20 2.58 -2.02 0.07 
Duration of MV 6.72 4.36 1.54 0.15 
Hospital and ICU length of stay  
ICU length of stay 0.35 0.28 1.23 0.24 -0.02 0.45 
Hospital LOS  -0.13 0.21 -0.61 0.55 
Patient factors 
Gender -0.67 1.15 -0.58 0.57 0.55 0.00*** 
Prematurity  0.87 2.14 0.40 0.69 
Low birth weight 0.00 0.00 0.46 0.65 
Down syndrome -6.33 1.31 -4.83 0.00*** 
Growth (weight-for-
age) 
0.56 0.44 1.29 0.21 
Socio-demographic factors 
Distance service point 0.01 0.00 1.51 0.15 0.26 0.06 
Age of mother -0.26 0.09 -3.00 0.01 ** 
Maternal Education 0.42 0.53 0.80 0.44 
Socioeconomic status  -0.80 2.48 -0.32 0.75 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
Disease type and severity were predictive of cognitive outcome only before cardiac 
intervention. Patient specific factors (especially the presence of DS) were predictive 
of cognitive outcome both before and after cardiac intervention. As a group of 
variables, socio-demographic factors were only predictive of cognitive outcome at 
three-month post cardiac intervention. However, maternal age as an individual 
variable was predicative of cognitive outcome both before and after cardiac 
intervention. Distance to the cardiac service point as an individual variable was also 
found to be predictive of cognitive outcome at three-month post cardiac intervention. 
 
Variables relating to the cardiac surgery and post-operative medical course as well 
as ICU and hospital length of stay were not predictive of cognitive outcome before or 
after cardiac intervention.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Language development 
 
Table XIV.4: Variables predictive of BSID-III language scores at baseline  
 
BSID-III language 
scores (baseline) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
p-value 
Type and severity of CHD 
Disease severity  -11.62 14.28 -0.81 0.42 0.02 0.37 
Type CHD  -19.40 10.23 -1.90 0.07 
Surgery an medical course 
Age at first surgery -1.46 0.44 -0.36 0.00** 0.30 0.02* 
CPB time -0.01 0.05 -0.29 0.77 
Postop complications -2.92 7.34 -0.40 0.70 
Duration of MV -6.67 9.73 -0.69 0.50 
Hospital and ICU length of stay  
ICU length of stay -0.48 0.87 -0.55 0.59 -0.00 0.39 
Hospital LOS  -0.04 0.26 -0.14 0.87 
Patient factors 
Gender 2.34 4.20 0.57 0.58 0.23 0.01** 
Prematurity  5.88 5.98 0.98 0.33 
Low birth weight 7.88 3.82 0.02 0.98 
Down syndrome -1.51 4.76 -3.18 0.00** 
Growth (weight-for-age)) 2.72 1.42 1.93 0.06 
Socio-demographic factors 
Distance to service point 0.02 0.01 9.59 0.12 -0.01 0.48 
Age of mother -0.33 0.30 -1.10 0.28 
Maternal education 1.32 1.75 0.76 0.46 
Socioeconomic status  -3.00 7.21 -.0.41 0.68 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
Table XIV.5: Variables predictive of BSID-III language scores at three-months 
post cardiac intervention  
 
BSID-III language 
scores (3-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
p-value 
Type and severity of CHD    
Disease severity  4.00 3.32 1.21 0.24 0.06 0.25 
Type CHD  -1.00 3.96 -0.25 0.80 
Surgery an medical course 
Age at first surgery -0.34 0.21 -1.62 0.13 0.20 0.16 
CPB time 0.06 0.04 1.52 0.16 
Postop complications -5.05 3.86 -1.31 0.22 
Duration of MV -5.05 3.86 -1.31 0.22 
Hospital and ICU length of stay  
ICU length of stay 0.09 0.56 0.17 0.87 -0.02 0.46 
Hospital LOS post-
surgery 
0.09 0.19 0.46 0.65 
Patient factors 
Gender -0.79 1.94 -0.40 0.69 0.33 0.02* 
Prematurity  0.23 3.17 0.07 0.94 
Low birth weight 0.00 0.00 0.22 0.83 
Genetic comorbidity (DS) -7.68 2.30 -3.34 0.00** 
Growth (weight-for-age) 1.26 0.75 1.68 0.11 
Socio-demographic factors 
Distance to service point 0.01 0.01 1.56 0.13 -0.02 0.52 
Age of mother -0.15 0.14 -0.08 0.29 
Education of mother 0.31 0.92 0.34 0.74 
Socioeconomic status  -1.31 4.30 -0.30 0.76 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
Table XIV.6: Variables predictive of BSID-III language scores at six-months 
post cardiac intervention  
 
BSID-III language 
scores (6-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted  
R-squared 
p-value 
Type and severity of CHD 
Disease severity  0.27 3.57 0.08 0.94 -0.14 0.92 
Type CHD  2.93 4.24 0.69 0.50 
Surgery an medical course 
Age at first surgery -0.40 0.24 -1.67 -0.13 -0.05 0.54 
CPB time -0.01 0.24 -0.30 0.77 
Postop complications -1.16 4.0 -0.29 0.78 
Duration of MV 1.10 6.70 0.16 0.87 
Hospital and ICU length of stay  
ICU LOS -0.08 0.42 -0.19 0.85 -0.07 0.72 
Hospital LOS -0.13 0.31 -0.42 0.68 
Patient factors 
Gender 1.31 5.86 0.22 0.83 0.29 0.74 
Prematurity  1.10 8.07 0.14 0.90 
Low birth weight 0.00 0.00 0.63 0.54 
Down syndrome -8.71 8.26 -1.06 0.31 
Growth (weight-for-
age) 
1.32 1.81 0.73 0.47 
Socio-demographic factors 
Distance service point 0.01 0.01 1.51 0.15 0.01 0.40 
Age of mother -0.21 0.14 -1.45 0.16 
Education of mother 0.54 0.88 0.61 0.55 
Socioeconomic status  -0.24 4.11 -0.06 0.95 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
Variables relating to surgery and medical course (in particular age at surgery) were 
predictive of language performance before cardiac intervention. Patient specific 
factors (in particular the presence of DS) were predictive of language outcomes 
before cardiac intervention and at 3-months post cardiac intervention.  
 
Disease severity and type, hospital and ICU length of stay, and sociodemographic 
variables were not found to be predictive of language outcomes. 
 
Motor development 
 
Table XIV.7: Variables predictive of BSID-III motor scores at baseline 
 
BSID-II motor scores  
(Baseline) 
Estimate Standard 
error 
t-value P>| t | Adjusted  
R-squared 
p-value 
 
Type and severity of CHD    
Disease severity  -21.50 18.60 -1.16 0.26 -0.09 0.88 
Type CHD  -1.00 13.33 -0.08 0.94 
Surgery an medical course 
Age at first surgery -0.50 0.67 0.75 0.46 -0.06 0.65 
CPB time 0.05 0.07 0.70 0.49 
Postop complications -14.27 11.25 -1.27 0.22 
Duration of MV 7.58 14.90 0.51 0.62 
Hospital and ICU length of stay  
ICU LOS 1.91 1.02 1.88 0.07 0.05 0.15 
Hospital LOS  -0.59 0.30 -1.97 0.06 
Patient factors 
Gender 1.45 4.66 0.31 0.76 0.38 0.00*** 
Prematurity  4.90 6.63 0.74 0.47 
Low birth weight -1.09 4.25 -0.03 0.98 
Down syndrome -2.41 5.28 -4.57 0.00*** 
Growth (weight-for-age) 3.27 1.63 -1.02 0.06 
Socio-demographic factors 
Distance to service point 0.01 0.02 0.41 0.69 0.05 0.22 
Age of mother -0.67 0.37 -1.83 0.07 
Education of mother 2.03 2.09 0.97 0.34 
Socioeconomic status  -9.24 8.64 -1.07 0.29 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table XIV.8: Variables predictive of BSID-III motor scores at three-months post 
cardiac intervention  
 
BSID-III motor scores  
(3-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
p-value 
Type and severity of CHD    
Disease severity  4.00 3.32 1.21 0.24 0.06 0.25 
Type CHD  -1.00 3.96 -0.25 0.80 
Surgery an medical course 
Age at first surgery -0.34 0.21 -1.62 0.13 0.20 0.16 
CPB time 0.06 0.04 1.52 0.16 
Postop complications -5.05 3.86 -1.31 0.22 
Duration of MV 6.18 5.10 1.21 0.25 
Hospital and ICU length of stay  
ICU LOS 0.09 0.56 0.17 0.87 -0.02 0.46 
Hospital LOS 0.09 0.19 0.46 0.65 
Patient factors 
Gender 0.79 1.95 -0.41 0.69 0.33 0.02* 
Prematurity  0.23 3.17 0.07 0.94 
Low birth weight 0.00 0.00 0.22 0.83 
Down syndrome -7.67 2.30 -3.34 0.00** 
Growth  (weight-for-age) 1.26 0.75 1.68 0.11 
Socio-demographic factors 
Distance service point 0.01 0.01 1.56 0.13 -0.03 0.52 
Age of mother -0.15 0.14 -1.08 0.29 
Education of mother 0.31 0.92 0.34 0.74 
Socioeconomic status  -1.31 4.30 -0.30 0.76 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table XIV.9: Variables predictive of BSID-III motor scores at three-months post 
cardiac intervention  
 
BSID-III motor scores  
(6-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  -2.53 4.81 -0.53 0.61 -0.02 0.49 
Type CHD  7.80 5.72 1.36 0.19 
 Surgery an medical course 
Age at first surgery -0.08 0.35 -0.25 0.81 -0.05 0.53 
CPB time 0.03 0.36 0.88 0.40 
Postop complications -9.62 5.78 -1.67 0.13 
Duration of MV 14.89 9.78 1.52 0.16 
Hospital and ICU length of stay  
ICU LOS 0.75 0.57 1.31 0.21 -0.01 0.43 
Hospital LOS  -0.34 0.43 0.79 0.44 
Patient factors 
Gender -0.36 2.74 -0.13 0.90 0.39 0.02* 
Prematurity  4.54 5.09 0.89 0.39 
Low birth weight 0.00 0.00 1.28 0.22 
Down syndrome -11.61 3.11 -3.73 0.00** 
Growth (weight-for-
age) 
0.90 1.04 0.87 0.40 
Socio-demographic factors 
Distance service point 0.01 0.01 1.1 0.29 0.48 0.00*** 
Age of mother -0.64 0.15 -4.41 0.00*** 
Maternal education 1.17 0.90 1.30 0.21 
Socioeconomic status  -4.30 4.22 -1.02 0.32 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
Patient variables (in particular the presence of DS) were predictive of motor 
outcomes both before and after cardiac surgery. Socio-demographic variables (in 
particular maternal age) were found to be predictive of motor outcome at six-month 
post cardiac intervention. 
 
Disease severity and type, surgery and medical course, hospital and ICU length of 
stay were not found to be predictive of motor outcomes. 
 
VARIABLES PREDICTIVE OF HRQOL OUTCOMES  
 
Table XIV.10: Variables predictive HRQOL scores at baseline 
 
HRQOL total score 
(Baseline) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  -15.04 12.08 -1.25 0.22 0.09 0.14 
Type CHD  8.08 8.65 0.93 0.36 
Perioperative risk factors 
Age at first surgery 0.33 0.50 0.67 0.51 0.08 0.14 
CPB time 0.09 0.05 1.72 0.10 
Patient factors 
Down syndrome -1.49 4.68 -0.32 0.75 -0.00 0.43 
Growth (weight-for-
age) 
-0.16 1.38 -0.12 0.91 
Feeding problems 7.31 4.67 1.56 0.13 
Socio-demographic factors 
Age of mother -0.34 0.26 -1.31 0.20 -0.00 0.42 
Maternal education 1.23 1.51 0.81 0.42 
Socioeconomic status  -2.99 6.31 -0.47 0.64 
Neurodevelopmental outcome 
Cognitive  0.01 0.14 0.12 0.91 0.17 0.02* 
Language -0.40 0.17 -2.37 0.02* 
Motor  0.40 0.15 2.73 0.01** 
Levels of parenting stress 
PSI-SF total score -0.57 0.23 -2.49 0.01* 0.12 0.02* 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
Table XIV.11: Variables predictive HRQOL scores at three-months post cardiac 
intervention 
 
HRQOL total score 
(3-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  -3.14 15.15 -0.21 0.84 -0.10 0.83 
Type CHD  7.58 18.11 0.42 0.68 
Perioperative risk factors 
Age at first surgery -1.58 1.10 -1.44 0.17 0.07 0.24 
CPB time 0.10 0.18 0.55 0.60 
Patient factors 
Down syndrome -7.92 12.33 -0.64 0.53 -0.08 0.74 
Growth (weight-for-
age) 
-2.51 3.50 -0.72 0.48 
Feeding problems 5.53 10.08 0.55 0.59 
Socio-demographic factors 
Age of mother 0.07 0.59 0.13 0.90 -0.07 0.70 
Maternal education 4.26 3.90 1.09 0.29 
Socioeconomic status  -14.01 18.58 -0.75 0.46 
Neurodevelopmental outcome 
Cognitive  0.13 0.35 0.39 0.70 -0.12 0.95 
Language -0.24 0.47 -0.52 0.61 
Motor  0.08 0.39 0.20 0.84 
Levels of parenting stress 
PSI-SF total score -0.92 0.50 -1.83 0.08 0.89 0.08 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
Table XIV.12: Variables predictive HRQOL scores at six-months post cardiac 
intervention 
 
HRQOL total score 
(6-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R2 
P-value 
Type and severity of CHD 
Disease severity  -2.77 15.40 -0.18 0.86 -0.17 0.95 
Type CHD  9.96 25.05 0.40 0.70 
Perioperative risk factors 
Age at first surgery -3.11 1.48 -2.11 0.06 1.19 0.16 
CPB time 0.01 0.19 0.04 0.97 
Patient factors 
Down syndrome -2.62 13.82 -0.19 0.85 -0.17 0.93 
Growth (weight-for-
age) 
-1.21 3.86 -0.31 0.76 
Feeding problems 6.63 11.70 0.57 0.58 
Socio-demographic factors 
Age of mother 0.43 0.64 0.67 0.51 -0.06 0.59 
Maternal education 5.07 4.28 1.19 0.25 
Socioeconomic status  -12.57 19.69 -0.64 0.53 
Neurodevelopmental outcome 
Cognitive  -0.09 42.7 -0.23 0.82 -0.13 0.83 
Language 0.39 0.53 0.75 0.47 
Motor  0.04 0.44 0.09 0.93 
Levels of parenting stress 
PSI-SF total score -0.02 0.58 -0.03 0.97 -0.06 0.97 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
Neurodevelopmental outcome (in particular poor language and motor performance) 
and levels of parenting stress prior to cardiac intervention were predictive of parents 
having a poorer perception of their childs HRQOL. 
 
Disease type and severity, perioperative factors, patient factors and socio-
demographic factors were not predictive of HRQOL outcomes. 
 
 
 
 
VARIABLES PREDICTIVE OF PARENTING STRESS OUTCOMES  
 
Table XIV.13: Variables predictive parenting stress scores at baseline 
 
PSI-SF total score 
(Baseline) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  -5.35 8.52 -0.63 0.54 -0.04 0.64 
Type CHD  1.60 6.10 0.26 0.80 
Perioperative risk factors 
Age at first surgery -0.39 0.24 -1.65 0.11 0.04 0.11 
Patient factors 
Down syndrome -5.01 3.09 -1.62 0.11 -0.01 0.44 
Growth (weight-for-
age) 
0.16 0.91 0.17 0.86 
Feeding problems -0.81 3.08 -0.26 0.79 
Socio-demographic factors 
Age of mother -0.10 0.18 -0.56 0.58 0.01 0.38 
Maternal education -1.50 1.00 -1.50 0.14 
Socioeconomic status  2.84 4.14 0.69 0.50 
Neurodevelopmental outcome 
Cognitive  -0.06 0.09 -0.65 0.52 0.07 0.13 
Language 0.21 0.12 1.75 0.09 
Motor  0.07 0.10 0.68 0.50 
Perceived HRQOL  
PedsQL total score -0.25 0.10 -2.49 0.01* 0.12 0.02* 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table XIV.14: Variables predictive parenting stress scores at three-months 
post cardiac intervention 
 
PSI-SF total score 
(3-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  3.83 5.85 0.66 0.52 -0.09 0.80 
Type CHD  5.83 7.00 0.84 0.41 
Perioperative risk factors 
Age at first surgery -0.66 0.30 -2.23 0.03* 0.14 0.03* 
Patient factors 
Down syndrome 3.87 4.69 0.82 0.42 -0.04 0.57 
Growth (weight-for-
age) 
1.51 1.33 1.13 0.27 
Feeding problems -1.55 3.83 -0.40 0.69 
Socio-demographic factors 
Age of mother 0.39 0.21 1.86 0.08 0.15 0.12 
Maternal education -2.59 1.37 -1.89 0.07 
Socioeconomic status  10.45 6.39 1.64 0.11 
Neurodevelopmental outcome 
Cognitive  -0.07 0.12 -0.69 0.50 0.15 0.09 
Language 0.42 0.16 2.66 0.01* 
Motor  -0.17 0.13 -1.29 0.21 
Perceived HRQOL  
PedsQL total score -0.14 0.08 -1.83 0.08 0.09 0.08 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table XIV.15: Variables predictive parenting stress scores at six-months post 
cardiac intervention 
 
PSI-SF total score 
(6-months) 
Estimate Standard 
error 
t-value P>| t | Adjusted 
R-squared 
P-value 
Type and severity of CHD 
Disease severity  -0.60 5.80 -0.10 0.92 -0.09 0.73 
Type CHD  -0.93 6.91 -0.14 0.89 
Perioperative factors 
Age at first surgery -0.26 0.32 -0.81 0.43 -0.02 0.43 
Patient factors 
Down syndrome 2.25 4.72 0.48 0.64 -0.08 0.70 
Growth (weight-for-
age) 
-0.99 1.39 -0.71 0.49 
Feeding problems 4.30 4.33 0.99 0.33 
Socio-demographic factors 
Age of mother 0.29 0.22 1.30 0.21 0.11 0.20 
Maternal education -2.65 1.39 -1.91 0.07 
Socioeconomic status  -0.00 0.01 -0.09 0.93 
Neurodevelopmental outcome 
Cognitive  -0.19 0.14 -1.37 0.19 -0.02 0.49 
Language -0.03 0.15 -0.21 0.84 
Motor  0.20 0.15 1.36 0.19 
Perceived HRQOL  
PedsQL total score -0.00 0.10 -0.03 0.97 -0.06 0.97 
Indication of statistical significance: * P < 0.05, ** P < 0.01 and *** P < 0.001 
 
 
Parents perception of their childs HRQOL was predictive of parenting stress prior to 
cardiac intervention. Age at first cardiac surgery and language performance, as 
individual variables were predictive of parenting stress at three-month post cardiac 
intervention.  
 
Disease type and severity, patient-specific factors and socio-demographic factors 
were shown not to be predictive of parenting stress. 
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Findings for between group differences of children in this study with CHD with DS 
compared with those with CHD without DS for all reported parameters are reported 
below. 
 
Table XV.1 Key demographic information  
 
Variable CHD with DS 
 (n=10) 
CHD without DS 
 (n=30) 
Age child at baseline (months) 
 
Median  
Mean and SD 
 
 
9.3 [3.3  20.3] 
10.3 (±5.3) 
 
 
7.2 [1.4 20.9] 
8.9 (± 5.5) 
Gender of the child 
 
Male  
Female 
 
 
2 (20%) 
8 (80%) 
 
 
13 (43.3%) 
17 (56.7%) 
Gestational age  (weeks) 
 
Median  
Mean and SD 
 
Preterm (<37 weeks gestation) 
Term  
 
 
38 [32  40] 
37.5 (±2.2) 
 
1 (10%) 
9 (31%) 
 
 
38[31  41] 
37.5 (±2.02) 
 
8 (26.7%) 
22 (73.3%) 
Birth weight (grams) 
 
Median 
Mean and SD 
 
LBW (< 2500g) 
NBW (2500-4000g) 
 
 
 
2950 [1640  3950] 
2904 (±680.3) 
 
3 (30%) 
7 (70%) 
 
 
 
2795 [1690  3920] 
2870.3 (± 594.8) 
 
7 (23.3%) 
23 (76.7%) 
Age of the mother (years) 
 
Median  
Mean  
 
 
 
37 [24  42] 
35.7 (±6.1) 
 
 
27.5 [16  43] 
27.6 (± 7.7) 
 
 
Table XV.2 Socioeconomic statuses of families  
 
Variable CHD with DS (n=10) CHD without DS (n=30) 
Mean of education of mothers 
 
Grade 9-11 Grade 9-11 
Mean education level of fathers 
 
 
 
Grade 9-11 
 
Grade 9-11 
Mean socioeconomic status  Lower class  
 
Lower class  
 
 
 
Table XV.3 Cardiac diagnostic information 
 
Variable CHD with DS  
(n=10) 
CHD without DS 
(n=30) 
 Type of CHD  
 
Acyanotic 
Cyanotic  
 
 
 
7 (70%) 
3 (30%) 
 
 
23 (76.7%) 
7 (23.3%) 
Severity of the cardiac disease 
 
Mild 
Moderate 
Moderate to severe 
Severe 
 
Mean severity across the group 
 
 
 
0 
9 (90%) 
1 (10%) 
0 
 
Moderate 
 
 
1 (3.3%) 
21 (70%) 
7 (23.3%) 
1 (3.4%) 
 
Moderate 
Table XV.4 Surgical information and postoperative medical course 
 
Variable CHD with DS  
(n=10) 
CHD without DS  
(n=28) 
 Age at first surgery (months) 
 
Median 
Mean  
 
< 12 months at first surgery 
> 12 months at first surgery 
 
 
 
9.3 [3.3  20.3] 
10.2 (±5.3) 
 
7 (70%) 
3 (30%) 
 
 
7.2 [1.4  20.9] 
9.1 (±5.7) 
 
19 (67.9%) 
9 (32.1%) 
Cardiopulmonary bypass used 
 
Yes 
No 
 
CPB time (min) 
 
Median CPB time (minutes) 
Mean CPB time and SD 
 
 
 
8 (80%) 
2 (20%) 
 
 
 
100.0[58  182] 
108.8 (±41.4) 
 
 
18 (64.3%) 
10 (35.7%) 
 
 
 
104.5[41  300] 
113.1 (±60.9) 
Cross-clamping of the aorta 
 
Yes 
No  
 
Aorta cross-clamp time 
(minutes)  
 
Median 
Mean  
 
 
 
8 (80%) 
2 (20%) 
 
 
 
75.0 [24  124] 
75.3 (±32.7) 
 
 
19 (67.9%) 
9 (32.1%) 
 
 
 
76.0 [15  132] 
68.3 (±37.2) 
Cardiothoracic ICU LOS (days) 
 
Median  
Mean  
 
CTU stay > 7 days  
CTU stay <7 days 
 
 
 
5 [4  28] 
7.3 (±7.3) 
 
1 (10%) 
9 (90%) 
 
 
6 [3 - 22] 
7.6 (±4.9) 
 
11 (39.3%) 
17 (60.7%) 
Hospital LOS post surgery 
(days) 
 
Median 
Mean  
 
Length of stay >14 days 
Length of stay !14 days  
 
 
9 [6  108] 
18.6 (±31.5) 
 
1 (10%) 
9 (90%) 
 
 
9 [3  64] 
13.3 (±12.2) 
 
7 (25%) 
21 (75%) 
 
 
 
 
 
  
Table XV.5 Growth outcomes for participants with CHD with DS compared to 
CHD without DS 
 
Growth parameter CHD with DS  CHD without DS  
Baseline (n=10) (n=30) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-2.6 
-2.3 (±1.6) 
 
 
-2.6 
-2.6 (±1.5) 
 
Height-or-age z-score 
 
Median  
Mean and SD 
 
 
 
-0.9 
-1.5 (±3.0) 
 
 
-2.0 
-2.4 (±2.3) 
 
Head circumference-for-age z-score 
 
Median  
Mean and SD 
 
 
-1.7 
-1.6 (±0.9) 
 
 
-1.4 
-1.3 (±1.7) 
 
Three-months post cardiac 
intervention  
(n=5) (n=20) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.1 
-1.1 (±2.6) 
 
 
-2.2 
-2.0 (±1.4) 
 
Height-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.1 
-2.2 (±2.5) 
 
 
-0.7 
-1.1 (±1.5) 
 
Head circumference-for-age z-score 
 
Median  
Mean and SD 
 
 
-0.9 
-1.8 (±1.9) 
 
 
 
-1.0 
-0.6 (±1.7) 
 
Six-months post cardiac 
intervention 
(n=5) (n=17) 
Weight-for-age z-score 
 
Median  
Mean and SD 
 
 
-1.2 
-0.9 (± 2.1) 
 
 
 
-1.7 
-1.8 (±1.8) 
 
Height-for-age z-score 
 
Median  
Mean and SD 
 
 
 
-1.6 
-2.1 (±1.4) 
 
 
-1.5 
-1.7 (±1.7) 
Head circumference for age z-score 
 
Median  
Mean and SD 
 
 
-1.6  
-2.1 (±1.4) 
 
 
 
-1.5 
-1.7 (±1.7) 
 
  
Table XV.6 Classification of growth status according to z-scores for 
participants with CHD with DS compared to CHD without DS 
 
Variable CHD with DS CHD without DS 
Baseline 
 
(n=10) (n=30) 
Malnutrition  6 (60%) 21 (70%) 
Stunting  
 
4 (40%) 14  (46.7%) 
Microcephaly  
 
2 (20%) 8 (26.7%) 
Three-months post cardiac 
intervention  
 (n=5)  (n=20) 
Malnutrition  2 (40%) 12  (60%) 
Stunting  
 
2 (40%) 7 (35%) 
Microcephaly  
 
2 (40%) 3 (15%) 
Six-months post cardiac 
intervention 
 (n=5) (n=17) 
Malnutrition  1 (20%) 8  (47%) 
Stunting  
 
2 (40%) 6 (35.3%) 
Microcephaly  
 
1 (20%) 2 (11.8%) 
* z-score<-2 indicated malnutrition, stunting and microcephaly 
 
 
 
 
 
 
 
 
 
 
 
Table XV.7 Neurodevelopmental outcomes for BSID-III scores for the cognitive, 
language and motor sub-scales for participants with CHD with DS compared 
to CHD without DS 
 
Variable CHD with DS CHD without DS 
Baseline 
 
(n=10) (n=30) 
Cognitive sub-scale 
 
Median  
Mean and SD 
 
 
60 [55  90] 
65 (±10.5) 
 
 
95 [55  130] 
91.5 (±16.5) 
 
Language sub-scale 
 
Median  
Mean and SD 
 
 
 
75.5 [62 - 112] 
78.2 (±15.2) 
 
 
94 [65  115] 
94.5 (±11.3) 
Motor sub-scale 
 
Median  
Mean and SD 
 
 
58 [46 - 88] 
61 (±14.1) 
 
 
86.5 [58  112] 
85.7 (±13.8) 
 
Three-months post 
cardiac intervention 
(n=5) (n=20) 
Cognitive sub-scale 
 
Median  
Mean and SD 
 
 
55 [55  70] 
60 (±7.1) 
 
 
90 [55 -105] 
90.8 (±12.7) 
 
Language sub-scale 
 
Median  
Mean and SD 
 
 
 
71 [50  83] 
69.2 (±12.1) 
 
 
92.5 [71  112] 
93.2 (±13.1) 
Motor sub-scale 
Median  
Mean and SD 
 
46 [46 -73] 
55 (±12.7) 
 
 
91 [46  112] 
89.3 (±14.7) 
Six-months post 
cardiac intervention 
 
(n=5) (n=17) 
Cognitive sub-scale 
 
Median  
Mean and SD 
 
 
55 [55  65] 
58 (±4.5) 
 
 
90 [55 -100] 
90.9 (±13.3) 
 
Language sub-scale 
Median  
Mean and SD 
 
 
65 [57  79] 
66.2 (±6.9) 
 
91 [65  109] 
88.8 (±13.5) 
Motor sub-scale 
 
Median  
Mean and SD 
 
 
55 [49  70] 
57.4 (±8.3) 
 
 
97 [49 -121] 
92.3 (±18.9) 
 
* score < 70 = delayed,  70-84 at risk and >85 normal 
Table XV.8 Classification of developmental performance according to the 
BSID-III scores for cognitive, language and motor sub-scales for participants 
with CHD with DS compared to CHD without DS 
 
Variable Time point  CHD with DS CHD without DS 
Cognitive   Baseline  (n=10) (n=30) 
 Average or above 1 (10%) 22 (73%) 
 At risk 3 (30%) 6 (20%) 
 Delayed  6 (60%) 2 (7%) 
Language  
Average or above 2 (20%) 26 (86.7%) 
 At risk 4 (40%) 3 (10%) 
Delayed  4 (40%) 1 (3.3%) 
Motor   
Average or above 1 (10%) 
 
18 (60%) 
 At risk 2 (20%) 8 (26.7%) 
Delayed 7 (70%) 4 (13.3%) 
Cognitive  Three-
month 
follow-up 
(n=5) (n=20) 
 Average or above 0 (0%) 17 (85%) 
 At risk 1 (20%) 2 (10%) 
 Delayed  4 (80%) 1 (5%) 
Language   
Average or above 0 (0%) 14 (70%) 
At risk 3 (60%) 6 (30%) 
Delayed 2 (40%) 0 (0%) 
Motor   
 Average or above 0 (0%) 15 (75%) 
 At risk 1 (20%) 3 (15%) 
Delayed 4 (80%) 2 (10%) 
Cognitive   Six-month 
follow-up 
(n=5) (n=17) 
 Average or above 0 14 (82.4%) 
 At risk 0 2 (11.8%) 
 Delayed 5 (100%) 1 (5.8%) 
Language   
Average or above 0 9 (52.9%) 
 At risk 1 (20%) 6 (35.5%) 
Delayed 4 (80%) 2 (11.7%) 
Motor   
 Average or above 0 12 (70.6%) 
 At risk 1 (20%) 3 (17.6%) 
Delayed 4 (80%) 2 (11.8%) 
* scores < 70 delayed development , 70-84 at risk  of developmental delay and  " 85 normal 
 
 
  
Table XV.9 Perceived HRQOL for participants with CHD with DS compared to 
CHD without DS 
 
PedsQL® total score CHD with DS CHD without DS 
Baseline  
 
Median (range) 
Mean and SD 
 
 
77.5 [63.9  88.2] 
75.5 (±8.1) 
 
 
 
81.3 [48.6  97.2] 
78.4 (±13.6) 
 
Three-months post cardiac 
intervention 
 
Median (range) 
Mean and SD 
 
 
 
 
77.8 [29.2  93.3] 
69.7 (±29.8) 
 
 
 
90.3 [64.4  100] 
87.9 (±11.2) 
Six-months post cardiac 
intervention  
 
Median (range) 
Mean and SD 
 
 
 
 
76.1 [74.4 -79.4] 
76.5 (±2.1) 
 
 
 
89.5 [52.2  100] 
87.3 (±11.3) 
 
  
Table XV.10 Levels of parenting stress for participants with CHD with DS 
compared to CHD without DS 
 
Sub-scales of the PSI-SF CHD with DS CHD without DS 
Baseline 
 
(n=10) (n=30) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
87.5 [35  99] 
74.4 (±24.9) 
 
 
 
90 [10  99] 
86.4 (±17.3) 
Parent-child dysfunction 
 
Median (mean) 
Mean and SD 
 
 
 
95 [40  99] 
86.7 (±19.2) 
 
 
 
80 [40  99] 
77.8 (±19.8) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
75 [25  95] 
73 (±20.8) 
 
 
77.5 [1  99] 
65.2 (±27.9) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
92.5  [40  99] 
82.4 (±20.9) 
 
 
90 [5 - 99] 
84.3 (±18.9) 
 
Sub-scales of the PSI-SF CHD with DS CHD without DS 
Three-months post 
cardiac intervention 
(n=5) (n=20) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
80 [30  95] 
68 (±30.9) 
 
 
 
 
75 [1  95] 
62.8 (±32.9) 
Parent-child dysfunction 
 
Median (range) 
Mean and SD 
 
 
 
95  [85 - 99] 
(93.6 (±6.1) 
 
 
 
70 [5  99] 
67 (±27.9) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
75  [50 - 95] 
75 (±18.4) 
 
 
52.5  [1  95] 
47.1 (±26.9) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
90 [60 - 99] 
84.6 (±16.9) 
 
 
77.5  [1  99] 
65.1 (±29.8) 
 
  
Sub-scales of the PSI-SF CHD with DS CHD without DS 
Six-months post cardiac 
intervention 
(n=5) (n=17) 
Parenting distress 
 
Median (range) 
Mean and SD  
 
 
65 [35  95] 
62 (±24.9) 
 
 
 
65 [1  95] 
56.5 (±34.3) 
Parent-child dysfunction 
 
Median (range) 
Mean and SD 
 
 
 
95 [80  99] 
91 (±7.3) 
 
 
 
55 [5  95] 
55.1 (±34.6) 
Difficult child 
 
Median (range) 
Mean and SD 
 
 
 
80 [35  99] 
(76.8 (±24.7) 
 
 
40 [1  90] 
39.1 (±34) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
80 [55  99] 
81.8 (±17.3) 
 
 
 
50 [1  95] 
50.8 (±35.8) 
 
  
Table XV.11 Classification of levels of parental stress for participants with CHD 
with DS compared to CHD without DS 
 
Timeframe  Sub-scale CHD with DS 
(n=10) 
CHD without DS  
(n=30) 
Baseline  Parenting stress  
Clinically significant  5 (50%) 19  (63.3%) 
High 6 (60%) 25 (83.3%) 
Normal  4 (40%) 4 (13.3%) 
Low  0 (0%) 1 (3.4%) 
Parent-child dysfunction 
Clinically significant  8 (80%) 14 (46.7%) 
High 8 (80%) 14 (46.7%) 
Normal  2 (20%) 16 (53.3%) 
Low  0 (0%) 0 (0%) 
Difficult child  
Clinically significant  3 (30%) 4 (13.3%) 
High 4 (40%) 10 (33.3%) 
Normal  6 (60%) 18 (60%) 
Low  0 (0%) 2 (6.7%) 
Total stress 
Clinically significant  7 (70%) 17 (56.7%) 
High 7 (70%) 20 (66.7%) 
Normal  3 (30%) 9 (30%) 
Low  0 (0%) 1 (3.4%) 
* >90th percentile clinically significant, >85th percentile high, 15th to 80 percentile low and <15th percentile low 
 
Timeframe  Sub-scale CHD with DS 
(n=5) 
CHD without DS  
(n=20) 
Three-months post 
cardiac 
intervention  
Parenting stress  
Clinically significant  2 (40%) 5 (25%) 
High 2 (40%) 9 (45%) 
Normal  3 (60%) 8 (40%) 
Low  0 (0%) 3 (15%) 
Parent-child dysfunction 
Clinically significant  4 (80%) 7 (35%) 
High 5 (100%) 8 (40%) 
Normal  0 (0%) 11 (55%) 
Low  0 (0%) 1 (5%) 
Difficult child  
Clinically significant  2 (40%) 1 (5%) 
High 2 (40%) 2 (10%) 
Normal  3 (60%) 16 (80%) 
Low  0 (0%) 2 (10%) 
Total stress 
Clinically significant  3 (60%) 3 (15%) 
High 3 (60%) 6 (30%) 
Normal  2 (40%) 12 (60%) 
Low  0 (0%) 2 (10%) 
* >90th percentile clinically significant, >85th percentile high, 15th to 80 percentile low and <15th percentile low 
  
Timeframe  Sub-scale CHD with DS 
(n=5) 
CHD without DS  
(n=17) 
Six-months post 
cardiac 
intervention  
Parenting stress  
Clinically significant  1 (20%) 4 (23.5%) 
High 1 (20%) 6 (35.5%) 
Normal  4 (80%) 8 (47.1%) 
Low  0 (0%) 3 (17.6%) 
Parent-child dysfunction 
Clinically significant  4 (80%) 5 (29.4%) 
High 4 (80%) 5 (29.4%) 
Normal  1 (20%) 9 (52.9%) 
Low  0 (0%) 3 (17.6%) 
Difficult child  
Clinically significant  2 (40%) 1 (5.9%) 
High 2 (40%) 3 (17.6%) 
Normal  3 (60%) 8 (47.1%) 
Low  0 (0%) 6 (35.3%) 
Total stress 
Clinically significant  2 (40%) 5 (29.4%) 
High 2 (40%) 5 (29.4%) 
Normal  3 (60%) 8 (47.1%) 
Low  0 (0%) 4 (23.5%) 
* >90th percentile clinically significant, >85th percentile high, 15th to 80 percentile low and <15th percentile low 
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Findings for between group differences for children with cyanotic compared with 
acyanotic heart defects for all parameters is reported below. Values reported are 
frequencies with percentages, medians with ranges and means with standard 
deviations. 
 
Table XVI.1 Key demographic information  
 
Variable Cyanotic  
(n=8) 
Acyanotic  
(n=32) 
Age child at baseline (months) 
 
Median (range) 
Mean and SD 
 
 
6.1 [3.3  20.9] 
8.4 (± 6.4) 
 
 
 
 
7.7 [1.4  20.3] 
9.4 (± 5.2) 
Gender of the child 
 
Male  
Female 
 
 
2 (25%) 
6 (75%) 
 
 
 
13 (40.6%) 
19 (59.4%) 
Gestational age  (weeks) 
 
Median (range) 
Mean and SD 
 
Preterm (<37 weeks gestation) 
Term  
 
 
 
38 [32  41] 
38.1 (±2.7) 
 
1 (12.5%) 
7 (87.5%) 
 
 
38 [31 -40] 
37.3 (±1.8) 
 
8 (25%) 
24 (75%) 
Birth weight (grams) 
 
Median (range) 
Mean and SD 
 
LBW (< 2500g) 
NBW (2500-4000g) 
 
 
 
2684.5 [2085  3920] 
2825.5 (±707.4) 
 
3 (37.5%) 
5 (62.5%) 
 
 
2975 [1640  3950] 
2892.2 (±593) 
 
7 (21.9%) 
25 (78.1%) 
Age of the mother (years) 
 
Median (range) 
Mean and SD 
 
 
 
26.5 [19  43] 
28.9 (±10.30) 
 
 
30 [16  42] 
29.8 (±7.6) 
 
  
Table XVI.2 Socioeconomic status of families  
 
Variable Cyanotic (n=8) Acyanotic (n=32) 
Mean of education of mothers 
 
Grade 9-11 Grade 9-11 
Mean education level of fathers 
 
Grade 9-11 Grade 9-11 
Mean socioeconomic status  Low class Low class 
 
 
 
Table XIV.3 Cardiac diagnostic information 
 
Variable Cyanotic  (n=10) Acyanotic  (n=32) 
Severity of the cardiac disease 
 
Mild 
Moderate 
Moderate to severe 
Severe 
 
Mean severity across the group 
 
 
 
0 (0%) 
1 (12.5%) 
6 (75%) 
1(12.5%) 
 
Moderate to severe 
 
 
1 (3.1%) 
29 (90.6%) 
2 (6.3%) 
0 (0%) 
 
Moderate 
 
  
Table XVI.4 Surgical information and postoperative medical course 
Variable Cyanotic  (n=8) Acyanotic  (n=30) 
 Age at first surgery (months) 
 
Median (range) 
Mean and SD 
 
< 12 months at first surgery 
> 12 months at first surgery 
 
 
 
6.1 [3.3  20.9] 
8.5 (±6.4) 
 
6 (75%) 
2 (25%) 
 
 
8.1 [1.4  20.5] 
9.6  (±5.4) 
 
20 (66.7%) 
10 (33.3%) 
 
Cardiopulmonary bypass used 
 
Yes 
No 
 
CPB time (minutes) 
 
Median (range) 
Mean and SD 
 
 
 
3 (37.5%) 
5 (62.5%) 
 
 
 
134 [58  300] 
164 (± 123.8) 
 
 
23 (76.7%) 
7 (23.3%) 
 
 
 
104 [41-190] 
105 (±40) 
Cross-clamping of the aorta 
 
Yes 
No  
 
Aorta cross-clamp time 
(minutes)  
 
Median (range) 
Mean and SD 
 
 
 
3 (37.5%) 
5 (62.5%) 
 
 
 
 
74 [19 - 100] 
64.3 (±41.4) 
 
 
 
24 (80%) 
6 (20%) 
 
 
 
 
76 [15  132] 
71.1 (±35.6) 
Cardiothoracic ICU LOS (days) 
 
Median (range) 
Mean and SD 
 
CTU stay > 7 days  
CTU stay !7 days 
 
 
 
7.5 [4  22] 
9.8  (±6) 
 
7 (87.5%) 
1 (12.5%) 
 
 
 
5 [3 -28] 
7 (±5.4) 
 
8 (26.7%) 
22 (73.3%) 
Hospital LOS post-surgery 
(days) 
 
Median (range) 
Mean and SD 
 
Length of stay >14 days 
Length of stay !14 days  
 
 
 
14 [6  33] 
16.8 (±9.7) 
 
4 (50%) 
4 (50%) 
 
 
 
 
8.5 [3 - 108] 
14.1 (±20.7) 
 
4 (13.3%) 
26 (86.7%) 
 
  
Table XVI.5 Growth outcomes for participants with cyanotic compared to 
acyanotic heart defects 
 
Growth parameter Cyanotic Acyanotic 
 
Baseline (n=8) (n=32) 
 
Weight for age z-score 
Median  
Mean and SD 
 
-2.8 
-2.5 (±1.4) 
 
 
-2.6 
-2.5 (±1.5) 
Height for age z-score 
Median  
Mean and SD 
 
 
-2.5 
-3.3 (±2.8) 
 
-1.6 
-1.9 (±2.3) 
Head circumference for age 
 z-score 
Median  
Mean and SD 
 
 
-1.4 
-1.5 (±2.2) 
 
 
 
-1.4 
-1.3 (±1.4) 
Three-months post cardiac 
intervention 
(n=4) (n=21) 
Weight for age z-score 
Median  
Mean and SD 
 
-2.9 
-3.0 (±0.8) 
 
-1.7 
-1.6 (±1.7) 
 
Height for age z-score 
Median  
Mean and SD 
 
 
-1.0 
-1.2 (±1.6) 
 
-1.2 
-1.6  (±1.9) 
Head circumference for age  
z-score 
Median  
Mean and SD 
 
 
0.3 
0.2 (±1.7) 
 
 
 
-1.2 
-1.1 (±1.7) 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Weight for age z-score 
Median  
Mean and SD 
 
-2.2 
-1.8 (±2.5) 
 
 
-1.8 
-1.6 (±1.7) 
Height for age z-score 
Median  
Mean and SD 
 
 
-1.8 
-1.7 (±1.8) 
 
 
-1.6 
-1.8 (±1.6) 
 
Head circumference for age  
z-score 
Median  
Mean and SD 
 
 
0.3 
0.5 (±1.3) 
 
 
 
-0.6 
-0.5 (±1.9) 
 
 
 
 
 
Table XVI.6 Classification of growth status according to z-scores participants 
with cyanotic compared to acyanotic heart defects 
 
Variable Cyanotic Acyanotic 
 
Baseline 
 
(n=8) (n=32) 
Malnutrition  6 (75%) 21 (65.6%) 
Stunting  
 
5 (62.5%) 13 (40.6%) 
Microcephaly  
 
2 (25%) 8 (25%) 
Three-months post cardiac 
intervention  
(n=4)  (n=21) 
Malnutrition  4 (100%) 10 (47.6%) 
Stunting  
 
1 (25%) 8 (38.1%) 
Microcephaly  
 
0 (0%) 5 (23.8%) 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Malnutrition  2 (50%) 7 (38.9%) 
Stunting  
 
2 (50%) 6 (33.3%) 
Microcephaly  
 
0 (0%) 3 (16.7%) 
* z-score<-2 indicated malnutrition, stunting and microcephaly 
 
 
 
 
 
 
 
 
 
 
Table XVI.7 Neurodevelopmental outcomes for BSID-III scores for cognitive, 
language and motor sub-scales for participants with cyanotic compared to 
acyanotic heart defects 
 
Variable Cyanotic Acyanotic  
 
Baseline (n=8) (n=32) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD 
 
 
92.5 [55  105] 
89.4 (±17) 
 
 
 
85 [55  130] 
83.8 (±19.6) 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
100 [65  112] 
93.9 (±17.5) 
 
 
91 [62  115] 
89.6 (±13.3) 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
85 [46  112] 
82.8 (±18.8) 
 
 
 
82 [49  110] 
78.7 (±17.3) 
 
Three-month post cardiac 
intervention 
(n=4) (n=21) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD 
 
 
90 [85  95] 
90 (±4.1) 
 
 
90 [55  105] 
83.6 (±18.5) 
 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
106 [ 91  109] 
103 (±8.5) 
 
 
83 [50  112] 
85.6 (±15.7) 
 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
85 [82  94] 
86.5 (±5.7) 
 
 
 
91 [46  112] 
81.6 (±21.5) 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Cognitive sub-scale 
 
Median (range) 
Mean and SD  
 
 
95 [80  110] 
95 (±12.2) 
 
 
 
87.5 [55  110] 
80.8 (±18.7) 
 
Language sub-scale 
 
Median (range) 
Mean and SD 
 
 
 
90 [65  103] 
87 (±17.9) 
 
 
81 [59- 109] 
82.6 (±15.4) 
Motor sub-scale 
 
Median (range) 
Mean and SD 
 
 
89.5 [73  121] 
93.3 (±21.8) 
 
 
 
89.5 [49  121] 
82.3 (±22.8) 
* score < 70 = delayed,  70-84 at risk and >85 normal, >85 normall 
Table XVI.8 Classification of developmental performance according to the 
BSID-III for participants with cyanotic compared to acyanotic heart defects 
 
Variable Time point  Cyanotic Acyanotic  
Cognitive   
 
 
 Baseline  
(n=8) (n=32) 
 Average or above 6 (75%) 15 (46.9%) 
 At risk 1 (25%) 7 (21.8%) 
 Delayed  1 (25%) 10 (31.3%) 
Language  
Average or above 6 (75%) 22 (68.8%) 
 At risk 0 (0%) 7 (21.9%) 
Delayed  2 (25%) 3 (9.3%) 
Motor   
Average or above 4 (50%) 15 (46.9%) 
 At risk 3 (37.5%) 7 (21.9%) 
Delayed 1 (12.5%) 10 (31.3%) 
Cognitive   
 
Three-
month 
follow-up 
(n=4) (n=21) 
 Average or above 4 (100%) 13 (61.9%) 
 At risk 0 (0%) 3 (14.3%) 
 Delayed  0 (0%) 5 (23.8%) 
Language   
Average or above 4 (100%) 10 (47.6%) 
At risk 0 (0%) 9 (42.9%) 
Delayed 0 (0%) 2 (9.5%) 
Motor   
 Average or above 2 (50%) 13 (61.9%) 
 At risk 2 (50%) 2 (9.5%) 
Delayed 0 (0%) 6 (28.6%) 
Cognitive   
 
 
Six-month 
follow-up 
(n=4) (n=18) 
 Average or above 3 (75%) 11 (61.1%) 
 At risk 1 (25%) 1 (5.6%) 
 Delayed 0 (0%) 6 (33.3%) 
Language   
Average or above 2 (50%) 7 (38.9%) 
 At risk 1 (25%) 6 (33.3%) 
Delayed 1 (25%) 5 (27.8%) 
Motor   
 Average or above 2 (50%) 10 (55.6%) 
 At risk 2 (50%) 2 (11.1%) 
Delayed 0 (0%) 6 (33.3%) 
* scores < 70 delayed development , 70-84 at risk  of developmental delay and  " 85 normal 
 
 
 
 
 
Table XVI.9 Perceived HRQOL for participants with cyanotic compared to 
acyanotic heart defects 
 
PedsQLTM total score Cyanotic  Acyanotic  
Baseline  
 
Median (range) 
Mean and SD 
 
(n=8) 
 
79.5 [48.6  93.3] 
75 (±16.2) 
 
(n=32) 
 
81 [49.3  97.2] 
78.3 (±11.5) 
Three-months post cardiac 
intervention 
 
Median (range) 
Mean and SD 
 
(n=4) 
 
 
91.7 [88.9  99.3] 
92.9 (±4.6) 
 
(n=21) 
 
 
88.2 [29.9  100] 
84.3 (±17) 
Six-months post cardiac 
intervention  
 
Median (range) 
Mean and SD 
 
(n=4) 
 
 
87.9 [84.8  90] 
87.6 (±2.3) 
(n=18) 
 
 
86.4 [52.2  100] 
84.6 (±11.9) 
 
  
Table XVI.10 Levels of parenting stress for participants with cyanotic 
compared to acyanotic heart defects 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
Baseline (n=8) (n=32) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
80 [50 -99] 
78.5 (±19.1) 
 
 
 
90 [5  99] 
85.2 (±19.3) 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
Three-months post 
cardiac intervention 
(n=4) (n=21) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
75 [15-80] 
61.3 (±31) 
 
 
80 [1  99] 
70.5 (±28.6) 
 
Sub-scales of the PSI-SF Cyanotic Acyanotic 
Six-months post cardiac 
intervention 
(n=4) (n=18) 
Total stress 
 
Median (range) 
Mean and SD 
 
 
 
25 [5 - 90] 
36.3 (±37.1) 
 
 
72.5 [1-99] 
62.6 (±33.4) 
 
Table XVI.11 Classification of levels of parental stress  
 
Timeframe  Sub-scale Cyanotic 
(n=8) 
Acyanotic  
(n=32) 
Baseline Total stress 
Clinically significant  3 (37.5%) 21 (65.6%) 
High 3 (37.5%) 24 (75%) 
Normal  5 (62.5%) 7 (21.9%) 
Low  0 (0%) 1 (3.1%) 
 
Timeframe  Sub-scale Cyanotic 
(n=4) 
Acyanotic  
(n=21) 
Three-month Total stress 
Clinically significant  0 (0%) 6 (28.6%) 
High 0 (0%) 9 (42.9%) 
Normal  4 (100%) 10 (47.6%) 
Low  0 (0%) 2 (9.5%) 
 
Timeframe  Sub-scale Cyanotic 
(n=4) 
Acyanotic  
(n=18) 
Six-month Total stress 
Clinically significant  1 (25%) 6 (33.3%) 
High 1 (25%) 6 (33.3%) 
Normal  2 (50%) 9 (50%) 
Low  1 (25%) 3 (16.7% 
* >90th percentile clinically significant, >85th percentile high, 15th to 80 percentile low and <15th percentile low 
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The HRQOL outcomes of children aged one to 12 months and 13 to 24 
months  respectively on the PedsQLTM Infant Scales are reported below. 
Values reported are medians with ranges and means with standard deviations  
 
Table XVII.1 Perceived HRQOL of children aged one to 12 months on the 
PedsQLTM Infant Scales 
 
Sub-scales  Baseline 
(n= 29 ) 
Three-months post 
cardiac intervention 
(n= 15 ) 
Six-months post 
cardiac intervention 
(n= 8 ) 
Physical functioning  
 
Median (range) 
Mean and SD  
 
 
88.3 [16.7-100] 
77  (±22.29) 
 
 
 
100 [37.5  100] 
89.9  (±31.46) 
 
 
 100 [33  100] 
 88.5  (±18.75) 
Physical symptoms 
 
Median (range) 
Mean and SD 
 
 
77.5 [35  95] 
75.5  (±15.73) 
 
 
 
90 [45  100] 
84.7  (±15.75) 
 
 
 
88.8 [50  100] 
84.6 (±13.21) 
 
Emotional symptoms 
 
Median (range) 
Mean and SD 
 
 
  
68.8 [16.7  100] 
68.4  (± 19.08) 
 
 
87.5 [25  100] 
80.6  (±15.75) 
 
 
87.5 [62.5  100] 
81.5  (±10.86) 
 
 
Social functioning 
 
Median (range) 
Mean and SD 
 
 
 
100 [50 -100] 
95.7  (±11.58) 
 
 
 
100 [0 -100] 
92.5  (±25.79) 
 
 
100 [62.5  100] 
94.3 (±11.5) 
Cognitive functioning 
 
Median (range) 
Mean and SD 
 
 
 
100 [37.5  100] 
90.7  (±18.19) 
 
 
100 [25-100] 
92.8  (±20.62) 
 
 
100 [25  100] 
83.7 (±23.36) 
SUMMARY SCALES FOR THE PEDSQL® INFANT MODULES AS CALCULATED FROM THE 
ABOVE SUB-SCLAES 
 
Psychological health 
 
Median (range) 
Mean and SD 
 
 
 
78.8 [48.8  100] 
78.3  (±12.85) 
 
 
92.5 [20  100] 
85.3  (±19.81) 
 
 
84.7 [59.6  100] 
83.4 (±11.67) 
Physical health 
 
Median (range) 
Mean and SD 
 
 
 
79.9 [29.7  95.8] 
76.1  (±17.27) 
 
 
93.8 [42  100] 
86.4  (±17.22) 
 
 
89.1 [42.1  100] 
86 (±14.15) 
 
Total HRQOL score 
 
Median (range) 
Mean and SD 
 
 
80.6  [48.6  97.2] 
77.3  (±13.24) 
 
 
90.3 [29.9  100] 
86  (±17.89) 
 
 
87.9 [52.2  100] 
85.1 (±11.18) 
Table XVII.2 Perceived HRQOL of children aged 13 months to 24 months 
on the PedsQLTM Infant Scales 
 
Sub-scales  Baseline 
(n= 11) 
Three-months post 
cardiac intervention 
(n=  9) 
Six-months post 
cardiac intervention 
(n= 10 ) 
 
Physical functioning  
 
Median (range) 
Mean and SD  
 
 
75 [34  100] 
75 (±19.85) 
 
 
 
94.4 [79.2  100] 
94 (± 7.34) 
 
 
 100 [33  100] 
88.5 (±18.75) 
Physical symptoms 
 
Median (range) 
Mean and SD 
 
 
 
80 [45  100] 
78.9 (±16.93) 
 
 
90 [72.5  100] 
89.2 (±9.10) 
 
 
 
88.8 [50  100] 
84.6 (±13.21) 
Emotional symptoms 
 
Median (range) 
Mean and SD 
 
 
  
79.2 [ 52.1  95.8] 
77.3 (±12.62) 
 
 
60.4 [43.8  100] 
71.7 (±21.89) 
 
 
87.5 [62.5  100] 
81.5 (±10.86) 
Social functioning 
 
Median (range) 
Mean and SD 
 
 
 
100 [55  100] 
92.3 (±14.72) 
 
 
100 [55 -100] 
88.3 (±18.71) 
 
 
100 [62.5  100] 
94.3 (±11.5) 
Cognitive functioning 
 
Median (range) 
Mean and SD 
 
 
 
77.8 [44 -100] 
81.1 (±20.61) 
 
 
88.9 [0 -100] 
78.1 (±34.21) 
 
 
100 [25  100] 
83.7 (±23.36) 
SUMMARY SCALES FOR THE PEDSQL® INFANT MODULES AS CALCULATED FROM THE 
ABOVE SUB-SCLAES 
 
Psychological health 
 
Median (range) 
Mean and SD 
 
 
 
74 [58.8 -95.2] 
78.3 (±11.76) 
 
 
80.8 [45.2  100] 
78.1 (±20.30) 
 
 
84.7 [59.6  100] 
83.4(±11.67) 
Physical health 
 
Median (range) 
Mean and SD 
 
 
 
78.1[53.9  97.4] 
7.5 (±15.28) 
 
 
90.8 [79.7  100] 
91.5 (±6.35) 
 
 
 
89.1 [42.1  100] 
86 (±14.15) 
Total HRQOL score 
 
Median (range) 
Mean and SD 
 
 
 
78.3 [64.4  95.6] 
78.5 (±10.57) 
 
 
84.4 [63.9  - 100] 
83.8 (±13.44) 
 
 
87.9 [52.2  100] 
85.1(±11.18) 
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NEURODEVELOPMENT, QUALITY OF LIFE AND BURDEN OF CARE OF YOUNG 
CHILDREN WHO HAVE UNDERGONE CARDIAC INTERVENTIONS IN CENTRAL 
SOUTH AFRICA:  
SIX WEEK AND SIX MONTH POST CARDIAC INTERVENTION OUTCOMES 
 
 
Dear parent(s)/caregiver 
 
As you know my name is Robyn Smith and I am a physiotherapist. I am currently doing 
research as part of my Doctorate of Philosophy (PhD) studies at the University of the 
Witwatersrand (WITS). Research is simply the process by which one finds the answers 
to a question. 
 
Background and motivation 
 
It is well known that many children with congenital heart defects have developmental 
problems. Currently no set developmental stimulation programme exists aimed at 
specifically addressing the developmental needs of children with congenital heart 
defects. Such a programme is aimed at optimising a childs development over time 
ensuring he reaches his full potential. 
 
Aim of the study 
 
As parents/caregivers you are a vital stakeholder in the process of developing a 
suitable home- based, parent driven developmental stimulation programme that meets 
your needs as you will be the one implementing this programme in conjunction with 
your physiotherapist.  
 
Your participation in the first phase of the study assisted me in identifying typical 
developmental problems found in children with congenital heart disease in central 
South Africa.  I have used this information to now develop a programme that I need 
your help in evaluating.  
 
Format of the study 
 
You have been selected from the group of parents/caregivers that took part in Phase I 
and Phase II completing the first part of the study, I would now like to invite you to 
assist me in evaluating the home-based developmental stimulation programme that I 
have developed.  
 
After agreeing to participate in the group discussion I will provide you with a date and 
time for the scheduled group session, I will reminded you telephonically of the session 
three days beforehand. The group will be held in an office at the Paediatric Cardiology 
Department, Universitas Academic Hospital in Bloemfontein that you are familiar with. 
 
At the session you will be orientated about procedures and you will be asked to sign a 
consent form agreeing to participate.  You will be provided with a pencil and eraser. A 
sheet with a question asking about the aspects you would like to have included in a 
home programme and another question about considerations you would like to have 
taken into account regarding a home programme will be handed out to you. Each 
question will be provided with a list of options. I will ask you to rank the aspects that 
you find important in order of priority in the blank block provided next to the items. The 
most important item is to be allocated the highest score. Once this is done I will issue 
you with a copy of the home programme I have compiled for the various age-groups. 
You will again go through the items per age group programme and rank each of the 
items independently in order of priority/importance for each age group specific 
programme in the blank block provided next to the items. Again the most important 
item is to be allocated the highest score. After this has been completed, the session 
will then be adjourned and a date and time for a follow-up session will be fixed.  This 
will give me a chance to calculate and consolidate your responses into a programme 
that reflects entire groups priorities.  
 
You will again be reminded of the scheduled group appointment telephonically three 
days beforehand.  At the  next session the re-prioritised programme will be presented 
to the group and discussed until consensus is reached by the entire group that the 
programme address everybodys needs. 
 
Each group session will take approximately one hour.  Additional sessions may be 
needed if we have difficulty in finding consensus.  
 
Benefit of participating in the study  
 
Your input into the home programme will be invaluable in ensuring a relevant 
programme that also addresses your needs as parents/caregivers.  
 
It is hoped that following this study this programme will be piloted and potentially 
implements for all children attending the Paediatric Cardiology Department at 
Universitas Academic Hospital if shown to be effective. 
 
Ethical considerations 
 
This part of the study holds no anticipated risk to you.  
 
Your participation in this study is voluntary, you may decline to participate or withdraw 
from this part of the study at any point without the risk of discrimination or penalty. 
Your child will continue to receive standard care irrespective of your participation. 
 
You will not be remunerated for your participation in this part of the study, but the 
researcher will reimburse you for your travelling costs for visits directly related to your 
participation in this study. An amount of R150 per visit will be provided per visit for 
transport. No additional costs will be incurred due to your participation. 
 All information you and others provide in these group sessions will be treated 
confidential.   
 
Complete confidentiality cannot however be guaranteed, as this information may be 
required to be disclosed if requested by a court of law or an ethics committee. 
 
Feedback on study outcome 
 
The results of the study can be requested from the researcher following the completion 
of the study.  
 
Presentation and publication of research findings 
 
The results of the study may be used in presentations at academic congresses or in 
print in the form in an accredited journal. In the above cases all data pertaining to 
participants will be presented in an anonymous manner and no individual will be 
identifiable. 
 
Ethical inquiries 
 
This protocol has been reviewed by two ethics committee. If you have any questions or 
concerns pertaining to the ethical aspects of the study you may contact the researcher 
or the secretariats of the following ethics committees: 
 
Ethics Committee of the Faculty of Health Sciences, University of Free State 
Office of secretariat  051-4052812 
    StraussHS@ufs.ac.za 
 
Medical Human Research Ethics Committee, University of Witwatersrand 
Office of secretariat  011-7171234  
    anisa.keshav@wits.ac.za 
 
 If you have any inquiries, questions or concerns the research can be contacted 
at the following numbers: 
 
Robyn Smith       051- 4013303 (w) 
Lecturer /Physiotherapist     082 925 9367 (cell) 
Department of Physiotherapy 
University Free State 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Informed consent 
 
 
I ............................................................, have been informed about the study by the 
researcher Mrs. Robyn Smith. I  ....................................................... agree to 
participate in this study.  
 
 I am aware that my participation is voluntary, and that I can decline participation or 
withdraw at any point without the risk of penalty. I am aware that my child will continue 
to receive standard care irrespective of my participation.  
 
I am aware that I will only receive compensation of R150 per visit for travelling costs 
for my visits directly relating to my participation in this part of the study. I agree to 
attend the sessions as scheduled by Ms. Smith. 
 
 I have been informed that the information discussed in the groups is confidential and 
that I may not report any of the discussions to persons outside the confines of the 
group.  
 
I am aware that if I have any ethical concerns I may approach the researcher or the 
secretariat of the ethics committees. I am aware that I can request the results of the 
study upon its completion. 
 
I am aware that the results of the study may be presented at academic congresses or 
in print in the form in an accredited peer reviewed journal. 
I am aware that I will be provided with a copy of the information letter and the 
signed copy of the informed consent for personal reference. 
 
Signature of the parent/caregiver  _______________________ 
Name in print     _______________________ 
Date      _______________________ 
 
Signature of the researcher   _______________________ 
Name in print     _______________________ 
Date      _______________________ 
 
Signature of a witness   _______________________ 
Name in print    _______________________ 
Date      _______________________ 
 
Signature of a translator    _______________________ 
(If applicable) 
Name in print    _______________________ 
Date      _______________________ 
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TITLE OF THE RESEARCH STUDY 
 
NEURODEVELOPMENT, QUALITY OF LIFE AND BURDEN OF CARE OF YOUNG 
CHILDREN WHO HAVE UNDERGONE CARDIAC INTERVENTIONS IN CENTRAL 
SOUTH AFRICA:  
THREE-MONTH AND SIX-MONTH POST CARDIAC INTERVENTION OUTCOMES 
  
 
 
Dear Madam, 
 
My name is Robyn Smith and I am a physiotherapist employed at the University of the 
Free State. I am currently doing research as part of my Doctorate of Philosophy (PhD) 
studies at the University of the Witwatersrand (WITS).  
 
Background and motivation 
 
Congenital heart defects (CHD) are the most common type of congenital defects. 
Approximately 1% of children are born with a heart defect. It is a serious health 
condition, and in more severe cases the defect can hold the risk of associated 
problems including impaired growth, delayed development and more serious 
neurological consequences such as cerebral palsy.  
 
As a result of recent advances in the diagnosis, treatment and post-operative care, 
most heart defects can be successfully corrected during infancy. Today up to 85 % of 
children born with CHD, who receive the appropriate medical and/or surgical treatment 
survive. CHD is now viewed as a chronic health condition. 
Increased survival has necessitated a shift away from simply looking at survival as a 
measure of outcome. There is a move toward considering longer-term outcomes and 
associated morbidity, these measures include functionally ability or developmental 
status, health-related quality of life and the extent of the continued burden of care 
place on families. 
 
To date very little research regarding cardiovascular disease in children has been done 
in South Africa, resulting in a significant gap in information regarding the pre- and post- 
cardiac intervention outcomes of young children living with CHD. 
 
We do know that children with CHD living in South Africa have a vastly different 
prognosis regarding morbidity and mortality when compared to children in developed 
countries. Late diagnosis and delayed treatment of CHD continues to place a 
significant burden on the healthcare system of South Africa aside from the detrimental 
effects this has on the outcome of the child, and the continued burden of care placed 
on the family. 
 
The implementation of early developmental intervention services such as 
physiotherapy, occupational therapy and speech therapy in the holistic management of 
the child with CHD has universally been poorly delineated. Currently developmental 
intervention and rehabilitation guidelines for this population remain vague with a 
paucity of appropriate, standardised and validated home-based, caregiver-driven 
developmental stimulation programmes aimed at optimising developmental outcome in 
children with CHD.  Only two research studies have been conducted to date on the 
implementation of early developmental therapy in this population. Both studies have 
unanimously concluded that hospital-based services do not meet the needs of children 
living with CHD. Compliance with hospital-based therapy has been shown to be 
extremely poor. It has been strongly recommended that appropriate home-based, 
caregiver-driven developmental stimulation programmes would serve best to address 
the needs of CHD survivors and their families.  
 
Based on the developmental outcomes of participants in Phase I and Phase III of the 
study a home-based, caregiver-driven developmental stimulation programme has been 
developed. Standardised and validated developmental test items contained in the 
Bayley Scales of Infant and Toddler development III (BSID III) were used as the basis.  
Anecdotal information provided by parents upon exiting the study was also taken into 
consideration when developing the programme. The programme thus includes 
information on age appropriate skills that need to be achieved, identification of 
worrying signs and guidelines for activities, play and toys caregivers can use to 
enhance development.  
 
As an experienced physiotherapist, occupational therapist or speech therapist working 
in early intervention services in South Africa I am in need of your input into this 
programme. I would therefore like to invite you to participate in this phase of the study.  
 
By reviewing and providing feedback on the programme you are consenting to 
your participation in the study.  
 
Aim of the study 
 
The aim of this study has been threefold; Phase I and II has determined the pre-
cardiac intervention, as well as the three month and six month post cardiac 
intervention developmental outcome, health-related quality of life and burden of care in 
young children with congenital heart disease in central South Africa. 
 
The aim of this, Phase III, of the study has been determining the nature and extent of 
the developmental challenges faced CHD survivors in central South Africa, and the 
subsequent development of a home-based, caregiver driven developmental stimulation 
programme to meet the needs of these children and their families.  
 
  
Format of the study 
 
Phase III of the study involves the participation of selected parents, and an 
experienced rehabilitation professionals to review and provide input on the 
programme.  
 
You participation in this phase of the study will involve reviewing, and providing 
feedback on the developmental stimulation programme that has been developed. This 
will require approximately 45 minutes of your time. 
 
The programme has been forwarded to you electronically. You are requested to note 
your comments and suggestions in writing on a hard copy if you wish, or electronically 
by making use of track changes on the document.  
 
You will be given three (3) to review and submit the document. A reminder to submit 
your feedback will be sent to you electronically and via SMS one (1) week before the 
submission deadline. You feedback can be submitted electronically, or in hard copy 
form for written changes. You are welcome to contact the researcher should you have 
any questions.  
 
The researcher will consolidate the feedback provided by the rehabilitation 
professionals and the caregivers. The programme will be revised as needed and a 
revised copy will be forwarded to you for any final comments before the programme is 
finalised. 
 
Value in the study  
 
The development of a validated home-based caregiver driven developmental 
stimulation programme will serve to address the developmental needs of children living 
with CHD, their families and the therapists who serve them.  
 
This programme will be piloted in the population going forward in further research 
projects. 
Ethical considerations 
 
There are no anticipated risks involved in your participation.  
 
The study has been provided with ethical clearance from the University of the Free 
State (ECUFS 177/2013) and the University of the Witwatersrand (M131056). 
 
Participation is voluntary, you may decline participation or withdraw from the study at 
any point without the risk of discrimination or penalty.  
 
You will not be remunerated for your participation in the study.  You may also not 
directly benefit from your participation. 
 
All personal information will be treated as confidential, only the researcher will have 
access to this information. Complete confidentiality cannot however be guaranteed at 
this information may be required to be disclosed if requested by a court of law or by an 
ethics committee. 
 
Feedback on study outcome 
 
You may also request feedback following the conclusion of the study. 
 
Presentation and publication of research findings 
 
The results of this study may be used in presentations at academic congresses or in 
print in the form as a scientific article published in an accredited peer reviewed journals 
both locally and internationally. In the above cases all data pertaining to participants 
will be presented in an anonymous manner. 
 
Ethical inquiries 
 
If you have any questions or concerns pertaining to the ethical aspects of the study 
please feel free to contact the researcher or the secretariats of the respective Ethics 
Committees following submission of the protocol to the committees for review. 
 
Ethics Committee of the Faculty of Health Sciences, University of Free State 
Office of secretariat  051- 4052812  
    ethicsfhs@ufs.ac.za 
 
Medical Human Research Ethics Committee, University of Witwatersrand 
Office of secretariat  011-7171234  
    anisa.keshav@wits.ac.za 
 
If you have any inquiries, questions or concerns the research can be contacted 
at the following numbers: 
 
Robyn Smith       051- 4013303 (w) 
Lecturer /Physiotherapist     082 925 9367 (cell) 
Department of Physiotherapy                                        051-4368311 (home) 
University Free State 
 
Informed consent 
 
By reviewing and providing feedback on the programme you are consenting to 
your participation in the study.  
 
You aware that your participation is voluntary, and that you can withdraw at any point.  
 
You are aware that you will not be compensated for your participation in this study. 
You hereby agree to review the programme and then submit the reviewed documents 
as requested by Ms. Smith within the stipulated timeframes. 
 
 You have been informed that the information that you provide will be treated as 
confidential.  
 
You are aware that if you have any ethical concerns you may approach the researcher 
or the secretariat of the ethics committees. You are aware that you can request the 
results of the study upon its completion. 
 
You are aware that the results of the study may be presented at academic congresses 
or in print in the form in an accredited peer reviewed journal. 
 
 
THANK YOU FOR YOUR PARTICIPATION 
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What is congenital heart defect (CHD)? 
Congenital heart defects (CHD) are the most common type of congenital birth 
abnormality found in children. One in every hundred children is born with a heart 
defect.  A congenital heart defect is an abnormality or abnormalities in the formation 
of the rooms of the heart and/or the big blood vessels before birth.  
How is a congenital heart defect treated? 
Treatment will depend on how severe the heart defect is, and may require 
medication and/or cardiac procedures (catheterisation) and/or surgery. 
Why are children with congenital heart defects at a higher risk of 
developmental difficulties? 
CHD can cause changes in the blood flow to the brain before and after birth, this 
might affect the brains development. In some cases low levels of oxygen in the 
blood and the fact that the heart is not working properly may result in your child 
being too tired to play and explore their surroundings.  Often children with heart 
defects do not eat well and do not gain weight, leaving them without enough energy 
to play and explore. 
Children who are admitted to hospital often or who spend long periods of time in 
hospital with chest infections or heart problems, may be at risk of developmental 
problems. Being in hospital is not the best environment for your childs development. 
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Children who have long hospital stays or other complications (premature birth, 
genetic or neurological conditions) are also at risk. Having heart surgery can also 
pose a risk to your childs development.   
Not all children with heart defects, or those that have heart surgery will necessarily 
have delayed development. 
Why is it important to stimulate my childs development? 
It is very important for you to stimulate your childs development as much as possible 
both before and after heart surgery. The first three years of life are critical to your 
childs development. This is the period of time when the brain grows the fastest and 
they learn the most new things.  
The most important factors in your childs development are eating well and growing, 
having a good home environment, providing them with the right care, having a loving 
caregiver and having the right type of stimulation. You as the caregiver have a big 
influence on your childs development, and by helping to provide the right type of 
stimulation at home you will help them reach their full developmental potential. 
What are the right type of activities and stimulation I need to give my child? 
Children develop certain skills at certain ages. Play is very important in young 
children for learning. It is important to make use of play- and daily activities such as 
dressing, feeding and bathing to encourage your childs development.  
Through playing with your child and talking to them you will teach them to talk, 
explore their environment and learn new things. It is important that you do the right 
activities for your childs age and developmental level.  
Refer to the activity tables for ideas on appropriate activities.  
Why is it important to monitor my childs development at home? 
It is important for you to monitor if your child is able to perform the activities and 
master the skills expected for their age.  
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This will include skills relating to: 
§ Speaking and understanding language. 
§ Thinking, learning and solving problems. 
§ Grasping and manipulation skills (hand function). 
§ Big muscle movements and physical activities such as sitting, crawling, 
standing and walking.  
 
You will need to continue to monitor these activities and skills as your child grows, 
even if there are not any problems now. Problems with learning, concentration, 
schoolwork and behavior may only be noticed later on.  Refer to the activity tables 
for the age appropriate skills your child should master. This will help you see if your 
child is not reaching the skills they are supposed to for their age. 
 
Why is it important to monitor your childs weight and if they are growing? 
It is important that you provide your child with good nutrition. Being well fed helps to 
provide the energy the brain needs to develop and for the muscle to get strong. Food 
also gives your baby energy to play and explore their surroundings. If your child is 
not growing well this could also have a negative effect on their development and 
prevent them from reaching the skills they should reach for their age. This is why it is 
important to have your child weighed regularly at the clinic and to monitor if they are 
gaining weight. If your child is not gaining weight talk to your local nursing sister.  If 
there is a problem they will refer you to a doctor or dietician. 
What should I do if I am worried about my childs development? 
If your child is not reaching their age specific skills or is not gaining weight and 
growing it is worrying. You know your child best, so if you notice any worrying signs 
(see listed in the activity tables for his age group) or you are worried about your 
childs development talk to a healthcare worker as soon as possible (this could be a 
nurse, your doctor, a physiotherapist or an occupational therapist).  If they think it is 
necessary they will refer you to a doctor, physiotherapist, occupational therapist, 
speech therapist, dietician or psychologist for further testing. 
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So what should I do if my child does have a developmental delay? 
If a healthcare worker has identified a developmental delay it may be necessary for 
your child attend early intervention therapy services such as physiotherapy, 
occupational therapy or speech therapy at your nearest service point in order to help 
your child achieve their full developmental potential. Children do best if their 
developmental problems are addressed as soon as possible, but it is never too late 
to do something about it. 
The therapists will provide you with advice, as well as an activity and exercise 
programme for you do at home daily. You might need to follow up with her on a 
regular basis to monitor your childs progress.  
You can also do the activities as suggested in the activity tables to help your child in 
their development. Try and do these activities daily and incorporate them during 
activities such as play, dressing, bathing and feeding. 
What if my child also has Down syndrome? 
Down syndrome is a genetic abnormality, and 40 to 50% of children with Down 
syndrome also have heart defects.  
Children with Down syndrome development slower than other children. Children with 
Down syndrome develop big muscle actions e.g. sitting, crawling and walking and 
other activities against gravity at a slower rate due to their low muscle tone (floppy), 
weak muscles and hypermobile joints. Children with Down syndrome also have 
delayed development of speech and language, thinking and problem solving skills as 
well as hand skills and grips.  
Their heart defect therefore puts them at risk of making the developmental delay 
even worse for the reasons discussed in the sections above.  
If your child has Down syndrome you should have your child referred to early 
intervention services (physiotherapy, occupational therapy and speech therapy) as 
soon as possible after birth at your nearest service point. Early intervention therapy 
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will be necessary to assist you in helping your child achieve and master 
developmental skills. 
Remember when monitoring your childs developmental skills using the activity table 
below you will need to take into account their naturally slower rate of development by 
making use of the table at least one age group below his actual age. Look for the 
table which contains activities he can already do or start to do and work from there.  
What precautions do I need to take after my childs heart operation? 
Following your childs heart operation there will be some special instructions for 
caring for them. Please read the information below regarding limits on physical 
activity, wound care and general instructions. 
 
 
Image courtesy of GOOGLE images 
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PAEDIATRIC CARDIAC SURGERY DISCHARGE INSTRUCTIONS 
Physical activity limitations for the first 6 weeks after surgery 
Younger children  (0 - 3 years) 
Do not pick your child up by his/her arms or underneath their arms for at least 6 weeks. 
Rather pick your child up by scooping him/her up with one arm around the head, neck 
and shoulders and the other under the bottom. 
Dont pull on your childs arms. 
Try and avoid activities with the arms above the head, and try and avoid activities that 
require pushing with the arms or carrying heavy objects. 
Put on clothing that buttons down the front rather than round necked tops that you need 
to pull over their head, this requiring you to lift their arms above their head to get into this 
can be painful and cause movement of the breastbone. 
If your child has a cut through their sternum (breastbone) avoid putting them on their 
stomach for the first 4-6 weeks after the surgery as this is often very uncomfortable for 
your child. The breastbone heals in 6 weeks and from 6 weeks you should then again 
encourage tummy time during play with a goal of 30 minutes/day (this can be broken 
down into 4 sessions of 8-10 minutes each if your child does not like the position). Make 
sure your baby is breathing comfortably when you are putting them on their stomach. 
Try and keep your child from crying for too long in the first weeks after surgery. 
If you child is walking or is able to run try and avoid any activities that could cause your 
child to fall flat onto their chest. Also avoid activities that could cause your child to get a 
hard bump against their chest. 
If your child is at an age where they are crawling it is difficult to prevent them from 
crawling. They will stop or avoid crawling if it is painful. 
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How much activity may my child do? 
· For the most part it is difficult to limit childrens levels of activity. They will rest 
when they are tired. It is however important in the period after the operation to 
watch them for signs of tiredness, and encourage them to rest when tired.  
· It is normal for your child to rest and sleep more than usual in the weeks after 
the operation. 
Return to day care or preschool 
· If your child is attending day care or nursery school, you should discuss your 
childs return with your cardiologist or cardiothoracic surgeon before going 
home or at your first follow up visit. Your child will usually be allowed to return 
at 4-6 weeks after the operation. They may at first go back to school for half 
the day or only three days a week. Ask your doctor for clear instructions about 
this. 
If my child has a developmental delay when can I start or restart early 
intervention services (physiotherapy, occupational therapy and speech 
therapy) after the surgery?  
· It is important to give your child a chance to rest and recover after the surgery 
for at least 6 weeks.  
· Therapy can be resumed after your 6 week follow-up at the cardiothoracic 
surgeon, but often children are only pain free from 3 months after the surgery 
when the sternum has healed completely. Discuss your childs return to 
therapy with your doctor and your therapists.  
· Remember to inform your therapists that your child has had heart surgery 
recently as they may not always be aware.   
Wound Care  
· The wound can be left open to air once the nursing staff in the ward have 
taken of the dressing. Keep the wound dry and clean by following the wound 
care instructions given to you by the nursing staff. 
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·  In smaller children the wound can be covered with a dry gauze dressing 
where there is moisture e.g. drooling or if they tend to spill drinking liquids 
onto the front of the chest. Immediately remove wet dressing and replace with 
a new dry dressing. 
· Consider gauze dressing if the wound is being irritated by clothing or is itchy. 
Itching is a normal sign of healing. 
· Protect the wound from the sun when it is still pink to decrease darkening of 
the scar. Keep the wound covered with clothing or a gauze dressing when 
your child is playing outside.  
· Keep your childs nails short and do not let them scratch the wound or scar. 
·  DO NOT APPLY any creams or lotions to wound. 
· Check the wound daily for any signs of infection e.g. redness, swelling, 
drainage from wound site or discomfort over the area (anything different than 
what you are used to seeing). This should be reported immediately to your 
local nursing sister or your doctor. 
· Your child should only take a sponge bath (let the water run over the back) 
from the fifth day after surgery try and keep the wound dry. Avoid bathing 
where the wound getting wet or being soaked until your doctor tells you 
otherwise. 
General information 
· Keep your child at home for the first few weeks after surgery and avoid 
crowded places like shopping malls to prevent exposure to germs. 
· Wash your hands with soap and water before touching your child to avoid 
spreading any germs to your child. 
· Postpone or delay scheduled immunizations until 6 weeks after the operation. 
· Postpone or delay scheduled dentist appointments up until 3 months after the 
operation. 
· Take the medication as instructed by your doctor- do not stop taking any 
medication or start a new medication before talking to your doctor. Make sure 
you attend your clinic visits to renew your medication prescriptions in time. 
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· It is essential that you attend your scheduled doctors and therapy 
appointments. If you cannot make an appointment please reschedule as soon 
as possible. 
When should I take my child to the clinic or doctor? 
· Running a fever. 
· Has a very fast heartbeat. 
· Is breathing very quickly or struggling to breathe. 
· The wound looks infected (see above). 
· Continuing nausea, vomiting and diarrhea. 
· Poor feeding or if your child is not interested in eating. 
· Discomfort or pain causing your child not to be comfortable or be able to 
sleep, and you feel your child is not getting better. 
· Child is just lying and does not want to play. 
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DEVELOPMENTAL ACTIVITY SHEETS 
How do I use the activity sheets below? 
Please find tables below with activities your child should be doing for their age, 
worrying signs, and advice on activities you can do at home, and toys and items that 
are appropriate to play with.  
Please note that if your child was born prematurely (before 37 weeks), and is still 
under the age of two years, you will need to subtract the weeks or months they were 
born early from their age to take into account for them being born early. This will 
ensure you measure your child development against the correct age expected skills.  
Start with the activity sheet at your childÕs age (corrected age if born early). If they 
are unable to do the skills in this age group, work back one age group until you find 
an age group where they can do some of the skills or are starting to do some of the 
skills. Your child may not be on the same table for all the various skill areas e.g. 
physical activity, social and emotional and communication. 
Illustrations by Rebecca Potterton!
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
0-3 MONTHS 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ When lying the baby moves arms and legs actively and the movements are 
   smooth and rhythmical. 
¥ When held upright over your shoulder baby can lift their head for a moment. 
¥ When lying on their tummy baby can turn their head to both sides. 
¥ Is able to watch your face or a toy with their eyes when it is moved in            
   front of their face. 
¥ Is able to bring both their hands to their mouth. 
Learning, thinking and solving problems:  
¥  Pays attention to faces and recognises you. 
¥ Looks around. 
¥  Turns their eyes and head towards the side of the sound when a rattle is shaken 
            or someone speaks loudly. 
Language and communication: 
¥  Smiles at the person speaking to them. 
¥ Coos and makes gurgling sounds. 
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Social  and emotional skills 
¥  Can calm themself by bringing their hands to their mouth. 
¥ Will begin to smile. 
You should be worried if your baby does not:  
¥ Does not respond to loud noises. 
¥ Does not bring hands to their mouth. 
¥ Does not watch things as they move, or smile at you. 
¥ Does not lift up their head when placed on their tummy, and dislikes the position. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist. 
*** !
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Things you can do to help your babyÕs development: 
! Talk, read, sing and play with your baby during feeding, dressing, and bathing.  
! Help your baby learn to calm herself. ItÕs okay for them to suck on their hand and fingers to 
soothe themselves.  
! Begin to help your baby get into a routine, such as sleeping at night more than in the day. 
  
! Act excited and smile when your baby makes sounds. Copy your babyÕs sounds 
sometimes, but also talk normally to them using clear understandable language.  
! Let baby practice watching a small toy by holding it up above their face and moving it up 
and down and to the left and right. 
! It is important to hold your baby in an upright position over your shoulder allowing them to 
start lifting up their head off your shoulder. This will help to strengthen the neck muscles. 
Support the neck with your hand as needed. 
¥ It is important to allow your baby to lie on their tummy when awake and during play, put 
toys nearby them when doing so. Encourage your baby to lift their head up when lying on 
their tummy by holding toys at eye level for them to look at.  
¥ If your baby is not comfortable  lying on its tummy on the floor you can let them lie on your 
chest while you lean back in a comfortable chair. 
¥ It is best not to let your baby sleep on their stomach but rather on their back or side. 
Toys and items you can use at home: 
¥ Rattles (If you do not have a rattle use an empty pill container and fill with rice grains or 
maize pips- make sure container is sealed tightly). 
¥ Hand held mirror for baby to look at themselves in (if you donÕt have a hand held mirror sit 
with your child in front of a large mirror). 
¥ Bangle or plastic ring hung on a shoe lace or piece of string to encourage following with 
the eyes. 
¥ Make sure toys do not have small loose parts which can be swallowed and cause your 
baby to choke. 
¥ Make sure toys are small and light enough for baby to hold easily. Keep plastic toys clean 
by regularly washing them in warm water and dishwashing liquid. 
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
4-6 MONTHS 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ Can hold their head steady, without support when held in an upright position. 
¥ Rolls from lying on their side back onto their back. 
¥ Lying on their tummy, is able to push up on their arms and lift the head and 
   upper body up off the ground. 
¥ Sits with some support at the hips and back. 
Learning, thinking and solving problems: 
¥ Responds to the attention given by parent(s) or caregivers. 
¥ Looks at their own hands. 
¥ Explores objects by shaking them it or by putting them in their mouth. 
¥ Approaches his/her image in a mirror with their body and/or touches the mirror. 
¥ Always tries to reach for objects to get hold of them. 
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Language and communication 
¥ ÒBabblesÓ or makes baby noises. 
¥ Cries in different ways when they are hungry, wet or tired. 
¥ Put sounds together like ÒahÓ, ÒehÓ and ÒohÓ. 
Social  and emotional skills: 
¥ Knows familiar faces and may not like strangers.  
¥ Clearly responds to sounds and voices. 
¥ Responds to others emotions and is often happy.  
¥ Like to look at themself in a mirror. 
You should be worried if your baby does not:  
¥ Does not try and get objects that are within 
reach. 
¥ Does not to respond to the sounds around them. 
¥  Does not show affection towards you.  
¥ Cannot bring objects to their mouth to explore. 
¥  Does not make sounds or respond to you. 
¥ Does not roll over to the sides. 
¥  Dislikes being placed on their tummy. 
¥  Has difficulty calming down or getting into a routine. 
¥ Does not smile or laugh. 
¥ Feels very floppy or very stiff. 
¥  Only uses one side of the body.                        
                                        
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist. 
*** !
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Things you can do to help your babyÕs development: 
! Talk, read, sing and play with your baby during feeding, dressing, and bathing.  
! Set a routine for sleeping and feeding.  
! Act excited and smile when your baby makes sounds. Repeat your childÕs sounds and say 
simple words with those sounds. For example, if your child says Òbah,Ó say ÒbabyÓ or Òball.Ó 
! Give age-appropriate toys to play with, such as rattle, ring or a small plastic blocks.  
! Allow your baby to lie on a blanket on the floor, providing safe opportunities for your baby 
to play and reach for toys and explore their surroundings.  
! Put toys near your baby so that she can reach for them. This will encourage them to start 
rolling. 
! Put toys or rattles in your babyÕs hand and help him to hold them and pass them from one 
hand to the other. 
! Hold your baby upright with feet on the floor as they will begin to ÒstandÓ with support. 
! Place your baby on their tummy when awake and during play, put toys nearby them.  This 
will encourage them to reach out for the toys. 
! If your baby finds it hard to play while they are on their tummy, place a small rolled up 
towel under their chest. 
! Use ÒreciprocalÓ playÑwhen they smiles, you smile; when they makes sounds, you copy 
them.  
! Read childrenÕs story books or picture books to your child every day. Praise them when 
they babble and ÒreadÓ too.  
Toys and items you can use at home: 
¥ Rattles (if you do not have a rattle use an empty pill container and fill with rice grains or 
maize pips- make sure container is sealed tightly) or small toys that he/she is able to grasp 
easily and that are light. 
¥ Small wooden or plastic blocks (if you do not have blocks use  small empty match boxes). 
¥ Hand held mirror or sit with your child in front of a large mirror. 
¥ Bangle/plastic ring on a shoe lace or piece of string. 
¥ A small ball e.g. a tennis ball 
¥ Hard cover picture books (if you do not have a picture book you can use a magazine with 
bright pictures of familiar items. You can also cut pictures out of a magazine and paste in 
an exercise book to make your own picture book). !
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
7 - 9 MONTHS 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ Sits with slight support and later alone from around 8 months.                           
¥ Can roll from the back onto both sides, and later onto the tummy. 
¥ Stands holding on to your hands or stands at a couch or low table. 
 
¥ Can move frcrylying onto their tummy and up into a crawling position. 
¥ Starts to crawl. 
¥ Picks up a block with one or both hands. 
¥ Able to pick up a small object e.g. cereal ÒcheeriosÕÕ. 
¥ Can pass a plastic ring or block from one hand to the other. 
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Learning thinking and problem solving: 
¥ Child plays with their image in a mirror (smiling, touching and mouthing). 
¥ Plays with a string tied to a ring or bangle by pulling or chewing on the string. 
¥ Bangs blocks, spoons during play.  
¥ Looks for a fallen toy when dropped on floor. 
¥ Reaches for toys all the time. 
Language skills: 
¥ Turns head towards the side of sounds. 
¥ Recognises and turns head when their name is called. 
¥ Makes sounds and tries use their voice to gain attention. 
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¥ Makes sounds like ÒgagaÓ ÒbabaÓ, ÒdadaÓ 
Social  and emotional skill: 
¥ Responds to others emotions and is often happy.  
¥ Like to look at themself in a mirror. 
¥ Makes noises and laughs in response to speakerÕs attention. 
You should be worried if your baby does not:  
¥ Does not take weight on their legs when you hold them in standing. 
¥ Does not make sounds like ÒgagaÓ, ÒmamaÓ, ÒdadaÓ or ÒbabaÓ. 
¥ Does not sit alone or with very little help.  
¥ Does not play games taking turns back and forth. 
¥ Does not roll over to both sides and onto the stomach. 
¥ Does not pass toys from one hand to the other, cannot pick up a small item. 
¥ Seems very floppy or very stiff. 
¥ If the muscles are weak. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist. 
*** !
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Things you can do to help your babyÕs development: 
! Pay attention to the way they react to new situations and people; try to continue to do 
things that make your baby happy and comfortable. As they moves around more, stay 
close so they know that you are near. 
! Describe what your baby is looking at; for example, Òred, round ball.Ó  Copy your 
babyÕs sounds and words. But also talk to them using normal language. 
! Ask for behaviours that you want e.g. ÒletÕs sit downÓ or Òturn onto your tummyÓ.  
! Teach cause-and-effect by letting an object fall to the floor and help them look for it. 
! Provide lots of room for your baby to move and explore in a safe area on the floor for 
example on the soft mat or on a blanket. 
! Encourage play in sitting, give toys to your child from the front and sides to help 
develop sitting balance. 
! When lying on their tummy put toys out in front of them just out of reach encouraging 
them to crawl forwards to get to the toy. 
Toys and items you can use at home: 
¥ Small plastic or wooden blocks (if you do not have blocks use a small empty match 
boxes). 
¥ Kitchen spoons (metal or wooden) for banging. 
¥ CheeriosÕ cereal to develop small hand skills.  
¥ Plastic stack rings or bangle on a string or shoelace. 
¥ Hand held mirror or sit with your baby in front of a large mirror. 
¥ Hard cover picture books (if you do not have a picture book use a magazine with bright 
pictures and make a picture book). 
¥ Plastic ball. 
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
10-12 MONTHS 
  WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
             
¥  Sits alone with good balance, and can turn and reach for toys put to the sides. 
¥ When holding child under their arms in standing they step with their feet. 
¥ Able to move around by crawling. 
¥ Moves from lying to sitting or into a crawling position on their own. 
¥ Stands against furniture for support. 
 
¥ Able to pull themself up into standing from the ground against the furniture. 
¥ Walks sideways along the furniture. 
¥ Able to pick up a small object e.g. cereal ÒcheeriosÕÕÓ using thumb 
and first finger. 
¥ Can pass ring or block from one hand to the other. 
¥ Bangs spoons or blocks together or against surfaces. 
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Learning thinking and problem solving: 
¥  Child will pick up two small blocks one in each hand. 
¥ Will look at pictures with interest. 
¥ Will pull on a string attached to a ring to bring it closer to grab. 
             
Language skills: 
¥ Turns head and stops playing when their name is called. 
¥ Can start to identify different sounds. 
¥ Tries to get your attention using their voice. 
¥ Child will use gestures to indicate what they want e.g. point to 
something when 
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Social  and emotional skills: 
¥ Shy and nervous around strangers. 
¥ Cries when mom, dad or  a caregiver leaves them. 
¥ Has favourite toys and people.Gets scared in some situations.  
¥ Plays games e.g. hide and seek. 
You should be worried if your baby does not:  
Does not crawl. 
¥ Cannot stand with support. 
Does not search for things that fall. 
¥ Does not point to things.  
¥ Does not use gestures e.g. waving and pointing. 
¥ Does not say any words. 
Seems very floppy or very stiff. 
¥ Loses skills that they had. 
Struggling to learn to chew food. 
¥ Difficulty seeing or hearing. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist. 
*** 
!
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Things you can do to help your babyÕs development: 
! Give your child time to get to know a new caregiver. Bring a favourite toy, stuffed animal, 
or blanket along to help comfort your child.  
! In response to unwanted behaviours, say ÒnoÓ firmly. 
! Give your child lots of hugs, kisses, and praise for good behaviour. Encourage good 
behaviour. 
! Talk to your child about what youÕre doing. For example, Òmommy is washing your face 
with a cloth.Ó  
! Read to your child every day and tell them stories. 
! Build on what your child says or tries to say, or what he points to. If he points to a truck 
and says ÒtÓ or Òtruck,Ó say, ÒYes, thatÕs a big, blue truck.Ó  
! Play with blocks and other toys that encourage your child to use their hands. Offer them 
blocks by handing it to them one at a time (up to three blocks). 
! Hide small toys and other objects under a facecloth and have your child find them.  
Toys and items you can use at home: 
¥ Small wooden or plastic blocks (if you do not have blocks use a small empty match boxes). 
¥ Spoons (metal or wooden), pots and plastic containers. 
¥ CheeriosÕ cereal rounds to develop fine grasp (safe as it dissolves if swallowed- avoid 
other small objects as they are choking hazards). 
¥ Hard cover picture and story books (if you do not have a picture book use a magazine with 
bright pictures and make a picture book). 
¥ Furniture such as low coffee tables, benches, chairs and couches to pull up against and 
walk alongside. 
¥ Ball. 
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
13 -18 MONTHS 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development:  
¥ Can sit down from a standing position. 
¥ Can stand up alone from the ground. 
¥ Can walk on their own (at least by 18 months). 
¥ Can stand and throw a ball. 
¥ Can turn pages in a book. 
¥ Builds a two  block tower. 
¥ Starts to scribble on paper with a pencil or usually a 
crayon. 
Learning thinking and problem solving: 
¥ Looks for blocks in a cup/ container once they have 
been removed. 
¥ Can take blocks out of cup/ container and back them 
back in.        
¥ Can find a hidden toy under a face cloth. 
¥ Child can turn a bottle/ jar upside down to get an item 
out of the bottle/ jar. 
¥ Can push a car with all four wheels flat on the ground. 
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Language skills: 
¥ Child stops playing or what they are doing when you call his/her name. 
¥ Makes sounds like ÒgagaÓ ÒbabaÓ, ÒdadaÓ. 
¥ Uses sounds that sound like a word e.g. ÒmamaÓ, ÒdadaÓ. 
¥ Points to objects you ask him to show you. 
¥ Stops an activity when you say no-no. 
Social and emotional skills: 
¥ Likes handing objects to people as part of play. 
¥ Can have temper tantrums. 
¥ Scared of strangers. 
¥ Show affection to familiar persons. 
¥ Clings to parent when faced with new situations. 
You should be worried if your baby does not:  
¥ Does not point to things.                                                                        
¥  Does not know what familiar things are. 
¥ Very slow to walk and cannot yet walk.                                                  
¥ Does not notice or mind if parent leaves the room. 
¥ Does start to say words.                                                                        
¥  Difficulty sleeping. 
¥ Difficulty eating solid food.                                                                      
¥ Extreme fear of new people or situations. 
¥ Loses skills that he/she had. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist 
*** !
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Things you can do to help your babyÕs development: 
! At this age, children still play next to (not with) each other and donÕt share well. For play 
dates, give the children lots of toys to play with. Watch the children closely and step in if 
they fight or argue for a toy. They have not yet learnt to share. 
! Give your child attention and praise when they follow instructions. Do not pay a lot of 
attention to bad behaviour. Spend a lot more time praising good behaviours than punishing 
bad ones.  
! Do not scold your child when he says words incorrectly. Rather, say it correctly. For 
example, ÒThat is a ball.Ó  
! Encourage your child to say a word instead of pointing. If your child canÕt say the whole 
word (ÒmilkÓ), give her the first sound (ÒmÓ) to help. Over time, you can encourage your 
child to say the whole sentence Ñ ÒI want milk.Ó  
! Hide your childÕs toys around the room and let him find them.  
! Encourage your child to play with blocks. Take turns building towers and knocking them 
down.  
! Do art projects with your child using crayons, paint, and paper. Describe what your child 
makes and hang it on  
Toys and items you can use at home: 
¥ Small blocks (if you do not have blocks use a small empty match boxes). 
¥ Spoons (metal or wooden), plastic containers, pots and plastic containers. 
¥ CheeriosÕ cereal rounds are a safe item to use to develop fine grasping skills (avoid other 
small items as they pose a choking hazard). Can pack them into a container/ jar and take 
them out. 
¥ Cars and dolls. 
¥ Hard cover picture books (if you do not have a picture book use a magazine with bright 
pictures and make a picture book). 
¥ Paper and crayons or pencils. 
¥ Everyday items e.g. plastic cup, spoons, facecloth and comb. 
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¥ Shape board with circle, square and triangle. If you do not have a shape board you can 
make your own out of a thick piece of cardboard from a shop box. Cut out a square board 
and copy the shapes included at the back of the document onto the cardboard. Cut out 
matching shapes from another piece of cardboard. To make picking the pieces up easier 
stick on a plastic coke bottle lid. !
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
19 - 24 MONTH 
  
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ Can bend down from a standing position to pick up a ball on the floor. 
¥ Can climb up stairs using a hand rail, he/she puts both feet on a step before climbing 
up the next step. 
¥ Can walk by themself and is stable on their feet. 
¥ Can stand up alone, not holding onto anything.  
¥ Can hold a crayon and scribbles on paper, grasps crayon with whole hand. 
¥ Can build a two block tower. 
¥ Can pack blocks into a container, and take them out again.           
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Learning thinking and problem solving: 
¥ Able to find a completely hidden toy. 
¥ Can unscrew lid from a container/ jar that is not tightly screwed on.                 
¥ Can play with spoon, cup, and facecloth using the items correctly.  
¥ Can put at least one piece correctly in a shape board (square, circle, triangle). 
¥ Can pack blocks into a container, and take them out again. 
Language skills: 
  
¥ Can respond to, and follow a simple spoken request e.g. come here. 
¥ Identifies and names familiar items in their environment e.g. cup, ball, spoon. 
¥ Identifies and names familiar pictures in a picture book or magazine. 
¥ Understands concept like wait, my turn, and stop. 
¥ Combines words and gestures e.g. by-bye with waving, want that with pointing. 
Social  and emotional skills:  
¥ Copies adults and other children. 
¥ Enjoys being with other children. 
¥ Is more independent. 
¥ Does what he has been told not to do. 
¥ Plays beside other children rather than with 
them. 
You should be worried if your baby does not:  
¥ Does not know what to do with familiar things 
e.g. spoon.                     
¥ Does not follow up actions with words. 
¥ Cannot walk steadily on their own.                                                          
¥ Cannot follow simple instructions. 
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¥  Does not gain new words.                                                                      
¥ Difficulty sleeping. 
¥ Difficulty eating solid food.                                                                       
¥ Extreme fear of new people or situations. 
¥ Loses skills that they had. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist. 
*** !
Department of Paediatric Cardiology, University of the Free State ©
!  of !24 40
Things you can do to help your babyÕs development: 
! At this age, children still play next to (not with) each other and donÕt share well. For play 
dates, give the children lots of toys to play with. Watch the children closely and step in if 
they fight or argue.  
! Give your child attention and praise when he follows instructions. Limit attention for defiant 
behaviour. Spend a lot more time praising good behaviours than punishing bad ones.  
! Do not correct your child when he says words incorrectly. Rather, say it correctly. For 
example, ÒThat is a ball.Ó  
! Encourage your child to say a word instead of pointing. If your child canÕt say the whole 
word (ÒmilkÓ), give her the first sound (ÒmÓ) to help. Over time, you can prompt your child to 
say the whole sentence Ñ ÒI want milk.Ó  
! Hide your childÕs toys around the room and let him find them.  
! Encourage your child to play with blocks. Take turns building towers and knocking them 
down, as well as activities packing blocks into plastic cup/ container and taking them out. 
! Play games such as hide-and-seek and catches. 
! Do art projects with your child using crayons, paint, and paper. Describe what your child 
makes and hang it on the wall or refrigerator.  
Toys and items you can use at home: 
¥ Small blocks (if you do not have blocks use a small empty match boxes). 
¥ Cereal CheeriosÕ to practice fine grips- packing them into a container/ jar and taking them 
out. 
¥ Cars and cars. 
¥ Balls. 
¥ Everyday items e.g. comb, face cloth, cup, spoon etc. 
¥ Hard cover picture books (if you do not have a picture book use a magazine with bright 
pictures and make a picture book). 
¥ Paper and crayons or pencils. 
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¥ Shape board with circle, square and triangle. If you do not have a shape board you can 
make your own out of a thick piece of cardboard from a shop box. Cut out a square board 
and copy the shapes included at the back of the document onto the cardboard. Cut out 
matching shapes from another piece of cardboard. To make picking the pieces up easier 
stick on a plastic coke bottle lid. !
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
24 -36 MONTHS 
 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ Can bend down from a standing position to pick up a 
ball. 
¥ Runs with good coordination. 
¥ Can climb up- and down stairs using a hand rail. 
¥ Can take steps backwards and to the sides. 
¥ Can stand on one leg while holding on. 
¥ Can hold a crayon and scribbles on paper. 
¥ Can build a block tower with more than two blocks. 
¥  Grasps crayon with thumb, index and middle finger 
(three finger grip). 
¥ Starts to use one hand more than the other for 
activities.  
¥ Can take connecting blocks (blocks that stick /fit 
together) apart. 
Learning thinking and problem solving: 
¥  Places all three shapes in shape board (circle, square and triangle). 
¥   Can listen to a whole story in a book with attention. 
¥   Can assemble a two piece puzzle. 
¥   Can match pictures of the same thing. 
¥   Can use item in an imaginary way e.g. a ball as an apple, a block as soap. 
Language skills: 
  
¥ Can follow instructions with two steps e.g. go and fetch the ball and bring it here. 
¥ Identifies and names familiar items in the environment. 
¥ Identifies clothing items e.g. shoes, shirt, hat, socks. 
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¥ Identifies action pictures e.g. sleeping, eating, playing, and driving a car. 
¥ Knows what objects are used for. 
¥ Uses at least eight words correctly. 
¥ Can answer ÒyesÓ and ÒnoÓ. 
¥ Uses two word sentences e.g. mommy ball. 
Social  and emotional skills:  
¥ Copies adults and other children. 
¥  Shows affection towards friends. 
You should be worried if your baby does not:  
¥ Does not know what to do with familiar things e.g. spoon.                     
¥ Does not follow up actions with words and has trouble understanding. 
¥ Cannot walk steadily and climb stairs holding on.                                   
¥ Cannot follow simple instructions. 
¥ Does not gain new words or speak clearly      .                                      
¥ Poor coordination 
¥ Extreme and frequent tantrums.                                                            
¥ Loses skills that he/she had. 
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist.!
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Things you can do to help your babyÕs development: 
! Go to play groups with your child or other places where there are other children, to 
encourage getting along with other children. "
! Set rules and limits for your child, and stick to them. If your child breaks a rule, give 
him a time out for 30 seconds to 1 minute in a chair or in his room. Praise your child 
for following the rules. "
! Give your child instructions with two or three steps e.g. ÒGo to your room and get 
your shoes and hat.Ó "
! Read to your child every day. Ask your child to point to things in pictures and ask 
them to repeat words after you. Also ask them to identify objects."
! Give your child an Òactivity boxÓ with paper, crayons, colouring books or paper. 
Colour and draw lines and shapes with your child. "
! Play matching games. Ask your child to Þnd objects in books or around the house 
that are the same."
! Hold your childÕs hand going up and down stairs. When she can go up and down 
easily, encourage him/ her to use the railing. "
! Play outside with your child. Allow your child to play"
Toys  and items you can use at home: 
¥ Small blocks (if you do not have blocks use a small empty match box). 
¥ CheeriosÕ to practice small grasp. 
¥ Cars and dolls.  
¥ Balls. 
¥ Everyday items e.g. comb, face cloth, cup, spoon etc. 
¥ Hard cover picture books (if you do not have a picture book use a magazine with bright 
pictures and make a picture book). 
¥ Paper and crayons or pencils. You can even use colouring in books if available. 
¥ Connecting blocks (plastic block that stick and fit onto each other like Lego). 
¥ Shape board with circle, square and triangle. If you do not have a shape board you can 
make your own out of a thick piece of cardboard from a shop box. Cut out a square 
board and copy the shapes included at the back of the document onto the cardboard. 
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Cut out matching shapes from another piece of cardboard. To make picking the pieces 
up easier stick on a plastic coke bottle lid. 
¥ Matching pictures (cut out and stick on cardboard) or snap cards with pictures. 
¥ Two piece puzzles (cut out a circle and colour in as a ball, stick it on cardboard and cut 
into two pieces). !
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ACTIVITY GUIDELINE FOR INFANTS AND TODDLERS 
36 Ð 42 MONTHS 
WHAT BABIES SHOULD DO AT THIS AGE: 
Physical development: 
¥ Can keep their balance while kicking a ball. 
¥ Can jump off a step and jump forward when standing on the ground. 
¥ Can start walking up and down a few steps without a hand rail. 
¥ Can balance for a few seconds when standing on one leg. 
¥ Child can draw a Vertical ( | ) and a  horizontal ( __ ) line  on a paper.  
¥ Can string three blocks/ or rings on a string. 
¥ Can snip a piece of paper with a childÕs scissors and cut along a line. 
¥ Can button a big button with a large buttonhole. 
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¥ Can start tracing shapes.  
¥ Can stack six to eight blocks on top of each other or in a straight row. 
Learning thinking and problem solving: 
¥  Can match objects of the same colour e.g. red, yellow, and blue. 
¥ Can match pictures.  
¥ Can assemble a three or four piece puzzle.  
¥ Can identify items in pictures correctly. 
¥ Can use item in an imaginary way e.g. a ball as an apple, a block as soap. 
¥ Can count in order from one to ten. 
¥ Can match shapes. 
¥ Can put a shoelace through small hole. 
Language skills: 
¥  Can follow two or three step instructions e.g. fetch the ball, bring it here,             
             and put it in the basket. 
¥ Can name most familiar objects. 
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¥ Can name basic colours e.g. red, yellow, green, and blue. 
¥ Understands concepts like ÒinsideÓ, Òon topÓ and ÒunderÓ.  
¥ Uses words like ÒIÓ, ÒmeÓ, ÒweÓ and ÒyouÓ. 
¥ Uses plurals (multiples of objects) e.g. cars, cats, dogs, dolls. 
¥ Can identify action e.g. waving, riding, eating, and sleeping. 
¥ Uses two to three sentences to have a conversation, and strangers for the most part 
understand them. 
Social  and emotional skills:  
¥ Copies adults and friends. 
¥ Enjoys playing with friends more than playing alone. 
¥ Enjoys games that involve make-believe or imaginary play. 
¥ Dress and undress themself.  
¥ Separates easily from parents. 
¥ Enjoys new things.  
 
You should be worried if your baby does not:  
Cannot jump on one place.                                      
¥ Does not pretend play. 
¥ Has difficulty scribbling on a piece of paper or cutting.                                
¥ Is not interested in playing games. 
¥ Does not gain new words, and communicates poorly                               
¥ Has difficulty playing with other children and does not make friends 
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¥ Does not follow instructions with more than one step                                
¥ Does not want to get dressed, use the toilet or want to sleep, 
¥ Has trouble learning to dress and do buttons.                                           
¥ Problems learning numbers. 
¥ Over active                                                                                                  
¥ Short attention span 
¥ Loses skills that he/she had. 
      
If you noticed any of the above problems immediately tell a nurse at your local clinic, 
a doctor, physiotherapist or occupational therapist 
*** !
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Things you can do to help your babyÕs development: 
! Give your child instructions with two or three steps. For example, ÒGo to your room and 
get your shoes and coat.Ó "
! Read to your child every day. Ask your child to point to things in the pictures and repeat 
words after you. "
! Give your child an Òactivity boxÓ with paper, crayons, and colouring books. Colour and 
draw lines and shapes with your child. Practice tracing shapes and cutting along a line."
! Play matching games. Ask your child to Þnd objects in books or around the house that 
are the same."
¥ Play make-believe with your child. Let her be the leader and copy what she is doing.  
¥ Give your child simple choices whenever you can. Let your child choose what to wear, 
play, or eat for a snack. Limit choices to two or three options. 
¥ During play dates, let your child solve her own problems with friends, but be nearby to help 
out if needed.  
¥ Encourage your child to use words, share toys, and take turns playing games. 
¥ Give your child toys that encourage them to use their imagination, like dress-up clothes, 
kitchen sets, and blocks.  
¥ Use good grammar and language when speaking to your child. Instead of ÒMommy wants 
you to come here,Ó say, ÒI want you to come here.Ó  
¥ Use words like Òfirst,Ó Òsecond,Ó and ÒfinallyÓ when talking about everyday activities. This 
will help your child learn about sequence of events.  
¥ Take time to answer your childÕs ÒwhyÓ questions. If you donÕt know the answer, say ÒI donÕt 
know,Ó or help your child find the answer in a book, on the Internet, or from another adult.  
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¥ When you read with your child, ask him to tell you what happened in the story as you go.  
¥ Ask your child to identify colours in books, pictures, and things at home.  
¥ Count common items, like the number of blocks, stairs, or toys.  
¥ Teach your child to play outdoor games.  
¥ Play your childÕs favourite music and dance with your child. Take turns copying each 
otherÕs moves.  
Toys and items you can use at home 
¥ Small blocks (if you do not have blocks use a small empty match boxes). 
¥ Plastic connecter blocks.  
¥ Cars and dolls. 
¥ Balls. 
¥ Everyday items e.g. comb, face cloth, cup, spoon etc. 
¥ Hard cover picture books (if you do not have a picture book use a magazine with bright 
pictures and make a picture book) 
¥ Paper and crayons or pencils. Shape outlines to trace (see at the back). 
¥ Large pasta rounds, beads or toilet paper roll cut into pieces and a shoelace to string. 
¥ Child safe scissors to practice cutting along a line (see at the back). 
¥ Pictures to match or snap cards. 
¥ Coloured items to match in red, yellow, blue and green. 
¥ Three or four piece puzzles. !
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Shapes to make a shape board and/or 
to copy: 
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Shapes to draw between the lines: 
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Lines to cut along with a pair of scissors: 
 
!
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Lines to copy: 
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Reference documents 
Pearson. 2006. Administration manual and record form of the Bayley Scales of 
Infant and Toddler Development. Third Edition.  
Centre for Disease control and Prevention (CDC). Milestone moments. Learn 
the signs. Act early [available online].
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STEP 2: CHILD UNDERGOES CARDIAC INTERVENTION 
STEP 4: FOLLOW- UP AND EVALUATION EFFECTIVENESS OF THE PROGRAMME 
· Send weekly text message reminders to parents to adhere to the home-based activity 
programme. 
· Phone parents at least  every second week at the initiation of programme implementation 
to answer any questions and update activities. Encourage parents to phone the therapist 
if they have any questions regarding the programme. Later,monthly follow-up  is advised. 
· The frequency of  formal follow-up visits with the therapist will be determined by  the 
developmental status of the child.  
· Developmental re-evaluation is to be scheduled to coincide with cardiology follow-up or 
other hospital appointments (where possible at three-monthly intervals).   
· Suggested follow-up timeframes for formal assessment of at-risk children: during the first 
year, again between three and five years, at school entry, again at middle school and 
during adolescence. 
STEP 3: EDUCATION AND TRAINING SESSION BEFORE DISCHARGE 
· Parents to attend a two-hour education and information session where the home-based 
developmental activity programme is initiated in line with the childs developmental 
assessment findings. Parents to be issued a logbook to monitor  and encourage 
participation. Demonstration of  developmental activities where indicated.  
· Allow time for questions and encourage adherence. Clearly explain the  principles to be 
applied with activity prescription, including the frequency, intensity and time (duration).  
· Reaffirm precautions and activity limitations, provide clear time-frames for their 
application.  
· Refer parents to support group (arrange for additional psychological support if required) 
 
STEP 1: CHILD ADMITTED FOR CARDIAC INTERVENTION  
· Establish a collaborative relationship with family 
· Initial developmental  assessment of child (if possible),  anddetermination of parental 
stress  and perceived HRQOL  of the child.  
· Issue information document and explain post-operative precautions  
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APPENDIX XXIII 
TURNITIN ORIGINALITY REPORT 
 
 
The thesis was run through Turnitin software to determine the level of similarity in 
the research document. The digital receipt of the submission of the document from 
Turnitin and the page indicating the percentage similarity have been included in the 
Appendices. The entire Turnitin report runs to 400 pages and has therefore on been 
included in the hard copy of the thesis. The complete report has been include in the 
electronic format on the CD copy of the thesis should one wish to access the full report.  
 
 
  
 
 
  
 
 
 
